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The purpose of this cross-sectional, retrospective, descriptive study was to 
characterize frailty in hospitalized adults 55 years of age and older admitted to medical 
units at one large academic medical center during a 15-month time frame and determine 
if level of frailty on admission predicted length of stay (LOS) and 30-day readmission. 
Frailty is a syndrome characterized by multisystem physiologic dysregulation due to 
intrinsic and extrinsic stressors resulting in decreased compensatory reserve and ability to 
effectively respond to destabilizing health events. Stressors associated with 
hospitalization may increase risk for frailty or accelerate its development. Frailty is a 
significant concern as it is associated with morbidity, functional decline, long LOS, 
readmission, institutionalization, and mortality. There is scant research on frailty in 
acutely-ill hospitalized adults, especially those ≥ 65 years of age. Understanding frailty in 
this population is imperative because frailty is potentially preventable, treatable, and 
reversible. Frailty was operationalized as 14 evidence-based frailty components defined 
by 26 indicator variables. Frailty components were Nutrition, Weakness, Fatigue, 
Chronic Pain, Dyspnea, Falls, Vision, Depression, Cognition, Social Support, low 
Hemoglobin, low Albumin, high C-reactive protein (CRP) or hs-CRP, and abnormal 
WBC count. Each frailty component was scored as one p int if at least one indicator 
variable was present on admission, and summed to derive a Frailty Score, where a higher 
Frailty Score suggests greater level of frailty (range, 0 to 14). Sociodemographic, clinical, 
and laboratory data were retrieved from the electronic medical record through web-based 
data query tools and record review (N = 278). Mean age was 70.2 (SD = 1.3; range, 55–
98), slightly over half were female, 64% were White, one-third were Black. The mean 
comorbidity count was 13 (SD = 4.56; range. 1–26) and medication count was 12 (SD = 
5.2; range, 0–31). The most prevalent frailty components (> 81%) were Fatigue, 
Weakness, Nutrition, Hemoglobin, Albumin, and CRP or hs-CRP. The mean Frailty 
Score was 9.03 (SD = 1.98; range, 2–13). Multiple linear regression was performed with 
20 predictor variables and the Frailty Score and then with 14 of the 20 predictor variables 
that were significant in bivariate linear regression with the Frailty Score using the 
ENTER and STEPWISE method. All multiple regression models yielded seven 
significant predictor variables. Six predictors were common to all models: comorbidity, 
acute pain, ADL assistance, urinary incontinence, Braden Scale score, current tobacco 
use. In multiple regression with 20 predictors, agewas a significant predictor however in 
multiple regression using ENTER and STEPWISE for 14 predictors, female gender was 
significant but not age. Results from STEPWISE regression yielded seven significant 
predictors that explained 27% of the variance in the Frailty Score (adj. R2 = .266, df (14, 
263), F = 8.163, p = .000). Mean LOS was 9.92 days (SD = 9.58; range, 1–72; median, 7; 
mode, 5). Simple linear regression for the Frailty Score and log10 transformed LOS was 
statistically significant (adj. R2 = .090, df (1, 276), F = 29.293, p = .000). Twelve percent 
experienced 30-day readmission. Logistic regression conducted for the Frailty Score and 
30-day readmission was not statistically significant (X 2 = 4.121, df (5), p = .532; β 
coefficient = .100, df (1), 95% CI = .913–1.1337, p = .307). The Frailty Score 
characterized this hospitalized population as acutely ill with high comorbidity, symptom 
burden, nutrition deficits and evidence of physiologic vulnerability and inflammation. 
Study findings have implications for nursing practice, interdisciplinary collaboration, 
education, research, and public policy. 
Key words:  frailty, stress, hospitalization, eldery, middle-aged, C-reactive 
protein, Braden Scale 
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CHAPTER I 
 
INTRODUCTION 
 
 
Overview 
 
Frailty is an important concept in care of the elderly. Frailty is a clinical condition 
that presents in atypical and non-specific manifestations that transcend disease categories, 
functional impairment, and disability (Fried, Ferrucci, Darer, Williamson, & Anderson, 
2004). The terms frail and frailty have appeared in various types of literature since 
ancient times but it was not until the 1980s when frailty was acknowledged in the 
medical community and in scientific and popular publications (Hogan, MacKnight, & 
Bergman, 2003; Nash, 2008). Frailty was described as a multifactorial state of decline 
related to old age, disease, weakness, decline in cog itive and physical function, weight 
loss, and social isolation (Burnside, 1990, Ferrucci, Mahallati, & Simonsick, 2006; Fillit 
& Butler, 2009; Hogan et al., 2003; Phillipson, 200). Prior to 1995, there were no 
publications indexed in MEDLINE for the MeSH terms frail or frailty (Nash, 2008).  
Frailty is an enigmatic condition since it is not alw ys visibly apparent thus the 
boundary between frail and nonfrail state is blurred (Bergman et al., 2007; Gealey, 1997; 
Grenier, 2002; Levers, Estabrooks, & Ross-Kerr, 2006; Markle-Reid & Browne, 2003). 
Although comorbidity, functional impairment, disability, and clinical features such as 
low body weight, muscle atrophy, weakness, fatigue, slow gait, poor balance, falls, and 
cognitive impairment are associated with frailty, frailty can be present without obvious 
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deficits. Therefore, frailty presents a complex clini al picture with a wide spectrum of 
ambiguous signs and symptoms and clinical manifestations. 
Frailty is a significant concern among health care providers and researchers 
because there are no common diagnostic criteria, assessment methodologies, or evidence-
based prevention and treatment guidelines (Bergman et l., 2007; Ensrud et al., 2007, 
2008; Fried, Tangen, et al., 2001; Fried et al., 2005; Weiss, 2011). Frailty is associated 
with unanticipated complications that arise from intrinsic and extrinsic stressors such as 
acute illness, chronic disease exacerbation, adverse events (e.g., falls, infection, delirium, 
pain, malnutrition, dehydration, functional decline, pressure ulcers), diagnostic 
procedures, surgery, and pharmacologic and medical treatment (Afilalo et al., 2010; I. 
Brown, Renwick, & Raphael, 1995; Fried, Tangen, et al., 2001; Fulop et al., 2010; 
Gobbens, Luijkx, Wijnen-Sponselee, & Schols, 2010c; Hadley, Ory, Suzman, Weindruch 
& Fried, 1993; Hogan, 2006; P. O. Lang, Michel, & Zekry, 2009; Nowak & Hubbard, 
2009; Walston et al., 2006). There has been increased ttention to frailty because it is 
significantly associated with morbidity, debilitating symptoms, functional decline, 
disability, dependence, falls, institutionalization, a d shortened life span, yet there are 
ways to reduce the burden of this condition (Abellan v n Kan et al., 2010; Ahmed, 
Mandel, & Fain, 2007; Buchman, Wilson, Bienias, & Bennett, 2009; Karunananthn, 
Wolfson, Bergman, Béland, & Hogan, 2009; Levers et al., 2006; Markle-Reid & Browne, 
2003; National Institute on Aging, 1991; Strandberg & Pitkälä, 2007). 
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Features of Frailty 
Current research indicates that frailty is a distinct clinical condition that increases 
with age but is neither a universal nor inevitable correlate of aging. However, frailty lacks 
specific, objectively identifiable and measurable indicators that are different from normal 
age–related changes and pathologic processes associated with disease. There is limited 
evidence about its antecedents, risk factors, precursor or subclinical conditions, 
pathogenesis, genetic or epigenetic contributors, and other possible correlates (Ahmed et 
al., 2007; Bergman et al., 2007; Lally & Crome, 2007). Frailty is characterized as a 
multidimensional clinical syndrome and non-specific state in which there are no 
individual or groups of etiologies identified that cause or facilitate its development 
(Ahmed et al., 2007; Inouye, Studenski, Tinetti, & Kuchel, 2007; Xue, 2011). There is no 
empirical evidence for a biologic or clinical marke, medical diagnosis, sign or symptom 
presentation, diagnostic test, or performance measur  that defines frailty (Bergman et al., 
2007; Fulop et al., 2010; Xue, 2011). Frailty is enigmatic and often not observable, 
evolves sub-clinically in those who appear healthy, dynamic and heterogeneous in its 
manifestations, and may remain undetected until an intri sic or extrinsic stressor 
overcomes physiologic compensatory mechanisms that promote homeostasis (Ahmed et 
al., 2007, Bergman et al., 2007; Bortz, 2002; McEwen & Wingfield, 2010; Studenski et 
al., 2004; Yang & Lee, 2010). During the aging process, multiple neurohormonal 
mechanisms maintain homeostasis in the context of global diminishing biologic function 
and chronic exposure to stressors. Frailty becomes clinically apparent when physiologic 
processes and cellular functions are disrupted by the impact of interactions between 
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disease conditions, lifestyle behaviors, acute and chronic psychosocial stressors, and 
adverse environmental exposures (Ahmed et al., 2007; Glei, Goldman, Chang, & 
Weinstein, 2007; Xue, 2011). 
Early theories of frailty suggest that physiologic vulnerability is an individual trait 
but recent research suggests that interactions between normal biological aging changes, 
pathophysiologic processes, acute and chronic disease, and psychosocial and 
environmental factors are influential (Fedarko, 2011; Yang & Lee, 2010). Data from the 
Health and Retirement Study found substantial heterogeneity in the rate of biologic aging 
and accumulation of diseases, disabilities, and other deficits which suggests that multiple 
interacting factors contribute to frailty (Mitniski, Graham, Mogilner, & Rockwood, 2002; 
Mitniski, Song, & Rockwood, 2004). Development of frailty is not a linear process that is 
readily explained by age, disease, or disability. Risk for frailty may be related to loss of 
complexity in dynamic biologic processes that consta tly make adjustments through 
highly integrated interactions of chemical mediators across multiple body systems that 
promote biologic function and homeostasis (Fried et al., 2009; Lipsitz, 2004; Lipsitz & 
Goldberger, 1992). 
The natural history of frailty is unclear, but two patterns are described. The first 
pattern describes frailty as an insidious, covert process whereas the second pattern 
describes frailty is a subjectively observable and clinically apparent state. In the first 
description, non-specific, subclinical changes occur early in the development of frailty. 
Incremental deterioration in multiple body systems leads to decline in function and ability 
to effectively respond to and recover from intrinsic and extrinsic stressors. Over time, an 
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increasingly fragile homeostasis is acquiescent until a  acute decompensating health 
event occurs resulting in worse than expected responses and outcomes (Ahmed et al., 
2007; Bandinelli, Corsi, Milaneschi, & Vazzana, 2010; Bortz, 2002; Studenski et al., 
2004). Frailty is associated with failure of functional homeostasis or the capacity to 
appropriately respond to stressors (E. Carlson et al., 1998). 
In the second description, frailty advances as an ambiguous and poorly 
differentiated decline in various physiologic systems. Clinical manifestations emerge but 
often are not directly traceable to a specific disease. Whitson, Purser, and Cohen (2007) 
similarly characterized two types of frailty: physiologic frailty or Ph-frailty and full 
frailty or F-frailty. Ph-frailty portrayed a state of physiologic vulnerability with preserved 
physical and cognitive function, whereas F-frailty portrayed full-blown functional frailty, 
with observable and measurable clinical signs. F-frailty can be accompanied by 
functional limitations that reflect the interacting effects of normal aging, acute illness, 
chronic disease, medications, and psychological, social, and environmental factors. 
Features of these two types of frailty may overlap, reflecting a dynamic continuum of 
physiologic stability and instability. These portrayals broaden understanding of frailty as 
a condition that is distinct from morbidity and precedes disability in its early inception in 
some clinical situations (Whitson et al., 2007). Clinicians often rely on subjective 
assessment and clinical judgment to identify frailty, however, in risk assessment and 
clinical decision-making about medical or surgical treatment, subjective assessment may 
miss identifying individuals who are frail, since objective indicators would not be 
apparent (Bergman et al., 2007; Studenski et al., 2004). Consequently, unexpected 
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adverse events and poor outcomes are more likely occur due to the lack of opportunity to 
initiate protective or preventive strategies. 
Hospitalization and Frailty 
Hospitalization is common in adults as they age. It is estimated that 40% of 
inpatient beds and 60% of critical care beds are occupied by persons over 65 years of age 
(Fulmer et al., 2002; Hall, DeFrances, Williams, Golonsky, & Schwartzman, 2010). 
Greater hospital rates in older adults is associated with higher rates of acute illness and 
chronic disease exacerbation, falls, trauma, surgery, adverse medication effects, and 
changes in cognition and physical function (Heppenstall, Hanger, & Wilkinson, 2009; 
Lichtenberg, MacNeill, Lysack, Bank, & Neufeld, 2003; Campbell, Seymour, & 
Primrose, 2004). Research is sparse on frailty in acutely ill hospitalized adults. However, 
existing evidence indicates that hospitalized older adults who are frail experience worse 
outcomes compared to persons who are not frail (Afialo et al., 2012; Anpalahan & 
Gibson, 2007; Boyd, Xue, Simpson, Guralnik, & Fried, 2005; C. J. Brown, Williams, 
Woodby, Davis, & Allman, 2007; Callen, Mahoney, Wells, Enloe, & Hughes, 2004). 
Substantial literature describes the deleterious effects of hospitalization in older 
adults (Creditor, 1993; Lafont et al., 2011; Lefebvre et al., 1992; Mitty, 2010). 
Hospitalization can lead to profound negative consequences beyond factors related to the 
reason for hospitalization. Hazards of hospitalization are well-documented: falls, injury, 
infection, delirium, dehydration, malnutrition, pressure ulcers, functional decline, 
prolonged recovery, new or worsening dependence, and mortality (T. M. Gill, 2010; T. 
M. Gill, Gahbauer, Han, & Allore, 2011; Hoogerduijn, Schuurmans, Duijnstee, de Rooij, 
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& Grypdonck, 2007; de Saint-Hubert, Jamart, Boland, Swine, & Cornette, 2010). 
Importantly, functional decline may be integral in the development of frailty or influence 
its progression. Functional decline associated withacute illness or hospitalization in 
otherwise healthy, vigorous persons with or without chronic disease is more likely to be 
temporary with lower risk for irreversible functional decline, new dependence, and 
disability. The indeterminate clinical presentation of frailty suggests that frailty has a 
complex underlying pathogenesis that may be distinctly different from functional decline 
(Boltz, Resnick, Capezuti, Shuluk, & Secic, 2012; Callen, Mahoney, Grieves, Wells, & 
Enloe, 2004; Callen, Mahoney, Wells, Enloe, & Hughes, 2004; K. E. Covinsky et al., 
2003; K. E. Covinsky,  Pierluissi,  & Johnston,  2011; Zisberg et al., 2011). However, 
frailty and functional decline are often inextricably linked as an etiologic factor, outcome, 
or correlate, thus attention to functional decline i  hospitalized adults is crucial. 
Purpose 
The purpose of this cross-sectional, retrospective, descriptive study was to 
characterize frailty in hospitalized adults 55 years of age and older admitted to general 
medicine, cardiology, or orthopedic services at one large academic medical center during 
a 15-month time frame and to determine if level of frailty on admission predicted hospital 
length of stay (LOS) and 30-day readmission. Understanding frailty in this population is 
imperative because frailty is potentially preventable, treatable, and reversible. 
The conceptual framework for the study utilized the biological-psychological-
social-spiritual (BPSS) model and stress theory to explore frailty as a multidimensional, 
multifactorial construct with dynamic interactions between the BPSS domains and 
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intrinsic and extrinsic stressors that impacts physiologic compensatory reserve and risk 
for frailty and adverse outcomes. Fourteen theory- and evidence-based frailty 
components were operationally defined for the study based on the conceptual model and 
data available from the electronic medical record (EMR). Frailty components included 
demographic, clinical, and laboratory data that included four plasma biomarkers 
empirically associated with inflammation, malnutrition, and frailty. 
Background 
Historical Trends and Landmark Studies 
Heightened interest in frailty began in the 1970s as a result of demographic 
changes reflected in increased longevity and increasing numbers of older adults with 
multiple morbidity, functional limitations, disability, and cognitive impairment that led to 
higher utilization of emergency departments and increased hospitalizations (Butler, 1969; 
Vellas, Cestac, & Moley, 2012). Geriatrics was recognized as a specialty in medicine, 
nursing, and the social sciences which led to reseach  that investigated biomedical and 
psychosocial aspects of aging and how to best care for an aging population (Bergman et 
al., 2007; Burnside, 1990; Gealey, 1997; Karunananthan et al., 2009; Levers et al., 2006; 
Markle-Reid & Browne, 2003; Vellas et al., 2012). Later interest in frailty was influenced 
by growing research on the physiology of aging or senescence, normal aging processes, 
differentiation of normal aging from disease and disab lity, atypical illness presentation, 
geriatric syndromes, comprehensive geriatric assessm nt, and interdisciplinary models 
for care (Isaks & Westendorp, 2003; Jarrett, Rockwood, Carver, Stolee, & Cosway, 1995; 
Palmore, 1977; Rockwood, Fox, Stolee, Robertson, & Beattie, 1994; Rockwood & 
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Hubbard, 2004; Rockwood & Mitnitski, 2007). Conventio al stereotypes of growing old 
and being old were challenged and increasing heterogeneity among older adults was 
recognized, which spurred change in care delivery, health professional education, and 
public policy (Burnside & Touhy, 2006; Butler, 1969; Fillit & Butler, 2009; Lefevre et 
al., 1992; Matteson & McConnell, 1985; Institute of Medicine [IOM], 1991, 2008; 
Palmore, 1977; Vellas et al., 2012). Researchers and cli icians identified a subgroup of 
older adults portrayed as frail, a condition distinctly different from comorbidity and 
disability. 
One of the first definitions of frailty was proposed by Brocklehurst (1985) who 
defined frailty as the breakdown of a dynamic balance between biomedical and social 
components due to decline in physiologic function and reduced reserve capacity that 
accelerates organ system deterioration, a cascade of health problems, and death.  Since 
then, many definitions of frailty were proposed. National consensus conferences and 
professional geriatric organizations stimulated debat  about frailty and frailty research 
advanced considerably. The general trend in frailty research and clinical practice was to 
define frailty according various indicators that included age, physical and cognitive 
function, activities of daily living (ADL) performance, disability status, comorbidity, and 
subjective appearance of weakness, feebleness, low body weight, and poor resilience. 
In the 1980s and 1990s, early investigations of frailty proposed that frailty was a 
state of health in older adults with comorbidity and disability, and among the oldest-old 
(Burnside, 1990). Frailty was a state of physical and mental debilitation and functional 
impairment requiring substantial assistance from others for personal care, activities of 
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daily living (ADL), and social support in managing daily life (Gillick, 1989; Hadley et 
al., 1993; Shapiro & Tate, 1985; Tenntedst &McKinley, 1994; Woodhouse, Wynn, 
Baillie, James, & Rawlins, 1988). Having multiple biologic, physiologic, psychologic, 
and social deficits or impairments was considered salient as these contributed to 
dependence and adverse outcomes including worse disability, institutionalization, and 
mortality (Rockwood, Fox, Stolee, Robertson, & Beatti , 1994; Strawbridge, Shema, 
Balfour, Higby, & Kaplan, 1998; Winograd et al., 1991). Early frailty definitions 
included measures for physical function, nutrition, sensory ability, comorbidity, 
symptoms, medication, and others (Hamerman, 1999; Heuberger 2011). Some early 
definitions considered cognitive impairment a central feature of frailty (Burnside, 1990; 
M. Collins & Abeles, 1996; McDougall & Balyer, 1998; Parmelee, Lawton, & Katz, 
1998; Tennstedt & McKinlay, 1994). 
As research advanced, two major frailty perspectives emerged. The first 
perspective defined frailty as a uni-dimensional construct based on a biologic model for a 
frailty phenotype. The second model defined frailty as a multidimensional, multifactorial 
condition where frailty was the manifestation of the accumulation of deficits in 
biopsychosocial function and other factors, where the accrual of increasing numbers of 
deficits of any type over time increased risk for frailty, disability, and mortality. Both 
frameworks differentiated a subgroup of older adults as frail and at high risk for 
deleterious health events, poor recovery, and adverse outcomes. Other definitions of 
frailty in the literature vary widely and include any number of biopsychosocial and 
clinical or laboratory components. 
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Frailty phenotype. The first landmark study on frailty in the U.S. was conducted 
by the Cardiovascular Health Study (CHS) Collaborative Research Group (Fried, Tangen, 
et al., 2001) where frailty was defined as a syndrome based on a uni-dimensional biologic 
model for a frailty phenotype. Frailty was characteriz d by decreased compensatory 
reserve and poor resistance to stressors resulting in cumulative decline in cellular and 
organ function. Progressive physiologic breakdown across multiple organ systems leads 
to global physiologic dysregulation, increased vulnerability, ineffective response to 
stressors, and high risk for frailty and adverse outc mes (Fried, Tangen, et al., 2001). 
The frailty phenotype is based on the premise that underlying physiologic 
disturbances manifest in integrated biologic and functional impairments. The CHS 
definition of frailty, often referred to as the Fried Frailty Index, included five domains 
and operational  criteria: nutrition (unplanned weight loss of 15 pounds in past six 
months), energy (self-report of exhaustion, fatigue), physical activity (self-report of 
leisure time activity questionnaire); mobility (gait speed, timed four meter walk), and 
weakness (hand grip strength using dynamometer). According to the frailty phenotype, 
having three of the five criteria suggested a frail state, one or two criteria, an intermediate 
or pre-frail state, and no criteria, a robust, nonfrail state. The CHS frailty definition was 
validated in the CHS cohort of community-living older adults (N = 5,317, ≥ 65 years; 
Fried, Tangen, et al., 2001). The frailty criteria theoretically relate to a cycle of frailty 
that reflects declining physiologic complexity, energ tics, compensatory reserve, and 
homeostasis. The Fried Frailty Index has been validated in numerous epidemiologic and 
cohort studies although exact replication of the fiv criteria has been inconsistent. 
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Research has expanded the Fried Frailty Index to include biopsychosocial constructs such 
as cognition, mood, social function, aerobic capacity, insomnia, nutrition, and 
physiologic biomarkers to improve sensitivity in case-finding and prediction of outcomes 
(Afilalo, Karunananthan, Eisenberg, Alexander, & Bergman, 2009; Afilalo, et al., 2012; 
Ávila-Funes et al., 2008; Bartali et al., 2006; Boxer, Wang, Walsch, Hager, & Kenny, 
2008; Cawthon et al., 2007; Gobbens, Luijkx, Wijnen-Sponselee, & Schols, 2010a, 
2010b; Gobbens et al., 2010c; Gruenewald, Seeman, Karlamangla, & Sarkesian, 2009; 
Rothman, Leo-Summers, & Gill, 2008; Vaz Fragoso, Gahbauer, Van Ness, & Gill, 2009). 
The Fried Frailty Index is a parsimonious tool with good psychometric properties in 
community populations and is relevant in clinical practice and research. 
Deficit accumulation. The second framework was advanced by Rockwood and 
others (1994) who proposed the concept of deficit accumulation based on Brocklehurst’s 
(1985) conception of frailty as a model of breakdown. A balance between biological and 
psychosocial components represents complex, dynamic interactions that affect 
independence and function. When intrinsic and extrinsic disturbances create an 
imbalance among these components, breakdown in the functioning of integrated body 
systems ensues leading to biopsychosocial dysfunction (Rockwood et al., 1994). 
According to this model, assets and deficits interact dynamically and can create 
instability. Even a small deficit can tip the balance and compromise the ability to live 
independently (Rockwood et al., 1994). An excess of deficits creates imbalance that leads 
to breakdown in multiple body and social systems and greater risk for frailty. 
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The deficit accumulation model has been tested in population-based studies using 
deficit counts of 20 to 90 (R. R. Cohen et al., 2012; Hastings, Purser, Johnson, Sloane, & 
Whitson, 2008; Kulminski et al., 2007; Mitniski, Graham, et al., 2002; Rockwood , 
Hogan, & MacKnight, 2000; Rockwood et al., 2004, 2005; Rockwood, Song, & 
Mitnitski, 2011). The accumulation of any type of deficit created a physiologic burden. 
Individual deficits were not weighted however mathematical models were used to 
compute risk for disability, mortality, and level of frailty. This model is limited in 
determining frailty prevalence and translating data in o practical approaches for clinical 
care. However, the deficit accumulation framework has been widely used in public policy 
and administrative sectors to assess population frailty to project and analyze resource 
needs, utilization, and costs. The deficit accumulation framework has included different 
numbers and types of deficits, incorporated comprehensive geriatric assessment and 
performance measures, and utilized simpler mathematical computations to assess frailty 
trajectories and outcomes in populations (Jones, Song, Mitniski, & Rockwood, 2005). 
More recent research has adopted a multidimensional approach in defining frailty. 
Some frailty definitions incorporate elements of the frailty phenotype, deficit 
accumulation, biopsychosocial-spiritual and environme tal factors and physiologic 
biomarkers. As a result, there is considerable divers ty in frailty definitions, 
measurement, and study design. Cross-comparison studie  where different frailty 
definitions were applied in a single study population report inconsistent results in frailty 
characterization, prevalence, and outcomes. 
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International conferences and expert panels that aimed to develop a consensus 
definition of frailty have not endorsed a frailty definition for use in clinical practice, 
research, and for administrative and public policy purposes. More recently, the Frailty 
Operative Definition-Consensus Conference Project reached agreement on six domains 
for frailty assessment: physical performance, gait speed, mobility, nutritional status, 
mental health, cognition, and biomarkers (Rodríguez-Mañas et al., 2012). However, an 
operational definition for key indicators of frailty was not specified. The I.A.N.A. Task 
Force and other groups recommend development of frailty screening tools that are 
quickly and easily administered in general practice and more detailed comprehensive 
assessment for at risk, high risk, and frail subgroups (Abellan van Kan, Rolland, 
Bergman, et al., 2008). There is agreement that assessment instruments will need to be 
designed based on the purpose, provider goals and objectives, characteristics of the 
sample and setting, and how the information will be us d. Some frailty assessment 
instruments are more appropriate for research (e.g., Fried Frailty Index), for 
administrative and public health (e.g., deficit accumulation framework), and for clinical 
practice (e.g., FRAIL scale or single performance measure such as gait speed). 
Frailty Representation 
Clinical Features 
Frailty is a dynamic process described as fluctuations in homeostasis and shifting 
levels of vulnerability in response to intrinsic and extrinsic stressors (A. J. Campbell & 
Buchner, 1997; Slaets, 2006). Minor stressors that would be unlikely to provoke 
significant adverse sequela in healthy older persons with or without morbidity incite 
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acute biologic instability that precipitates a downward clinical trajectory in persons who 
are frail or are highly vulnerable (Ahmed et al., 2007; A. J. Campbell & Buchner, 1997; 
Fried Tangen, et al., 2001; Morley, Haren, Rolland, & Kim, 2006). Frailty is a complex 
condition that defies traditional biomedical diagnostic approaches (Cesari, 2011b). 
Clinical manifestations are ambiguous and present as a constellation of seemingly 
unrelated signs and symptoms which vary considerably mong individuals. Thus, 
determination of frailty is by exclusion of other definable medical diagnoses (Cesari, 
2011b; Gobbens et al., 2010a, 2010c; Gobbens, van Assen, Luijkx, & Wijnen-Sponselee, 
2010; Levers et al., 2006; Morley et al., 2006; Yang & Lee, 2010). 
Common clinical indicators of frailty are muscle wasting (sarcopenia), fatigue,  
weakness, exhaustion, poor endurance, low physical activity level, poor balance, 
abnormal gait, slow gait speed, falls, poor appetite or anorexia, malnutrition, weight loss, 
cachexia, cognitive impairment, depression, and delirium (Bergman et al., 2007; Fried, 
Tangen, et al., 2001; Hogan, 2006; Rockwood, 2005). Metabolic indicators include 
decreased bone mineral density, reduced lean muscle mass and quality, low serum 
cholesterol and hemoglobin level, elevated creatinine level, reduced insulin sensitivity, 
coagulation and immune system dysfunction, increased levels of serum inflammatory 
biomarkers such as C-reactive protein (CRP) or hs-CRP, white blood cell count (WBC), 
interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNFα; De Martinis, Franceschi, 
Monti, & Ginaldi, 2006; Ershler, 2003; Ferrucci et al., 1999; Leng, Chaves, Koenig, & 
Walston, 2002; Sipe, 1995; Tak, Bakker, Slaet, & Rosmalen, 2009; Visser et al., 2005; 
Walston et al., 2002, 2006). Frailty is not always observable, thus differentiating persons 
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who are frail from those who are fit and robust is challenging and unreliable in clinical 
practice (Bergman et al., 2007). Examination of biomarkers as physiologic indicators of 
frailty may improve detection of subclinical vulnerability, risk status, and level of frailty. 
Natural History 
Research has yet to validate etiologies of frailty, definitive predictors, or a 
typology based on different causal pathways. Frailty is often described as a progressive 
condition that follows an intractable, irreversible course, but longitudinal research 
indicates that frailty demonstrates a dynamic trajectory where level of frailty fluctuates 
under variable conditions  with transitions between higher and lower levels of frailty 
(Buchman et al., 2009; Cesari, 2011b; T. M. Gill, Gahbauer, Allore, & Han, 2006; Puts, 
Lips, & Deeg, 2005a). 
The incidence, prevalence, and severity of frailty increase with advancing age. 
Frailty has been viewed as a geriatric condition, thus the majority of research has been 
conducted in those who are older than 65 or 70 years of age. Advanced age is not a 
prerequisite or reliable predictor of frailty since many older adults are not frail (Ahmed et 
al., 2007; Fried, Tangen, et al., 2001; Heppenstall e  al., 2009). Aging is associated with 
asynchronous, usually asymptomatic, incremental decline in structure and function of 
cells, organs, and systems that is accelerated by low levels of physical activity and poor 
nutrition (Bortz, 1993, 2002; Heuberger, 2011). Frailty has been proposed as an 
aberration of the aging process that is influenced by lifestyle habits, genes, and other 
factors (Bortz, 1989, 1993). 
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In the Cardiovascular Health Study, the prevalence of frailty was 3.2% in the 65 
to 70 year old age group, 5.3% in the 71 to 74 yearold age group, and 9.5% in the 75 to 
79 year old age group (Fried, Tangen, et al., 2001). Several studies have examined frailty 
in middle-aged adults. In the Canadian Health and Aging Study (N = 14,713), the 
prevalence of frailty was 2% in those ≤ 30 years of age, 22.4% in those ≤ 65 years, and 
43.7% in those ≥ 85 years (Rockwood et al., 2011). At all ages, the 160-month mortality 
rate was lower among those who were fit compared to those who were frail: 2% versus 
16% at 40 years of age; 42% versus 83% at 75 years or older, respectively (Rockwood et 
al., 2011). Santos-Eggimann, Cuénoud, Spagnoli, and Ju od (2009) assessed frailty 
(using the Fried Frailty Index) in adults from 10 European countries (N = 18,227) where 
3.4-4.7% in the 55 to 64 year old age group and 15.3% to 18.7% in the 65 years of age  
and older group were frail. Alvarado, Zunzuneui, and Béland (2008) assessed frailty in 
adults age 60 years and older (N = 10,661) using a modified Fried Frailty Index in seven 
Latin American and Caribbean cities. Frailty prevalnce was not reported but frailty was 
demonstrated at all ages. 
Pathogenesis of Frailty 
Aging, inflammation, and frailty. Chronic, low-grade inflammation is important 
in the pathogenesis of frailty. Aging and frailty are both associated with a pro-
inflammatory state and chronic inflammation (S. S. Chang, Weiss, Xue, & Fried, 2012; 
McDermid, Stelfox, & Bagshaw, 2011; Yao, Li, & Leng, 2011). Aging is characterized 
by a chronic, low-grade inflammatory state, termed inflamm-ageing, which is influenced 
by genetics, exposure to infectious agents and lifelong antigenic load (De Martinis et al., 
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2006; Franceschi et al., 2000). Balance between anti-inflammatory and pro-inflammatory 
processes that are protective in younger years are compromised with advancing age, 
leading to a pro-inflammatory state (McDermid et al., 2011). Inflamm-ageing and a 
dysregulated pro-inflammatory state is strongly affected by stressors (De Martinis et al., 
2006; Ferrucci et al., 2002; Franceschi et al., 2000). 
Aging is accompanied by a two- to four-fold increas in circulating levels of 
inflammatory mediators (Krabbe, Pederson, & Bruunsgaard, 2004). Activation of 
inflammatory pathways is recognized by increased levels of IL-6 and its metabolite CRP, 
albumin, and WBCs (H. J. Cohen, Harris, & Pieper, 2003). Persistent dysregulation of 
physiologic systems due to chronic inflammation leads to altered levels of circulating 
biomarkers (Ferrucci et al., 2002; Gruenewald et al., 2009) and adverse consequences 
such as poor physical function, survival, and frailty (Rønning et al., 2010). 
Frailty, inflammation, and stress. The relationships between frailty, age, 
inflammation, and chronic stress is an important area of research because mechanisms 
that provoke organ and cellular damage that leads to physiologic decline found in aging 
and frailty are poorly understood (H. J. Cohen et al., 2003; De Martinis et al., 2006; 
Kanapura & Ershler, 2009; Leng, Xue, Tian, Walston, & Fried, 2007). Frailty is 
significantly associated with chronic systemic low-grade inflammation (Cesari et al., 
2004; H. J. Cohen et al., 2003; Phan, Alpert, & Fain, 2008; Puts, Visser, Twisk, Deeg, & 
Lips, 2005; Tracy, 2003; Walston et al., 2002). Low-grade chronic systemic 
inflammation may be responsible for functional decline in the elderly from the lifelong 
antigenic burden of inflamm-ageing (De Martinis et al., 2006). Theories on the role of 
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inflammation in the development of frailty suggest that inflammation serves as a causal 
mechanism, a compensatory response to infectious disease, or a marker of 
pathophysiologic processes such as oxidative stress that leads to physiologic 
abnormalities (Hubbard & Woodhouse, 2010). Inflammation has been describes as part 
of the driving force toward frailty (Hubbard & Woodhouse, 2010). 
Research indicates that detrimental effects of chronic stress precipitate 
maladaptive inflammatory responses that contribute to illness, disease, and frailty 
(Hubbard & Woodhouse, 2010; McEwen, 1993; Xue, 2011). Complex psychobiological 
mechanisms underlie physiologic responses to stressors that affect the immune, 
endocrine, hematologic, and coagulation systems resulting in chronic inflammation 
(Glaser & Kiecolt-Glaser, 2005; McEwen & Wingfield, 2010; Puts et al., 2005; Steptoe, 
Hamer, & Chida, 2007; Walston et al., 2002; Yao et al., 2011). The long term effect of 
low-grade chronic inflammation creates widespread systemic disruption in homeostasis 
and aberrant allostasis mechanisms. The cumulative damage from chronic inflammation 
leads to loss of cellular and organ function and system redundancies that are needed to 
activate physiologic processes for managing stressos (Abellan van Kan, Rolland, 
Bergman, et al., 2008). An enhanced proinflammatory state results from disruption or 
failure of mechanisms that balance proinflammatory and anti-inflammatory mediators 
that regulate normal immune function (McDermid et al., 2011; Walston et al., 2002; Yao 
et al., 2011). A persistent proinflammatory state leads to cellular damage and 
development of sarcopenia, muscle wasting, weakness, fatigue, reduced energy and 
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activity, malnutrition, weight loss, functional decline, and increased risk for accelerated 
aging, disease, and frailty (Franceschi et al., 2000, 2 07; McDermid et al., 2011). 
Significance 
Frailty is recognized as a significant public health concern as the numbers of 
those over the age of 65 years increase and the prevalence of chronic diseases among 
younger adults steadily grows. The human life span has increased as a result of decades 
of public health and medical advancements that reduc  infant mortality and improved 
health and survival (Federal Interagency Forum on Aging-Related Statistics, 2010; Fries, 
1988, 2005). However, contemporary societal factors int oduced new risks for chronic 
disease, early disability, and frailty. Chronic disea es such as hypertension, heart disease, 
stroke, cancer, diabetes, arthritis, obesity, and respi atory disorders are becoming more 
prevalent and each is contributory to frailty risk factors and precursors (Bergman et al., 
2007; Fries, 1988, 2005; Hackstaff, 2009; Jeune, 2002; Lally & Chrome, 2007; P. G. Lee, 
Cigolle, & Blaum, 2009;  Mor, 2005; Phan et al., 2008; Pel-Little, Schuurmans, 
Emmelot-Vonk, & Verhaar, 2009; Woo, Goggins, Sham, & Ho, 2006; Fugate Wood et 
al., 2005). Social determinants such as low income r financial stressors, limited 
education, under- or unemployment, unhealthy lifestyl  behaviors, exposure to daily life 
hassles and discrimination (ageism, racism, sexism, classism), and toxic living 
environments are each influential in increasing risk for frailty (Katz et al., 1983; Laditka 
& Laditka, 2002; Mullings, 2005; Szanton, Gill, & Allen, 2005; Szanton et al., 2008, 
Szanton, Seplaki, Thorpe, Allen, & Fried, 2010). Public policy and public health 
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initiatives will be necessary to effect changes in ociopolitical and healthcare systems in 
order to have the greatest impact on health status. 
Aging Demographics 
 The current U.S. population exceeds 314 million peopl  and about one in eight, or 
12.6%, is over 65 years of age. These estimates are expected to increase to 30% by 2050 
The over 85 years age group continues to steadily increase with projections of almost 10 
million by 2030, with the  number of centenarians icreasing dramatically (Federal 
Interagency Forum on Aging-Related Statistics, 2010; U.S. Census Bureau, 2008). In 
2000, there were 50,454 centenarians (1 out of every 5,578) compared to 1990, where 
there were 37,306 centarians (1 out of 6,667; Hetzel & Smith, 2001). The male to female 
ratio has also changed, with increasing numbers of women in relation to men at advanced 
ages (Hetzel & Smith, 2001). Life expectancy projected at 65 years of age is 17.6 years in 
men and 20.3 years in women (American Fact Finder, 2012). Population projections are 
presented in Table 1. The proportion of racial and ethnic minority populations is also 
increasing. Currently, more than one third of the U.S. population belongs to a minority 
group. In 2010, Whites accounted for 74.3%, Hispanic, 15.1%, African American or 
Blacks, 12.3% Asian, 4.4%, and American Indian and Alaska Native, 0.8% 
(Administration on Aging, 2011). 
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Projections of the Population by Selected Age Groups and Sex for the U.S.: 2010–2050 
Resident Population in Thousands, by Sex and Age 
 2010 2015 2020 2025 2030 2035 2040 2045 2050 
Both sexes 310,233 325,540 341,387 357,452 373,504 389,531 405,655 422,059 439,010 
45-64 yrs. 80,980 83,911 84,356 83,510 84,296 87,608 92,000 95,333 98,490 
≥ 65 yrs. 40,229 46,837 54,804 63,907 72,092 77,543 81,238 84,456 88547 
≥ 85 yrs. 5,751 6,292 6,597 7,239 8,745 11,450 14,198 16,985 19,041 
≥ 100 yrs. 79 105 135 175 208 239 298 409 601 
Male          
45–64 yrs. 17,292 20,542 24,323 28,560 32,294 34,749 36,396 37,905 39,917 
> 65 yrs. 17,292 20,452 24,323 28,560 32,294 34,749 36,396 37,905 39,917 
> 85 yrs. 1,893 2,163 2,344 2,652 3,284 4,387 5,481 6,609 7,458 
> 100 yrs. 15 21 29 40 51 62 81 114 172 
Female          
45-64 yrs. 41,513 42,939 43,065 42,498 42,747 44,743 46,573 48,308 49,974 
> 65 yrs. 22,937 26,295 30,481 35,346 39,798 42,794 44,842 46,551 48,630 
> 85 yrs. 3,859 4,130 4,253 4,587 5,461 7,063 8,717 10,376 11,583 
> 100 yrs. 65 84 106 134 156 177 217 295 429 
Source: U.S. Census Bureau, 2008 
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 Demographic data describing an increasing aging population has drawn attention 
to frailty in the health care and public policy sector since the incidence and prevalence of 
frailty and health care costs is expected to increase. Although many older adults 
experience some decline in physical, cognitive, and/or functional status at advanced ages, 
not all are destined to become frail (Molina-Garrido & Guillen-Ponce, 2010). Frailty may 
represent a proxy for chronologic age for many aspect  of health status that are difficult 
to measure and interpret in adults with diverse morbidity, symptoms, and BPSS function 
(McDermid et al., 2011). How the needs of a diverse aging population will be met is of 
concern (Karunananthan et al., 2009; Morley et al., 2006; Szanton et al., 2005). A wide 
range of health and social services that emphasizes health promotion, prevention of 
disease and disability, and optimal management of chronic conditions will be required to 
achieve HP 2020 goals for increased active life expectancy and quality of life (Fries, 
1988; Hackstaff, 2009; Healthy People 2020, 2013; Izaks & Westerdorp, 2003; Mor, 
2005; Woo et al., 2006). Integration of comprehensive geriatric assessment and  nursing 
and interdisciplinary team collaboration would facilitate identifying and coordinating 
care for the aging population that can improve chronic disease management, 
biopsychosocial function, and quality of life, and reduce preventable hospitlizations. 
Hospitalization and Frailty 
Frailty is associated with increased odds for hospitalization. In the Women’s 
Health Initiative-Observational Study, the largest population-based study to examine 
frailty, hospitalization for frailty and intermediate frailty was associated with odds ratios 
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(OR) of 2.0 (1.7-2.2) and 1.3 (95% CI, 1.2-1.5). These findings compare to data or men 
and women in the Cardiovascular Health Study (Fried, Tangen, et al., 2001). 
Adverse Consequences of Hospitalization 
Hospitalization is associated with many intrinsic, extrinsic, and system-related 
stressors with significant life-altering and life-threatening consequences. Hospitalized 
adults are exposed to increased risk for adverse events and poor outcomes that develop 
rapidly with cascading detrimental effects (Graf, 2006; de Saint-Hubert et al., 2010). 
Many hospitalized older adults experience higher rates of surgical or treatment-related 
complications, falls, delirium, pressure ulcers, under-treated pain, malnutrition, and 
dehydration with detrimental consequences, a phenomn described as cascade 
iatrogenesis (Potts et al., 1993; Thornlow, Anderson, & Oddone, 2009), but little is 
known about how to improve care to reduce these situations (Finlayson & Birkmeyer, 
2001; Nalysnyk, Fahrbach, Reynolds, Zhao, & Ross, 2003;  T. N. Robinson, Wu, 
Stiegmann, & Moss, 2011; Rolfson et al., 1999; Zalon, 2004). Frailty is a strong 
independent predictor of ADL dependence, morbidity, worsening frailty, and mortality. 
In a study of hospitalized older women (N = 749,  ≥ 65 years), where 25% were frail at 
baseline, 56% developed ADL dependence at three-year follow up compared to 20% who 
were not frail at baseline (Boyd et al., 2005). In a prospective study in community older 
adults, transitions in frailty level associated with hospitalization, 88% had at least one 
frailty transition and 89.4% were hospitalized during 108-month follow-up (N = 754,  ≥ 
70 years; T. M. Gill et al., 2011). At baseline, 26.6% were frail, 51.5% prefrail, and 
22.9% nonfrail. The most common transition was from nonfrail to prefrail, and the least 
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common, frail to nonfrail. The risk for transition to a higher level of frailty increased with 
hospitalization. Transition from nonfrail to frail was uncommon in those who were not 
hospitalized. Hospitalization was strongly associated with mortality at all frailty levels. 
Hospitalization is associated with prolonged activity restriction and immobility. 
Factors such as intravenous tubes, oxygen masks, catheters, wound dressings, cardiac 
monitoring electrodes, and devices limit mobility in addition to imposed restriction due to 
the medical condition. The detrimental pathophysiological, psychological, and functional 
impact of immobility has been well-described for decades (Fretwell, 1993; Harper & 
Lyles, 1988; Mahoney, 1998; Olson, Johnson, & Thompson, 1990). The cascading and 
interacting effects of activity restriction and immobility on physiologic function produce 
striking responses in all body systems. Risk for frailty is markedly increased in the 
context of immobility (J. E. Carlson et al., 1998; Heppenstall et al., 2009). 
Immobility during hospitalization is an under-recognized clinical care issue with 
serious and potentially irreversible consequences (Boyd et al., 2005; C. J. Brown, 
Friedkin, & Inouye, 2004; Brown, Redden, Flood, & Allma, 2009; Callen, Mahoney, 
Wells, et al., 2004). Health care providers cite barriers to mobilizing acutely ill 
hospitalized older adults that can be insurmountable; however, proactive measures for 
early mobilization including bed mobility and progressive physical activity is uncommon 
in many clinical settings (Boltz et al., 2008a, 2008b; C. J. Brown et al., 2007; Callen, 
Mahoney, Grieves, et al., 2004). Functional decline is a significant consequence of 
hospitalization-associated immobility and is estimaed to occur in 30% to 60% of older 
adults (K. E. Covinsky et al., 2003; K. E. Covinsky et al., 2011; T. M. Gill, Gahbauer, 
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Han, & Allore, 2009; Inouye, Bogardus, Baker, Leo-Summers, & Cooney, 2000; Lafont 
et al., 2011). Hospitalization is independently andsignificantly associated with new-onset 
ADL dependence, functional decline, and disability (Boyd et al., 2005; T. M. Gill, Allore, 
Gahbauer, & Murphy, 2010; Hirsch et al., 2006; Sager & Rudberg, 1998). The trajectory 
of functional decline may begin prior to admission due to acute illness or chronic disease 
exacerbation which may sensitize providers that admission functional status is also 
baseline status. Consequently, planned efforts for remobilization and rehabilitation may 
be deferred or delayed. The impact of acute illness or surgery would be expected to 
compromise mobility function and perhaps lead to slower recovery however without 
individualized, aggressive interventions for graded mobilization and re-conditioning, 
functional decline will worsen in many older adults. Therefore, despite resolution of the 
medical problems that precipitated hospitalization, the downward  trajectory of functional 
decline will continues to worsen during hospitalization and continue after discharge (K. 
E. Covinsky et al., 2011). Research indicates that hospital-associated immobility and 
functional decline is significantly associated with failure to return baseline status and 
higher level of dependence and increased mobility and ADL limitations. 
Nursing Home Discharge 
Hospitalization is associated with greater risk for nu sing home discharge. 
Functional decline is often a critical factor that precipitates nursing home discharge (T. 
M. Gill et al., 2009). In a retrospective study of Medicare beneficiaries ≥ 66 years (N = 
762,243), 5.55% were living in a nursing home 6-months after discharge compared with 
0.54% of non-hospitalized controls, often due to functional decline (Goodwin, Howrey, 
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Zhang, & Kuo, 2011). In a study of nondisabled community persons  ≥ 70 years 
hospitalized and discharged to a nursing home within 46 months (N = 754, n = 296 who 
were admitted to a nursing home, nine-year follow up), the most common trajectory was 
discharge home with disability followed by discharge to a nursing home with disability 
(46.3%), discharge home without disability (27.4%), discharge home without disability 
(21.6%), and non-continuous disability in the nursing home (4.4%; T. M. Gill et al., 
2009). Prior to hospitalization, 63.9% had no disability. Only 32.4% returned home at or 
above their pre-hospitalization functional status.  
Hospital Readmission 
Hospitalization rates and readmission rates are high among older adults and many 
are potentially avoidable. In 2010, of 31 million Medicare beneficiaries, about 10 million 
(4%) were hospitalized. The 30-day all-cause readmission rate among those who were 
hospitalized was 19.2% at a cost of $17.5 billion t the Medicare program (Centers for 
Medicare and Medicaid Services [CMS], 2012a). In a study of hospitalizations of 
Medicare and Medicaid beneficiaries (N = 1,571,920), of 960,000 hospitalizations, 
383,000 were potentially avoidable compared to 577,000 that were deemed unavoidable 
(Ouslander & Berenson, 2011). About 24% of nursing home discharges were readmitted 
within 30 days. 
Frailty Assessment in Hospitalized Adults 
There is limited literature on frailty assessment in hospitalized adults. Since 
advanced age and physical signs and symptoms are not liable indicators of frailty, it can 
be difficult to determine who is at risk for frailty or who is frail since frailty precursors 
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and risk factors are detected in midlife adults (Hubbard & Woodhouse, 2010; Shore & 
DeLateur, 2007; Xue, 2011). The heterogeneity among adults presents challenges since 
conventional assessments are not reliable in identifying frailty (Afilalo et al., 2009; 
Albert, Im, & Raveis, 2002; American Medical Association [AMA], 1990; Manton, 
2008; Raphael et al., 1995; Woo et al., 2006; Yang & Lee, 2010). Most frailty research in 
hospitalized older adults (most often in surgical populations) utilized assessment tools or 
measures employed in frailty research in community older adults that may exhibit 
multiple morbidity and disability but are medically stable (Afilalo et al., 2012; 
Gharacholou et al., 2012, Hilmer, Perera, et al., 2009; Makary et al., 2010; T. N. 
Robinson et al., 2009; Robinson, Wallace, et al., 2011; Robinson, Wu, et al., 2011; 
Rønning et al., 2010). Assessment approaches in these populations are often non-
transferable to the hospital setting in acutely ill, medically complex, and unstable 
patients. Research on frailty in hospitalized adults has primarily focused on older adults 
admitted for elective surgery to determine if frailty assessment identified patients who 
were more likely to experience post-operative complications, functional decline, 
disability, longer length of stay, institutionalization, and mortality. In a study of older 
adults 70 years of age and older admitted to a cardiology unit that compared the findings 
of  two different frailty assessment models (Fried Frailty Index, deficit accumulation 
framework) and individual performance measures (gait speed, handgrip strength) found 
that frailty classificition identified by the composite assessment models or individual 
performance measures significantly predicted six-month mortality (Purser et al., 2006). 
Gait speed was the strongest predictor of poor outcomes. 
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Emerging research in hospitalized populations indicates that frailty assessment 
augments traditional medical assessments for specific chronic conditions such as heart 
failure and multiple medical conditions (Cacciatore et al., 2005; Pilotto et al., 2012; T. N. 
Robinson et al., 2009) and preoperative risk assessm nt (Afilalo et al., 2012; N. A. 
Brown & Zenilman, 2010; Cleveland, 2010; R. R. Cohen et al., 2012; Dasgupta, Rolfson, 
Stolee, Borrie, & Speechley, 2009). Chronologic agend comorbidity have been relied 
upon as primary risk indicators, but they have not pr ven to be consistently stable 
predictors of complications and survival in older adults due to heterogeneity in the aging 
population. Biologic age is now viewed as a more reliable predictor of risk suggesting 
that other influential factors are not accounted for in standard risk assessment (Castle, 
Uyemura, Rafi, Akande, & Makinodan, 2005; Mitnitski, Graham, et al., 2002; Mitnitski, 
Mogilner, & Rockwood, 2001). Frailty assessment captures multidimensional factors that 
influence risk for poor outcomes, for example, tolerance of invasive procedures, toxic 
pharmacologic therapy, and high risk medical and surgical interventions (Afilalo et al., 
2009). There is growing agreement that standard risk as essment tools fail to differentiate 
a subgroup of older adults who are at high risk for p or outcomes who my fare worse 
than expected compared to others who may be older and appear less resilient, but recover 
better than expected (Makary et al., 2010). Frailty ssessment augments standard clinical 
tools to improve detection of patients who appear medically stable and do not score as 
high risk on standard risk assessments but unexpectedly experience complications and 
poor outcomes (Makary et al., 2010). 
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Less frequently studied for their influence on frailty in hospitalized adults are 
geriatric syndromes such as delirium, falls, functional decline, pain, fatigue, incontinence, 
poor appetite, malnutrition, sleep problems, pressure ulcers, and others (Ahmed et al., 
2007; K. E. Campbell, 2009; C. C. Chen, Dai, Yen, Huang, & Wang, 2010; C. C. Chen, 
Yen, Dai, Wang, & Huang, 2011; P. G. Lee et al., 2009; Inouye et al., 2007; Lafont et al., 
2011; Quinlan et al., 2011; Schwab, 2008). These syndromes may be present on 
admission or develop during hospitalization. Geriatric syndromes are associated with 
increased risk for frailty and adverse consequences related to new dependence, new 
morbidity and poor discharge health status, longer length of stay, nursing home 
discharge, long term institutionalization, and shortened life span. Since frailty is 
considered a syndrome, the extent to which other syndromes can be addressed 
concurrently as part of frailty assessment may improve detection and prevention since 
there is evidence of shared risk factors among these syndromes (K. E. Campbell, 2009; 
Donini, De Felice, Tagliaccica, De Bernardini, & Cannella, 2005; Inouye et al., 2007; 
Kane, Talley, Shamiliyan, & Pacala, 2011; Tinetti, Inouye, Gill, & Doucette, 1995). 
Particular attention to functional decline in hospitalized adults is warranted since 
functional decline may be a primary etiologic factor in frailty and deleterious geriatric 
syndromes. Poor functional status on admission and excessive decline during 
hospitalization may signal high risk frailty status and alert providers to assess and initiate 
appropriate prevention and intervention (Hoogerduijn et al., 2007; Hoogerduijn, 
Schuurmans, Korevaar, Buurman, & de Rooij, 2010; de Saint Hubert et al., 2010). 
However, functional decline and frailty may be distinc ly different. Although there can be 
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overlap in presentation and etiologic factors, frailty reflects global multisystem 
physiologic dysregulation and poor compensatory reserve whereas functional decline 
may be due to an immobility and various intrinsic and hospital-associated factors that 
may be self-limiting (Creditor, 1993; Lafont et al., 2011; Lefevre et al., 1992). 
Differentiating frailty from functional decline would facilitate targeting treatment to 
address multifactorial features of these conditions (Afilalo et al., 2012; J. E. Carlson et 
al., 1998; de Saint-Hubert et al., 2010; Hilmer, Mager, et al., 2009; Pilotto et al., 2012; 
Sutton, Grimmer-Somers, & Jeffries, 2008). 
Research is needed to characterize frailty in acutely ill hospitalized adults in 
different age ranges and at different time points during hospitalization (Boyd et al., 2005; 
Mitty, 2010; Rozzini, Frisoni, Franzoni, & Trabucchi, 2000). Most frailty research in 
hospitalized adults is focused on older adults 65 or 70 years of age and older (Afilalo et 
al., 2010, 2012; J. E. Carlson et al., 1998; Dasgupta et al., 2009; Freiheit et al., 2010; T. 
M. Gill, Allore, et al., 2010; Kristjansson et al., 2010; Makary et., 2010; Pilotto et al., 
2012; Purser et al., 2006; T. N. Robinson et al., 2009; Rønning et al., 2010). However, 
frailty indicators are detected in middle-aged adults (Pol et al., 2011). There are no 
evidence-based guidelines about frailty indicators hat are predictive of adverse frailty 
trajectories and outcomes by different age strata or if frailty components should be 
normed by age, gender, race/ethnicity, or other factors (Heuberger, 2011). 
Public Health Implications of Frailty 
Healthy People (HP) 2020 is an important U.S. public health initiative to advocate 
that people live long, healthy lives free of preventable disease, disability, injury and 
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premature death (Healthy People 2020, 2013). The HP 2020 objectives for older adults 
formulate a blueprint for healthy aging. Objectives r levant to frailty and this study are to 
increase the proportion of older adults who report c nfidence in managing their chronic 
condition, reduce the proportion of adults with moderate to severe functional limitations, 
increase the proportion of adults with physical or c gnitive limitations to participate in 
physical activity, reduce the rate of pressure ulcer-related hospitalizations, and reduce the 
rate of emergency department visits due to falls (Healthy People 2020, 2013). 
Research and clinical practice initiatives that address frailty are crucial to meeting 
HP 2020 objectives. Relying on factors other than chronologic age in public health 
planning will be necessary. Older age is associated with more chronic conditions but age 
of onset and disease severity varies. Medical expenditures for older adults with multiple 
chronic conditions are eight-times higher compared to those with few chronic conditions 
(Fries, 1988; IOM, 1991, 2001). Public health initiat ves such as enhanced screening for 
frailty in hospitalized adults (Sutton et al., 2008), disease management and transitional 
care programs ,and community based health and social ervices are needed to facilitate 
effective self-management of chronic conditions, reduce symptom burden and disease 
exacerbation, decrease risk for preventable complications and disability, increase active 
life expectancy and quality of life, and prevent or delay frailty (Burke et al., 2001; 
Hamerman, 1999; Landi, Abbatecola, et al., 2010; Landi, Russo, et al., 2010; Morley, 
2010; Ozaki, Uchiyama, Tagaya, Ohida, & Ogihara, 2007; Peterson et al., 2009; Raphael 
et al., 1995; Shore & DeLateur, 2007; Tennstedt & McKinlay, 1994; Wolff & Kasper, 
2006; Woo et al., 2006). Frailty assessment, prevention, and intervention is needed to 
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reduce its incidence and prevalence and alleviate the burden it imposes at great cost to 
individuals, families and communities (Aggar, Ronaldson, & Cameron, 2010; Bergman et 
al., 2007; Healthy People 2020, 2013; Wolff & Kasper, 2006). 
A greater understanding of frailty in the acutely ill hospitalized population is 
needed since research is lacking and hospitalization is a sentinel event that can precipitate 
or worsen frailty. Assessing frailty in adults 55 years of age and older is important since 
primary and secondary prevention holds greater potential for benefit at younger ages 
(Hackstaff, 2009; IOM, 1991; Peterson et al., 2009). Frailty can be halted, ameliorated, 
reversed, or its progression delayed with appropriate interventions (Heuberger, 2011). 
Hospitalization presents an opportunity to assess and intervene early in order to interrupt 
the frailty trajectory and initiate targeted intervntions that maximize individual outcomes 
and health system indicators associated with cost and quality of care. 
Definition of Frailty for this Study 
For this study, frailty was defined as a dynamic, multidimensional, multifactorial 
syndrome associated with poor compensatory reserve in response to intrinsic and 
extrinsic stressors and greater risk for the accumulation of deficits in biopsychosocial-
spiritual function that leads to incremental or precipitous physiologic dysfunction and 
failure to effectively respond to and recover from destabilizing health events to restore 
homeostasis. Frailty arises from the interacting effects of age, chronic disease, symptom 
burden, functional limitations, disability, and other intrinsic and extrinsic biopsychosocial 
stressors that lead to poor outcomes (Bergman et al., 2007; Coles, 2004; Fried, Tangen, et 
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al., 2001; Fried et al., 2004; Geronimus, 2001; Hamerman, 1999; Hubbard & 
Woodhouse, 2010; Lally & Crome, 2007; Rockwood, 2005; Whitson et al., 2007). 
Conceptual Framework 
Introduction 
This study was guided by a conceptual framework that links the biological-
psychological-sociocultural-spiritual (BPSS) model and stress theory. The BPSS-Stress 
model framed frailty as a process that evolves across the life course in response to 
dynamic interactions occurring within the person and between the person and the 
environment. The BPSS-Stress model emphasizes holism where intrinsic and extrinsic 
factors that influence health status and well-being are inseparable. The BPSS-Stress 
model is appropriate for characterizing multidimensio al, multifactorial aspects of frailty 
over time (Bowsher, Bramlett, Burnside, & Gueldner, 1993; Engel, 1977; Young, Frick, 
& Phelan, 2009; Zittel, Lawrence, & Wodarski, 2002). 
The Biological-Psychological-Social (BPS) Model 
In the 1970s, the biological-psychological-social (biopsychosocial, BPS) model 
was introduced as an alternative to the biomedical model that dominated medical 
education and health care as scientific innovations ncreased and medical care became 
more specialized (Engel, 1977, 1981). The biomedical model emphasized the Cartesian 
separation of the mind and body and advocated new scientific knowledge about cellular 
pathology and posited causal relationships between signs, symptoms and disease (Main, 
Richards, & Fortune, 2000). Rapid advancement in science and technology was driven by 
reductionist cause-and-effect models in the study of disease delimited by separate organ 
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or body systems (Schwab, 2008). The notion of “one microbe-one illness” was promoted 
in medical education leading to specialization (Borrell-Carrió, Suchman, & Epstein, 
2004, p. 578). Subsequent research, however, substantiates the complex inter-
relationships within and across organs and body systems that depend on non-linear 
process for up-regulation and down-regulation of chemical mediators that maintain 
homeostasis. Research has demonstrated that disease, ymptom burden, functional 
decline, and disability are due to biologic, psychologic, and social factors and not the 
product of pathologic physiologic processes alone (Fried et al., 2009; Lipsitz, 2004; 
Lisitz & Goldberger, 1992; Main et al., 2000). 
The BPS model is based on systems theory that identifies elements of a domain, 
how they are interrelated, and the significance of their integration in creating human 
wholeness (Engel, 1981). The person is viewed as a unique individual who functions 
within a social and cultural context that strongly influences the perception and meaning 
of illness and how to best manage its disruptive eff cts (Engel, 1977, 1981). The BPS 
model underscores the inseparability of the parts of he human experience from the whole 
person, and that the whole is greater than the sum of its parts. Engel (1981) asserted that 
the presence of a biological derangement does not reflect the meaning of that problem to 
the person or that the problem represents a state of illness. Illness and symptoms arise 
from interactions of diverse factors, where psychological factors can be more important 
determinants of an illness and its severity and course than can be explained from a 
biomedical perspective (Borrell-Carrió et al., 2004; Engel, 1977, 1981). The BPS model 
draws a distinction between disease and the person’s perception of the impact of disease 
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on their health, family and social network, and daily life. Upon its introduction, the BPS 
model was controversial as it signaled a paradigm shift from a focus on disease to a focus 
on health by acknowledging that psychological and social factors impact development of 
acute illness, chronic disease, and patterns of recvery. 
Contemporary Application of the BPS Model 
The BPS model is described as a philosophy of clinical care and a guide for 
clinical practice. Borrell-Carrió et al. (2004) described the BPS model as a framework for 
understanding how illness and suffering impact the individual at multiple levels, from the 
molecular to the societal. Spirituality was included as a fourth domain. In practice, the 
BPS model continues to be relevant by providing a framework for understanding the 
patient’s experience in order to determine more accurate diagnoses, provide humane, 
person-centered care, foster autonomy, and achieve b tt r outcomes (Adler, 2009).  The 
acronym BPSS was used in this study for the biologic-psychologic-social-spiritual model. 
Stress Theory 
Stress is inherent in daily life and essential for healthy human function. Stress 
theory was first introduced by Hans Selye (1955) who defined stress as a “nonspecific 
response of the body to any demand” and developed a hysiologic model called the 
General Adaptation Syndrome (GAS; Selye, 1974, p. 14). In early research, Selye proved 
that stress-induced breakdown in neurohormonal systems could lead to diseases of 
adaptation, such as heart disease and hypertension (Selye, 1974). The GAS focused on 
acute stress that activates the fight-or-flight response when a person confronts a perceived 
threat. Selye’s focus on the pathophysiology of the str ss response contributed new 
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knowledge about the biology of stress and the brain’s role in physiological regulation of 
feedback between the brain and the body. This pioneeri g work introduced the 
importance of the mind-body connection (Schulkin, 2003) and broadened understanding 
of health and disease as inseparable from biopsychoo ial factors (James, Keenan, 
Strogatz, Browning, & Garrett, 1992; McEwen, 2003b, 2008; McEwen & Stellar, 1993; 
Mullings, 2005; Sterling, 2004). 
Homeostasis is an integrated, whole-body process of coping and adaptation to 
stress. Exposure to stressors does not automatically result in long term harmful effects. 
Homeostasis maintains of physiologic parameters in esponse to stressors that operate 
within a relatively narrow range of set-points (H. J. Cohen, 2000; Glei et al., 2007; 
Schulkin, 2003; Selye, 1983). Prolonged exposure to stressors or a an episode of acute 
stress precipitates sustained mobilization of physiologic stress responses, disruption of 
normal cellular and organ system function, and failure to restore homeostasis (McEwen, 
2008; McEwen & Lasley, 2003). Chronic stress can be toxic due to the adverse effects of 
prolonged activation of neuroendocrine, inflammatory, cardiovascular, immune, 
metabolic, and coagulation systems (Geronimus, Hicken, Keene, & Bound, 2006; 
McEwen, 1993, 2008; McEwen & Lasley, 2003; Nielson, Seeman, & Hahn, 2007). 
Unremitting negative stress leads to sustained physiologic aberration in regulatory 
functions and failure of adaptive mechanisms that are critical in maintaining homeostasis. 
Chronic stress is a risk factor for morbidity, cognitive impairment, function decline, 
disability, and mortality (M. S. Clark, Bond, & Hecker, 2007; Geronimus, 2001; 
Geronimus et al., 2006; Glei, Goldman, Chuang, & Weinst in, 2007; McEwen, 1993, 
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2008; Newman et al., 2001). Chronic BPSS stress leads to physiologic wear-and-tear and  
compromised organ and system function, physiological dysregulation, and disease 
(Geronimus, 2001; Geronimus, Hicken, Keene, & Bound, 2006; Geronimus, Bound, 
Keene, & Hicken, 2007; Gruenewald et al., 2009). Chronic BPSS stress across the 
lifespan has been proposed as “catalysts of accelerat d aging and agitators of disease 
trajectories” (Juster, McEwen, & Lupien, 2010, p. 2). The toxic effect of chronic stress is 
more prevalent in certain minority and high risk groups and may contribute to greater 
morbidity, mortality, and health disparities (M. S. Clark et al., 2007; Crimmins, Kim, & 
Seeman, 2009; Geronimus, 2001; Geronimus et al., 2006, 2007; McEwen, 1993, 2008; 
McEwen & Lasley, 2003; McEwen & Stellar, 1993; Szanton, Allen, Seplaki, Bandeen-
Roche, & Fried, 2009; Whitson et al., 2011). 
Acute and chronic cumulative stress is a pathogenic me hanism in disease and 
potentially in frailty through mechanisms related to prolonged dysregulation of biologic 
functions and proliferation of stress mediators that initiate inflammatory responses 
instrumental in development of disease and frailty. S ress theory strengthens the BPSS 
model by providing a theoretical and empirical base for the linkage between BPSS 
stressors, physiologic function, health, illness, and disease (McEwen, 1993, 2008; Puts et 
al., 2005; Sanders, Boudreau, Fried, Walston, Harris, & Newman, 2011; Seely & 
Christou, 2000; Stewart, 2006). The BPSS-Stress model, illustrated in Figure 1, offers a 
comprehensive framework for examining frailty. 
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Figure 1. The Biologic-Psychologic-Social-Spiritual and Stress Model. 
 
Biologic Domain 
The biologic domain refers to life-sustaining biologic and physiologic processes 
that enable human function. Healthy biologic function requires the seamless coordination 
of cells, tissues, organs and organ systems. Age-related changes in the neuroendocrine 
and immune systems contribute to abnormal levels of inflammatory, immunologic, and 
hormonal biomarkers and chronic low-grade inflammation (Ko, 2011; Phan et al., 2008; 
Yao et al., 2011; Walston & Fried, 1999; Walston et al., 2002). For example, acute phase 
reactant CRP which is produced and directly up-regulated by IL-6 is associated with 
increased risk for morbidity, sarcopenia, poor physical function, disability, and frailty 
(Cesari et al., 2004; H. J. Cohen et al., 2003; H. J. Cohen, Pieper, Harris, Rao, & Currie, 
1997; De Martinis et al., 2006; Ershler & Keller, 2000; Ko, 2011; Leng et al., 2002; 
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Nielson et al., 2007; Okamura et al., 2008; Puts et al., 2005, 2005a; Walston et al., 2002). 
The combination of high CRP and low albumin level is associated with frailty (Harimurti 
& Setiati, 2007). Chronic elevation of the WBC count is associated with frailty (Leng, 
Hung, et al., 2009; Leng, Xue, et al., 2009). Hemoglobin and albumin are associated with 
inflammation, malnutrition, frailty, morbidity, and mortality even if abnormal levels can 
be explained by disease factors or nutritional defici ncy (Arques, 2008; Don & Kaysen, 
2004; Ko, 2011; Leng et al., 2002; Zakai et al., 2006). Inflammatory conditions such as 
rheumatoid arthritis, stroke, and cardiovascular disease are associated with frailty (S. S. 
Chang, Vaz Fragoso, Van Ness, Fried, & Tinetti, 2011; S. S. Chang et al., 2012; Phan et 
al., 2008; Silvestri et al., 2004). Other biomarkers have been studied in relation to frailty 
but it is unclear which biomarkers or clusters of bi markers are most influential in its 
inception or progression (De Martinis et al., 2006; Ferrucci et al., 2002; Kanapura & 
Ershler, 2009; Ko, 2011) but biomarkers associated with inflammation are highly 
relevant since these types of biomarkers are also as ciated with chronic BPSS stress, 
chronic disease states including low grade infection (periodontitis, cytomegalovirus), and 
acute illness. Gender and race are biologic variables that are significantly associated with 
frailty, specifically, female gender and African American race (Hirsch et al., 2006; Puts 
et al., 2005a; Szanton et al., 2009; Yang & Lee, 2010). 
Symptoms and conditions significantly associated with frailty are weakness, 
fatigue, dyspnea, pain, high and low BMI, obesity, cognitive impairment, depression, 
delirium, malnutrition, weight loss, pressure ulcers, visual impairment, and falls (Fried, 
Tangen, et al., 2001; Hackstaff, 2009; Hadley et al., 1993; Heuberger, 2011; Pel-Little et 
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al., 2009; Shega et al., 2012; Speechley & Tinetti, 1991; Xue, 2011; Xue, Bandeen-
Roche, Varadhan, Zhou, & Fried, 2008). Symptoms are frequently related to different 
diseases. Comorbidity may be associated with sympto atterns that may provide a 
better understanding of overall morbidity status and function than comorbidity indexes 
alone (Whitson et al., 2009, 2011). Medication use impacts biologic function in positive 
and negative ways. Pharmacologic treatment of disease c n improve health outcomes but 
medication side effects can introduce new risk. 
Psychologic Domain 
The psychologic domain refers to cognitive, affective, intellectual, and behavioral 
processes that provide the human interface with physical and social environments. 
Measurement of psychologic function may be obtained by in-person interviews and 
interactions, self-report through completion of questionnaires, and via direct observation 
of behavior under naturalistic conditions or under conditions intended to provoke specific 
psychological or behavioral responses. Psychologic factors that are relevant to frailty are 
emotional health and coping, depression, anxiety, and attitudes and beliefs about health 
and illness that influence behaviors that are influential in the development of risk factors 
for frailty or are protective in the promotion of resilience. 
Social Domain 
The social domain refers social networks, or the number and types of social 
contacts in a person’s social circle, social integration, or the degree of connectedness and 
quality of relationships among social contacts and having a confidante, communicating 
and relating to others, having close personal ties and emotional connections with family, 
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friends, and the community (Loucks, Berkman, Gruenewald, & Seeman, 2006; T. E. 
Seeman, 1996; T. E. Seeman, Lusignolo, Albert, & Berkman, 2001). Social factors are 
influenced by cultural norms, beliefs, traditions, and practices. Social interaction and 
social support norms and preferences can differ markedly between cultural groups. 
Social support may involve emotional support, companionship, illness-related 
care, informational support and problem-solving assistance, and instrumental support 
through provision of financial or material resources (Andrew, Mitnitski, & Rockwood, 
2008; Nicklett et al., 2012; T. E. Seeman, 2000). Positive social support is related to good 
mental health and cognitive function (T. E. Seeman et al., 2001). Newsom and Schulz 
(1996) found that instrumental and emotional support alleviated the effects of disability 
on depressive symptoms and improved life satisfaction. In a concept analysis of support, 
Langford, Bowsher, Maloney, and Lillis (1997) found that the social network, 
embeddedness, and climate were antecedents of social upport; consequences were 
personal competence, effective health maintenance ad coping behaviors, perceived 
control, sense of stability, self-worth, and well-being, positive affect, and decreased 
anxiety and depression. 
Cultural diversity is increasing in the U.S. Recent population data document that 
by 2050, racial and ethnic minority groups will continue to increase and Caucasians will 
be a minority group. Attention to cultural differences and the influence of culture on 
health and illness require understanding of cultural norms. Cultural norms and practices 
may differ by race and ethnicity based on geographic location, local family and 
community characteristics, socioeconomic status, education, religion, political 
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environment, and other factors. Within-group differences among racial and ethnic groups 
warrant attention when considering social support since assumptions about racial/ethnic 
groups cannot be assumed to generalize to the entire population. Cultural beliefs and 
racial and ethnic identity can influence health beliefs and healing practices, lifestyle 
behaviors, medical treatment adherence, caregiving patterns, and perspectives on 
dependence, interdependence, and independence in the context of aging and disease. 
Spiritual Domain  
The spiritual domain includes the constructs of spirituality and religiosity. These 
terms been used interchangeably to describe ways in which people transcend their current 
experience or perception of self, relate to a spiritual entity or God, and enhance 
connectedness with others (Harvey & Silverman, 2007). Spiritual beliefs may be more 
salient than formal religious affiliation. Attitudes toward health may involve spiritual 
factors that help integrate physiologic, psychologic, emotional, social, and physical 
elements of disease or disability (Zittel et al., 200 ). Spirituality and religiosity may have 
a positive effect on physical and mental health outc mes through different ways of 
ascribing meaning to  health and illness (Harvey & Silverman, 2007; Koenig, George, & 
Titus, 2004; Levin, 1994; Levin, Taylor, & Chatters, 1994; Musick, 1996). 
Research Questions  
Research Question 1 
What is the proportion of each of the 14 frailty components in hospitalized adults 
55 years of age and older? 
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Research Question 2 
What is the level of frailty in the sample of hospitalized adults, based on the 
Frailty Score (0–14)? 
Research Question 3 
What are the relationships between demographic, biological, psychological, and 
sociocultural health status variables and each of te 14 frailty components? 
Research Question 4 
What are the relationships between the demographic, biological, psychological, 
and social health status variables and level of frailty or the Frailty Score that ranged from 
0–14? 
Research Question 5 
What is the relationship between level of frailty or the Frailty Score (range, 0 to 
14) and length of hospital stay? 
Research Question 6 
What is the relationship between level of frailty or the Frailty Score (range, 0 to 
14) and 30-day hospital readmission? 
Justification 
 This study is needed in order to advance understanding of frailty in hospitalized 
adults because there is scant research on frailty in this population, especially in adults 55 
years of age and older. Frailty is a formidable healt  care issue since it is associated with 
worse outcomes, longer length of stay, hospital readmissions, morbidity, and mortality. 
Empirical evidence for key components of frailty in hospitalized adults 55 years of age 
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and older is lacking therefore research is needed that extends the study of frailty from a 
biologic perspective to a comprehensive biopsychosocial perspective, and from adults 55 
years of age and older who may be at risk for frailty or frail. There is little known about 
frailty and its assessment, primary and secondary prevention, and intervention to guide 
nursing practice in the hospital setting. Conceptual and operational criteria and defining 
characteristics for a frailty nursing diagnosis is needed but there is scant nursing research 
to guide this work. Nursing models for care for frailty are lacking. Strategies to enhance 
clinical nursing leadership at the bedside to facilitate interdisciplinary communication 
and collaboration to improve care of frail adults are lso needed. A diversity of expertise 
ensures that patient and family needs and preferencs are addressed by those most 
prepared to fully assess certain frailty issues. 
Contributions of this Study 
 This study expanded the study of frailty from older adults to include midlife 
adults 55 years of age and older, since evidence sugge ts that frailty and frailty risk 
factors and precursors are found well before the age of 65. Frailty was examined from a 
multidimensional BPSS perspective utilizing evidenc-based frailty components derived 
from existing, readily available clinical data in the EMR to characterize frailty in 
hospitalized adults. A unique feature of this study was inclusion of four plasma 
biomarkers as frailty components that represent physiologic indicators that are 
significantly associated in prior research with inflammation, malnutrition, and frailty. 
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Chapter Summary 
Frailty is associated with chronic inflammation, multisystem physiologic 
dysregulation, biologic instability, and reduced compensatory reserve and ability to 
effectively respond to intrinsic and extrinsic stresors to maintain homeostasis (Abellan 
van Kan, Rolland, Morley, et al., 2008; Fried, Tange , et al., 2001; Fullop et al., 2010; 
Zittel et al., 2002). Understanding frailty in hospitalized adults 55 years of age and older 
is important given lack of research in this vulnerable population and the deleterious 
outcomes. The multi-dimensional BPSS-Stress model was used to examine frailty in this 
study. The model aligns with nursing perspectives about health and illness, caring 
practices, and person-centered care. 
The changing demographics of the U.S. population prject greater longevity, 
increasing incidence and prevalence of chronic disease and obesity, and the limitations of 
existing knowledge about frailty is of considerable concern. Given the personal, societal, 
economic, and public health impact of frailty, it is vital that frailty not be ignored or 
interpreted as a terminal condition of old age with no hope for prevention or 
improvement (Fillit & Butler, 2009; Kanapura & Ershler, 2009; Palmore, 2004; Sarkisian 
& Lachs, 1996; Sarkisian, Gruenewald, Boscardin, & Seeman, 2008; T. E. Seeman, 
Merkin, Crimmins, & Karlamangla, 2010; Stone, Cafferata, & Sangl, 1987). Nursing 
research on frailty in hospitalized adults is limited thus there is little evidence to guide 
nursing practice (Mezey & Fulmer, 1998; Mitty, 2010). This study contributed to a body 
of literature that lacks substantive nursing research with the potential for advancing 
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understanding of frailty and elucidating implications for clinical practice, 
interprofessional collaboration, education, research, and public policy. 
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CHAPTER II 
 
REVIEW OF THE LITERATURE 
 
Introduction 
Prior to the 1980s, frailty was an undefined term used to describe elderly who 
were very old, appeared feeble, thin, and fragile, had multiple chronic diseases, ADL 
limitations, disability, cognitive impairment, resided in a nursing home, or were near the 
end-of-life (Ahmed et al., 2007; Bergman et al., 2007; Heuberger, 2011; Karunananthan 
et al., 2009; Levers et al., 2006; Markle-Reid & Browne, 2003; Strawbridge et al., 1998). 
There was little recognition of frailty as a distinct clinical problem until the 1990s when 
demographic shifts demonstrated a steady increase in population longevity and higher 
rates of health care and social service resource utilization, particularly among the very old 
and frail elderly (Fries, 2005; Hackstaff, 2009; Mor, 2005; Izaks & Westendorp, 2003; 
Woo et al., 2006). Continued change in aging demographics and expected increases in 
morbidity and disability project that the incidence and prevalence of frailty and health 
care utilization and costs will also increase.  
Around the 1970s, geriatric medicine became a subspecialty of internal medicine 
and family medicine that focused on prevention and treatment of diseases and disability 
in older adults. Similarly, gerontology emerged as a subspecialty in nursing and the social 
sciences where a focus on the biopsychosocial-spiritual dimensions of the aging process 
emerged (Burnside, 1990; Burnside & Touhy, 2006; Heuberger, 2011; Matteson & 
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McConnell, 1985). However, it was not until the 1990s when frailty gained increased 
attention from clinicians, researchers, and leaders in health care and public policy. 
Increased longevity and total life expectancy increased at a rate that exceeded active life 
expectancy (Ferrucci et al., 2006; Katz et al., 1983). The notion that aging and frailty may 
be intrinsically connected and evolve in parallel drew attention to the need for better 
understanding about what mediates these two processes since living longer with more 
years of dependence and disability imposes significant burden on the individual and 
society with implications for health and social services, resource utilization, and public 
policy (Albert, Im, & Raveis, 2002; Ferrucci et al., 2006; Fries, 1980, 1988; Jeune, 2002). 
Interdisciplinary conferences, international symposiums, and expert panels 
advanced theoretical perspectives, launched research, and began to characterize frailty 
and consider the clinical practice implications of the growing number of older adults,  
especially frail elderly (Abellan van Kan, Rolland, Morley, et al., 2008; Hadley et al., 
1993; Hogan, MacKnight, & Bergman, 2003; Katz et al., 1983; Raphael et al., 1995; 
Rodríguez-Mañas et al., 2012; Vellas et al., 2012; Walston et al., 2006). Frailty emerged 
as an important area of research that focused on how to define frailty and provide care to 
this vulnerable population (Abellan van Kan, Rolland, Bergman, et al., 2008; Ferrucci et 
al., 2006; Gealey, 1997; Vellas et al., 2012; Fried, Herdman, Kuhn, Rubin, & Turano, 
1991; Fries, 1988). Despite an increasing body of science, frailty remains poorly 
understood from pathophysiologic and biopsychosocial perspectives with limited 
consensus on a theoretical or operational definition of frailty that is applicable across 
settings and populations (Abellan van Kan, Rolland, Bergman et al., 2008; Fried et al., 
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2005; Gobbens et al., 2010, 2010a, 2010c; Karunananthan et al., 2009; Kuh, 2007; Levers 
et al., 2006; Markle-Reid & Browne, 2003; Mohandas, Reifsnyder, Jacobs, & Fox, 2011; 
Rockwood, 2005; Rodríguez-Mañas et al., 2012).  
Significant gaps persist in understanding the biopsychosocial and physiologic and 
genetic underpinnings of frailty and its precursors, risk factors, defining characteristics, 
clinical indicators, and diagnostic criteria (Bortz, 2002, 2008; Ferrucci, Mahallati, & 
Simonsick, 2006; Rodríguez-Mañas et al., 2013; Sternberg, Wershof Schwartz, 
Karunananthan, Bergman, & Mark Clarfield, 2011; Xue, 2011). Most frailty research has 
been conducted in medically-stable community-living older adults with a primary focus 
on biologic frailty. Little is known about the natural history and early manifestations of 
frailty in younger adults and the psychosocial, cultural, and historical factors that link 
aging and frailty as related constructs (Ferrucci et al., 2004, 2006; Fried et al., 2005; 
Karunananthan et al., 2009; Levers et al., 2006; Nation l Institute on Aging, 1991; Pel-
Little et al., 2009; Rodríguez-Mañas et al., 2012). Of considerable importance is the lack 
of research on frailty in acutely ill hospitalized a ults, a group that may be uniquely at 
high risk due to the interactive and dynamic effects of acute illness, trauma, surgery, 
medications, procedures, treatments, immobility, pain and sleep disturbances, and a 
myriad of other factors. 
Defining frailty is challenging since there is insufficient evidence for an accurate 
description of its etiology, clinical indicators, or typology that captures the complexity of 
this condition (Ahmed et al., 2007; Bergman et al., 2007; Gobbens et al., 2010, 2010a; 
Fried et al., 2009; Hogan, 2006; Xue, 2011). Frailty presentation varies widely in its 
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onset and its clinical manifestations (Sternberg et al., 2011; Xue et al., 2008). Frailty is 
generally characterized as a progressive biologic pro ess of decline due to impaired 
physiologic function across multiple body systems resulting in reduced compensatory 
reserve, poor resilience, and lower response to and recovery from intrinsic and extrinsic 
stressors (Ahmed et al., 2007; Bergman et al., 2007; Bortz, 1993, 2008, 2010; Yassuda et 
al., 2012). It is unclear if frailty is a natural consequence of aging and disease, a product 
of interactions between aging processes, disease conditions, and biopsychosocial and 
environmental factors, or if frailty is a unique condition independent of these factors 
(Bergman et al., 2007; Bortz, 2002; Fulop et al., 2010; Izaks & Westendorp, 2003; 
Morley et al., 2006). There is substantial evidence that cumulative stress and activation of 
inflammatory and coagulation pathways are significant f ctors that create differential risk 
for frailty and its clinical presentation (Barzilay et al., 2007; De Martinis et al., 2006; 
Heuberger, 2011; National Institute on Aging [NIA], 2004; Schmaltz et al., 2005; 
Walston et al., 2002; Yao, Li, & Leng, 2011). Chronic i flammation is associated with 
detrimental physiologic changes that progressively lead to biologic vulnerability and 
frailty (S. S. Chang et al., 2012; Franceschi et al., 2000; Ho et al., 2011; Kanapuru & 
Ershler, 2009; Puts et al., 2005; Walston et al., 2002; Yao et al., 2011). 
Clinical features of frailty are vague and ambiguous. The literature is replete with 
commentary that clinicians recognize frailty based on personal experience and subjective 
appraisal that associates frailty with advanced age, changes in physical appearance and 
behavior, and other manifestations (Fried et al., 2004; Studenski, et al., 2004). Signs and 
symptoms may include muscle weakness, fatigue, low physical activity, poor endurance, 
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impaired physical function, low body weight, poor appetite, unplanned weight loss, 
cognitive impairment, depressive symptoms, and decreased social interaction (Ahmed et 
al., 2007; Fried et al., 2005; Gobbens et al., 2010a; Hubbard, O’Mahony, & Woodhouse, 
2008; Lally & Crome, 2007; Mitnitski, Fallah, Rockwood, & Rockwood, 2011; Morley, 
2010; Morley et al., 2006; Rodríguez-Mañas et al., 2012; Walston et al., 2006; Xue, 
2011; Yao et al., 2011). No single sign or symptom, cluster of signs and symptoms, or 
physiologic measures definitively characterized frailty. Indeed, frailty is not always 
visibly detectable and may only be discovered after an acute health threat where health 
status outcomes and recovery is far worse than would be expected in persons in similar 
circumstances (Slaets, 2006). Frailty has been describ d as a precarious state of health 
with greater susceptibility for negative outcomes from minor illness or trauma. Non-life-
threatening events such as acute urinary tract or pulmonary infection destabilizes 
homeostasis and unleashes a cascade of aberrant physiologic processes that result in a 
series of adverse consequences that negatively impacts health status and function (Fried 
et al., 2009; Puts, Lips, & Deeg, 2005b; Romero-Ortuno, Walsh, Lawlor, & Kenny, 2010; 
Sarkisian et al., 2008; Sourial et al., 2010; Xue, 2011 ).  
In early phases of frailty, minor declines in physiologic function evolve and 
progress at different rates across multiple organ systems with little objective evidence of 
diminishing physiologic reserve or impaired function. Thus, frailty may be undetected 
when intrinsic and extrinsic stressors do not exceed biopsychosocial adaptive and 
compensatory responses that maintain homeostasis. However, when intrinsic or extrinsic 
stressors are of sufficient magnitude to overcome marginal physiologic reserves, 
53 
 
compensatory biologic processes are inadequate and fail to effectively respond to 
stressors and a downward trajectory of decline in physiologic function ensues (Ahmed et 
al., 2007; De Lepeleire, Iliffe, Mann, & Degryse, 2009). Frailty is not a static condition, 
nor is its course predictable, inevitably progressive, or irreversible. Data from 
longitudinal cohort studies characterize frailty as a tate of stable-instability with 
dynamic interactive physiologic processes, fluctuating levels of vulnerability, and shifts 
between levels of frailty (Gill et al., 2006; Puts et al., 2005b). Thus, identifying frailty is 
challenging with profound implications for clinical decision-making regarding medical, 
surgical, procedural, and pharmacologic intervention in the management of acute illness, 
trauma, and chronic disease in hospitalized adults. 
Frailty has been proposed as a better predictor of compromised organ system 
function and risk for disease and poor outcomes than c ronological age and 
sociodemographic indicators (De Lepeleire et al., 2009; Sanders et al., 2011). The 
heterogeneity in health status and function noted in older adults of similar ages is partly 
explained by the different ways in which people age. Individual differences in biology, 
genetics, disease conditions, lifestyle behaviors, access to health care, living 
circumstances, the physical and social environment, and other factors dynamically 
interact across the lifespan leading to considerabl variability among individuals in aging 
processes, health status, and disease. Given this, it is not surprising that what instigates 
frailty remains unclear since no single etiology or group of etiologies can explain how or 
why frailty develops in aging adults represented by such diversity. 
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Frailty is of concern at the individual and societal level because it is associated 
with a myriad of negative outcomes including morbidity, functional decline, disability, 
hospitalization, prolonged or poor recovery, institutionalization, and mortality (Fried, 
Tangen, et al., 2001; Fried et al., 2004; Fugate Woods et al., 2005; Heppenstall, Hanger, 
& Wilkinson, 2009; Karunananthan et al., 2009; Levers t al., 2006; Raphael et al., 
1995). Hospitalization poses a threat to frailty trajectories with increased risk for 
functional decline, new dependence, disability during and after hospitalization and 
nursing home discharge (T. M. Gill, Allore, et al., 2010; Gill et al., 2009; Gill, Gabhauer, 
Han, & Allore, 2010; Gill et al., 2011; Heppenstall et al., 2009). Of considerable 
importance is evidence that frailty is potentially reversible or its progression halted or 
delayed. Interventions that address risk factors, symptoms, and disease management can 
lead to significant gains in health status and functio  (Gill et al., 2006; Mitniski et al., 
2011; Mitnitski, Song, & Rockwood, 2007; Puts et al., 2005b; Rockwood et al., 2011).  
Frailty is a compelling national and global public health issue that significantly 
impacts individuals, families, communities, and society. Because of the magnitude of the 
impact of frailty on an aging population and all sectors of society, the IOM has identified 
frailty as a priority for improvement in health care quality (Adams & Corrigan, 2003). 
The future needs of the growing aging population has dr wn attention to a health care 
delivery system that is poorly prepared to help aging adults, especially those who are 
medically complex and frail. Existing health care delivery models are primarily oriented 
towards specialty practice that is disease- and organ-system focused. As a result, care 
delivery is often fragmented, and patient education ca  be confusing and conflicting. 
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According to the IOM, the current health care system has failed to have a significant 
impact on health outcomes, readmission rates, and costs despite many health care 
innovations (De Lepeleire et al., 2009; IOM, 2008; CMS, 2012a). Given demographic 
trends and changing family structures, there will be greater need for a wider range of 
services that promote effective transitions in care and resources that enable independent 
living and other supportive living arrangements. Thus, frailty assessment, primary and 
secondary prevention, and targeted intervention will be crucial in clinical practice. The 
anticipated increase in the incidence and prevalence of frailty and its adverse 
consequences underscores the need to better understand frailty especially in hospitalized 
adults since there is insufficient research to guide practice.  
Conceptual Model 
 The conceptual model for this study is based on the biologic, psychologic, social, 
spiritual model and stress theory (BPSS-Stress model). This model was appropriate for 
the study because frailty is a multidimensional, multifaceted condition that affects all 
aspects of human function through complex nonlinear inte actions within the individual 
and between the individual and the external social and physical environment. Stress 
theory is an important part of the conceptual model because there is strong evidence that 
chronic stress directly and indirectly affects the BPSS domains and function (Logan & 
Barksdale, 2008; McEwen, 1993, 2008; McEwen & Stellar, 1993; McEwen & Wingfield, 
2010; Nielson, Seeman, & Hahn, 2007; Schulkin, 2003; T. E. Seeman, 2000; T. Seeman, 
Dubin, & Seeman, 2003). Chronic stress incites physiologic processes that adversely 
impact BPSS function and increases risk for acute illn ss, chronic disease, disability, and 
56 
 
frailty (Logan & Barksdale, 2008; McEwen, 1993, 2008; McEwen & Wingfield, 2010; 
Szanton et al., 2005). 
Stress Theory 
Stress is a common human experience. Stress refers to the human response 
manifested through physical and emotional stimulus that disrupts equilibrium, causing 
mental or emotional strain or worry. Stress arises from psychological, social, biological, 
and environmental stimuli that incite various degres of physiological stress responses 
(Selye, 1955, 1974). Physiologic responses are mediated by a person’s perception and 
interpretation of the stressor as benign, an annoyance, or a threat. The stress response is 
highly individualized and contextual (Lazarus & Folkman, 1984). While some stress is 
necessary for normal function, prolonged stress perceived as negative adversely affects 
health (E. D. Carlson & Chamberlain, 2005; Geronimus, 2001; James et al., 1992; 
McEwen, 1993, 2008; McEwen & Stellar, 1993; Mullings, 2005). A person’s cognitive 
appraisal of stressful events, life circumstances, and stress burden influences physiologic 
stress responses (Lazarus & Folkman, 1984). According to Lazarus and Folkman (1984), 
stress involves three processes. Primary appraisal is the cognitive process of perceiving a 
threat to oneself, secondary appraisal  the process of conceiving of potential responses 
to the threat, and coping is the process that involves taking action in response to the 
perceived threat. These processes are nonlinear and interactive with one’s emotional 
state. Further, the outcome of a coping response may lead to other stressors and 
emotional reactions. Lazars and Folkman’s work focused primarily on chronic stress and 
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its adverse effects, whereas in comparison, Selye used the term distress for negative 
stress and eustress for positive stress. 
Perception of a stressor as negative activates behavioral and physiologic stress 
responses that instigate biologic processes that contribute to development of illness and 
disease (Goldman, Glei, Seplaki, Liu, & Weinstein, 2005; Schulz & Williamson, 1993). 
Although the term stress was not widely recognized by nurse researchers until the 1970s, 
references to stress began appearing in nursing journals in the 1950s. Anecdotal reports 
from patients and empirical evidence from researchers in nursing and other disciplines 
indicated that stress and health were inextricably related concepts.  
Chronic stress is particularly damaging because it results in a prolonged state of 
hyper-vigilance, anxiety, and worry that can lead to significant biologic dysregulation. 
Chronic stress activates physiologic responses in multiple inter-related organ systems and 
produces significant abnormal changes in neuroendocrine, cardiovascular, hematologic, 
metabolic, and immunologic function. Chronic stressor  have been described as a 
“catalysts of accelerated aging and agitators of disease trajectories” (Juster et al., 2010, p. 
2).  Chronic stress and poor cognitive and biologic adaptation responses lead to disease 
risk factors and eventually to disease (E. D. Carlson & Chamberlain, 2005; Clark, 
Anderson, Clark, & Williams, 1999; Clark et al., 2007; Glei et al., 2007; Juster et al., 
2010; Logan & Barksdale, 2008; McEwen, 1993, 2003b, 2008; Stewart, 2006).  
Research suggests that stressors and adverse conditions uring childhood and 
throughout the lifespan produce variations in health status and risk for poor health 
outcomes within and across groups (Clark et al., 1999; Jung, Gruenewald, Seeman, & 
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Sarkisian, 2010; Kuh, 2007; T. E. Seeman, 1996; T. E. Seeman & Crimmons, 2001; T. E. 
Seeman & McEwen, 1996). Socioeconomic stressors (poverty, poor living conditions, 
financial hardship, workplace pressure, family conflict, low education) are potent sources 
of stress that confer biological risk that may accelerate aging and the early onset of 
disease, disability, and frailty (Crimmons et al., 2009; Geronimus et al., 2006; Gill & 
Szanton, 2011; Gregory et al., 2011; Guralnik, Land, Blazer, Fillenbaum, & Branch, 
1993; Szanton et al., 2008; Szanton, Seplaki, et al., 2010).  
Inflammation. Stress is associated with inflammation. The aging immune system 
manifests as a state of low-grade, chronic, systemic inflammation (Franceschi et al., 
2000; Xue, 2011). Age-related chronic inflammation, r inflamm-ageing, is hypothesized 
to be the underlying pathogenesis of tissue damage and organ dysfunction (De Martinis et 
al., 2006; Franceschi et al., 2000). Systemic inflammation progressively causes cellular 
and organ system dysregulation and directly contributes to functional decline, disability, 
and morbidity (Bandeen-Roche, Walston, Huang, Semba, & Ferrucci, 2009; Kanapuru & 
Ershler, 2009; Xue, 2011). Cumulative stress stimulates complex responses in the 
sympathetic and parasympathetic nervous systems and the hypothalamus-pituitary-
adrenal axis (HPA) which activates neuroendocrine, cardiovascular, hematologic, 
immune, and metabolic systems (McEwen, 1993; Sterling, 2004). Under normal 
conditions, these systems dynamically interact in complex ways to facilitate homeostasis. 
Homeostasis represents the coordination of a wide range of biologic processes that 
operate within relatively narrow parameters to sustain normal biologic function (e.g., core 
body temperature, hydration). Homeostasis fails when stressors (e.g., infection, 
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dehydration,  hypoxia) induce physiologic conditions that exceed adaptive parameters. 
Biologic efforts that mobilize corrective responses are ineffective, resulting in life-
threatening situations (e.g., hyperthermia, hypernatremia, cardiac arrhythmias, seizures). 
Chronic, low-grade inflammation may be a consequence of lifelong exposure to 
the cumulative effects of stress and negative physiologic stress responses, genetics, 
increased antigenic load, chronic disease, and lifestyl  behaviors (De Martinis et al., 
2006; Franceschi et al., 2000). Chronic low-grade systemic inflammation is a significant 
contributor in the pathogenesis of medical conditions associated with frailty including 
atherosclerosis, hypertension, cardiovascular disease, myocardial infarction, stroke, 
cancer, depression, osteoarthritis, rheumatoid arthritis, systemic lupus erythematous, 
Alzheimer’s disease, Parkinson’s disease, coagulation disorders, chronic infection, 
HIV/Aids, post-traumatic stress disorder, and Crohn’s disease (Ahmed, Sherman,  & 
Vanwyck, 2008; Cacciatore et al., 2005; Cesari et al., 2003a, 2003b; De Martinis et al., 
2006; Don & Kaysen, 2004; Ishihara-Paul et al., 2008; Kanapuru & Ershler, 2009; Kiss 
& Szodoray, 2010; Koelewijn, Schwartz, Samsom, Oldenburg, 2008; Leng et al., 2002; 
Linares, Gomez-Reino, Carreia, Morillas, & Ibero, 1986; Mohile et al., 2009; Nielson, 
Seeman, & Hahn, 2007; Phan et al., 2008; Puts et al., 2005). 
Chronic inflammation is independently associated with frailty without 
comorbidity (Ferrucci et al., 2002; Kanapuru & Ershler, 2009; Leng et al., 2007; Puts et 
al., 2005; von Känel, 2006; Walston et al., 2002; Williams, Harmon, Burlingame, & Du 
Clos, 2005; Xue, 2011). Inflammatory biomarkers such as abnormal levels of serum IL-6, 
CRP and hs-CRP, albumin, hemoglobin, and WBC count are associated with poor 
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physical function, disability, mortality, and frailty (Bautmans, Njemini, Lambert, 
Demanet, & Mets, 2005; De Martinis et al., 2006; Ferrucci et al., 2002; Ishihara-Paul et 
al., 2008; Leng et al., 2002; Newman et al., 2001; Puts et al., 2005; Steptoe et al., 2007; 
Walston et al., 2002; Xue, 2011). 
In the MacArthur Studies of Successful Aging of healthy community adults (N = 
870, 70–79 years), serum albumin, cholesterol, IL-6, and CRP were analyzed as a 
composite measure of inflammation (Reuben, Judd-Hamilton, Harris, & Seeman, 2003). 
For each biomarker, one point was allotted for labor tory values that were above or 
below established parameters. A composite sum for in lammation was computed to 
determine risk for mortality and functional decline. Mortality at three and seven years 
was 6% and 23%, respectively. Those with 1 or 2 biomarkers were at moderate risk for 
mortality at each time point (adjusted OR = 1.5 and 1.3, respectively, not statistically 
significant). Those with three or four biomarkers had statistically significantly higher 
mortality risk (adjusted OR = 6.6 and 3.2, respectively) compared to those who had none.  
Abnormal inflammatory biomarkers are associated with psychosocial stressors 
such as low socioeconomic status (SES), work stress, early life adversity, hostility, and 
social isolation (Alley et al., 2006; Danese, Pariante, Caspi, Taylor, & Poulton, 2007; 
Kiecolt-Glaser et al., 2005; Koster et al., 2006; Steptoe et al., 2007; Ranjit, Diez-Roux, 
Shea, Cushman, Ni, et al., 2007; Ranjit, Diez-Roux, Shea, Cushman, Seeman, et al., 
2007). Stress-related lifestyle factors associated with frailty are physical inactivity, poor 
nutrition, smoking, excessive alcohol use, and obesity (Hackstaff, 2009; Hadley et al., 
1993; Rapuri, Gallager, & Smith, 2007; Reuben et al., 2003). Sustained abnormal levels 
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of inflammatory biomarkers provide a physiologic imprint of chronic stress that 
manifests as the loss of adaptive processes that ultimately exerts deleterious 
consequences on health status and increases risk for frailty (Gruenewald et al., 2009; 
Logan & Barksdale, 2008; McEwen, 1993, 2008).  
Homeostasis, Allostasis, and Allostatic Load 
The concept of allostasis was introduced in 1988 by Sterling and Eyer to describe 
a process that operates in tandem with homeostasis to maintain normal ranges for 
physiologic parameters. Unlike homeostasis which operates within narrow ranges for set 
points to maintain physiologic parameters for body temperature, pH and hydration status, 
allostasis activates adaptive responses that have a wider range of physiologic parameters 
that involve many complex, nonlinear, inter-related systems and chemical mediators.  
Homeostasis and allostasis are both dynamic endogenous physiologic systems that 
together maintain the internal stability of an organism (Glei et al., 2007; McEwen, 1993, 
2008; Sterling, 2004; Stewart, 2006).   
Homeostasis derives from the Greek term, homeo, which means similar, while 
stasis means stand. In contrast to perspectives of homeostasis as a static state of 
physiologic stability, homeostasis is a physiologically dynamic state. Allostasis derives 
from the Greek term, allo, which means variable. Allostasis refers to biologic functions 
that maintain stability through change (Sterling, 2004). Allostasis facilitates rapid 
physiologic responses that results in elevated blood pressure, pulse, and respiratory rate, 
diaphoresis, cognitive alertness, and neuromusculoskeletal reactivity. When the stressor 
abates, allostasis facilitates normalization of biochemical mediators and normal 
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physiologic function gradually resumes (Karlamangla, Singer, McEwen, Rowe, & 
Seeman, 2002; Logan & Barksdale, 2008; McEwen, 2008; Nicolson, Storms, Ponds, & 
Sulon, 1997; Nicolson & van Diest, 2000). 
Multiple physiologic systems and their biochemical mediators are activated in the 
stress response, including the hypothalamus-pituitary-adrenal (HPA) axis (cortisol, 
epinephrine, norepinephrine), immune system (IL-6, CRP, TNF-α), and hematologic and 
metabolic system (fibrinogen, d-dimer, insulin-like growth factor). These mediators of 
the stress response have both protective and damaging effects on the body. In the short 
run, they are essential for adaptation, homeostasis, nd survival. Repeated exposure to 
stressors or sustained cumulative stress leads to persistent activation of allostasis 
processes. Persistent over-activation of the stress response and sustained allostasis leads 
to significant physiologic dysregulation, poor adaptation and recovery, and failure of 
allostasis to normalize physiologic processes.  
Sustained dysregulation adversely affects multiple organ systems and is described 
as allostatic load (McEwen, 2003a; McEwen & Lasley, 2003; McEwen & Wingfield, 
2010; Stewart, 2006). The aberrant physiologic respon es that lead to allostatic load are 
described as follows: (a) repeated, frequent exposure to multiple stressors; (b) failure of 
body systems to habituate to repeated exposure to the same stressors; (c) failure to down-
regulate and turn-off the body’s response to stressors in a timely manner; and (d) 
inadequate response by biochemical mediators to stresso s that lead to compensatory 
hyperactivity of other mediators (McEwen, 2003a, 2008; Sterling, 2004; Stewart, 2006). 
Allostatic load eventually leads to changes in cellular and organ function and ultimately, 
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progressive decline across multiple organ systems and finally, end-organ damage (Glei et 
al., 2007; Karlamangla et al., 2002; Logan & Barksdale, 2008; McEwen, 1993, 2008; 
McEwen & Stellar, 1993; Szanton et al., 2009). Sustained activation of the stress 
response and allostatic load have profound detrimental health effects including increased 
risk for disease and disabling symptoms, impaired physical and cognitive performance, 
disability, and frailty (Bandeen-Roche et al., 2006; Goldman et al., 2005; Gruenewald et 
al., 2009; Hogan et al., 2003; Juster et al., 2010; Kumari et al., 2009; McEwen, 2008; 
McEwen & Lasley, 2003; Nielson et al., 2007; Stewart, 2006).  
High allostatic load is toxic. Allostatic load is asociated with cardiovascular 
disease and atherosclerosis (Logan & Barksdale, 2008; McEwen, 2008; Newman et al., 
2001; Szanton et al., 2005), early onset of disease, di ability, and mortality (Geronimus et 
al., 2006; Reuben et al., 2002; T. E. Seeman, Singer, Rowe, Horwitz, & McEwen, 1997), 
functional decline (Karlamangla et al., 2002), cognitive impairment (Wikby et al., 2005), 
mood disorders (McEwen, 2003b), chronic fatigue syndrome (Maloney, Boneva, Nater, 
& Reeves, 2009), post-traumatic stress disorder (Gill & Szanton, 2011 ), cancer 
(Retornaz et al., 2008), HIV/AIDs (Kuller et al., 2008; Terzian et al., 2009), and frailty 
(Gruenewald et al., 2009; Szanton et al., 2009; Toye et al., 2006).  
In a longitudinal study of high-functioning older adults 70 to 79 years of age, the 
association between 13 biomarkers included in an index for allostatic load and frailty was 
examined (Gruenewald et al., 2009). In multivariable modeling adjusted for 
sociodemographic, health, and behavioral factors, a one-unit increase in the allostatic 
load score at baseline was associated with a 10% greater likelihood of frailty at three-year 
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follow-up (cumulative AOR=1.10;  95% CI = 1.03-1.19) (Gruenewald et al., 2009, p. 
1525). No single biomarker independently predicted frailty. Multisystem physiological 
dysregulation was associated with greater risk of frailty. It was unclear if certain 
biomarkers or combinations of biomarkers are predictive of frailty. Evidence of 
significant relationships between chronic stress, dy regulated physiologic stress 
responses and poor adaptive stress responses, low-grade chronic inflammation, allostatic 
load and high risk for frailty warrants further research.  
Demographic Data 
 Demographic data include the deidentified patient identification number for the 
study, preadmission location, and admitting service (general medicine, cardiology, 
orthopedics), hospital length of stay, and 30-day hospital readmission. 
Biologic Domain 
Age. Age is defined as the accumulation of damage to cells leading to incremental 
organ dysfunction and loss of biologic system redundancies, complexity and physiologic 
adaptability under stress (Izaks & Westendorp, 2003). Fedarko (2011) defines aging as 
deterioration of functional properties of cells, tisues and organs that gradually 
diminishes homeostasis and adaptability to internal a d external stressors. The World 
Health Organization divides old age into three groups: young-old (60–74 years), old-old 
(75–84 years), and oldest-old (over 85 years). Centenarians are over 100 years of age and 
middle-aged adults are between 45 and 65 years of age. 
 The aging process, independent of disease, is chara terized by progressive 
decline in cellular and organ mass and function that progresses at different rates over 
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time, but do not fall below a threshold that permits normal life (Bortz, 1993, 2008; 
Ferrucci et al., 2002). Aging changes evolve as the interplay of intrinsic and extrinsic 
factors unique to the individual and manifests in a“mosaic” progression (Fulop et al., 
2010, p. 549). Aging is associated with complex nonli ear changes in physiologic and 
reduced and inefficient compensatory reserve and resilience, described as homeostenosis 
(Bortz, 2008; Fried et al., 2009; Lipsitz, 2004; Lipsitz & Goldberger, 1992; Shega et al., 
2012). Surprisingly, most aging organ systems retain considerable function despite 
substantial loss of cellular function. Up to 70% of organ function can be compromised or 
lost before clinically significant failure occurs (Bortz, 2002).  
Research suggests that chronological and biologic age are different paradigms for 
evaluating health status since they are poorly correlated until around 85 to 90 years of age 
when the cumulative effects of normal aging processes, chronic disease, lifestyle habits, 
and functional impairments become more intricately linked (Bortz, 2010; Fedarko, 2011; 
Woodhouse & O’Mahony, 1997). Aging is not an autonomous process unaffected by 
internal and external biopsychosocial factors and stres ors (Bortz, 2002; Fillit & Butler, 
2009; Fulop et al., 2010). Chronological age may be useful in assessing physical 
performance and organ systems function but is of limited value in those who are 
medically and functionally complex. The biologic complexity of aging and cumulative 
effect of comorbidity is more accurate and relevant in assessment (Yang & Lee, 2010). 
Biologic age provides a better estimation of health status than chronologic age, especially 
among those who experience accelerated aging where health status is worse than 
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expected for stated years (Crimmins et al., 2009; Federal Interagency Forum on Aging-
Related Statistics, 2010; Lally & Crome, 2007; Montesanto et al., 2010).  
Although frailty is associated with the aging process since its incidence and 
prevalence increases over time, underlying physiolog c mechanisms are not entirely 
related to chronology (Afilalo et al., 2009). Frailty follows a physiologic pathway 
separate from aging and disability) and may represent an intermediate state between 
successful aging and pathological processes (Bortz, 2002; Purser et al., 2006; Whitson et 
al., 2007).  
Gender. Research indicates that women have higher incident and prevalent frailty 
compared to men (Fernandez-Bolaños et al., 2008; Fried, Tangen, et al., 2001; Jones et 
al., 2005; Peterson et al., 2009; Puts et al., 2005a; Walston & Fried, 1999). In the 
Cardiovascular Health Study, 7.3% of women were frail compared to 4.9% of men. 
Research indicates that frail men experience earlier mortality but frail women live longer 
and have greater morbidity and disability (Puts et al., 2005a). Gender differences in 
anatomic structure (e.g., muscle mass and quality), hormonal influences, lifestyle 
behaviors, occupation, social roles, living circumstances, and exposure to stressors and 
stress responses may contribute to physiologic changes and differential risk for frailty 
(Fernandez-Bolaños et al., 2008; Ferrucci et al., 2004; Puts et al., 2005a).  
In a study static and dynamic frailty in older adults (N = 2,257), more women than 
men were frail in both the static and dynamic trajectory (10% and 6.9%, respectively) but 
the prevalence of static frailty was higher in women than men (18% versus 14%) and the 
prevalence of dynamic frailty was similar in both men and women (17% and 18%, 
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respectively; Puts et al., 2005b). Among women, weight loss, reduced peak flow, 
cognitive decline, vision loss, depressive symptoms, and low physical activity were 
associated with mortality. In men, only weight loss and depressive symptoms were 
associated with mortality. Despite differences in frailty risk factors, mortality was higher 
in frail men (50%) compared to women (27%) and nonfrail men (15%) compared to 
women (7%), independent of chronic disease and disability.  
A biologic model for frailty may explain the higher p evalence rates of frailty in 
women compared to men based on gender differences related to sarcopenia, hormonal 
and neuroendocrine decline, and immune dysfunction (Walston & Fried, 1999). Men 
have higher baseline levels of muscle mass that may protect against the rapid muscle loss 
and strength associated with sarcopenia. Neuroendocri e and hormonal factors such as 
higher levels of testosterone and growth hormone may preserve muscle mass longer in 
men. Changes in the immune system increases risk for infection in men and chronic 
inflammatory conditions and muscle mass loss in women. Among women, certain 
biological, social and behavioral factors may contribute to greater longevity as well as 
factors that result in a greater frailty burden (Rockwood & Hubbard, 2004). Reduced 
longevity in men is associated with lower physiological reserve at older ages and health 
deficits that are more lethal. In contrast, women rquire high levels of energy and 
nutritional reserves related to childbearing, and if exhausted, may later experience poorer 
physiologic reserve (Rockwood & Hubbard, 2004). Gender differences in frailty 
incidence and prevalence may also be related to lifestyle behaviors such as physical 
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activity and exercise that is of lower frequency, intensity, and duration, and less high 
quality nutrient intake which is more common in women (Walston & Fried, 1999). 
Race/Ethnicity. Research documents the highest prevalence of frailty among 
African Americans (Afilalo et al., 2009; Bergman et al., 2007; Cigolle, Ofstedal, Tian, & 
Blaum, 2009; Fried, Tangen, et al., 2001; Fugate Woods et al., 2005; Hirsch et al., 2006; 
Whitson et al., 2011). In the Cardiovascular Health Study (N = 5,277, ≥ 65 years, 15% 
African American) African American race was an independent predictor of frailty and 
African American women had the highest rate of frailty (Hirsch et al., 2006). Fifteen 
percent of African American women were frail compared to 6.8% of White women, 4.6% 
of White men and 8.7% of African American men. In adjusted models, non-obese 
African Americans had four-fold greater odds of frailty compared to Whites. In the 
Health and Retirement Study (N = 11,113, ≥ 65 years, community and nursing home) 
African American women were more likely to be frail than White women (Cigolle et al., 
2009). In the Women’s Health Initiative–Observational Study (N = 40,657, 6.5% African 
American), African American women were significantly more likely to be frail (28%) 
than White women (15%), and more White women (57%) than African American women 
(38%) were nonfrail (Fugate Woods et al., 2005). 
In a cross-sectional analysis of the Women's Health and Aging Studies (N = 727 
women ≥ 65 years) relationships between race, SES measures (education, income), and 
frailty were examined (Szanton, Seplaki, et al., 2010). In adjusted models, older women 
with low education had three times the odds of frailty compared with more educated 
women. Women with an annual income < $10,000 had two times the odds of frailty 
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compared to those with higher income, independent of age, race, health insurance status, 
comorbidity, and smoking. African Americans were significantly more likely to be frail 
than Caucasians but not after adjusting for education. An important consideration is that 
African American women experience earlier onset and accelerated progression of disease 
and disability compared to White women thus higher rates of frailty in this population is 
of concern (Geronimus, 2001; Hirsch et al., 2006; Whitson, Landerman, et al., 2010). 
Research suggests that African Americans experience high levels of stress that are 
associated with negative health outcomes and frailty (Hirsch et al., 2006; Szanton, 
Thorpe, & Whitfield, 2010; Szanton et al., 2008). Key stressors are susceptibility to poor 
health and mental health problems, job discrimination, poor housing, low education, 
financial pressures, low access to and utilization of health and social services, and 
chronic exposure to racism and sexism (Clark, 2001; Clark et al., 2007; James et al., 
1992; Mullings, 2005; Phillipson, 2002; Szanton, Seplaki, et al., 2010). Research 
indicates that perceived racism is a source of stres  that influence early onset and severity 
of disease, greater symptom burden, disability, and has a deleterious impact on mental 
health and well-being (Clark, 2001; Clark et al., 1999; Crimmins et al., 2009; Geronimus, 
2001; James et al., 199; Mullings, 2005; Weber & Fore, 2007).  
Body mass index. Body mass index (BMI) is defined by World Health 
Organization (WHO) criteria (WHO, 2006) as weight in k lograms divided by square of 
height in meters (kg/m2). BMI classifies underweight, normal weight, overwight and 
obesity in adults using the following metrics: Sever  thinness (< 16 kg/m2), Underweight 
(< 18.5 k/m2); Normal (18.5-24.9 kg/m2), Overweight (> 25 kg/m2), Preobesity (25-29.9 
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kg/m2); Obesity (> 30 kg/m2), and Obese Class I (30-34.9 kg/m2), Obese Class II (35-
39.9 kg/m2), and Obese Class III (≥ 40 kg/m2) (WHO, 2006). BMI values are not 
differentiated by age or sex therefore different body proportions, bone structure, and 
degree and location of adiposity should be considered. Abdominal adiposity, not reflected 
in BMI, is significantly associated with increased l vels of inflammatory biomarkers and 
risk for disease. Recent unplanned weight loss and either low and high BMI are 
predictors of frailty (Ávila-Funes et al., 2009; Fried, Tangen, et al., 2001; Fugate Woods 
et al., 2005; Rothman et al., 2008; Sarkisian et al., 2008; Xue et al., 2008). Weight loss 
not due to exercise or diet may be the result of disease processes or chronic stressors that 
exert catabolic effects via increased inflammatory neuroendocrine activation, processes 
that alter glucose metabolism, medications that decrease appetite, higher energy 
expenditure that exceeds nutritional intake, and socioeconomic factors that limit access to 
high quality nutrients (Bartali et al., 2006; Walston et al., 2006; Yao et al., 2011).  In 
healthy older adults biomarkers associated with inflammation and malnutrition were 
associated with shorter lifespan (Carrière, Dupuy, Lacroux, Cristol, & Delcourt, 2008). 
Although most frailty research cites low BMI or unplanned weight loss as 
predictors of frailty, a U-shaped curve has been documented for BMI where the BMI 
<18.5 kg/m2 and BMI > 30 kg/m2 were both significantly associated with frailty and 
sarcopenia. The Women’s Health Initiative-Observational Study was the first to identify a 
significant association between obesity and frailty (Fugate Woods et al., 2005), validated 
in the Women’s Health and Aging Studies (Blaum, Xue, Michelon, Semba, & Fried, 
2005), and documented in other frailty research (Hubbard, Lang, Llewellyn, & 
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Rockwood, 2010; Stenholm et al., 2008). Another measure of adiposity, waist 
circumference greater than 102 cm in men and 88 cm in women is another 
anthropometric measure that has been used as a nutritio al indicator and found to be 
significantly associated with frailty and other adverse health conditions such as metabolic 
syndrome, osteoarthritis, and falls and fractures (Ensrud et al., 2007; WHO, 2006). 
Obesity is increasingly conferred as a significant predictor of frailty because it 
induces a pro-inflammatory state that influences th pathogenesis of frailty (Blaum et al., 
2005; Hubbard et al., 2010; Villareal, Banks, Sinacore, Seiner, & Klein, 2006; Visser, 
2011). Adipose tissue, especially abdominal fat, is biologically active and a source of 
proinflammatory cytokines such as IL-6 and CRP thatfos er a catabolic state and 
development of sacropenia (Blaum et al., 2005; Visser, 2011). IL-6 stimulates production 
of CRP and increases an inflammatory milieu. Higher w ight corresponds linearly with 
higher CRP (Blaum et al., 2005). In the Third National Health Survey and Nutrition 
Examination Survey, CRP was higher in obese adults (Visser, Bouter, McQuillan, Wener, 
& Harris, 1999). Increased levels of inflammatory biomarkers associated with obesity 
exert catabolic effects on muscle mass. Chronic low grade systemic inflammation 
reflected in elevated IL-6 and CRP levels is associated with oxidative stress and 
immunologic and pathophysiologic impairments that le d to muscle wasting, sarcopenia, 
and frailty (Hubbard & Woodhouse, 2010). Sarcopenia is  muscle wasting disorder that 
leads to weakness and mobility impairment. Sarcopenia is an important correlate of 
frailty in obese adults that can be overlooked as afrailty risk factor that leads to 
physiologic decline and entry into the cycle of frailty (Blaum et al., 2005; Fried, Tangen, 
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et al., 2001; Visser, 2011). Along with its physiologic consequences, sarcopenic obesity 
is related participation in decreasingly lower levels of physical activity and reduced effort 
and energy expenditure. These behaviors are often secondary to obesity-related 
symptoms such as joint pain, activity-induced dyspnea, poor aerobic capacity and 
endurance, fatigue, weakness, and urinary incontinece. The cluster of symptoms induced 
with physical activity leads to further physiologic and physical performance 
deconditioning and reduction in physical activity. In addition to increasing risk for frailty, 
obesity exerts widespread adverse systemic consequences on all organ systems. 
Comorbidity. Chronic diseases and conditions have been described as the “public 
health challenge of the 21st century” (Centers for Disease Control and Prevention [CDC], 
2009). The seven most common chronic diseases are cancer (several types), diabetes, 
hypertension, stroke, heart disease, pulmonary conditi s, and mental disorders. Chronic 
disease prevalence increases with age but chronic disease precursors and initial 
manifestations often present at midlife. In 2005, over half of the U.S. population reported 
one chronic disease, and by 70 years of age, half reported having one or more chronic 
diseases (CDC, 2012). In the U.S., the number of peple with chronic conditions is 
projected to steadily increase (AMA, 1990; Yach, Hawkes, Gould, & Hofman, 2004). 
Similarly, marked increase in the number of adults and children with obesity has recently 
led the American Medical Society to classify obesity as a medical disease at its 2013 
annual meeting due to its association with serious medical conditions, especially Type II 
diabetes mellitus, cardiovascular disease, hypertension, stroke, sleep apnea, metabolic 
syndrome, osteoarthritis, cancer, and others (American Medical Association, 2013).  
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Although higher comorbidity is associated with frailty, the relationship between 
frailty and comorbidity is not completely explained by the number or type of chronic 
diseases (J. E. Carlson et al., 1998). Among frail elders, 7% have none of the most 
common chronic diseases, 25% have one, but more than 90% of persons with ≥ 2 were 
not frail (Ahmed et al., 2007). In the Women’s Health Initiative-Observational Study (N 
= 4,657, age 65–79 years), 78% of frail women had more than two comorbidities 
compared to 47.4% of the nonfrail women (Fugate Woods et al., 2005). However, 18.1% 
of nonfrail women had no comorbidity compared to 3.8% of frail women. In the 
Cardiovascular Health Study, among the 6% who were frail, 46% had comorbidity, but 
22% had comorbidity and ADL disability, and 27% had neither ADL disability nor 
comorbidity (Fried, Tangen, et al., 2001).  
The number and severity of chronic diseases contribute to high symptom burden, 
disability, early onset of mortality, and frailty (AMA, 1990; Fried, Tangen, et al., 2001; 
Weiss, 2011) and the disabling impact of symptoms increases with age (Klijs, Nusselder, 
Looman, & Mackenbach, 2011). Fatigue is significantly associated with chronic disease 
and may play an important role in the cycle of frailty (Avlund, Rantanen, & Schroll , 
2006, 2007). Comorbidity and associated symptoms adversely impact BPSS function and 
increases stress since symptom management can be complex, complete resolution of 
symptoms is unlikely, and side effects of symptom management may be distressing 
(Sawatzky, Liu-Ambrose, Miller & Marra, 2007; Whitson et al., 2009).  
Identifying frailty is confounded by the overlap of comorbidity, disability, and 
frailty, where some frail persons may have no readily i entifiable indicators of 
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vulnerability. Thus, considering other factors such as physical activity, nutrition, 
symptoms, and psychosocial and economic issues and life stressors become more 
relevant in frailty assessment. 
Comorbidity has an adverse effect on immunity that is not found in healthy aging 
adults. Chronic illness burden is a potential indicator of physiologic aging that is a more 
reliable than chronologic age in understanding older adults’ blunted immune response to 
infection, sepsis, and vaccination (Castle et al., 2005). Further, many chronic diseases 
have underlying inflammatory components (Castle et al., 2005). In older adults, higher 
comorbidity correlates with the magnitude of the immune response due to the effect of 
comorbidity on altering immune cell response capacity. Research in healthy older adults 
without comorbidity found that immune function was near normal (Castle et al., 2005). 
Thus, it is important to consider the number of chronic diseases as well as conditions that 
have inflammatory or immunologic pathogenesis since frailty risk may increase. In 
addition, the efficacy of chronic disease management and magnitude of psychosocial 
stressors should be considered as these factors influence inflammatory and immune 
reactivity and activation that can accelerate system dysregulation and disproportionately 
increase risk for frailty.  
Fatigue. Fatigue is a common symptom in adults. Prevalence stimates vary 
considerably and can range from 5% to 50% (Alexander et al., 2010; Cella, Lai, Chang, 
Peterman, & Slavin, 2002).  In a cohort of ambulatory assisted-living residents (N = 199) 
where fatigue was measured by the Piper Fatigue Scal , the vast majority ( 98%) reported 
at least mild fatigue. However, 40% reported moderate f tigue and 7% reported severe 
75 
 
fatigue (Liao & Ferrell, 2000). In this study, multivariate regression analyses, depressive 
symptoms, pain, number of medications, and the three-minute walk were significant 
predictors of fatigue intensity (multiple R = 0.68, r2 = 0.46, P < .02). Similarly, Avlund et 
al. (2006) found that tiredness in daily activities was significantly associated with 
disability in 419 nondisabled 75-year-old persons. I  a study to describe the symptoms 
experienced by hospitalized adults on medical-surgical units using Memorial Symptom 
Assessment Scale, a self-rating scale of 31 symptoms (N = 334, mean age, 57 years, 
range, 18–93 years), the mean symptom count was 9.31 (SD = 5.15) and the mean 
symptom distress rating was 1.8 (SD = .84) and mean symptom severity rating was 1.65 
(SD = .83) based on a scale of one to five (Kris & Dodd, 2004). Higher symptom distress 
was identified in women and persons who were single. Th  five most frequent symptoms 
were pain (74%), dry mouth (67%), lack of energy (58%), difficulty sleeping (55%), and 
feeling drowsy (50%). Lack of energy was ranked third for symptom distress (57%). 
Fatigue is reported almost twice as often in women compared to men. Self-
reported fatigue may vary less by age since younger adults may be more physically 
active, be employed, and have family responsibilities, which imposes high demands on 
physical activity. Older adults may report less fatigue because they may become more 
sedentary and progressively reduced physical activity levels to minimize activity-induced 
fatigue. Consequently, deconditioning and exercise intolerance progresses as fatigue 
increases. Thus, self-reported fatigue might not vary considerably across the lifespan 
since as people age, adjustments in types of activity and the intensity, duration, and 
frequency is often adjusted to accommodate reduced capacity and more sedentary 
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behavior. However, self-reported fatigue is more lik ly to differ when persons of 
different ages are challenged to perform the same activity with standardized procedures 
and guidelines for intensity and duration (Hardy & Studenski, 2008). 
Fatigue is a normal response to physical exertion or cognitive or emotional strain 
but is considered abnormal when it is persistent and not relieved by rest, when it 
interferes with usual function, leads to restriction of daily activities, and is emotionally 
distressing. Fatigue is associated with chronic disease, acute illness, physical 
deconditioning, and frailty. Definitions of fatigue and descriptors in fatigue assessment 
instruments vary widely (Alexander et al., 2010). Terms used to describe fatigue include 
tiredness, exhaustion, physical or mental weariness, dullness, heaviness, listlessness, 
lethargy, depleted, drained, debilitated, devitalized, bushed, and petered out. Phrases 
include slow moving, inability to get going, and frequent need to rest. Many definitions 
include low energy, based on the premise that fatigue may be a disorder of energy 
imbalance, characterized by the term fatigability, or the relationships between activity 
level, capacity for activity, the tolerable rate and i tensity of activity before fatigue is 
experienced, and the point at which activity must be reduced or stopped because fatigue 
is intolerable and exhaustion has been reached (Alexander et al., 2010; Hardy & 
Studenski, 2008). Fatigabilty is relevant in frailty because slowing down and reducing 
physical activity has a global impact on biologic function and physical performance. 
Fatigue is a central feature of frailty. Fried, Tange , et al. (2001) defined a frailty 
phenotype as a clinical syndrome consisting of fivecriteria, where each criterion impacts 
certain biologic parameters and physical performance that represents a hierarchical 
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configuration of body system integration and functioning that influences level of fitness 
or frailty. The cycle of frailty is the cumulative effect of an iterative pattern of low level 
of physical activity, poor nutrient intake, weakness, muscle atrophy, diminished bone 
density, and fatigue. Low physical activity and poor nutrition contribute to reduced 
metabolic rate, energy expenditure, and fatigue. As a consequence, there is down-
regulation of physiologic systems and oxygen utilization, which leads to less physical 
activity, muscle wasting, weakness, and greater fatigue and fatigability.  Chronic disease 
can also adversely influence these processes. Fatigue is a strong predictor of functional 
limitations, disability, mortality, and other advers  outcomes in young-old and old-old 
populations (Avlund et al., 2006, 2007).  
Xue, Walston, Fried, and Beamer (2011) examined individual Fried Frailty 
criteria in the Women’s Health and Aging Studies II cohort. Weak hand grip strength was 
the most common frailty criteria but was least predictive of incident frailty. In 76% of the 
sample, weakness, slow gait speed, and low physical activity preceded fatigue/exhaustion 
and weight loss. Progression to frailty was not influenced by the number of criteria 
present. Incident frailty was three to five times more likely in women presenting with 
fatigue/exhaustion or weight loss, in adjusted models. Similarly, in another cohort of the 
Women’s Health and Aging Study II (N = 420, 70–79 years, cognitively intact, mild or 
no physical disability), compared to nonfrail women, those who were prefrail at baseline 
had a statistically significant threefold higher risk of developing frailty (Xue et al., 2008). 
Weakness was the most common initial manifestation of frailty, but fatigue/exhaustion 
and weight loss identified women who were most at risk for transition to frailty. 
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In a study of community-living older adults to examine tiredness and its impact 
on function (N = 496, 65 years and older, cognitively intact or mildly impaired, can walk 
four meters, gait speed between .2 and 1.3 meters per econd, three-year follow-up), 44% 
reported feeling tired most of the time (Hardy & Studenski, 2008). Tiredness was 
assessed by one question that asked if during the past month, did the person feel tired 
most of the time. Of those reporting tiredness, 16% indicated that tiredness did not affect 
their function, 29% reported their function was affected a little, 29% moderately, and 
26% quite a lot. Tiredness was associated with femal  gender, non-white race/ethnicity, 
certain medical conditions (sleep problems, chronic pain, emotional problems), greater 
comorbidity, and more depressive symptoms. Tiredness at baseline was associated with 
worse baseline function, which persisted during three-year follow-up. Functional status 
impairment persisted in adjusted models for chronic conditions. Those not tired at 
baseline experienced a similar rate (but not severity) of functional decline. 
Sleep disorders such as sleep apnea, insomnia, poor sleep quality, and restless leg 
syndrome may contribute to fatigue through metabolic and energetic abnormalities 
(Alexander et al., 2010). Sleepinenes is commonly repo ted in the the context of fatigue. 
Underlying mechanisms of fatigue are not well understood but hypotheses are that it is 
associated with dysregulation of physiologic systems, early manifestations of subclinical 
disease, inflammation, increased biologic effort to maintain homeostasis, mitochondrial 
dysfunction, changes in white matter in the brain and neurological aberrations, and 
oxidative stress (Alexander et al., 2010; Avlund et al., 2006; Hardy & Studenski,  2008).  
79 
 
Fatigue is ubiquitous in health and illness states cross the life span and should 
not be dismissed as “just an unpleasant symptom” (Hardy & Studenski, 2008, p. 1391). 
Fatigue is poorly recognized, under-treated, and contributes to poor quality of life and 
considerable risk for frailty (Liao & Ferrell, 2000). 
Urinary incontinence. Urinary incontinence (UI) is a common problem in adults 
that becomes more prevalent in men and women at midlife and with advancing age. 
Higher rates of UI are found in women compared to men due to anatomic differences and 
consequences of vaginal delivery and multiparity. In older adults, UI is often due to 
functional impairments, comorbidity, and medications but lifestyle issues such as under-
hydration, caffeine consumption, and constipation are influential factors that are 
treatable. Symptoms associated with different types of UI include urinary urgency, 
frequency, nocturia, nocturnal enuresis, leakage during physical activity or increased 
intra-abdominal pressure (cough, sneeze, bend over,lift heavy object). UI is with bladder 
outlet obstruction and urinary retention with overflow urine leakage that is commonly 
due to an enlarged prostate gland in men or cystocele in women (DuBeau, Kuchel, 
Johnson, Palmer, & Wagg, 2010; Gammack, 2004). 
Negative psychosocial consequences and reduced quality of life attributed to UI 
have been well documented (Bogner, 2004; Bogner & Gallo, 2004; Bogner,  
Gallo, Sammel, Ford, Armenian, & Eaton, 2002; de Vries, Northington, & Bogner, 
2012). UI is also associated with high symptom burden (Walke, Gallo, Tinetti, & Fried, 
2004). UI is an important factor in decisions about n rsing home admission since this 
condition can be challenging and burdensome for individuals to manage and creates 
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additional stress for caregivers. UI is considered a syndrome with multiple interacting 
risk factors such as age-related changes in urinary tr ct structure and function, 
comorbidity, and lifestyle behaviors. Common pathways between these factors produce 
accumulated effects in association with other impairments that arise from or impact 
systems outside of the lower urinary tract (DuBeau t al., 2010). UI is multifactorial, has 
a range of defining characteristics, etiologies, and symptom manifestations, and is 
influenced by medical conditions and situational factors (Inouye et al., 2007). This 
complexity supports the concept that there are potential shared risk factors between UI 
and other syndromes such as falls, functional declin , mobility impairment, delirium, 
cognitive impairment, pressure ulcers, depression, malnutrition, and others (Ensrud et al., 
2007, 2008, 2009;  Inouye et al., 2007; Tinetti et al., 1995). UI is associated with 
recurrent urinary tract infection and frequent hospitalizations in older adults. 
In a study to assess relationships between UI and fr ilty and mortality in two age 
groups of older adults (Sample 1, N = 270, 65–89 years; Sample 2, N = 300, 90–107 
years, Italy), UI was independently and significantly associated with both mortality and 
frailty in those 90 years of age and older (Berardelli et al., 2013). In those 65–89 years of 
age, the correlation between UI and mortality was related to its correlation with frailty. 
However, severe UI was correlated with mortality after adjustment for frailty. The overall 
prevalence of UI in this study was much higher in women compared to men (35.1% and 
13.8%, respectively; p < 0.001). This finding supports increased attention o incontinence 
in women since research indicates there is higher prevalent and incident frailty in women. 
Study findings suggest that UI is related to the home static and physiological decline 
81 
 
associated with frailty. The strong correlation of UI with frailty and mortality warrants 
attention to UI as an indicator or risk factor for railty. 
In a longitudinal population-based survey of older Mexican Americans (N = 2660, 
≥ 65 years, five states) comparing the strength of association between frailty indicators 
(ADL, IADL, performance measures: timed walk, timed chair rise, tandem balance) with 
baseline UI and  new-onset incident UI, incident UI was associated with increased risk of 
more global functional impairment (Miles et al., 2001). Baseline prevalence of UI was 
14.1% and at two-year follow-up, new onset incident UI was 11.6%. In adjusted models, 
prevalent UI was only associated with a 60% increased risk of difficulty walking 8 feet, 
but not other performance measures. However, incidet UI was associated with a twofold 
increased risk of ADL and IADL impairment, and poor performance on all three 
performance measures. This study highlights the importance of new onset of UI as a 
potentially important early indicator for frailty.  
Further support for the role of UI as a risk factor or etiologic pathway for frailty 
was provided by a scientific report from the 4th International Consultation on 
Incontinence (ICS) that provided evidence for multiple pathophysiological mechanisms 
that link UI and frailty. The ICS committee urged increased attention to early recognition, 
assessment, and treatment of UI since there are effective interventions for older adults 
and the very old (DuBeau et al., 2010). Implementation of  UI best practices is imperative 
in hospitalized adults since new onset of UI is common and may be reversible (Roe et al., 
2004). There is a gap in knowledge about relationships between UI and frailty in 
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hospitalized adults and the added value of incorporating systematic UI assessment in 
frailty assessment (DuBeau et al., 2010). 
Activities of daily living. Activities of daily living (ADL) refer to basic self-care 
functions necessary for independent living. The Katz ADL Index is the most widely used 
ADL tool in health science research and consists of six unctions: bathing, dressing, 
toileting, transferring, continence, and feeding (Katz, Ford, Moskowitz, Jackson, & Jaffe, 
1963). Disability refers to the inability to fulfill customary and desired roles due to the 
inability to perform social and work-related tasks independently. The Nagi Disability 
Scale is based on the disablement model and is widely us d in research (Nagi, 1976). The 
scale consists of activities rated according to level of difficulty and includes: (a) pulling 
or pushing a large object; (b) bending over, crouching, or kneeling; (c) raising arms over 
head; (d) picking up or handling small objects with your fingers; (e) lifting something 
that widths over 10 pounds; (f) walking up or down a flight of stairs; and (g) walking one 
mile. The Nagi disability model distinguishes disea from impairments or symptoms in 
the disablement process where symptoms provide the pathway by which disease produces 
functional limitations and disability (Whitson et al., 2009). 
The U.S. Census Bureau reports that disability prevalence was 41% among those 
over 65 years of age compared to 12.3% in the 16-64 year age group and 6.3% in the 5-
15 year age group. Future projections suggest that dis bility may rise and life span may 
be shortened due to the increasing incidence and prevalence of obesity and morbidity 
associated with high body weight (Manton, 2008). 
83 
 
ADL impairment can be a predictor, correlate, and/or outcome of frailty. Mild 
functional limitations may precede ADL impairment ad dependence (Pine, Gurland, & 
Chren, 2000). Fatigue may be a significant factor in the development of ADL impairment 
(Avlund et al., 2007). Modification in task performance may occur before functional 
limitations develop that require adaptation, personal assistance or environmental 
modifications or assistive devices. In a study of older adults (N = 287, Northern 
Manhattan Aging Project/Active Life Expectancy Among Urban Minority Elderly 
Study), walking habits, self-reported difficulty in various walking activities, and gait 
speed, report of slowing down over was significantly associated with decline in gait 
speed at one- and 10-year follow-up (Pine et al., 2000, p. M378). In those reporting 
slowing down, seven percent developed new difficulty walking indoors, 10% experienced 
new difficulty walking outdoors, and 19% stopped walking for pleasure. Slowing down 
was associated with worse self-rated health, lower cognitive function, and increased 
morbidity especially hypertension, arthritis, and joint/muscle pain.  
Preclinical walking disability and unrecognized behavioral adaptations may 
reflect subclinical physiologic changes that signal early frailty since research suggest that 
frailty precedes disability and there are only modest correlation between the two (Fried et 
al., 2005; Pine et al., 2000). For example, in the Cardiovascular Health Study, 21.5% 
were frail with ADL disability and morbidity (Fried, Tangen, et al., 2001). Among this 
group, 27% could not complete ADLs and 60% had difficulty with IADLs (Fried et al., 
2004). In the Women’s Health Initiative-Observational Study, of the 16.3% who were 
frail at baseline, 5.9% had significantly greater ADL disability, compared to 0.7% in the 
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nonfrail group (Fugate Woods et al., 2005). In the MacArthur Study of Successful Aging, 
28% classified as frail by the CHS Frailty criteria and 39% classified as frail by CHS 
Frailty criteria plus criteria for cognitive function, subjective weakness, anorexia, IL-6, 
and CRP, had neither disability nor morbidity (Sarkisian et al., 2008).  
Consensus conference expert panels recommend excluding measures of ADL 
function and disability in frailty assessment since in theory, the two are distinctly 
different phenomenon, frailty precedes disability, disability can exist without evidence of 
frailty, and ADL impairment or disability are not requisite criteria for frailty (Abellan van 
Kan, Rolland, Bergman, et al., 2008; Abellan van Kan et al., 2010; Bergman et al., 2007; 
Rodríguez-Mañas et al., 2012; Sternberg et al., 2011). In a study comparing different 
definitions of frailty, a definition based on ADL limitations under-estimated frailty, while 
the addition of IADL impairment or cognitive limitation provided more clinically 
plausible estimates suggesting that frailty prevalence can vary considerably if disability is 
included in the definition (The Canadian Study of Health and Aging Working Group, 
2001). Progression of functional decline and disability may not mirror the natural history 
of frailty (Fried et al., 2005). However, the boundaries between disability and frailty blur 
at advanced ages. Different causal pathways may contribute to each of their development 
but over time their co-occurrence has a synergistic impact on the development of frailty. 
Assistive devices. Assistive devices are prosthetics that enhance physical function 
in ADLs or IADLs. The need for an assistive device indicates the presence of a gait 
and/or balance disorder or functional limitation that requires adaptation for self-care, 
mobility, safety, and independence. Although intended to promote safety, assistive 
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devices can increase risk for falls and injury (Speechley & Tinnetti, 1991). In one study, 
use of an assistive device prior to hospitalization was associated with decline in walking 
ability and progressive and irreversible functional decline (Mahoney, Sager, & 
Jalaluddin, 1988). 
Medication. Medication usage is common in adults. The number of prescription 
and nonprescription medications increase with age primarily as a consequence of 
comorbidity and the need for symptom management. Persons with multiple morbidity 
often require treatment by several health care providers. Inter-provider communication 
can be fragmented which adversely impacts medication reconciliation, medication errors, 
polypharmacy, PIM and risk for adverse drug events, cognitive and functional 
impairment, falls, adherence problems, and health cre utilization (Fulton & Allen, 2005; 
Hajjar et al., 2007; Inouye et al., 2007; Page, Linnebur, Bryan, & Ruscin, 2010).  
 Polypharmacy is defined as “the use of multiple medications and/or the 
administration of more medications than are clinically indicated, representing 
unnecessary drug use” (Hajjar, Cafiero, & Hanlon, 2007, p. 345). Potentially 
inappropriate medication (PIM) is defined as the usof medications that are not clinically 
indicated or pose a hazard to the person (Fulton & Allen, 2005). Certain types of 
medications are considered high risk or contraindicated in the elderly, and if used, must 
be used with caution with appropriate monitoring (Hajjar et al., 2007; Murphy, Agostini, 
Van Ness, Peduzzi, Tinetti, & Allore, 2008; The American Geriatrics Society 2012 Beers 
Criteria Update Expert Panel, 2012). In one study, taking two drugs was associated with a 
13% risk of adverse drug-drug interactions and taking four drugs increased the risk to 
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38% (Goldberg, Mabee, Chan, & Wong, 1996). In a study of emergency department 
visits by older adults, where one-third of visits involved prescription medication, adverse 
drug events were common (Budnitz, Shehab, Kegler, & Richards, 2007). Limiting 
numbers of medications may be challenging or counterproductive in persons with 
multiple chronic diseases (Fulton & Allen, 2005; Page et al., 2010).  
Vision. Vision problems are common in older adults even in the absence of 
diagnosed eye disease. Data from the National Health Interview Survey indicate that 17% 
of adults ≥ 65 years report visual problems even when vision is corrected with glasses or 
lenses (Federal Interagency Forum on Aging-Related S atistics, 2010). Vision 
impairment has a direct adverse effect on physical function, ADL and IADL 
performance, disability, social interaction, cognition, depression, falls risk, morbidity, 
and mortality (Bookwala & Lawson, 2011; Klein, Moss, Klein, Lee,  & Cruickshanks, 
2003; Klein, Klein, Knudtson, & Lee, 2005; Whitson et al., 2007; Whitson, Ansah, et al., 
2010). In the North Carolina Established Populations for the Epidemiologic Studies of 
Elderly (EPESE; N = 3,878), those with visual and cognitive impairment had three to six 
times the odds of disability, poorer self-rated health, depression, and comorbidity 
(Whitson et al., 2007). In adjusted models, visual and cognitive impairment strongly 
predicted ADL, IADL, and mobility disability. In the National/Social Life, Health, and 
Aging Project (N = 1,178, 57–85 years), poor self-rated vision contribu ed to depressive 
symptoms by predicting more physical limitations and social isolation (Bookwala & 
Lawson, 2011). In the Beaver Dam Study (N = 2,962, 43–86 years), a frailty index that 
included vision assessment (best-corrected distance visual acuity, contrast sensitivity), 
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gait velocity, timed chair stands, peak expiratory flow rate, and hand grip strength found 
that severe frailty was significantly associated with the poorest visual acuity and contrast 
sensitivity, when controlling for age (Klein, Klein, Knudtson, & Lee, 2003). Using data 
from direct measurement of vision versus diagnosed cular disease in the frailty index 
was based on the premise that frailty is a state of compromised integrated function rather 
than the result of a specific ocular disease. Including measured visual acuity in frailty 
assessment may improve prediction of outcomes (Knudston, Klein, & Klein, 2009).  
Falls. Population studies indicate that the prevalence of falls in older adults is 
30%-60% annually, and 10%-20% of falls result in injury, hospitalization, or mortality 
(Rubenstein, 2006). In community older adults, about 40% will fall at least once a year 
and one in 40 will require hospitalization (Rubenstin, 2006). In a study of 200 
consecutive falls experienced by hospitalized adults on medicine and surgery units, of 
those who had one fall (n = 183), 42% sustained an injury and 8% had moderate to severe 
injury (Hitcho et al., 2004). The high incidence of falls in older adults and susceptibility 
to injury due to morbidity and age-related changes (e.g., delayed reflex responses, 
decreased bone density) can make any fall dangerous (Rubenstein, 2006). Fear of falling 
may increase fall risk through abnormal alterations in gait and posture and reduced 
physical activity with resultant muscle deconditioning, weakness, and poor balance 
(Rubenstein, 2006).  
There is substantial evidence for associations betwe n falls, frailty and poor 
outcomes (Ensrud et al., 2008, 2009; Nowak & Hubbard, 2009; Samper-Ternent R., 
Karmarkar, Graham, Reistetter, & Ottenbacher, 2012; Speciale, Turco, Magnifico, 
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Bellelli, & Trabucchi, 2004). In a study of community elderly (N = 336), frailty was 
defined by criteria for three levels: Frail, Transitional (criteria for both frail and 
vigorous), and Vigorous (Speechley & Tinetti, 1999). The Frail group was older, had 
more comorbidity, depression, cognitive impairment, functional disability, medications, 
and a history of falls. At one-year follow-up, the prevalence of falls was 52% in the Frail 
group, 32% in the Transition group, and 17% in the Vigorous group. In the Frail group, 
6% of falls resulted in serious injury compared to 22% in the Vigorous group.  
In the Study of Osteoporotic Fractures (SOF) in Older Women (N = 6,724, ≥ 69 
years), frailty was defined by a three-component index based on the CHS Frailty criteria 
(weight loss, inability to rise from a chair five times without using arms, reduced energy 
level; Ensrud et al., 2007). Eleven percent of women experienced more than two falls. In 
adjusted models, frail women had significantly more recurrent falls (multivariate OR 
[MOR] = 1.38, 95% CI, 1.02–1.88), hip fracture (multivariate hazards ratio [MHR] = 
1.40, 95% CI, 1.03–1.90), and non-spine fracture (MHR = 1.25, 95% CI, 1.05–1.49). Risk 
for falls, fracture, and mortality persisted with age and across BMI categories. During 
nine-year follow-up, 31% experienced non-spine fracture and 10% experienced hip 
fracture. Frail women were at greater risk for fracture (HR = 1.7, 95% CI, 1.35–2.15) 
compared to robust women. Similarly, in the Study of Osteoporotic Fractures (SOF) in 
Men (N = 3,132, ≥ 67 years) frail men had a significantly higher age- djusted risk of 
recurrent falls (OR = 3.0-3.6), disability (OR = 5.3-7.5), non-spine fracture (HR = 2.2–
2.3), and mortality (HR = 2.5–3.5; Ensrud et al., 2009). In the Women’s Health Initiative-
Observational Study, frailty and intermediate frailty were significantly associated with 
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hip fracture (adjusted HR = 1.6; 95% CI, 1.2–2.2 and adjusted HR = 1.3; 95% CI, 1.0–
1.7, respectively; Fugate Woods et al., 2005). 
The Hispanic Established Population for the Epidemiological Study of the Elderly 
(N = 847) found that frailty significantly increased the odds of falls (Samper-Ternent et 
al., 2012. Falls were associated with female gender, history of falls, functional 
impairment, single partner status, and poor health. The odds of falling was highest for 
poor balance (OR = 1.49; 95% CI, 1.15- 1.95), prefrail status (OR = 1.36; 95% CI, 1.11- 
1.67), and history of falls (OR = 1.26; 95% CI, 1.15- 1.37). 
Dyspnea. Dyspnea is defined as difficult or labored breathing a d shortness of 
breath. Dyspnea is a symptom that cross-cuts many medical conditions, lifestyle 
behaviors, and environmental factors. In a study to examine pulmonary function and 
respiratory symptoms in older adults (N = 2480, ≥ 65 years, NHANES III) where 55.4% 
had a smoking history and 44.2% had respiratory sympto s, at 12-year follow-up, 35% 
had expired. Poor performance on pulmonary function tests (7.7% to 13.4% of sample) 
was significantly associated with a higher prevalence of respiratory symptoms and 
increased mortality (Vaz Fragoso, Cancato, et al., 2009). 
COPD has a profound effect on physical activity dueto poor lung function, 
oxygenation, and dyspnea. In a study to examine exercise capacity and lung function in a 
sample of disabled, frail women (N = 547, ≥ 65 years, WHAS-I, plus 131 additional 
women), exercise capacity was lower among the frail compared to nonfrail for all 
exercise parameters that included exercise testing (seated step test), cardiac function 
(chronotropic index), pulmonary function (forced vital capacity), and musculoskeletal 
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function (quadriceps strength; Weiss, Hoenig, Varadhan, Simonsick, & Fried, 2010).  In 
women with poor quadriceps strength, frailty was associated with lower exercise 
capacity, physical and pulmonary function, and mobility and this effect became stronger 
as pulmonary function worsened. 
Inflammatory biomarkers have been used to evaluate disease severity and 
treatment response. In a review paper analyzing intervention studies in older adults with 
various chronic diseases, increased serum CRP and IL-6 levels were associated with 
poorer physical function, independent of age, gender, race, body composition, and 
disease status including COPD (Brinkley et al., 2009). For example, in an exercise 
intervention for COPD (N = 160, 55–80 years). Elevated plasma CRP level (M = 4.3, 
range, 1.9–9.2, normal < 3 mg/L) and slow gait speed w re indicators of disease severity, 
symptoms, poor function, and frailty. In a second study using the Short Physical 
Performance Battery, COPD was significantly associated poor physical performance and 
muscle loss, which are important frailty components (Guralnik et al., 2000).  
In a study to determine if frailty predicted mortality in persons with and without 
COPD (N = 13,288; n = 489 with COPD, n = 12,799 without COPD), mortality was 
significantly higher in those with COPD (60.7%) compared to those without COPD 
(48.1%) at 12-year follow-up (Galizia et al., 2011). As level of frailty increased, mortality 
increased, from 41.7% -75.1% in those without COPD and from 54.3% - 97% in those 
with COPD. Increasing frailty scores increased long-term mortality by 34% in those 
without COPD (HR = 1.34 for each unit of increase; 95% CI, 1.02–1.81; p < 0.05) and by 
80% with COPD (HR = 1.80 for each unit of increase; 95% CI, 1.28–2.53; p < 0.001). In 
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multivariate analysis, both COPD (HR = 1.34; 95% CI, 1.02–1.81; p = 0.042] and frailty 
score (HR = 1.69 for each unit of increase; 95% CI, 1.42–2.00; p < 0.001) were predictive 
of long-term mortality.  
 Poor appetite and anorexia. Decline in appetite and food consumption is 
considered normative as people age. Decreased intake is related to decline metabolic rate 
and caloric needs due to lower levels of physical ativity and reduced lean body mass and 
bioactive muscle which results in reduced metabolic demand. Poor appetite and reduced 
food consumption is also related to medications that alter taste and smell sensation and 
cause dry mouth, early satiety, and loss of appetite through central nervous system 
effects. Anorexia is an eating disorder distinguished by markedly reduce appetite, early 
satiety and inadequate food consumption, and total aversion to food (MedicineNet.com, 
2012). In older adults, anorexia was primarily attributed to chronic disease until Morley 
and Silver (1988) defined the syndrome “anorexia of ging” to reflect a pathophysiologic 
origin that leads to malnutrition (as cited in Cornali, Franzoni, Frisoni, & Trabucchi, 
2005, p. 354). In later stages of frailty, poor appetite, anorexia, malnutrition, cachexia, 
and fatigue often coexist (Jeejeebhoy, 2012). 
In the SENECA study (Survey in Europe on Nutrition and the Elderly, a 
Concerted Action), independent-living older adults (N = 859, 75 to 80 years, from nine 
countries), inactivity and weight loss were examined to determine if these two frailty 
criteria analyzed in different combinations were significantly associated with health 
status, physical function, and frailty (Chin A Paw et al., 2003). Compared to the weight-
stable, active reference group, both the inactive, weight losing group and the inactive 
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group reported significantly more chronic disease, disability, medication use, need for 
care, and poorer physical performance.  
In a study that evaluated relationships between anorexia and physical 
performance, muscle strength, and functional status in older persons (N = 364, ≥ 80 years, 
ilSIRENTE study, Italy; Landi, Russo, et al., 2010) the prevalence of anorexia (loss of 
appetite, lower food intake) was 20% and all physical performance measures were 
significantly associated with anorexia. Participants with anorexia had significantly slower 
walking speed, higher risk of disability, and were more likely to become frail. Poor 
appetite and anorexia may not be directly associated with disease thus early detection is 
important since prompt treatment increases the probability of success of nutritional and 
other interventions. Poor appetite, low nutrient intake, and anorexia are associated with 
frailty and mortality, thus early attention is warrnted (Cornali et al., 2005).  
 Pressure ulcers. Pressure ulcers are important quality indicators in hospitalized 
adults. A pressure ulcer is localized injury to the skin and underlying tissue that usually 
occurs over a bony prominence as a result of unreliev d pressure, or pressure in 
combination with shearing forces, friction, and/or moisture (National Pressure Ulcer 
Advisory Panel, 2007). Hospital prevalence ranges from 4%- 38% (Armstrong et al., 
2008; Bolton, 2007; C. C. Chen et al., 2011; Donini et al., 2005). The CMS and Centers 
for Disease Control and Prevention (CDC) analyzed Micare data to identify conditions 
that were high cost and/or high volume and reviewed evi ence-based guidelines to 
determine conditions that were “reasonably preventable” (Armstrong et al., 2008). 
Pressure ulcers were the most common complicating co dition with 257,412 cases of 
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hospital-acquired Stage III or IV ulcers costing an average of $43,180 per hospital stay. 
CMS changes authorized by Congress in the Deficit Reduction Act of 2005 addressed 
prevention of medical conditions for which there were vidence-based guidelines 
(Armstrong et al., 2008). For example, since October 2008, CMS classified pressure 
ulcers as preventable Hospital-Acquired Conditions (HAC) that will not be reimbursed in 
accordance with current guidelines.  
In a retrospective study of frail hospitalized patien s with pressure ulcers, 46.5% 
resolved, but only 31.2% improved (Donini et al., 2005). Pressure ulcer healing was 
worse in frail patients. Resolution or improvement in pressure ulcers occurred in 87.2% 
who showed improved frailty status, but in those whose frailty status worsened, only 
27.3% of pressure ulcers improved. Pressure ulcers and frailty are syndromes with 
multifactorial etiologies and potential shared risk factors (Campbell, 2009; Donini et al., 
2005; Inouye et al., 2007). In a study of frailty in older hospitalized adults admitted for 
abdominal surgery, where frailty was defined by a 39-item deficit accumulation index, 
the only significant predictor of post-operative complications was the Braden Scale, a 
validated pressure ulcer risk assessment instrument (R. R. Cohen et al., 2012). The 
Braden Scale aggregates multidimensional aspects of biopsychosocial vulnerability that 
may similarly portray the multisystem dysregulation associated with frailty. 
Weakness. Muscle weakness is a common symptom in older adults and is 
associated with poor physical function, ADL dependence, disability, and frailty (Avlund 
et al., 2007; Walke et al., 2004). Weakness is important in older adults with comorbidity 
due to interactions among multiple pathologic conditions and acute illness that contribute 
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to mobility impairment and reduced physical activity, functional limitations, disability, 
and dependence (Whitson et al., 2009). In a secondary an lysis of data for three 
medically-different cohorts of community-living older adults to describe correlations 
between symptom burden and the impact of symptoms and symptom clusters on mobility 
function, weakness was significantly associated with frailty across multiple chronic 
disease groups (Whitson et al., 2009). The three cohorts were defined as the 
cardiorespiratory fitness cohort (n = 15), the vertebral fractures cohort (n = 211), and the 
Parkinson’s disease cohort (n = 61). Measures included a symptom scale, disease scal , 
Medical Outcomes Study 36-item Short Form Survey (SF-36) Physical Functioning 
Scale, the Nagi Disability scale, 10-meter walk time, and timed supine to stand test. The 
most prevalent chronic disease was arthritis and the most commonly reported symptoms 
were shortness breath on exertion, pain, memory loss, fatigue, and anxiety. In the fitness 
cohort, the most explanatory three symptom model was muscle weakness, pain, and 
shortness of breath at rest, but weakness was the most explanatory single symptom. In 
these three cohorts, correlations between symptoms and mobility function were as strong, 
or stronger, than correlations between chronic disease and mobility function (Whitson et 
al., 2009). This study highlights the importance of symptom assessment that cross-cut 
multiple chronic conditions. Symptom management must be carefully tailored to reduce 
symptom burden while minimizing adverse side effects and preventing or immediately 
addressing treatment consequences that worsen some symptoms or create new ones. 
Ineffective symptom management may lay the groundwork for a pathway to frailty. 
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In longitudinal and cohort studies, there is strong support for direct measurement 
of muscle strength (Bandeen-Roche et al., 2006; Fried, Tangen, et al., 2001; Fugate 
Woods et al., 2005; Xue et al., 2008). In a study to examine CRP and four physical 
performance measures (handgrip strength, timed one-leg stand, gait speed at usual and 
maximal speed) in community older adults (N = 803, ≥ 65 years, Japan), high CRP was 
significantly associated with poor physical performance for all measures: handgrip 
strength (OR = 2.92; 95% CI, 1.53–5.58), timed one leg stand (OR = 1.96; 95% CI, 1.28–
3.00), maximal walking speed (OR = 2.46; 95% CI, 1.23–4.93; Yoshida, Iwasa, 
Kumagai,Yoshida, & Suzuki, 2010). Handgrip strength and walking speed are significant 
predictors of frailty (Fried, Tangen, et al., 2001; Fugate Woods et al., 2005). 
Chronic systemic inflammation is associated with the aging process and with 
decline in muscle mass and strength, and weakness. The magnitude of chronic 
inflammation plays a direct role in age-related declin  in physical function and morbidity 
through release of pro-inflammatory cytokine IL-6, a mediator of the acute inflammatory 
responses that stimulates hepatic production of CRP(Ershler, 1993). Inflammatory 
biomarkers have a catabolic effect on muscle mass that contributes to muscle weakness. 
High serum IL-6 level is associated with high CRP, sarcopenia, muscle atrophy, decline 
in muscle quality and power, and weakness, factors that are pathologic in the 
development of frailty (Ershler & Keller, 2000). 
Inflammation has a fundamental role in the pathogenesis of frailty. Chronic low-
grade inflammation contributes directly, or through intermediary mechanisms, to increase 
risk factors for frailty. Circulating inflammatory biomarkers such as CRP, hs-CRP, IL-6, 
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and tumor necrosis factor-alpha (TNFα) are associated with decreased muscle mass and 
strength, sarcopenia, weakness, poor physical performance, disability, morbidity, and 
mortality (Cesari et al., 2004; Ferrucci et al., 200 ; Leng et al., 2002, 2007; Maggio, 
Guralnik, Longo, & Ferrucci, 2006; Reuben et al., 200 ; Schaap et al., 2009). Both 
longitudinal and cross sectional studies have linked poor function and mobility, all-cause 
mortality, and frailty with high levels of inflammatory biomarkers (Cesari et al., 2004; 
Ferrucci et al., 2002; Reuben et al., 2002; Puts et al., 2005; Taaffe, Harris, Ferrucci, 
Rowe, & Seeman, 2000; Walston et al., 2002). High inflammatory biomarkers may be a 
clinical manifestation of inflammageing, high oxidative stress, and age-related damage 
that cause cellular and organ dysfunction, processes that are integral in the development 
of atherosclerosis, osteoporosis, sarcopenia, and others (De Martinis et al., 2005; 2006; 
Maggio et al., 2006).  
C-Reactive Protein (CRP) and hs-CRP.  CRP is a biomarker of inflammation 
and an acute phase reactant. An elevated CRP level is a nonspecific indicator of 
inflammation and is associated with the pathogenesis of disease. An acute phase response 
with rapid increases in CRP occur in conditions associated with inflammation, bacterial, 
viral, or fungal infection, trauma, tissue injury, tissue necrosis, malignancy, and 
autoimmune disorders. These conditions cause release of IL-6 and other cytokines that 
trigger the synthesis of CRP and fibrinogen by the liver. An elevated CRP level does not 
diagnose a specific disease since many conditions ca  increase CRP production. High-
sensitivity CRP (hs-CRP) is the same analyte as CRPbut newer assay equipment is able 
to detect CRP at lower levels. Most of the literatue on hs-CRP pertains to cardiovascular 
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risk assessment (Bassuk, Fifai, & Ridker, 2004). CRP is used commonly in inflammatory 
and infectious diseases. Until new assays for analyzing CRP and hs-CRP became 
available, the erythrocyte sedimentation rate (ESR) test was used to gauge nonspecific 
systemic inflammatory activity. This test is used lss often because CRP is considered a 
more reliable acute phase reactant with stable performance under acute and chronic 
conditions (Pepys & Hirschfield, 2003). 
During the acute phase response, CRP levels rapidly increase within two to six 
hours of the acute insult, reaching peak concentration t 48 hours. CRP has a short half-
life of 19 hours (Peppys & Hirschfield, 2003). CRP levels may increase up to 50,000-fold 
in acute inflammation, such as infection. The rapid rise in CRP is due to a rise in plasma 
concentrations of IL-6, which is produced predominantly by macrophages and 
adipocytes. CRP half-life is constant under all conditions of health and disease since 
serum concentrations are determined by the rate of production which reflects the 
precipitating cause (Pepys & Hirschfield, 2003). Surgery increases CRP levels but CRP 
returns to baseline during uncomplicated post-operativ  recovery within eight days 
(Pepys & Hirschfield, 2003). Since 1973, assessment of serum CRP has been advocated 
as an objective measure of inflammatory and infectious disease activity, progression and 
severity, and response to treatment (Otterness, 1994).  
 The reference range for normal CRP is < 3 mg/L. CRP between 3-10 mg/L 
suggests chronic inflammation. CRP > 10 mg/L indicates significant inflammatory 
disease (most often infectious or autoimmune) althoug  higher levels can be detected in 
genetically predisposed individuals. The reference range for hs-CRP is 1-3 mg/L, but 
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normal assays can be .1 mg/L or undetectable. High levels of CRP and hs-CRP are 
associated with cardiovascular risk (Ndumele et al., 2006). Greater than half of adults 55 
years of age and older have hs-CRP levels > 2 mg/L and 95% have levels < 10mg/L 
(Windgassen, Funtowicz, Lunsford, Haris, & Mulvagh, 2011).  
African-Americans have higher baseline CRP and hs-CRP levels compared to 
Whites. In a study of middle-aged African American men and women, there were strong, 
independent associations of higher CRP and poor physical performance, upper and lower 
extremity limitations, and disability, independent of chronic disease in adjusted models 
(Haren et al., 2010). Higher CPR or hs-CRP levels were associated with multifactorial 
processes that affected physical, cognitive, social, emotional, and behavioral decline.  
CRP levels increase with age and in the context of chronic disease, chronic low-
grade inflammation (e.g., periodontitis, cytomegalovirus), lifestyle behaviors (low 
physical activity, smoking, stress associated with inadequate social support), high 
antigenic load, and alterations in the immune system (Cesari, 2003a, 2003b; Ford, 
Loucks, & Berkman, 2006; Nielsen et al., 2007). In the InCHIANTI study (N = 871, ≥ 65 
years, Italy) elevated inflammatory cytokines IL-6, CRP, and IL-1 receptor antagonist 
were associated with poor muscle strength and sarcopenic obesity in adjusted models 
(age, sex, education, smoking, physical activity, comorbidity; Schrager et al., 2007). 
In the Cardiovascular Health Study, elevated CRP levels independently predicted 
incident frailty at nine-year follow-up (Barzilay et al., 2007). In the Longitudinal Aging 
Study of Amsterdam (LASA) study, moderately elevated CRP was associated with 
incident frailty (Puts et al., 2005). In a sub-cohort of the Cardiovascular Health Study (n 
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= 3141, 69–74 years, nonfrail, no inflammatory disease, nine-year follow-up), elevated 
WBC, CRP, and IL-6 were each significantly associated with incident frailty, but only 
CRP remained significant in adjusted models (Barzily et al., 2007). In the Women’s 
Health Initiative-Observational Study, higher WBC counts and IL-6 levels were 
independently associated with prevalent frailty (Fugate Woods et al., 2005).  
In a prospective study of frailty in older adults (N = 1,720 at inception, ≥ 65 years, 
n = 1,509 at three-year follow-up, Longitudinal Agin Study Amsterdam [LASA] study), 
the association of CRP, IL-6, serum of 25-hydroxyvitamin D [25(OH)D]), insulin growth 
factor-1(IGF-1) and frailty was investigated (Puts e  al., 2005). Frailty was defined by the 
presence of three of nine multidimensional indicators. At baseline, the 19% who were 
frail had significantly higher CRP and lower 25(OH)D levels. In adjusted models, low 
25(OH)D but not CRP remained significantly associated with frailty. Incident frailty was 
14.1% in those who were nonfrail at baseline. In adjusted models, incident frailty was 
significantly associated with moderately elevated CRP (3-10 mcg/ml) (OR = 1.69; 95% 
CI, 1.09–2.63) and low 25(OH)D (OR = 2.04; 95% CI, 1.01–4.13. Neither IL-6 nor IGF-
1were associated with frailty. 
In the longitudinal InCHIANTI study of community older adults (N = 716, ≥ 65 
years, Italy), an index of seven serum biomarkers associated with up-regulation and 
down-regulation of inflammation was assessed for associations with mobility and frailty 
(Stenholm et al., 2010). Increased up-regulation of IL-6, CRP, and other inflammatory 
mediators was significantly associated with slower gait speed and low physical activity 
and a 32% increase in the odds of being frail. CRP level was borderline significant but 
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IL-6 was significantly associated with frailty. Grip strength was evaluated in relation to 
biomarkers that have catabolic effects on muscle streng h: CRP, IL-6, IL-1 receptor 
antagonist (IL-1RA), TNF-α receptor 1, dehydroepiandrosterone sulfate (DHEA-S), 
insulin-like growth factor-1 (IGF-1), and testosterone. The rate of decline in grip strength 
was significantly greater as the number of abnormal levels catabolic biomarkers 
increased. Increased number of elevated catabolic bi markers predicted muscle strength 
decline better than a single biomarker, suggesting that systemic catabolic dysregulation is 
an important mechanism associated with decline in muscle strength and risk for frailty. 
Low level of physical activity is significantly associated with elevated levels of 
inflammatory biomarkers. In from the MacArthur Studies of Successful Aging and the 
Established Population of Epidemiologic Studies in the Elderly (EPESE), low levels of 
moderate and strenuous physical activity were related to higher IL-6 and CRP levels, and 
these findings persisted in adjusted models controlled for age and BMI. IL-6 and CRP 
significantly correlated with each other and were significantly associated with lower 
plasma albumin level (Taaffe et al., 2000). High intensity physical activity and exercise 
has been shown to reduce levels of inflammatory biomarkers while the presence of 
chronic disease is associated with high levels of inflammatory biomarkers (Brinkley et 
al., 2009; Mohandas et al., 2011; Walther et al., 2008). In a cross-sectional study of high 
functioning older adults to determine relationships between physical activity and serum 
levels of CRP and IL-6 (N = 870, 70–79 years), higher participation in house/yard work 
and recreational activity were significantly and inependently associated with lower 
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CRP. Low physical activity and overall sedentary behavior increased risk for frailty 
(Kaiser, Bandinelli, & Lunenfeld, 2010; Mohandas et al., 2011). 
Chronic infection is associated with low grade inflammation. Recent evidence 
indicates that chronic infection contributes to morbidity and mortality through increased 
inflammation and its impact on systemic changes that lead to disease and frailty 
(Schmaltz et al., 2005). In the Women’s Health and Aging Study I & II, relationships 
between chronic cytomegalovirus (CMV) infection, IL-6, and frailty were examined (N = 
724, 70–79 years; Schmaltz et al., 2005). In this study, 87% of women were seropositive 
for CMV infection. In adjusted models, chronic CMV infection was associated with 
frailty and prefrailty (AOR = 3.2, p = 0.03; CMV prefrail AOR = 1.5, p = 0.18). High IL-6 
interacted with CMV and significantly increased therisk for frailty but had little effect on 
frailty when IL-6 levels were low (CMV positive and low IL-6, frail AOR = 1.5, p = 0.53; 
CMV positive and high IL-6, frail AOR = 20.3, p = 0.007; CMV positive and low IL-6 
prefrail AOR = 0.9, p = 0.73; CMV positive and high IL-6 prefrail AOR = 5.5, p = 0.001; 
Smaltz et al., 2005). Frail women had slower gait speed and higher BMI.  
Socioeconomic status (SES) and CRP were examined in a ults ≥ 20 years of age 
from the Fourth NHANES cohort (N = 7634; Alley, Seeman, Kim, Karlamangla, Hu, & 
Crimmons, 2006). Socioeconomic variation occurred only at very high levels of serum 
CRP and was strongly significant when family income was at or below the poverty level. 
Acute illness, chronic conditions, and health behaviors accounted for two-thirds of the 
association between SES and CRP. African Americans, Hispanics, and women were 
more likely to have high CRP levels. Study findings support associations of SES stressors 
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with chronic inflammation and high CRP levels. In a meta-analysis examining acute 
psychological stress, inflammation, and psychobiological mechanisms underlying 
hypertension, activation of autonomic and neuroendocrine pathways and sympathetic and 
adrenal pathways resulted in increased levels of inflammatory biomarkers such as IL-6 
and CRP (Steptoe et al., 2007).  
In the Fourth National Health and Nutrition Examinat on Survey, the association 
between socioeconomic status and CRP was examined in adults over the age of 20 years 
(N = 7,634; Alley et al., 2006). Variation in CRP among different SES groups occurred 
only at very high levels of CRP (> 10 mg/L). Low SE, defined by family income at or 
below the poverty level, was associated with signifcantly higher CRP. Among low SES 
families, 15.7% had very high levels of CRP (> 10 mg/L) compared to 9.1% of families 
above the poverty level. Among adults with moderate (1.1–3 mg/L) or high CRP (3.1–10 
mg/L), there were no significant differences by SES. African Americans, Hispanics, and 
women were more likely to have higher levels of CRP. Obesity was the predominant risk 
factor for every level of CRP above normal. In regression models, acute illness, chronic 
disease, and health behaviors accounted for about tw -thirds of this association. Study 
findings suggest that very high CRP may be due to factors beyond acute illness and 
reflect chronic disease, lifestyle behaviors, and other factors associated with low SES. 
Albumin. Serum albumin is an indicator of health, disease, nutritional status, and 
inflammation (Corti, Guralnik, Salive, & Sorkin, 1994; Okamura et al., 2008). Serum 
albumin is the primary protein synthesized by the liv r and the most plentiful protein in 
the blood. It has five main functions: (a) maintenance of 75%–80% of intravascular and 
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interstitial colloid osmotic pressure in plasma; (b) binding and transport of free fatty 
acids, calcium, steroid hormones, and certain drugs; (c) free radical scavenging; (d), 
platelet function inhibition though anticoagulant ad antithrombotic effects; and (e) 
vascular permeability by acting as a reservoir for nitrous oxide and arteriol relaxation 
(Don & Kaysen, 2004). The rate of albumin synthesis is affected by nutrition and 
inflammation (Don & Kaysen, 2004). Adaptive responses are activated when nutritional 
protein intake is reduced but in the context of inflammation, albumin metabolism is 
altered (Don & Kaysen, 2004).  
Prealbumin is also used to assess protein status. Albumin has a long half-life, 
about 20 days and a large serum pool, and indicates a stable state of protein deficiency. 
Prealbumin has a shorter half-life, 2 days, a smaller serum pool, and is more sensitive to 
acute changes in nutritional status (Beck & Rosenthal, 2002). A shorter half-life permits 
frequent evaluation of nutritional status. In contras , changes in albumin level would not 
be detectable for several weeks thus albumen level provides a longer term picture of 
nutritional status. Guidelines suggest serum albumin be measured on admission and if 
low (< 3.2 g/dL), then prealbumin should be tested (Beck & Rosenthal, 2002). In high 
risk or malnourished patients, prealbumin should be part of nutritional assessment. 
Albumin is a negative acute-phase reactant in the inflammatory process. As an 
inflammatory biomarker, low albumin is associated with increased levels of CRP and 
other acute phase proteins such as WBC count (Nelson t al., 2000; Visser et al., 2005) 
and cytokines (Hazzard, 2001). Physiologic mechanisms that lead to alterations in the 
immune system include normal aging, development and progression of acute illness and 
104 
 
chronic disease, vulnerability to frailty and risk for mortality (Herrmann, Safran, Levkoff, 
& Minaker, 1992). Under dynamic conditions, activaton of a proinflammatory state 
releases cytokines (IL-6, TNF-α), positive acute-phase proteins (CRP), and reduce 
negative acute phase proteins (e.g., albumin; Hazzard, 2001). Low albumin is associated 
with diseases with an inflammatory component, cancer, stroke, trauma, surgical stress, 
diseases that cause protein depletion, poor functional status even among healthy adults, 
and mortality (K. E. Covinsky, Covinsky, Palmer, & Sehgal, 2002; Ferrucci, et al., 2002; 
Herrmann et al., 1992; Nelson et al., 2000; Okamura et al., 2008; Reuben et al., 2000; 
Visser et al., 2005). 
The prognostic significance of serum albumin and IL-6 in healthy, nondisabled 
older adults and mortality was examined in older adults with and without evidence of 
inflammation based on serum IL-6 levels (Reuben et al., 2000). Among older adults with 
low serum IL-6 (low inflammation), low albumin was sociated with an adjusted 
relative risk of 2.1 for 4-year mortality compared to those with higher albumin (Reuben 
et al., 2000). Lower albumin level predicted mortality in healthy older adults in the 
absence of high IL-6. Higher albumin level may have  protective effect in those without 
inflammation but not in those with evidence of inflammation.  
  In hospitalized adults, low serum albumin is a signif cant predictor of longer 
length of stay, complications, readmission, and mortality (Herrmann et al., 1992). In a 
study of medical patients (N = 1,638,  ≥ 65 years), high CRP (> 5 mg/L) and low albumin 
(< 3.5 mg/L) were associated with greater risk of in-hospital death (Iwata, Kuzuya, 
Kitagawa, & Iguchi, 2006). High CRP and low albumin levels were associated with an 
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adjusted relative risk of 3.8 for in-hospital mortality compared with the reference group 
(high albumin, low CRP). When CRP levels were not elevated, low albumin remained 
significantly associated with in-hospital mortality suggesting that higher albumin level 
may have a protective effect. CRP and albumin may operate synergistically. 
In the Health, Aging, and Body Composition Study, low albumin level was 
significantly associated with an l8% loss of appendicular skeletal muscle mass at five-
year follow-up (Visser et al., 2005). Significant associations were found between low 
albumin and high CRP and IL-6. Low albumin was associated with sarcopenia and frailty 
but not low protein intake, morbidity, anti-inflammatory medications, weight training, 
physical inactivity, or body weight.  
Serum albumin was examined as a predictor of disabil ty and mortality among 
frail elders (N = 4,116, 71–102 years). A frailty measure was operationalized by five 
levels of albumin and three levels of physical function (Corti, Guralnki, Salive, & Sorkin, 
1994). Pairing of gradients for albumin and disability classified frailty level. Serum 
albumin levels declined with age, but not all levels were abnormal. The prevalence of low 
albumin (< 35 g/L) was 2.8% in men, 3.2% in women. The prevalence of normal albumin 
(> 43 g/L) was 26.7% in men, 23.6% in women. In adjusted models, low albumin was 
significantly associated with increased all-cause mortality. A strong gradient of mortality 
risk was found in frail elders based on albumin anddisability levels. Within each level of 
disability, albumin levels < 43 g/L identified persons with excess risk of mortality 
compared to those with albumin levels > 43 g/L.  
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Low albumin is an important predictor of mortality, functional decline, and frailty 
in healthy persons and in those with acute illnesses, chronic disease and malnutrition 
(Corti et al., 1994; K. E. Covinsky et al., 2002; Visser et al., 2005). Serum albumin may 
provide clinically important information in frailty assessment since it is a composite 
marker for aging, malnutrition, inflammation, ADL impairment, sarcopenia, and cachexia 
(Arques et al., 2008). Low albumin may be overlooked based on beliefs that albumin 
levels normally decrease with advancing age and in chronic disease despite 
epidemiologic studies that refute this viewpoint (H. H. Keller, 1993). Further study of the 
significance of albumin in hospitalized adults is imperative since low albumin levels are 
prevalent in this population (K. E. Covinsky et al., 2003). 
White blood cell count (WBC). White blood cells and subpopulations of 
leukocytes, neutrophils, and monocytes (and others) play a critical role in innate and 
adaptive immunity and inflammation (Leng, Hung, et al., 2009). WBCs respond to 
infection through phagocytosis as well as production of antibodies. Normal WBC counts 
range from 4,300 (4.3 x109/L) to10,800 (10.8 x109/L), and averages 7,000 (7.0 x109). 
Counts slightly above or below parameters are considered normal. A WBC count of 
3,000–5,000 confers leukopenia, whereas 11,000–17,000 suggests mild leukocytosis. 
 Elevated WBC count is significantly associated with cardiovascular disease, 
mortality, and frailty. The Women’s Health and Agin Study I (WHAS-I) and 
Cardiovascular Health Study documented association of high baseline WBC count, 
excluding acute infection, with increased 5-year all-c use mortality (Leng et al., 2007; 
Leng, Hung, et al., 2009; Leng, Xue, et al., 2009). In the WHAS-I (N = 619, age ≥ 65 
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years), significant associations were found for WBC count and inflammatory biomarker 
IL-6, after adjusting for age, race, smoking, and excluding patients with abnormal WBC 
(Leng, Hung, et al., 2009; Leng, Xue, et al., 2009). 
Hemoglobin. Anemia, defined by the World Health Organization (WHO) as 
hemoglobin concentration < 12 g/dL in women and < 13 g/dL in men, is a common, 
multifactorial condition in older adults (Beutler & Whaalen, 2006). Anemia increases 
with age and ranges from 15%-25% in those ≥ 80 years living in the community and 
48%–63% in those living in nursing homes (Artz, 2011; Landi, Russo, et al., 2010; Patel, 
2008). The Third National Health and Nutrition Examination (NHANES III 1991–1994) 
survey found that 10.2% of community-living older adults were anemic (11% in men, 
10.2% in women), and the incidence doubles at 80 years of age (Patel, 2008; Roy, 2011). 
The severity of anemia is mild with less than 1% of c mmunity elders with hemoglobin 
concentrations below 10 g/dL (Patel, 2008). Anemia is clinically significant as it is 
associated with falls, reduced muscle strength and physical performance, fatigue, 
dysmobility, decline in ADL function and cognition, morbidity, and mortality 
independent of underlying disease (Artz & Thirman, 2011; Roy, 2011). Greater 
percentages of men and non-Hispanic Blacks develop anemia in old age compared to 
Whites and women (Patel, 2008; Roy, 2011). In a population-based study (N =1,806, ≥ 
65 years, 50% Black), the prevalence of anemia was 39% among Blacks and 17% among 
Whites and was associated with an estimated 90% increased mortality in Blacks and 85% 
increased mortality in Whites.  
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Decreasing hemoglobin levels increased mortality independent of comorbidity, 
behavioral risk factors, nutritional intake, and iron status (Dong et al., 2008). In the 
Health Aging and Body Composition Study there was no association between anemia and 
mortality in Blacks however, the population was healthier and higher functioning at 
baseline (Patel et al., 2007). In a community study of anemia in older adults and mortality 
(N = 775, ≥ 85 years, 10-year follow-up, Netherlands), anemia was significantly 
associated with increased mortality risk. The prevalence of anemia was 17% in women 
and 28% in men (Izaks, Westendorp, & Knook, 1999).  
Anemia may be due to nutrient deficiency, chronic disease, inflammation, and 
unexplained causes (Patel, 2008). Nutrient deficiencies account for about one-third of 
anemia (folate, vitamin B12, iron), immune system activ tion and chronic inflammation 
accounts for 20%, chronic kidney disease and impaired p oduction of erythropoietin 
accounts for 8%, and about one-third is unexplained. Morbidity and polypharmacy 
complicates determination of etiologies of anemia. In NHANES III, two-thirds of those 
with anemia had two or more chronic diseases (Patel, 2008).  
Anemia is associated with chronic inflammation, micronutrient deficiency, high 
CRP levels, and loss of physical function independent of disease (Ferrucci et al., 1999; 
Olivares, Hertrampf, Capurro, &Wegner, 2000). In the WHAS-I, chronic disease was 
defined as CRP > 6 mg/L, WBC > 11.0x109/L, elevated liver function enzymes, 
infection, liver disease, rheumatoid arthritis, oste arthritis, and cancer (Semba et al., 
2004). The prevalence of anemia was 5.8% and iron deficiency anemia was 3.8%, and the 
prevalence for was significantly increased in persons with worsening disability.  
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Low hemoglobin concentration as defined by the WHO criteria is associated with 
frailty. In the Cardiovascular Health Study, the prvalence of frailty increased as 
hemoglobin level decreased, even when levels were within normal range (Zakai et al., 
2005). Overall, 8.5% were in the lowest hemoglobin quintile for anemia. Mean 
hemoglobin concentration was 14 g/dL. Men had significantly higher mean hemoglobin 
concentrations (14.7 g/dL) compared to women (13.5 g/dL). Among Blacks, the 
prevalence of anemia was higher than in Whites. Lowlevels of hemoglobin were 
associated with higher levels of CRP, fibrinogen, and creatinine, and lower albumin 
levels and WBC counts. Severe anemia was significantly ssociated with age, smoking, 
inflammation, BMI, self-reported health, activity level, and chronic disease. Low and 
high hemoglobin concentrations were independently associated with mortality (Zakai et 
al., 2005). In older adults, levels of CRP > 1 mg/dL are associated with significantly 
lower hemoglobin levels (Beutler & Whalen, 2006). 
In a study of community older adults (N = 30, ≥ 70 years), frail elders had 
significantly higher IL-6 and lower hemoglobin and hematocrit levels compared to 
nonfrail elders, indicating systemic inflammation (Leng et al., 2002). There were no 
differences in other hematopoietic factors (e.g., WBC, platelets). Frail elders had more 
comorbidity (excluding conditions associated with inflammation or infection; Leng et al., 
2002). Anemia may be an independent and potentially modifiable predictor of poor 
muscle strength and performance, fatigue, activity ntolerance, poor cognition, and frailty 
(Chaves, Ashar, Guralnik, & Fried, 2002; Roy, 2011). 
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The inflammatory biomarkers CRP, hs-CRP, hemoglobin, WBC are important 
physiologic parameters in disease, muscle strength, physical function, and frailty. Acute 
and chronic, cumulative stress and systemic inflammtion may be important etiologic 
factors in frailty whose relationships may be better understood through physiologic 
measurement of inflammatory biomarkers. Research on relationships between 
biomarkers, function, disease, and outcomes is growing but there is limited research on 
biomarkers and frailty (Gruenewald et al., 2009; Szanton et al., 2009; Yao et al., 2011). 
There is insufficient evidence to confirm which biomarkers, number of biomarkers, or 
combinations of biomarkers are significantly associated with frailty. Currently, there is 
no single biomarker or index of biomarkers that predict frailty. The added value of 
inflammatory biomarkers in frailty assessment in hospitalized adults warrants further 
research (Walston et al., 2006). 
Social Domain 
Social support. Social support is widely regarded as a valuable resource that 
consists of tangible and intangible forms of assistance that individuals receive from 
family and friends. Domains of social support are social networks, social integration, 
social interaction, social space, informational support, emotional support, illness-related 
support, and family support (Andrew et al., 2008; Langford et al., 1997; Nicklett et al., 
2012; T. E. Seeman, 2000). Positive social support is related to positive mental health and 
cognitive function (T. E. Seeman et al., 2001). Newsom and Schulz (1996) found that 
instrumental and emotional support alleviated the eff cts of disability on depressive 
symptoms and improved life satisfaction. Lack of social interaction and close personal 
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relationships are associated with loneliness, depression, home confinement, physical and 
cognitive function decline, and disability (T. E. Seeman, 1996, 2000; T. E. Seeman & 
Crimmins, 2001; Simonsick, Kasper, & Phillips, 1998). In a study of women with a 
history of breast cancer, loneliness was associated with more pain, depression, and 
fatigued compared to those who were more socially connected (Jaremka, Fagundes, 
Glaser, et al., 2013). The symptom cluster of pain, depression, and fatigue is common in 
chronic disease. Loneliness is associated with chronic stress and activation of a 
proinflammatory state and immune system dysregulation and higher risk for pathological 
consequences. Subsequent research found that a greater d gree of loneliness stimulated 
increased production of inflammatory mediators and cytokines in response to stress 
(Jaremka, Fagundes, Peng, et al., 2013). The relationship between loneliness and 
activation of inflammatory mediators in response to stress may be a physiologic pathway 
that links emotional states with symptoms and disease states. Other research on the effect 
of social integration on health outcomes found thatsocial isolation and nonsupportive 
social interactions can result in lower immune function and higher neuroendocrine and 
cardiovascular activity while socially supportive interactions have more positive effects 
(T. E. Seeman, 1996). However, social ties that are stressful or conflicted may exert 
negative health effects thus the quality of social relationships is important. Lack of social 
support and poor social integration have been associated with morbidity, coronary heart 
disease mortality, and poor health outcomes (Loucks, Berkman, et al., 2006; Ranjit, Diez-
Roux, Shea, Cushman, Seeman, et al., 2007; Ranjit, Diez-Roux, Shea, Cushman, Ni, & 
Seeman, 2007; T. E. Seeman et al., 2001). There is strong evidence that social integration 
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and supportive relationships reduce mortality risk and improve mental health, but direct 
effects on physical health and disease incidence are less clear (T. E. Seeman, 1996). 
In a study of social integration, CRP level and risk for cardiovascular disease (N = 
14,818, ≥ 20 years, NHANES III), analysis of a social network index consisting of 
marital status, number of contacts with family, friends, and neighbors, religious service 
attendance, and participation in voluntary organizations and other sociodemographic 
factors found that elevated CRP levels of were significantly associated with men ≥ 60 
years of age with the fewest social ties compared to men with the most (OR = 1.80; 95% 
CI, 1.11–2.92), a finding that had a dose-response patt rn (Ford et al., 2006).  In 
multivariate adjusted models, social networks and CRP levels were not significantly 
associated in women or younger men. Further analyses examining chronic diseases, only 
arthritis, stroke, bronchitis, and possible infection remained significantly associated with 
social isolation and high CRP levels (but not cardiovascular disease, cancer, myocardial 
infarction, lupus, heart failure, chronic lung disea s, gout, angina). Gender and 
generational differences may potentially be explained by qualitative aspects of 
relationships, gender roles, relationship patterns, a d social environment characteristics. 
Two studies examined social integration and inflammatory biomarkers. In the MacArthur 
Successful Aging Study (Loucks, Berkman, et al., 2006), social integration was 
negatively associated with CRP in men but not in women in the least socially integrated 
quartile compared to the most socially integrated quartile, in adjusted models (age, 
race/ethnicity, smoking, alcohol, BMI, chronic conditions, cardiovascular disease, 
depression, physical function; OR = 2.23; 95% CI, 1.05–4.67, CRP > 3.19 mg/L). No 
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significant association was found between social integration and IL-6. In the Framingham 
study, social network measured by the Social Network Index was significantly inversely 
associated with IL-6 in men and women in adjusted mo els. CRP was marginally 
associated in men and women, but was not significant in multivariate analysis (Loucks, 
Sullivan, D’Agostino, Larson, Berkman, & Benjamin, 2006).  
Chronic stress, low social position, weak social networks and poor coping ability 
is associated with poorer physiological function (Glei et al., 2007). A physiologic basis 
for the effects of social interaction on health outc mes is supported by research 
demonstrating that social isolation and non-supportive social  interactions can lower 
immune function and increase neuroendocrine and cardiovascular activity, while socially 
supportive interactions have the positive effect (T. E. Seeman, 1996). In a study of 
healthy young adults and relationships between positive, negative and competitive social 
interactions and inflammation (N = 122), daily social interactions that were negative and 
competitive were associated with increased proinflamm tory cytokine activity evidenced 
by higher levels of IL-6 and TNF-α (Chiang, Eisenberger, Seeman, & Taylor, 2012). In 
the MacArthur Successful Aging Study cohort study, lack of social integration was 
significantly associated with higher CRP levels in men but not women in adjusted models 
(OR = 2.23; 95% CI, 1.05–4.76; Loucks, Berkman, et al., 2006). There were no 
significant associations between social integration and IL-6 in men or women. In the 
Framingham study, social networks, IL-6, and CRP were examined to explore the 
biologic pathways to cardiovascular disease (Loucks, Sullivan, et al., 2006). Social 
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networks were significantly inversely associated with IL-6 in adjusted models, and 
modestly associated with CRP in men, but not in multivariate analyses.  
Studies on factors associated with hospitalization and frequent hospital 
readmission often emphasize comorbidity, illness severity or instability, and symptom 
burden as the strongest predictors (Landi et al., 2004; Marcantonio et al., 1999; Williams 
& Fitton, 1988). However, social factors are also influential (Landi et al., 2004). In an 
observational cohort study of community-living older adults receiving home health care 
(N = 1,291, Silver Network Home Care Project, SILVER-NET, Italy), comorbidity and 
social factors were examined as predictors of hospitalization and hospital readmission in 
frail elderly (Landi et al., 2004). During 12-month follow-up, the hospitalization rate was 
26%. Social factors associated with hospitalization were living alone (OR = 2.59; 95% 
CI, 1.82-3.69) and economic hardship (OR = 3.01; 95% CI, 1.75–5.18). Comorbidity and 
prior hospitalization were also associated with higher risk for hospitalization. Study 
findings suggest that social factors are influential beyond the medical condition. In other 
research, greater social vulnerability was moderately correlated with frailty and mortality 
(Andrew et al., 2008). In the Women’s Health and Aging Study I cohort of moderately to 
severely disabled community women, 23% reported not visiting anyone outside their 
residence and 17% did not leave home the prior week (Simonsick et al., 1998). Complete 
social isolation, defined as living alone, having less than weekly social contact with non-
household members, and not leaving home in a typical week is rare (3%) in community-
living disabled older women and only 8% are homebound and have less than weekly 
social contact (Simonsick et al., 1998). In this study, social isolation was common. Risk 
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factors for social isolation were older age, worse ADL disability, not completing high 
school, lack of transportation, poor hearing, and incontinence. Older African American 
women living alone were especially vulnerable to home confinement. Low social contact 
was independent of disability since many severely disabled persons had daily social 
contact. Other consequences of social isolation noted in this study were depression, poor 
appetite, weight loss, and deconditioning. The potential adverse consequences of social 
isolation are germane to frailty. 
Social factors and nutritional quality determined by serum carotenoid level were 
assessed in a cohort of the Women's Health and Aging Study (n = 325, disabled, one-year 
follow-up) to determine if baseline social support (emotional support, social interaction, 
social space, family, change in social support) predict d serum carotenoid levels (Nicklett 
et al., 2012). Baseline social support did not consistently predict carotenoid level. 
Leaving home more often predicted increased carotenoid levels; attending few activities 
predicted decreased carotenoid levels. Change in soc al support predicted positive and 
negative change in diet quality, which suggested that social activity and family 
interaction might play meaningful roles in diet quality. Social support and nutrition are 
important to consider since poor nutrition is associated with frailty (Bartali et al., 2006). 
Frailty is significantly associated with living alone, inadequate social support 
from family and friends, few social contacts, and lack of someone to provide assistance 
when needed (Schulz & Williamson, 1993; Fugate Woods et al., 2005). In a population-
based study where frailty was defined by a 62-item Frailty Index (FI) (N = 2,032, age ≥ 
70), more severe frailty was associated with more deficits in social support (Woo, 
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Goggins, Sham, & Ho, 2005). A higher FI in men was as ociated with having few 
relatives or neighbors, little or no exercise, and infrequent or no participation in helping 
others. In women, having little contact with relatives (but not number of relatives) and 
lack of participation in community or religious activities was associated with a higher FI. 
Marital status. Being married has empirically been associated with positive 
social support and health outcomes, whereas single partner status or living alone has been 
associated with poor social support and health outcomes. The positive effects of 
relational qualities support health and well-being a d buffer negative psychological 
consequences of stressful life events, poor health, nd disability (S. Cohen, 2004). In the 
context of illness and disability, the quality of marital or partner social support is 
dependent on whether the type of support provided mets specific needs. Three types of 
support were emotional support (expressions of concern, share feelings), instrumental 
support (help with tasks, offer financial assistance), and informational support (advice, 
knowledge to help solve problems (S. Cohen, 2004). In a study of older married couples 
(N = 1,532), emotional closeness increased with age and moderated the effects of 
functional disability through improved self-esteem and reduction in anxiety, depression 
and mortality (Mancini & Bonanno, 2006). Emotional support was more influential than 
instrumental or informational support as described y S. Cohen (2004).  
The relationships between marital quality and healt, il ness, disability and 
potential for caregiver burden are variable (Yorgason, Booth, & Johnson, 2008). Decline 
in health and development of disability can affect marital quality in many ways, and 
differ by age cohort. Among younger couples, illness and disability can have a more 
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negative effect on marital quality, social networks, employment, child rearing, and a view 
of time that projects a longer future. In contrast, mong older couples confronted with 
illness and disability, there can be a primary focus on the spouse with less emphasis on 
those factors more salient to younger couples. When c ronic illness of a spouse or partner 
requires caregiving assistance, stress-related caregive  burden can have significant 
biopsychosocial health risks and other adverse implications for the caregiver. In the 
MacArthur Studies of Successful Aging, social support among married older adults 
varied by gender (N = 439). Although social support increased over time, en received 
emotional support primarily from their spouses, but women received more emotional 
support from friends, relatives and children (Gurung, Taylor, & Seeman, 2003). 
 In a study of stress related to caregivers for persons with Alzheimer disease (N = 
116 caregivers, 54 non-caregiving controls), levels of inflammatory biomarkers were 
elevated and frailty risk factors (poor health habits, less physical activity, increased 
morbidity, e.g., hypertension, depression, exhaustion) were increased compared to non-
caregiving controls (von Känel et al., 2006). 
In a study of the effects of stressors and social support on frailty among older 
Mexican-Americans over a 12-year period, participants were grouped into one of three 
trajectories differentiating frailty severity (Peek, Howrey, Ternent, Ray, & Ottenbacher, 
2012). The effects of stressors varied by trajectory where health and financial-related 
stressors were related to increases in level of frailty over time in comparison to the 
trajectory where effective social support which was related to a slower worsening of 
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frailty. The role of stressors, social support, andincidence and progression of frailty, 
particularly in hospitalized adults has not been studied. 
Live alone. Living alone is associated with greater risk for poor physical and 
mental health outcomes and frailty. In a study of living arrangements, marital status, and 
sources of care for IADL and emotional support, married couples tended to receive 
assistance from their spouse, those who live alone te ded to receive assistance from 
children or friends, and those living with non-spouse others receive more assistance from 
siblings (Chappell, 1991). The importance of relational and structural characteristics of 
living arrangements is an important indicator of access to caregiving assistance. 
In a study of older adults referred for comprehensive geriatric assessment and 
frailty assessment (N = 302, ≥ 65 years), those living alone (41%) were older, received 
less assistance from informal and formal caregivers, had poorer living and financial 
conditions, and better cognitive and physical function but worse emotional status 
compared to those not living alone (Bilotta et al., 2010). Among frail elders (38%), those 
living alone had a higher prevalence of a new diagnosis of dementia. Frail elders living 
alone were significantly more likely to experience severe acute disease (OR = 303.9, p < 
0.001), dependence in bathing (OR = 62.74), depression (OR = 10.43), and incontinence 
(OR = 3.98). Living alone was associated with less peronal assistance, more social and 
financial vulnerability, and greater risk of depression.  
Psychologic Domain 
 Depression. Psychological problems such as depression may predispose older 
adults to frailty through activation of psychoneuroimmunological mechanisms and 
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biochemical mediators in the brain that affect mood an  other biological functions (Fillit 
& Butler, 2009; McEwen, 2003b). In the Cardiovascular Health Study, the relationship 
between persistently depressive symptoms and changes i  functional disability in older 
adults was examined in three subgroups: persistently depressed (n = 119); temporarily 
depressed, (n = 259); and non-depressed (n = 378; Lenze et al., 2005). Persistently 
elevated depressive symptoms were associated with significantly worse functional 
disability. In adjusted models, the persistently depressed group had significantly 
increased functional disability during follow-up (adjusted OR = 5.27; 95% CI, 3.03–9.16) 
compared to the non-depressed group. The temporarily depressed group also 
demonstrated increased functional disability (adjusted OR = 2.39; 95% CI, 1.55–3.69) 
compared to the non-depressed group. In the Heart and Soul study (N = 667, outpatients 
with coronary heart disease), depressive symptoms predicted higher IL-6 and hs-CRP 
levels, but higher IL-6 and hs-CRP levels did not predict depressive symptoms (Duivis et 
al., 2011). After adjusting for health behaviors, asociations between depressive 
symptoms, IL-6 and hs-CRP were not significant, suggesting that health behaviors may 
mediate depressive symptoms.  
In a study to determine if middle-aged persons with depressive symptoms were at 
higher risk for developing ADL and mobility limitations with advancing age compared to 
persons without depressive symptoms (N = 7,207, 50 to 61 years, Health and Retirement 
Study, 12-year follow-up), 12% had significant depressive symptoms at baseline (K. E. 
Covinsky et al., 2010). Depressive symptomatology was a significant predictor of ADL 
and mobility limitations. Those with depressive symptoms were more than twice as likely 
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to have persistent ADL and mobility limitations (45%) than those who did not (23%). 
Middle-aged persons with depressive symptoms may be at greater risk for dependence 
and disability as they age.  
Persistent elevation of inflammatory markers due to chronic stress is associated 
with depression and cognitive decline (Bao, Meynen, & Swaab, 2008; Friedman, 
Karlamangla, Almeida, & Seeman, 2012). In a study of community adults with chronic 
illness (N = 1,280, Longitudinal Aging Study of Amsterdam [LAS ] study), depressive 
symptoms were significantly related to unhealthy lifestyles in middle-aged and older 
persons (van Gool et al., 2003). Baseline depression (n = 176) was significantly 
associated with smoking (OR = 1.71; 95% CI, 1.17–2.52) and excess alcohol use (relative 
risk-ratio [RRR] = 4.04; 95% CI, 0.97–16.09). Incident depression (n = 155) was 
significantly associated with decreased physical activity and sedentary behavior (RRR = 
1.62; 95% CI, 1.05–2.52), in adjusted models controlling for chonic disease. Smoking, 
excess alcohol consumption, and low physical activity were associated with chronic 
inflammation. In the Established Populations for Epidemiologic Studies of the Elderly, a 
bidirectional relationship was found between depression and disability in older adults 
(Bruce, 2001). Stable disability (ADL, strength, mobility) and transitions in disability 
were significantly related to change in depressive ymptoms. The onset of disability had 
stronger effects on change in depression than recovery or improvement in disability. 
In a cross-sectional study of community older adults to examine the relationship 
between depression and frailty, where frailty was defined by the Fried Frailty criteria (N 
= 567, ≥ 60 years), depression scores were statistically significantly higher in both pre-
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frail and frail groups compared to the robust, nonfrail group (Ní Mhaoláin et al., 2012). In 
adjusted models, the frail group remained significantly more depressed (OR = 4.3; 95% 
CI, 1.5-11.9). In a systematic review of cross-sectional (n = 16) and cohort (n = 23) 
studies of depression in later life and frailty, frailty and functional impairment were risk 
factors for depression (Mezuk, Edwards, Lohman, Choi, & Lapane, 2011). However, 
none of the studies used standardized tests for depression or accounted for antidepressant 
use. Positive affect and frailty was investigated in older nonfrail Mexican Americans 
from the Hispanic Established Populations for Epidemiological Studies of the Elderly 
cohort (N = 1558) frailty (Ostir, Ottenbacher, & Markides, 2004). High positive affect 
significantly reduced the risk of frailty. During seven-year follow-up, incident frailty was 
7.9%. Positive affect may be an important protective factor in frailty since in this study, 
each unit increase in baseline positive affect score was associated with a 3% decreased 
risk of frailty in adjusted models. Among African Americans, depression is highly 
prevalent, under-diagnosed, and under-treated (Wittink, Joo, Lewis, & Barg, 2009). In a 
study of relationships between faith, spirituality, and depression in African Americans (N 
= 47), a faith-based explanatory model of depression influenced decision-making about 
treatment (Wittink et al., 2009). Loss of faith was often cited as the cause of depression 
and “getting faith” was the cure since this restores hope and moral courage. African 
Americans with untreated depression may be at higher risk for frailty.  
Cognitive function. Research on relationships between cognitive functio and 
normal aging suggest that only modest changes occur. Impaired cognition is more 
strongly associated with illness and chronic disease, lifestyle habits (smoking, excessive 
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alcohol intake, low physical activity, stress-coping responses), brain trauma, and 
environmental conditions (Cesari et al., 2008; Fulop et al., 2010). In a population-based 
study of midlife women, cognitive function was significantly related to physical function 
(Ford et al., 2010). Inflammation is a component of atherosclerosis and small vessel 
disease that leads to ischemia in the white matter of the brain, increasing risk for stroke, 
heart failure, Alzheimer’s disease, Parkinson’s disease, cognitive impairment, and 
depression. The pathogenesis of inflammation and activation of inflammatory biomarkers 
exert detrimental physiologic effects on brain function and cognition. 
  Cognitive impairment is associated with frailty. In the French Three-City Study 
(N = 6,030, 65–95 years, four-year follow-up), Ávila-Funes et al. (2009) added the Mini-
Mental Status Exam (MMSE) and the Isaacs Set Test (IST) to the Fried Frailty criteria to 
determine if frailty prediction improved. Overall frailty prevalence was 7%, similar to the 
CHS study (Fried, Tangen, et al., 2001). Among the nonfrail, prefrail, and frail groups, 
cognitive impairment was present in 10%, 12%, and 22%, respectively. Lower MMSE 
and IST scores did not predict mortality but were significantly associated with frailty. In 
adjusted models, cognitively-impaired frail persons were significantly more likely to 
develop ADL and IAD disability, and had a small increased risk of incident mobility 
disability and hospitalization. Incident dementia ws greater in those with cognitive 
impairment in all frailty groups.  
Rothman et al. (2008) examined if three Fried Frailty Index criteria plus tests for 
cognitive function (Mini-Mental State Exam) and depr ssion (CES-D Scale) 
independently predicted adverse outcomes in non-disabled community older adults (N = 
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754,  ≥ 70 years, 96-month follow-up). Baseline prevalence for frailty criteria was highest 
for muscle weakness (54%) and slow gait speed (43%), followed by low physical activity 
(31%), depressive symptoms (22%), weight loss (23%), exhaustion and fatigue (13%), 
and cognitive impairment (11%). In adjusted models, slow gait speed, low physical 
activity, and weight loss were independently associated with disability, nursing home 
discharge, and mortality. Cognitive impairment was significantly associated with 
disability (HR = 1.82; 95% CI, 1.40–2.38), nursing home discharge (HR = 2.64; 95% CI, 
1.75–3.99), and mortality (HR = 1.54; 95% CI, 1.13–2.10). During follow-up, the 
prevalence of cognitive impairment nearly doubled, but slow gait speed, low physical 
activity, and weight loss changed little. Cognitive assessment improved predictive 
validity of the CHS (Fried, Tangen, et al., 2001) definition of frailty. 
In the Canadian Study of Health and Aging (N = 2,305, ≥ 70 years), three frailty 
instruments, the Frailty Index-Comprehensive Geriatric Assessment (FI-CGA, 47 
deficits), Clinical Frailty Score, and Fried Frailty Index, were used to classify frailty and 
determine their ability to predict changes in cognitio  and mortality (Mitnitski et al., 
2011). Cognitive function was assessed by the Modified Mini-Mental State Exam. 
Change in cognitive status was strongly associated with baseline cognition and frailty for 
each frailty assessment instrument. In adjusted models, all three frailty assessments were 
significantly associated with cognitive decline and mortality. Improvement in cognition 
was unlikely among those who were frail compared to those who were not frail.  
In a study of community older adults (N = 475, ≥ 70 years, Mexican Study of 
Nutritional and Psychosocial Markers of Frailty), the Fried Frailty criteria plus a 
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cognitive function test classified frailty to determine prevalent ADL and IADL disability 
(Ávila-Funes et al., 2011). In unadjusted models, al  criteria except weight loss were 
associated with IADL and ADL disability. In adjusted models, only low physical activity 
(OR = 3.27; 95% CI, 1.56–6.85) and cognitive impairment (OR = 2.06; 95% CI, 1.04–
4.06) were independently and significantly associated with IADL disability. Only low 
physical activity was significantly associated with ADL disability (OR = 7.72; 95% CI, 
1.28–46.46). Of the modified Fried Frailty criteria, only cognitive impairment and low 
physical activity were primary contributing factors to either ADL or IADL disability.  
In a study of acutely ill hospitalized older adults, cognitive function was assessed 
using the Short Portable Mental Status Questionnaire on admission and 90 days after 
discharge to determine if admission screening predict  functional recovery (N = 2557) 
(Sands et al., 2003). On admission, 14% had mild cognitive impairment and 28% had 
moderate to severely impaired cognitive function or we e unable to complete the test due 
to dementia. Cognitive function was significantly related to ADL and IADL assistance. 
Cognitive impairment was associated with greater likelihood for nursing home admission 
within 90 days of discharge (OR = 2.8; 95% CI, 1.8–4.5, mild impairment; OR = 6.7; 
95% CI, 4.5–9.8, moderate to severe impairment). Admission creening of cognitive 
function identified risk for ADL assistance, poor recovery, and nursing home admission. 
Delirium, also referred to as acute confusion or altered mental status, occurs 
among hospitalized adults of all ages. Delirium has been cited as the most frequent 
complication associated with hospitalization of older adults. Delirium is estimated to 
occur in 11%–42% of hospitalized  patients, may affect up to 50% who are at high risk, 
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and may be unrecognized in up to 70% (Siddiqi, Stockdale, Britton, & Holmes, 2007). In 
10%–30% of older adults admitted to the hospital from the emergency department, 
delirium is the presenting symptom. Delirium is often not recognized since it may be 
attributed to acute illness and dementia and may be overlooked or dismissed since it can 
be a difficult to measure. Contrary to common beliefs that delirium is self-limiting and 
reversible, research indicates that delirium is associated with both short and long term 
cognitive and functional impairment (M. G. Cole, Ciampi, Belzile, & Zhong, 2009). 
About 12% of older adults who developed delirium during hospitalized had persistent 
delirium at discharge (Siddiqi et al., 2007). Delirium is significantly associated with 
functional decline during hospitalization (Murray et al., 1993; Inouye et al., 2007; Tinetti 
et al., 1995). Preoperative frailty has been signifcantly associated with  post-operative 
delirium and other complications related to delirium such as longer length of stay and 
mortality (Kristjansson et al., 2010; Leung, Tsai, & Sands, 2011; Pol et al., 2011). 
Clinical features of delirium include clouding of mental status and fluctuating 
levels of consciousness, poor attention span and memory, disorientation, and illusions 
and hallucinations. Delirium is most often associated with hyperactivity and uncontrolled 
motor behavior and cognitive deficits. Hypoactive delirium is less readily identified since 
motor behavior is blunted; however, cognitive deficits similar to hyperactive delirium are 
present (de Rooij, Schuurmans, van der Mast, & Levi, 2005). 
C. C. Chen et al. (2011) studied common geriatric conditions in a cohort of 
hospitalized older adults (N = 455). Notably, delirium was not included, however many 
conditions are risk factors for delirium. Geriatric conditions were highly prevalent, and 
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included, in descending rank order, visual impairment, polypharmacy, sleep disturbance, 
anemia, chewing and swallowing difficulties, dehydration, malnutrition, depression, 
cognitive impairment, and pressure ulcers. Each of t ese conditions is associated with 
physiologic vulnerability and increased risk for both delirium and frailty in unstable, 
medically-compromised hospitalized adults. These and others geriatric syndromes share 
physiologic pathways and mechanisms with delirium and frailty (Quinlan et al., 2011). 
In a retrospective analysis of clinical data from an administrative hospital 
database to describe admission presentation of delirium for four categories of diagnosis 
related group (DRG) hospitalizations: pneumonia, congestive heart failure, urinary 
tract/kidney infection (UTI), and lower extremity orthopedic surgery (LEOS; Lin, 
Heacock, Bhargave, & Fogel, 2010). The prevalence of delirium in the cohort was 0.8% 
and 59% had an admission diagnosis of delirium. Admission diagnosis of delirium was 
strongly associated with dementia (AOR = 0; 95% CI, 5.8-6.3) and with adverse drug 
effects (ADEs; AOR = 4.6; 95% CI, 4.3, 5.0). After admission delirium was more 
strongly associated with ADEs (AOR = 22.2; 95% CI, 20.7-23.7). On admission, the UTI 
DRG had the greatest proportion of patients presenting with delirium on admission. After 
admission, delirium was more common in the LEOS DRG group along with increased 
proportions in the UTI DRG group.  In this study, the role of ADEs is important to note 
since polypharmacy is common in older adults and is often unavoidable in patients with 
multiple morbidity, greater symptom burden, in addition to acute illness, trauma, or need 
for surgery that precipitated hospitalization that may require new medications in addition 
to medications needed for chronic disease and sympto  management. Study findings 
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highlight the importance of recognition of delirium on admission and initiating early 
treatment and carefully monitoring medication regimes. 
In a systematic review of persistent delirium in hospitalized patients 50 years of 
age and older to determine its frequency and prognosis, failure to recover from delirium 
after discharge was documented in a high percentage of patients (M. G. Cole et al., 2009). 
In analysis of original research on persistent delirium (18 studies, 1,322 patients with 
delirium), the combined proportions of patients with persistent delirium at discharge, and 
one, three, and six month follow-up was 44.7% (95% CI, 26.8%, 63.7%) at discharge, 
32.8% (95% CI, 18.4%, 47.2%) at one month follow-up, 25.6% (95% CI ,7.9%, 43.4%) 
at three months, and 21% (95% CI, 1.4%, 40.6%) at six-months. Poor outcomes 
including mortality, nursing home placement, and impaired function and cognition were 
consistently worse in patients with persistent delirium compared to patients who had 
recovered from delirium. 
In a prospective cohort study of patients admitted o geriatric/medical wards in 
nine teaching hospitals (N = 870, ≥ 85 years, two-year follow-up [SAFES cohort: Frail 
Elderly Subject: Evaluation and Follow-up], France) a Mortality Risk Index was 
constructed to characterize frailty risk groups using comprehensive geriatric assessment, 
physical performance measures, nutritional assessment, comorbidity index, pressure ulcer 
risk assessment and sociodemographic data (Dramé et al., 2008). Three frailty risk groups 
were classified by the sum of points for weighted risk factors (theoretic range, 0–10). The 
mean score was 4 (SD = 2; range = 0–10). The High risk group scored  ≥ 6 points (17%), 
Medium risk group, 3–5 points (56%), and Low risk group, 0–2 points (17%). The 
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prevalence of delirium was 20%. Significant mortality predictors using this frailty 
schematic were age over 85 years, delirium, ADL dependence, malnutrition risk, high 
comorbidity, living in an institution, and female gnder. Mortality rate increased in 
higher levels of frailty risk groups. Delirium was  significant mortality predictor in both 
bivariable and multivariable analyses. 
In a prospective study of hospitalized older adults to examine relationship 
between delirium and frailty and mortality (N = 273, ≥ 75 years) where frailty status was 
measured by a Frailty Index (FI) consisting of 33 deficits and determination of “fit” or 
“frail” status (Eeles, White, O’Mahony, Bayer,  & Hubbard, 2012). Scoring was 
determined by computations based on the presence of d ficits in relation to the total 
number of deficits in the FI. Scoring ranged from 0 (no deficits) to 1.0 (all 33 deficits) 
where 0.25 was the cut-point score that differentiated patients who were either “fit” or 
“frail.” Forty-one percent (n = 111) were frail. Delirium was identified in 37% (n = 102; 
mean FI = 0.33) and excluded in 63% (n = 171, mean FI = 0.18; P < 0.005). In “fit” 
patients with delirium, median survival was 359 days (95% CI;  range, 118–600) 
compared with 88 days for those who were “frail” with delirium (95% CI; range, 5–171; 
P < 0.05). Study findings determined that delirium was associated with the higher levels 
of frailty based on higher FI scores. Mortality associated with delirium alone was poor; 
however, the presence of both frailty and delirium was associated with a worse prognosis. 
Several studies document failure of nurses to recognize delirium in hospitalized 
older adults. In a study comparing staff nurse and nurse researcher ratings of patients for 
the presence of delirium using the Confusion Assessm nt Method (CAM; N = 176 nurses  
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paired with a researcher) CAM (Confusion Assessment Method) ratings were completed 
at least every other day until discharge or delirium was detected by the researcher (Rice 
et al., 2011). There was poor agreement in observational ratings (κ = 0.34). Researchers 
identified delirium in 7% of patients, however, nurses recognized delirium only 25% of 
the time. Independent predictors of under-recognitio  of delirium were older patient age, 
longer length stay, dementia, and hypoactive delirium. Delirium was significantly 
associated with longer mean length of stay (about five days), however other studies report 
longer hospitalizations. Study findings have implicat ons for precepted nursing education 
in detection and assessment of delirium as this has implications for frailty. 
Chronic pain. Older adults frequently have medical conditions that are associated 
with persistent or chronic pain. Leong and colleagues (2007) found that comorbidity 
burden was associated with more severe pain and worse functional status in a pain-clinic 
cohort. Pain can be insidious, non-acute, and omnipresent (Tak et al., 2009). Symptoms 
such as pain are a mechanism through which disease impacts functions and well-being 
(Whitson et al., 2009). Pain may be due to morbidity (musculoskeletal, neurological, 
visceral, etc.) and can adversely affect mobility, ADL function, level of physical activity, 
mood, sleep, energy level, and quality of life. Pain scores were more strongly correlated 
with poor mobility and disability than chronic disease scores. Although pain is common 
in many chronic diseases and is associated with normal aging changes in body system 
structure and function, it may not be adequately explained by underlying disease 
processes (Tak et al., 2009).  
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The prevalence of chronic or persistent pain among elders in community and 
institutional settings is estimated at 45%-80% (Maxwell et al., 2008). About 25% who 
experience daily pain do not receive analgesics, especially minority populations, the very 
old, and those with cognitive or communication impairment (Maxwell et al., 2008). 
Ineffective pain management is associated with immobility, low physical activity, 
fatigue, and depression which can lead to muscle weakness and atrophy, deconditioning, 
poor balance, falls, sleep disorders, depression, social isolation, functional decline, and 
increased risk for frailty. In a large retrospective cohort study of pain and comorbid 
illness (N = 1,211,483 adults, ≥ 18 years, with at least one pain condition) pain co dition 
cohorts (n = 23) were defined by the first medical diagnosis on administrative claims data 
forms (Davis, Robinson, Le, & Xie, 2011). The mean number of comorbid pain 
conditions ranged from 1.39 (cancer, migraine) to 2.65 (multiple sclerosis), about four 
different pain medications were used, and the majority f participants across pain cohorts 
were women. Musculoskeletal pain was the most prevalent category (> 30%) and cancer 
was the least prevalent. There was substantial heterogeneity in types of chronic pain, 
diseases, mental health disorders (depression, anxiety, others), and sleep problems. The 
study underscores the importance of determining the presence, magnitude, and impact of 
pain for different disease conditions on BPSS functio  and well-being. 
Two studies examined pain and frailty. In a cross-sectional study comparing self-
rated pain and frailty (N = 4,958, ≥ 65 years, Canadian Study of Health and Aging), 
frailty was defined by deficit accumulation and thepr sence of 33 self-reported illnesses, 
functional impairments, and health attitudes. Pain was assessed using a five-point verbal 
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descriptor scale in response to one question, “How much bodily pain have you had during 
the past 4 weeks?” (Shega et al., 2012). Moderate o s vere pain, reported by 35.5%, was 
independently associated with frailty. This group was more likely to be older, female, and 
report a depressed mood. Of those reporting moderate o  severe pain, 49.8% were frail, 
34.1% were prefrail, and 16.2% were not frail. The odds of being prefrail versus frail was 
greater than twice as likely (OR =2.52; 95% CI, 2.13–2.99; p < .001) and of being frail 
versus not frail, greater than five times as likely (OR = 5.52; 95% CI, 4.49–6.64, p < 
.001). Frailty was significantly and independently associated with pain. 
In study of community-living men on intrusive pain a d frailty (N = 1705, ≥ 70 
years, Concord Health in Aging in Men Project, Australia), intrusive pain was assessed 
by the response to the question, “During the past 4 weeks, how much did pain interfere 
with your normal work, including both work outside the home and housework?” (Blyth et 
al., 2008). Responses were dichotomous (Not at all; a little bit or moderately; Quite a bit; 
Extremely). About one-quarter (23.4%) reported moderate to severe pain that interfered 
with activities. About 15% had four or more chronic d seases but only 2.2% reported 
opioid use. Arthritis was common (51.7%). The preval nce of frailty was 9.4%; 6.2% 
were frail with high comorbidity and 40.6% were prefrail. Frailty was significantly 
associated with pain. Frail men with high comorbidity were more likely to report 
moderate to severe intrusive pain (OR = 3.0; 95% CI, 1.6–5.5, p < 0.0004) after adjusting 
for depressive mood and arthritis. In frail men with low comorbidity, the association of 
frailty with pain was statistically significant (adjusting for demographics, arthritis) but 
not after adjusting for demographics and depressed mood. High comorbidity in nonfrail 
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men was less strongly associated with pain after adjustment for arthritis (OR = 1.5, p < 
0.002) and depressive mood (OR = 1.4, p < 0.08). Opioid use was highest among frail 
men, 6.5%, compared to 2.5% of prefrail men and 1.2% of nonfail men. 
In the 2004 Health and Retirement Study of community-living adults (N = 18,531, 
≥ 50 years) the relationship between functional limitations and pain from midlife to old 
age was explored to determine if significant pain, defined as having moderate or severe 
most of the time, affected four domains of function (K. E. Covinsky, Lindquist, Dunlop, 
& Yelin, 2009). Persons were classified according to mobility (jog 1 mile, walk several 
blocks, walk one block, unable to walk one block), stair climbing (climb several flights, 
climb one flight, not able to climb a flight), upper xtremity tasks (able to do 3, 2, 1, or 
0), and ADL function (could do without difficulty, had difficulty but able to do without 
help, needs help). In the HRS sample, 24% had significa t pain. Those with pain had 
significantly higher rates of functional limitations than those without pain and were 
comparable to persons two to three decades older. In adjusted models, across all four 
functional domains, persons with pain were at significantly higher risk for functional 
limitation: AOR = 2.85; 95% CI, 2.20–3.69, for mobility; AOR = 2.84; 95% CI, 2.48–
3.26, for stair climbing; AOR = 3.96; 95% CI, 3.43–4.58, for upper extremity tasks; and 
AOR = 4.33; 95% CI, 3.71–5.06, for ADL function. For example, regarding mobility, 
among persons age 50 to 59 years without pain, 37% could jog 1 mile, 91% could walk 
several blocks, and 96% could walk one block withou difficulty. In contrast, among 
persons 50 to 59 years with pain, 9% could jog 1 mile, 50% could walk several blocks, 
and 69% could one block without difficulty. The 50 to 59 years age group with pain was 
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similar in mobility limitations to the 80 to 89 years age group without pain. Pain may be a 
critical component in the cycle of frailty through mobility limitations that lead to physical 
inactivity, decreased energetics, metabolism and appetite, fatigue, muscle weakness, 
atrophy, sarcopenia, social isolation, and depression.  
Tobacco use. Smoking adversely affects multiple organ systems and is associated 
with poor physical performance and morbidity including cardiovascular disease, 
myocardial infarction, heart failure, stroke, peripheral vascular disease, cancer, chronic 
obstructive pulmonary disease, Alzheimer’s disease and decline in physical and cognitive 
function (Almeida et al., 2008; Rapuri et al., 2007). Data from the MacArthur Studies of 
Successful Aging (n = 880, a subset of high-functioning older adults [N = 1189]) and the 
Established Populations for Epidemiologic Studies of the Elderly (subset, n = 4030) 
examining inflammatory biomarkers and physical performance, IL-6 and CRP levels 
were significantly higher in current smokers than no smokers and was significantly 
associated with poor grip strength and slow gait speed (Taaffe et al., 2000). In the 
Canadian Study of Health and Aging (N = 9,008, ≥ 65 years), smoking was significantly 
associated with frailty when adjusting for covariates (Hubbard, Searle, Mitnitski, & 
Rockwood, 2009). Heavy smokers were more frail, light smokers were intermediate frail, 
nonsmokers were the fittest. Mortality, cognitive impairment, and worse health were 
significantly higher among smokers. Smoking, functional decline, and frailty may be 
linked through chronic inflammatory processes where cigarette smoke activates 
inflammatory mediators such as CRP and IL-6 (Cesari et al., 2004; Ferrucci et al., 1999) 
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that leads to muscle weakness, poor physical and pulmonary function, disability, and 
frailty (Hubbard et al., 2009; Semba et al., 2006). 
Defining Frailty 
There are multiple definitions of frailty. Frailty has been described using many 
combinations of signs and symptoms, medical diagnoses, physical, psychological, social, 
cognitive, and environmental factors and can range from one criteria (e.g., gait speed) to 
90 (e.g., deficit accumulation count). The wide spectrum of frailty definitions has been 
attributed to its recent recognition as a distinct clinical condition and the short time span 
for scientific research at the bench and at the bedsid . Lack of data from primary research 
makes efforts to reach a consensus definition of frailty challenging (Rodríguez-Mañas et 
al., 2012). Other barriers include isolation of researchers and clinicians that limit cross-
fertilization of ideas and collaborations to explore different perspectives of frailty and the 
lack of consistent research methodologies to define frailty (Ferrucci et al., 2004; 
Karunananthan et al., 2009; Levers et al., 2006; Sternberg et al., 2011). 
Recommendations from an international consensus conference to determine a 
definition of frailty using the Delphi method found support for several perspectives: (a) 
Six domains of frailty were endorsed and included malnutrition, performance measures, 
gait speed, mobility, cognitive function, mood; (b)The severity of frailty must be 
assessed, but there was no agreement on severity indicators; (c) There is a relationship 
between age and frailty but there was no agreement on establishing an age threshold for 
frailty assessment and if it should be delimited to advanced ages and older adults, adults 
< 65 years may be at risk; (d) Inclusion of biomarkers in frailty assessment is 
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recommended but there was no agreement on individual biomarkers or combinations of 
biomarkers that should be included; and (e) There was disagreement about the timeline 
for assessing clinical and laboratory biomarkers in the diagnostic process due to lack of 
evidence (Rodríguez-Mañas et al., 2012). Previously, the Interventions on Frailty 
Working Group strongly recommended that frailty definitions not include ADL measures 
of function or disability based on the theory that fr ilty precedes disability due to 
subclinical physiologic decline across multiple inter-related systems (Ferrucci et al., 
2004). This recommendation was endorsed by the Frailty Definition Working Group 
(Rodríguez-Mañas et al., 2012). Frailty is presumed to be already present in a preclinical 
state and evolving. Currently, many frailty assessment tools include ADL assessment 
since functional decline and impairment are visible and considered a hallmark feature of 
frailty. CMS has endorsed measurement of ADL function in its definition of frailty 
(Kautter, Ingber, & Pope, 2008–2009). 
There is support for defining frailty as a multidimensional construct that includes 
biologic factors and physical performance, psychological, social, and spiritual factors 
(Fillit & Butler, 2009; Gobbens et al., 2010; Markle-Reid & Brown, 2003; Nowak & 
Hubbard, 2009; Rodríguez-Mañas et al., 2012; Rockwood & Bergman, 2012; Romero-
Ortuno et al., 2010; Romero-Ortuno, 2013; Studenski et al., 2004). Qualitative and 
quantitative research is needed to elucidate relationships and interactions between frailty, 
gender, race/ethnicity, cultural perspectives, and the environment (Fernandez-Bolaños et 
al., 2008; Fugate Woods et al., 2005; Hirsch et al., 2006; Walston & Fried, 1999). Table 2 
lists selected frailty definitions from quantitative and qualitative research, consensus 
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reports, concept papers, and textbooks, which illustrate the diversity in frailty 
conceptualization and defining features. 
 
Table 2 
Definitions of Frailty 
Quantitative Research Source 
Independent function when feeling well but experience decline in 
physiologic function from reduced reserve capacity by a 
pathophysiologic factor sufficient to instigate a cas ade of adverse 
events that leads to or accelerates age-related detrioration in organ 
and system function; eventually death ensues. A dynamic balance 
between biomedical and social components. 
Brocklehurst, 1985 
Over 65 years of age with one or more functional, cognitive or social 
impairment. 
Matteson & 
McConnell, 1985 
Having any one of 28 risk factors for institutionaliz tion (≥ 85 years 
of age, lives alone, mental impairment, ADL limitation, others). 
Shapiro & Tate, 1985, 
1988 
Dependent on others for ADLs. Woodhouse et al., 
1988 
A correlate of aging, especially advanced old age and the oldest-old. 
An ordinary state of health for most people towards the end of life. 
Burnside, 1990; 
Walston & Fried, 
1999; Phillipson , 
2002; Woodhouse & 
O’Mahoney, 1997 
Poor mental health functioning, cognitive impairment, depression. Burnside, 1990; 
Parmelee et al., 1998 
Presence of any one criterion: CVA, chronic and disabl ng illness, 
confusion, ADL dependence, depression, falls, pressur  ore, 
impaired mobility, incontinence, malnutrition, polypharmacy, 
bedrest, restraints, sensory impairment, socioeconomic r family 
problems. Severely frail classified by severe dementia, ADL 
dependence, terminal illness. 
Winograd et al., 1991 
Chronically dependent older people with variety of physical and/or 
cognitive impairments that impede daily function. 
Tennstedt & McKinlay, 
1994 
Severely impaired strength, mobility, balance, and e urance that 
significantly diminish ADL ability. 
Hadley et al., 1993 
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Quantitative Research Source 
Differentiates frailty as a disease versus as a part of aging based on 
physics theory related to energy, nutrition, atrophy, disuse. 
Bortz, 1993 
Frailty occurs when there is diminished ability to carry out practical 
and social activities of daily living. Proposed 7 parameters for 
considering frailty: ability to carry out practical nd social ADLs; 
personal and environmental factors that contribute to frailty; 
continuum from hardiness to frail; frailty as temporary vs permanent; 
concept of reserve capacity; frailty vs disability; frailty related to age. 
I. Brown et al., 1995 
Cognitive and mental impairments such as dementia ad depression. M. Collins & Abeles, 
1996 
Homeostenosis, the exaggeration of age-related physiologic decline 
causing disruption in biologic function that maintas homeostasis. 
Campbell & Buchner, 
1997 
Consequence of multisystem dysregulation and high allost tic load 
resulting from chronic stressors that exert wear and tear on the body 
that impair organ system function over time. 
T. E. Seeman et al., 
1997 
Syndrome involving deficiencies in two or more domains involving 
physical, nutritive, cognitive and sensory capabilities. 
Strawbridge et al., 
1998 
Diminished function and self-rated health. Dayhoff, Suhreinrich, 
Wigglesworth, Topp, 
& Moore, 1998 
Mental frailty differentiated from physical frailty as memory 
vulnerability in cognitive domain and depression in psychologic 
domain. Depression may provoke anxiety, memory problems, 
reduced self-efficacy and confidence in cognitive and psychologic 
ability. 
McDougall & Balyer, 
1998 
Frailty is based on deficits determined in comprehensive geriatric 
assessment that warrants admission to a hospital-based geriatric and 
rehabilitation unit for interdisciplinary care. Focus areas include 
ADL, IADL, ambulation, transfers, continence, etc. with a detailed 
scoring system for goal setting and goal attainment. 
Yip et al., 1998 
State of age-related physiologic vulnerability resulting from impaired 
homeostatic reserve and reduced capacity to withstand stress. 
Fried & Walston, 1998 
Midpoint between independence and pre-death, a constellation of 
many conditions and risk factors rather than a distinct clinical entity. 
Hamerman, 1999 
Age ≥ 85 years, ADL dependence, comorbidity, geriatric syndromes, 
dementia,  ≥ 3 falls in past month, delirium (due to pulmonary o  
urinary tract infection, coronary ischemia, drugs), urinary and fecal 
incontinence, osteoporotic fractures, failure-to-thrive, neglect, abuse. 
Although not weighted, some criteria may be more salient than others 
(e.g., failure-to-thrive). 
Balducci & Stanta, 
2000 
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Quantitative Research Source 
Based on a phenotype of 5 criteria (weight loss, weakn ss, 
exhaustion, low physical activity, gait speed) where any three or more 
indicate frailty, 1-2 indicate pre-frail or intermediate frailty, 0 
indicates not frail or robust. 
Fried, Tangen, et al., 
2001  
Key indicators: functional abilities (cognition, ADL, IADL), 
physiologic stress (age, chronic diseases), social support (caregivers). 
Frailty classified by discharge disposition: (1) retu n home without 
services (mild frailty), (2) return home with services (moderate 
frailty), (3) hospitalization (severe frailty).  
Genge, 2001 
Loss of adaptive capacity due to a loss of complexity.  Lipsitz, 2004  
State of muscular weakness and other losses in function and structure.  Bortz, 2002  
Age related alteration in physiology and pathology that leads to 
vulnerability, loss of physiological reserve, poor medical and 
functional outcomes; a final common pathway of the eff ct of 
disease, disuse, and aging.  
Studenski et al., 2004  
A cascade representing pre-disability that depends o  the interaction 
of disease processes with normal, age-related processes, lifestyle and 
environment. 
Morley et al., 2006 
Age related alteration in physiology and pathology that leads to 
vulnerability, loss of physiological reserve, poor medical and 
functional outcomes; a final common pathway of the eff ct of 
disease, disuse, and aging.  
Studenski et al., 2004  
A cascade representing pre-disability that depends o  the interaction 
of disease processes with normal, age-related processes, lifestyle and 
environment. 
Morley et al., 2006 
Frailty defined hospitalized heart failure patients by modified Fried 
Frailty Index, three of five criteria denotes frailty: BMI <18.5 kg/m2 
or >30.0 kg/m2; Albumin <3.8 g/dl; Hemoglobin <13.5 g/dl for men 
or <12.5 g/dl for women; NYHA class III or IV heart failure and/or 
ejection fraction <40%; Iowa Fatigue Scale, score >35. 
S. Collins, 2007 
Physiologic frailty, or “phrailty,” covert vulnerability with preserved 
physical function; is undetected until an acute event exceeds critical 
threshold. Compare to Functional frailty or “F-frailty,” observable, 
multifactorial manifestations, due to interaction of aging, disease, 
functional limitations, disability. 
Whitson et al., 2007 
Age-related changes in molecular, cellular and physiologic systems, 
decreased physiologic reserves, reduced stress tolerance; related to 
chronic inflammation. 
Strandberg & Pitkälä, 
2007 
Increased vulnerability to stressors due to impairment in multiple, 
inter-related systems, reduced homeostatic reserve and resilience, risk 
for poor outcomes.  
Bergman et al., 2007  
A count of accumulated deficits in biologic, physical, cognitive 
function and other factors that accrue over time. 
Rockwood & 
Mitnitski, 2007  
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Quantitative Research Source 
Clinical syndrome due to multisystem impairment separate from 
normal aging. 
Abellan van Kan, 
Rolland, Bergman, et 
al., 2008 
Eligibility for PACE (Program of All-inclusive Care for the Elderly) 
developed for frail elderly: 55 years and older andcertified for 
nursing home care by appropriate state agency: needs assistance with 
≥ 1 ADLs, moderate cognitive impairment or diagnosed with 
dementia, dually eligible for Medicare and Medicaid benefits. 
CMS, 2006 
CMS Frailty Adjustment Model for Medicare payment to hospitals 
pertaining to preventable 30-day readmission. Frailty defined as 
difficulty performing ADLs based on objective measurement. Use of 
standardized ADL count scale improves statistical stability of ADL 
functional status and outperforms physical function measures 
(difficulty walking 2-3 blocks, lifting 10 pounds). ADL function 
superior to medical diagnosis, IADL, or self-report f ADL and 
assistance needed, since receipt of help is confounded by availability 
of assistance and cultural influences. 
Kautter et al., 2008–
2009 
Clinical phenotype combining impaired physical activity, mobility, 
balance, muscle strength, motor processing, endurance, 
polypharmacy, homebound or institution residence, high risk for 
disease, disability, hospitalization, death. 
DuBeau et al., 2010  
A weakened state with reduced reserve capacity that compromises 
health, functioning, and wellbeing. Frailty and its complications may 
be avoidable or preventable. Contributing factors may be poor care, 
neglect or abuse. 
Heath & Phair, 2009 
Study of hospitalized frail elders, Swedish National Centre of 
Epidemiology definition: persons ≥75 years of age hospitalized  three 
or more times in past year and has three or more diagnoses according 
to ICD-10. 
Ekdahl, Adersson, & 
Friedrichsen, 2010 
Medically distinct syndrome associated with decreased functional 
reserve and resilience to stressors.  
Fulop et al., 2010 
A state of reduced homeostasis and resistance to stress that leads to 
increased vulnerability and risk of adverse outcomes; s ven frailty 
markers: nutrition (weight loss, poor appetite, BMI), mobility 
(walking speed < 1 m/s, wheelchair), hand grip strength 
(dynamometer), energy/fatigue (questionnaire), physical activity (3 
questions, exercise frequency, intensity), cognitive impairment 
(MMSE, MoCA), mood (Hospital Anxiety and Depression Scale). 
Puts et al., 2010 
Frailty is a composite of age-associated disorders and deficits, 
symptoms, disabilities, and diseases; a systemic ind ator of aging 
and population heterogeneity. 
Yang & Lee, 2010 
Frailty is accelerated aging. Weiss, 2011 
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Quantitative Research Source 
A dynamic process, frequent transitions between frailty states over 
time. 
Gill et al., 2011 
A disorder of inter-related physiological systems and gradual decline 
in physiologic reserve with aging that is acceleratd with frailty 
where homeostatic mechanisms begin to fail. Complex m chanisms 
of aging promote cumulative decline in system function and depletion 
of homeostatic reserve and disproportionate changes i  health status 
after minor stressor events. 
Clegg, 2011 
Frailty is the result of impairment in the physical abilities needed to 
live independently and is usually the sum of impairments in muscle 
strength, posture and balance, gait, and bone mass and quality. 
NIH, 2012 
A multidimensional syndrome characterized by decreased reserve and 
diminished resistance to stressors. Frailty is differentiated from 
disability but relationships with comorbidity not established. 
Operational definition not confirmed but a comprehensive definition 
was proposed for 6 domains:  physical performance, gait speed, 
mobility, nutritional status, mental health and cognition, biomarkers 
(not specified). Age threshold was not determined. 
Rodríguez-Mañas et 
al., 2012 
Qualitative Research Source 
A lived experience, not biomedical problem. Attributed by others 
when there is undiagnosed, untreated, or worsening medical 
condition; may reflect an overwhelmed family and inadequate 
coping. Frailty is over-medicalized: there is over-emphasis on 
surveillance, safety, and treatment that creates a sense of 
disembodiment that separates the person from their medical 
problems/frailty.  
Kaufman, 1994 
Frailty is synonymous with disease, disability, and functional decline 
that interfere with autonomy and ADL function. Frail persons do not 
see themselves as frail and never use the word frail to describe their 
health status. Coping was achieved by letting things go, reducing 
expectations, changing goals, making adjustments, managing losses, 
accepting there will be good and bad days.  
Becker, 1994 
Frail means illness and suffering from chronic or acute disease but 
not necessarily diminished function or self-care. Aging was described 
as Up in years old (old age), Wore out old (accelerated aging with 
chronic disease or disability), and Up in years old but not Wore out 
old (old age but functional). These descriptors imply loss of ability 
rather than associations with illness or disease, and were similar to 
but not same as conceptions of frailty. Help seeking is a critical 
juncture that causes redefining oneself as frail. Blacks perceive 
themselves as ill or frail only when problems become ore severe 
compared to others of similar circumstances.  
Jett, 1994 
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Qualitative Research Source 
Frailty is a combined ADL and IADL impairment score that 
represents the contributions and combined effects of medical 
problems and cognitive impairments that lead to functio al decline. 
Gealey, 1997 
Frailty framed from a feminist, social constructionist perspective in 
discussions over six months with a task force of of older adults from 
a residential community and low income and disabled e ders from 
apartments. Themes were (a) frailty had no single useful definition; 
(b) professionals use the term frailty without discomfort but was 
considerered a potentially harmful label; (c) frailty label needs to be 
changed to focus on independence and inter-dependence community 
building; (d) use of the term thrive was preferred as it signifies 
potential for improvement, recovery, and empowerment. 
Gray, 1998 
Defined as dependence but recognized as a culturally-derived 
construct, a narrow perspective and label that doesn t reflect views 
of frail elders. Efforts to maintain continuity in lifestyle and routines, 
interdependence, social support preserves autonomy and a level of 
independence that is based on shifting expectations. These factors are 
influential in the life of frail elders but does not equate with being 
frail. These psychosocial issues can be present when on  is frail.  
Stephenson, Wolfe, 
Coughlan, & Koehn, 
1999 
Frail persons do not see themselves as frail in contrast to their care 
provider. Different patterns of frail elder/provider interactions were 
illustrative: Partnering (life-encouraging, positive self-image); 
Disenfranchising (life-discouraging, due to disconnected relationship, 
feelings of abandonment); Operating in tandem (mutual goals and 
priorities determined, action plan is collaborative). 
Higby, 2001 
Frail persons reject the medical label of frailty and its connotations; 
they do not feel frail since perceived boundaries btween frail and 
nonfrail are blurred. Frailty is contextual, temporal, personal, and 
relative. Connections between medical and social needs are 
important.  
Grenier, 2002 
Frailty characterized by residence in a hostel (assisted living) facility 
and reporting fatigue for 5 consecutive days. In one- -one 
interviews, 5 themes reflected participants’ experiences of fatigue: 
pacing yourself, battling on, hitting rock bottom, feeling safe, moving 
on. Fatigue created frustration as some participants struggled to 
maintain daily routines and engage in social activities. Others gave in 
and made adjustments, lowering expectations and changing routines. 
Frail elders need support to manage debilitating symptom of fatigue. 
Toye, Write, & 
Rooksby, 2006 
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Qualitative Research Source 
The social construction of frailty creates dissonance between the 
aging self and external social messages and health provider 
assumptions and attitudes. Frail elders do not see hemself as  old or 
frail. Self-image is separate from the provider’s objective assessment 
which focuses on medical issues and does not consider health and 
wellness and embodiment in the context of the aging experience, 
morbidity, disability. Adjusting to aging changes and frailty requires 
negotiating a sense of self and adjusting expectations. 
Grenier & Hanley, 
2007 
Frailty perceptions are based on comparison to referents (older and 
younger family and friends) and socially constructed symbols for the 
physical characteristics associated with old age (wrinkles, gray hair, 
slow, unsteady gait, decline in function and energy). Frail elders do 
not feel old or acknowledge getting old even when they acknowledge 
slowing down. Frailty is not always associated with disease or being 
sick. Aging was described as feeling worn out and/or tired and does 
not equate with frailty or disease. The biomedical focus on disease 
over-emphasizes negative aspects of health status, over-medicalizes 
frailty, and is at odds with the lived experience of frail elders. 
Chater, 2002 
In a survey of geriatricians, frailty was described as a critical mass of 
consequences of disease and aging changes manifested as weakness, 
poor endurance, weight loss, poor nutrition, inactivity, homebound, 
fear of falling, unsteady gait. Frailty, disease, and disability overlap 
but frailty can manifest without morbidity or disability. Frailty is 
represented by poor physical function, disease, and appearance of 
weakened state with poor tolerance for and recovery from stressors. 
Fried et al., 2004 
Interviews with experts, clinicians, frail patients, caregivers. Six 
domains (mobility, balance, strength, endurance, nutrition, 
neuromotor performance), 7 consequences (medical complexity, 
healthcare utilization, appearance, self-perceived health, ADLs, 
emotional and social status). Clinicians highly rated mobility, 
strength, balance, ADL function, life space. In web-based case 
studies, clinicians highly rated balance, nutrition, mobility, stamina, 
ADLs. Frail patients / caregivers rate emotional/social issues highest, 
clinicians rated them lowest. 
Studenski et al., 2004 
Interviews with experts, clinicians, frail patients, caregivers. Six 
domains (mobility, balance, strength, endurance, nutrition, 
neuromotor performance), 7 consequences (medical complexity, 
healthcare utilization, appearance, self-perceived health, ADLs, 
emotional and social status). Clinicians highly rated mobility, 
strength, balance, ADL function, life space. In web-based case 
studies, clinicians highly rated balance, nutrition, mobility, stamina, 
ADLs. Frail patients / caregivers rate emotional / social issues 
highest, clinicians rated them lowest. 
Studenski et al., 2004 
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Qualitative Research Source 
An empty or catch-all term that has little utility since it does not 
describe personal experiences or address the chasm between 
providers who diagnose frailty and frail elders who do not see 
themselves as frail. Frailty involves balancing, accepting, resisting 
dependency; these actions are disrupted by medical treatment of 
disease rather than frailty status. Frailty as a state of dependency is 
perpetuated by providers and has an adverse impact on frail elder 
perceptions of autonomy and engagement in decisions about issues 
that affect them. 
Bunk, 2007 
Frailty has three dimensions: physical, psychological/cognitive, 
social. Comorbidity,  poor health, walking difficulty, feeling down, 
anxiety, few social contacts, unable to do things one likes to do. 
Frailty is inevitable, cannot be prevented or contrlled. Frail men 
focused on physical impact (disease, functional limits, dependence); 
frail women, on psychosocial impact (feeling down, lo ely).  
Puts et al., 2007 
Frailty was based on opinions of health professional experts and was 
defined as multi-dimensional and distinct from disab lity, a dynamic 
state that affects individuals who experiences losses in one or more 
domains of human functioning (physical, psychological, social), 
which is caused by the influence of many factors. Failty increases 
the risk of adverse outcomes. 
Gobbens et al., 2010a 
Frailty defined by count of deficits in Chinese adults ≥ 55 years of 
age. Higher counts represent “variable vulnerability” in risk for 
adverse outcomes among persons of same age. The count of deficits 
does not consider type, severity, or impact of the deficit on health 
status and risk of adverse outcomes. Deficit accumulation in persons 
of the same age is more closely linked to mortality than age alone. 
Shi et al., 2011 
Frail elders describe themselves “living in the margin” with little 
recognition of or support for the work of living and dying during the 
aging process. The aging and frailty experience operates in binary 
modes: social or health; independent or dependent; livi g or dying 
and hinders ways to negotiate smooth transitions.Visible markers of 
functional limitations and increasing social losses make end-of-life 
concerns more real. To maintain continuity and grounding with 
present, frail elders put forth effort to develop and sustain 
connections to physical environment, routines and social networks.  
Nicholson, Meyer, 
Flatley, Holman, & 
Lowton, 2012 
 
 
Despite a preponderance of frailty definitions, many with common themes, no 
single definition has been adopted for use in research nd practice (Karunananthan et al., 
2009; Rodríguez-Mañas et al., 2012; Sternberg et al., 2011). Frailty encompasses a 
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variety of characterizations due to population heterog neity and situational factors 
(Rockwood et al., 2000).  It has been proposed that a single definition of frailty may not 
suffice for all populations, settings of care, and pplications.  Rockwood (2005) suggests 
that lack of a consensus definition for a frailty “should not be a source of concern” since 
different definitions may suffice for different purposes (p. 434). The diversity in frailty 
definitions reflects theoretical perspectives and observations of frailty in different 
populations and is based on the utility of the definition for application in practice, 
research, or public policy.  However, qualitative lit rature offers uniquely different 
perspectives of frailty from persons who have been id tified as frail that strikingly 
contrasts with conventional biomedical perspectives and much of the published literature. 
These perspectives have not been referenced in published consensus reports that propose 
definitions of frailty or terminology used to describe frailty status. 
Evaluating the psychometric properties of different operational definitions of 
frailty and cross-study comparisons will be important to advance the science. Romero-
Ortuno et al. (2010) note that there is no consensus on age parameters for frailty 
assessment since frailty relates more to biological age than chronological age, thus frailty 
research should not be limited to the old nor should frailty be dismissed as a concern in 
younger populations (Rodríguez-Mañas et al., 2012). From a practical perspective, 
Rockwood et al. (2000) asserts that there has been successful frailty intervention research 
without a definitive consensus definition of frailty. There is sufficient evidence for 
primary and secondary prevention, particularly related to physical activity and nutrition 
that merits clinical application (Kane et al., 2011). 
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In general, the literature suggests that a definitio  of frailty should (a) characterize 
frailty as multisystem impairment and differentiate it from aging, disability, and 
morbidity; (b) describe the etiology, instigating factors, typology, natural history, and 
different trajectories; (c) describe frailty as multidimensional and include biological, 
psychological, social, and spiritual domains, social determinants, physical environment, 
life stressors; (d) reflect complex interactions of b dy and social systems and capture 
instability and change over time; (e) be comprehensiv  in order to clarify the nature of 
dynamic interactions and nonlinear relationships of multiple components, that reflect 
system complexity and multiple pathways, where no si gle component is etiologic; (f) 
heterogeneity in the aging process and reduce emphasis on chronologic age thresholds; 
(g) facilitate estimation of risk level and prediction of adverse outcomes; (h) outcomes of 
interest should extend beyond mortality, disability, and other system-related factors and  
take into account subjective perspectives of frail elders and; and (i) avoid language that 
suggests ageism, pessimism, or therapeutic nihilism (Abellan van Kan et al., 2010; I. 
Brown et al., 1995; Clark et al., 2007; Fillit & Butler, 2009; Gobbens et al., 2010a, 
2010b; Grenier, 2002; Hogan et al., 2003; Izaks et al., 1999; P. O. Lang et al., 2009; 
Markle-Reid & Browne, 2003; Perera, Hilmer, & McLachlan, 2010; Rockwood et al., 
2000; Rodríguez-Mañas et al., 2012).  
Frailty prevalence estimates vary considerably due to differences in theoretical 
precepts, operational definitions and measurement, population characteristics, and study 
design. Multiple definitions present a challenge in determining incidence, prevalence, at-
risk populations, and outcome prediction (Kane et al., 2011). Lack of conceptual clarity 
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about frailty and poor concordance of frailty definitions underscores the importance of 
interpreting frailty research with caution (Pijpers, Ferreira, Stehouwer, & 
Nieuwenhuijzen Kruseman, 2012). 
Frailty Perspectives and Prevalence 
Theoretical and conceptual perspectives of frailty vary considerably given the 
dramatic increase in awareness of frailty as a distinct clinical condition and burgeoning 
research to determine its etiologic, diagnostic and clinical features (Gobbens et al., 
2010b; Hogan et al., 2003; Karunananthan et al., 2009, Levers et al., 2006; Markel-Reid 
& Browne, 2003). The frailty literature draws attentio  to the diverse perspectives in 
frailty conceptualizations and measurement that are appreciated by investigators with 
different goals and objectives (De Lepeleire et al., 2009). Frailty assessment can vary 
from one indicator (e.g., gait speed; Purser et al., 2006) to 90 indictors (Rockwood et al., 
1999). Five frailty perspectives are summarized below.  
Phenotype for Physical Frailty 
Fried, Tangen, et al. (2001) proposed a phenotype of hysical frailty defined as a 
clinical syndrome consisting of five distinct critea that operate in an iterative, cyclical 
process. The premise of the cycle of frailty is that certain criteria represent a hierarchical 
integration of body system functions that reflect the degree of intact homeostasis and 
level of fitness or frailty. Homeostasis depends upon complex integrative networks 
among many body systems, sufficient compensatory reserv  and capacity, and effective 
bidirectional system redundancies that permit approriate physiologic responses to 
stressors (Fried, Tangen, et al., 2001; Fried et al., 2005, 2009). As deficits such as 
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physiologic changes associated with advancing age, morbidity, mobility impairment, and 
functional decline accumulate, physiologic adaptive responses to acute and chronic 
stressors diminish. When a critical threshold is crossed, compensatory capacity exceeds 
demand and aggregated physiologic changes permit the evolution and unfolding of 
subclinical processes that lead to observable manifestations of frailty (P. O. Lang et al., 
2009). The trajectory may include transitions from a latent, pre-frail state to intermediate 
or full frailty when homeostasis and allostasis processes fail (Whitson et al., 2007). There 
are multiple points of entry into the cycle of frailty. Entry at any point propels a 
downward spiral and adverse consequences.  
Five frailty criteria constitute the Fried Frailty Index: unintentional weight loss, 
weakness, subjective exhaustion/fatigue, slow gait speed, and low level of physical 
activity. Three levels of frailty are determined: nonfrail, prefrail, and frail. Frailty is 
defined by having any three of the five criteria; intermediate frail, having any two 
criteria; prefrail, one criterion; and nonfrail, none. The phenotype for physical frailty was 
validated in the Cardiovascular Health Study (CHS), a prospective observational study of 
adults 65 years of age and older recruited from four U.S. communities (N = 5,201, final 
sample 4,735; additional cohort of African Americans, N = 687, final sample, n = 582; 
Fried, Tangen, et al., 2001). Exclusion criteria were Parkinson’s disease, stroke, Mini-
Mental Status Exam scores < 18, and prescriptions fr Sinemet, Aricept, or 
antidepressants. The Fried Frailty Index predicted significantly increased risk for four of 
five outcomes at seven-year follow-up: worse mobility, worse ADL function, 
hospitalization, mortality, but not incident falls (Fried, Tangen, et al., 2001). The Fried 
148 
 
Frailty Index has been utilized in other  populations in original or modified formats 
(Alvarado et al., 2008; Bandeen-Roche et al., 2006; Cawthon et al., 2007; Cigolle et al., 
2009; Ensrud et al., 2007; Fugate Woods et al., 2005; Graham et al., 2009; Romero-
Ortuno et al., 2010; Rothman et al., 2008; Santos-Eggimann et al., 2009; Sarkisian et al., 
2008; Semba et al., 2006; Szanton et al., 2009; Vaz Fr goso, Gahbauer, et al., 2009; 
Wilhelm-Leen, Hall, Tamura, & Chertow, 2009; Xue et al., 2008).  
The Women’s Health Initiative-Observational Study was the largest study to 
examine frailty using the CHS Frailty criteria (N = 40,657, 65 to 79 years, 40 centers; 
Fugate Woods et al., 2005). A modified version of the CHS Frailty included validated 
proxy measures for selected criteria. Frailty criteria included muscle weakness and slow 
walking speed (score, < 75 out of 100 on the RAND-36 physical function scale, counts as 
two components), exhaustion (score, < 55 out of 100, RAND-36 vitality scale), low 
physical activity (kilocalories of weekly energy expenditure in lowest quartile calculated 
from a physical activity questionnaire), and unintentional weight loss <5% during the 
past two years. 
Studies using the Fried Frailty Index. In the CHS, the prevalence of frailty was 
6.9% and ranged from 3.2% in those 65-70 years to 25% and in those ≥ 85 years (Fried, 
Tangen, et al., 2001). In the Women’s Health Initiative Observational Study (WHI-OS) 
of community women (N = 40,657, 65–79 years), frailty prevalence was 16.3% compared 
to 18% in a comparable sample in the CHS (Fried, Tangen, et al., 2001; Fugate Woods et 
al., 2005). In the Health and Retirement Study (N = 11,113, ≥ 65 years), 10.9% were frail 
(Cigolle et al., 2009). In the Women’s Health and Aging Studies I and II (WHAS-I, N = 
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1,002, ≥ 65 years, most disabled at baseline; WHAS-II, N = 436, 70–79 years, least 
disabled at baseline), overall frailty prevalence was comparable to the CHS study 
(Bandeen-Roche et al., 2006). In separate analyses of the WHAS-I and WHAS I cohorts, 
frailty prevalence was 11.6% and 11.3%, respectively (Xue et al., 2008). In the Study of 
Osteoporotic Fractures of Older Women (N = 6,724, community-living women, ≥ 69 
years), 16% were frail (Ensrud et al., 2007). In a study of micronutrient deficiencies using 
the Women’s Health and Aging Study I cohort of community-living disabled women (N 
= 766, ≥ 65 years, three-year follow-up), 33% were frail at b seline (Semba et al., 2006). 
Of 463 nonfrail women who had at least one follow-up visit, 31.9% became frail. 
Micronutrient deficiencies (serum vitamins A, D, E, B6  B12, carotenoids, folate, zinc, 
selenium) predicted frailty. In adjusted models, number of nutritional deficiencies and 
low serum carotenoids, vitamin E, and vitamin D were associated with higher risk for 
becoming frail. In a study to examine frailty and ki ney disease using data from the Third 
National Health and Nutrition Survey, a modified Fried Frailty Index identified frailty in 
2.8% with moderate kidney disease and 20.9% with severe chronic kidney disease 
(Wilhelm-Leen et al., 2009). The odds of frailty were significantly increased at all stages 
of chronic kidney disease, after adjusting for age, gender, race, and chronic disease.  
Several multi-country population-based studies used th  Fried Frailty Index. In a 
study conducted in five Latin American cities examining life course social and health 
conditions and frailty (N = 10,661, ≥ 60 years, Spanish for Health, Wellbeing and Aging 
Study; Alvarado et al., 2008) frailty prevalence ranged from 30%-48.2% in women and 
21.5%-35.4% in men. Substantial variability in preval nce across cities was attributed to 
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early life or long term psychosocial, socioeconomic, and environmental stressors. In a 
study of community adults ≥ 50 years in 10 European countries (N = 16,584, Survey of 
Health, Ageing and Retirement in Europe [SHARE]), the prevalence of pre-frailty and 
frailty was 4.1% and 37.4%, respectively (Santos-Eggimann et al., 2009). Women were 
significantly more frail (5.2%) and prefrail (42%) compared to men, (2.9% and 32.7%, 
respectively). In those ≥ 65 years, 17% were frail and 42.3% were prefrail. Frailty 
prevalence among older women was significantly higher compared to men: 21% and 
11.9%, respectively. More women were prefrail than men: 42.7% and 41.9%, 
respectively. In this study, all frailty criteria were modified. Questions were substituted 
for weight loss criteria (poor appetite, eating less), gait speed (difficulty walking 100 
meters, climb flight of stairs without resting), low physical activity (frequency, intensity 
of gardening, cleaning car, going for walk, etc.). Another study examining frailty in the 
SHARE population-based study in 12 European countries (N = 31,115, ≥ 50), where the 
SHARE-Frailty Index was developed based on the Fried Frailty Index, frailty prevalence 
was comparable to the CHS data (Romero-Ortuno et al., 2010). 
Investigators have included psychological and social variables, diagnostic tests, 
and biomarkers in frailty assessment using the Fried Frailty Index. In the Study of 
Osteoporotic Fractures in Men Research Group (N = 5,993, ≥ 65 years), dual energy x-
ray absorptiometry was added to assess sarcopenia and bone density (Cawthon et al., 
2007). Four percent were classified as frail and 40% were prefrail. In a community-based 
heart failure population (N = 169, ≥ 60 years) the six-minute walk test of aerobic capaity 
was added and 25% were classified as frail (Boxer et al., 2008). In a cross-sectional study 
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in community older adults (N = 374, ≥ 78 years) to evaluate sleep-wake disturbances and 
frailty, the Epworth Sleepiness Scale (ESS) and the Insomnia Severity Index (ISI) were 
added to the Fried Frailty Index (Vaz Fragoso, Gabhauer, et al., 2009). Analysis of sleep-
wake disturbances (daytime drowsiness, ESS > 10), sub-threshold insomnia (ISI, 8–14), 
and clinical insomnia (ISI > 14), and the Fried Frailty Index classified 41.2% as frail, 
where 23.8% were drowsy, 32.8% had sub-threshold insom ia, and 10.2% had clinical 
insomnia. Clinical insomnia and frailty were significantly associated in unadjusted 
models (OR = 2.77; 95% CI, 1.36–5.67) but not in adjusted models (OR = 1.93; 95% CI, 
0.81–4.61). Daytime drowsiness was significantly associated with frailty in adjusted 
models (OR = 3.67; 95% CI, 0.03–6.61). 
 Rothman et al. (2008) examined if individual Fried Frailty Index criteria and a 
measure of cognitive function (Mini-Mental Status Exam) and depression (CES-D Scale) 
were independent predictors of adverse outcomes in community older adults (N = 754, ≥ 
70 years, 96-month follow-up). Baseline frailty prevalence was highest for muscle 
weakness (54%) and slow gait speed (43%) followed by low physical activity (31%), 
depressive symptoms (22%), weight loss (23%), exhaustion/fatigue (13%), and cognitive 
impairment (11%). In adjusted models, three of the fiv  frailty criteria (slow gait speed, 
low physical activity, weight loss), were independetly associated with disability, nursing 
home placement, and mortality. Slow gait speed was the trongest predictor of chronic 
disability (HR = 2.97; 95% CI, 2.32–3.80), nursing home discharge (HR = 3.86; 95% CI, 
0.23–6.67) and injurious falls (HR = 2.19; 95% CI, 1.33–3.60. Cognitive impairment was 
significantly associated with disability (HR = 1.82; 95% CI, 1.40–2.38), nursing home 
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placement (HR = 2.64; 95% CI, 1.75–3.99), and mortality (HR = 1.54; 95% CI, 1.13–
2.10). The prevalence of cognitive impairment nearly doubled during follow-up, while 
gait speed, physical activity, and weight loss changed little. 
In a study of high functioning elders (70 to 79 years, MacArthur Study of 
Successful Aging), 13 biomarkers were included in frailty assessment. Abnormal 
biomarker values were scored as one point and the summed score was a measure of 
allostatic load and multisystem physiologic dysregulation (Gruenewald et al., 2009). 
Higher allostatic load scores indicated greater physiologic dysregulation and risk for poor 
outcomes. In regression models, a 1-unit increase in the allostatic load score was 
associated with a 10% greater likelihood of frailty a  three-year follow-up. Similarly, in 
the WHAS I and II studies (N = 728, 70 to 79 years), 11 biomarkers were added to frailty 
assessment to determine associations between allostatic load and frailty (Szanton et al., 
2009). At baseline, 10% were frail and 46% were prefrail. Allostatic load ranged from 0 
to 8 with 91% scoring 0 to 4. In regression models, a 1-unit increase in allostatic load was 
associated with increasing frailty in adjusted models (OR = 1.16; 95% CI, 1.04–1.28), 
supporting association of frailty with physiologic dysregulation. 
 Deficit Accumulation Framework 
The accumulated deficit framework defines frailty as the net effect of the 
accumulation of deficits in various domains over time that creates physiologic 
vulnerability and risk for frailty, mortality, and other adverse outcomes. The interaction 
of aging, disease, symptoms, poor nutrition, inactivity, poor social support, and other 
factors affects biologic aging and increases vulnerability to minor physiologic and 
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psychosocial stressors (Rockwood et al., 1999). The physiologic and psychologic burden 
of deficit accumulation contributes to decrements i function across multiple body 
systems that when a threshold is exceeded, system redundancies and regulatory functions 
break down and compensatory reserves decline. Over tim , as frailty evolves, 
vulnerability to stressors increases. Deficit accumulation may characterize the aging 
process better as an indicator of biologic age rathe  t an chronologic age (Mitnitski, 
Graham, et al., 2002; Mitnitski et al., 2001; Rockwood & Mitnitski, 2011).  
In an early longitudinal study of community-living older adults using this 
framework, a frailty scale was developed (N = 9008; Rockwood et al., 1999). Baseline 
assessment defined four levels: Class 0 (independent in ambulation and ADLs, continent, 
cognitively intact); Class 1 (bladder incontinence only); Class 2 (one [or two if also 
incontinent] if mobility or ADL assistance needed and cognitive impairment but no 
dementia); and Class 3 (two [three if incontinent] if totally dependent in mobility and 
transfers and one or more ADLs, incontinent of bowel or bladder, dementia. Frailty was 
defined by increasing dependency in ADLs and cognitive mpairment during follow-up. 
At baseline, 67% were independent (Class 0), 12% were Class 1, 16% were Class 2, and 
5% were Class 3. At five-year follow-up, 24% died, 12% were institutionalized. The 
frailty scale demonstrated a significant dose-respon e relationship in Cox proportional 
hazards modeling (adjusted for age and gender) between frailty level, institutionalization, 
and mortality. The highest risk level was Class 3.  
In the Canadian Study of Health and Aging (CSHA, N = 10,263), the deficit 
accumulation framework was used to describe health issues in the aged (Rockwood et al., 
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2005). From clinical exams, a rule-based definition was developed for a Frailty Index 
(FI) based on a count of 70 deficits (CSHA-I). The FI reflected a continuum for levels of 
fitness and frailty to stratify older adults based on deficit count and subsequent risk for 
mortality and institutionalization.  
In a study in community older adults (N = 66,589), the construct validity of the 
Frailty Index (FI) was examined  to estimate level of fitness and frailty in relation to 
biological age compared to chronological age. The average value of the FI increased with 
age in a log-linear relationship. In regression analyses, biological age was more 
significantly associated with mortality than chronological age. The average increase in 
the FI among those without cognitive impairment was 3% per year (r = 0.91; p < 0.001). 
The FI was proposed as a sensitive predictor of survival due to inclusion of novel frailty 
deficits not found in most frailty assessments and its ability to plot a mortality trajectory. 
In a study of community older adults (N = 2,914, ≥ 65 years), a Frailty Index (FI) 
included 20 deficits derived from the clinical exam ( vision loss, hearing loss, impaired 
mobility, vascular problems, abnormal gait, impaired vibration sense, abnormal limb 
tone, difficulty with cooking, bathing, toileting, oing out, grooming, skin, urinary, 
gastrointestinal problems, diabetes, hypertension) (Mitnitski, Mogilner, MacKnight, & 
Rockwood, 2002). Deficits were summed and computed to represent a proportion of the 
total possible number of deficits. The FI projected a linear relationship with mortality. 
Annually, women accumulated more deficits, were more frail, but had lower mortality 
risk compared to men of the same age. The FI identifi d gender differences in health 
status and frailty trajectories. 
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In a cross sectional population-based study (N = 26,712), which FI consisted of 32 
deficits (ADL, IADL, diseases, symptoms, self-rated health)), was used to determine if 
frail persons have more health problems than nonfrail counterparts (Kulminski et al., 
2007). Comparisons of cohorts found that the FI characterized age-associated processes 
and predicted morality better than chronological age. At younger ages, deficits accrue 
more slowly, but accelerate with age, and at very old ages, deficits in some decelerated.  
Rockwood and colleagues (2011) examined frailty in community adults (N = 
14,127, range, age 15-102 years, 14-year follow-up) using a 42-deficit FI (symptoms, 
disabilities, ADLs, IADLs, diseases, self-rated health). Frailty level was determined by 
summing the number of deficits and dividing by the otal number of deficits (42). The 
score was assigned to one of four categories: relativ y fit, less fit, least fit, or frail. At 
baseline, 50.8% were relatively fit and 7.2% were frail. At subsequent two-year follow-
up, the mean FI value increased exponentially. Frailty prevalence was linearly associated 
with age. In the 15-30 year old age group, the FI was 2%, in the ≥ 65 year age group, the 
FI was 22.4%, and in those ≥ 85 years, the FI was 43.7%. The relatively fit at b seline 
tended to remain healthy, while those who were less fit or more frail were more likely to 
worsen or die. About 25% fluctuated between fitness and frailty. Fitness declined with 
age and the less fit were unlikely to increase level of fitness. 
In another iteration of the deficit accumulation framework, Rockwood et al. 
(2005) examined the construct and predictive validity of the Clinical Frailty Scale (CFS) 
in the CSHA (N = 2,305) based on 70 deficits (ADL, IADL, physical and cognitive 
function, chronic diseases, neurological problems, geriatric syndromes, signs and 
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symptoms). Physician clinical judgment classified frailty into 7 categories, where 1 = 
Very fit (robust, active, energetic, motivated); 2 = Well (no active disease but less fit); 3 
= Well (with treated comorbid disease, disease sympto s well controlled); 4 = 
Apparently vulnerable (not frankly dependent, but “slowed up” and have disease 
symptoms); 5 = Mildly frail (limited IADL dependence); 6 = Moderately frail (need ADL 
and IADL assistance); and 7 = Severely frail (completely dependent on others or 
terminally ill) (Rockwood et al., 2005, p.490). Those with greater deficit accumulation 
and higher CFS scores tended to be older, female, cognitively and mobility impaired, and 
had more comorbid illness. Only 21% were Very fit or Well whereas 30% were 
Moderately or Severely frail. The CFS scores were compared with two other frailty 
indexes. The CFS had good criterion validity with a dose-response effect for 5-year 
mortality and institutionalization and acceptable construct validity, where worse health 
indicators and greater numbers of deficits were associated with severe frailty. 
In secondary analysis of data from the second Canadi  Study of Health and 
Aging (CSHA-II), a FI based on comprehensive geriatric assessment (CGA) was 
performed in clinics, nursing homes, and patients’ homes (N = 2,305, five-year follow-
up; Jones et al., 2005). The FI-CGA consisted of 10 impairment domains and 
performance measures. The proportion of deficits accumulated in each domain was 
computed to derive a score which correlated with 7 levels of fitness and frailty (as 
described above, Rockwood et al., 2005). Higher level of frailty was associated with 
older age, less education, and female gender. The FI-CGA correlated highly with other 
validated frailty indexes (r = 0.76). Frailty was significantly associated with mortality 
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(HR = 1.23; 95% CI, 1.18–1.29) and institutionalization (HR = 1.20; 95% CI, 1.10–1.32), 
in adjusted models for age, sex, education. The FI-CGA demonstrated a dose response 
where more deficits were associated with worse frailty nd increased health and social 
service utilization. 
The deficit accumulation framework was examined in two hospital-based studies. 
Hastings and colleagues (2008) conducted a secondary an lysis of data from the 
Medicare Current Beneficiary Survey (N = 1,851) of patients discharged from the 
emergency department and examined adverse outcomes including repeat ED visits, 
hospital admission, nursing home discharge, or mortality within 30 days of the ED visit. 
Older adults presenting to the ED with the highest number of deficits had the shortest 
time to first adverse outcome, higher risk for adverse outcomes (HR = 1.44; 95% CI, 
1.06–1.96) and serious adverse outcomes (hospitalization, nursing home admission, 
mortality; HR = 1.98; 95% CI, 1.29–3.05). There was no association between level of 
frailty and repeat ED visit within 30 days.   
In a retrospective study of hospitalized older adults admitted to a tertiary care 
academic hospital and underwent abdominal surgery (N = 102, ≥ 65 years, mean age, 72 
years), neither the deficit accumulation index (DAI) of 39 variables nor the ASA 
(American Society of Anesthesia) class > 3 predicte  post-operative complications (R. 
R. Cohen et al., 2012). The Braden Scale score, a validated measure of pressure ulcer 
risk, was the only independent predictor of post-operative complications; only length of 
stay was statistically significant. 
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Multidimensional Frailty Assessment 
An increasing number of research studies address biopsychosocial aspects of 
frailty. Medical problems and clinical decision-making can be complex due to 
heterogeneous combinations of sociodemographic, biological, psychological, social, 
behavioral, spiritual, environmental factors. Pathogenic processes such as inflammation 
and stress confound demarcations between aging, disease, disability, and frailty. Research 
is needed to examine individual differences in biopsychosocial factors, life circumstances 
and stressors, disease and symptom burden, and physiologic indicators of frailty (Steptoe 
et al., 2007). 
 In a study of the integral conceptual model of frailty in community-living older 
adults (n = 213, ≥ 75 years; Gobbens, van Assen, Luijkx, & Schols, 2011), relationships 
between life-course determinants, morbidity, and three domains of frailty (physical, 
psychological, social) and their effects on adverse outcomes were examined (Gobbens et 
al., 2011). Life-course determinants, morbidity, and frailty combined accounted for 26-
57% of variance in outcomes. The effect of morbidity on adverse outcomes was partly 
mediated by frailty, but not life-course determinants. Adverse outcomes were associated 
with physical, psychological, social domains of frailty, life-course determinants, and 
morbidity, supporting a multidimensional approach to frailty. 
In a study of outpatient chemotherapy patients (N = 50, ≥ 70 years), 
multidimensional frailty assessment was used to determine if this approach better 
predicted treatment tolerance than traditional oncology risk assessment that included age, 
health status, ADL, and IADL function (Retornaz, Potard, Molines, & Rousseau, 2011). 
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At baseline, participants were older and in good healt  with high ADL and IADL 
function. A 7-item frailty assessment (nutrition, mobility, strength, energy level, physical 
activity, mood, cognition) and assessment of ADL and IADL disability classified four 
groups: (a) no frailty criteria, IADL, or ADL disability; (b) frailty criteria without IADL 
or ADL disability; (c) IADL disability without ADL disability; and (d) ADL disability 
only. In this cohort, 42% were frail without ADL orIADL disability, 12% had no frailty 
criteria, and 16% had ADL disability only. Over two-thirds (68%) had more than two 
frailty markers. Frailty assessment identified more patients at risk for adverse effects 
from chemotherapy than the traditional risk assessmnt.  
The Edmonton Frail Scale (EFS) consists of 10 domains (17 items): general 
health status (hospitalization in past year, self-rated health), cognition (clock-drawing 
test), functional independence (IADL function), social support (available person for 
assistance), medication use (≥ 5 routine medications, forget to take medications), 
nutrition (weight loss), mood (self-reported sadness or depression), continence 
(uncontrolled loss of urine), functional performance (three-meter Timed Up-and-Go test; 
Rolfson et al., 1999). Frailty items were rated on a three-point scale and summed. A 
higher score suggested more severe frailty.  In a study of surgical patients (N = 125, ≥ 70 
years), a score > 3 on the EFS was predictive of frailty, post-operative complications, 
increased length of stay, and inability to be discharged home, independent of age 
(Dasgupta et al., 2009). In a sample of older adult inpatients and outpatients (N = 158), 
the EFS was compared to the Geriatrician’s Clinical Impression of Frailty (GCIF; 
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Rolfson et al., 1999). Scoring ranges from 0 (no frailty) to 5 (maximal level of frailty). 
The EFS significantly correlated with the GCIF and demonstrated validity and reliability.  
In a population-based study of older adults (N = 1,007, ≥ 65 years, four-year 
follow-up), Ravaglia et al. (2008) developed a frailty index based on self-report and 
standardized measures for 17 predictors. Statistical analyses identified nine independent 
mortality predictors for frailty: ≥ 80 years, male, low physical activity, sensory deficits, 
calf circumference ≤ 31 cm, IADL dependence, gait and performance score < 24, and 
pessimism about one’s health. Results indicated that a one-point increase in the frailty 
score doubled the risk for fractures, new or worsening ADL disability, hospitalization, 
and mortality. 
Balducci and Stanta (2000) developed a frailty instrument to differentiate persons 
with cancer and tolerance of oncology treatments. Frailty criteria were ≥ 85 years, 
dependence in ≥ 1 ADL, comorbidity (serious cardiovascular, respirato y, 
cerebrovascular disease ≥ diseases, or comorbidity index), one or more geriatric 
syndromes (moderate dementia, ≥ 3 falls in one month, delirium [due to pulmonary o 
urinary tract infection, coronary ischemia, drugs], urinary and/or fecal incontinence, 
osteoporotic fractures, failure-to-thrive, and neglect and abuse. A greater number of 
problems indicated more severe frailty, however, the investigators noted that some 
criteria may merit greater weighting in the scoring al orithm. For example, osteoporosis 
and incontinence may not have the same “ominous significance” as failure-to-thrive 
(Balducci & Stanta, 2000, p. 247). This was the only frailty instrument to include failure-
to-thrive in its operational definition. Age was qualified as a marker of potential 
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vulnerability which contrasts with inherent factors related to resilience where longevity is 
not inevitably linked to decline and frailty. 
The Frailty Staging System (FSS) is a screening tool developed for use in general 
practice to assess severity of functional impairment in domains often overlooked in 
routine physical assessment in older adults (Lachs et al., 1990). The FSS assesses vision, 
hearing, mental status, upper and lower limb function, urinary incontinence, ADL, IADL, 
environmental hazards, and social support. Scoring is based on the presence or absence of 
the function (0, 1) where a score of 1 triggers comprehensive assessment of that domain. 
The FSS does not stratify level of frailty.  
In a randomized control study to assess mortality in older adults with heart failure 
(N = 120 with heart failure, N = 1,139 without heart failure, ≥ 75 years, 12-year follow-
up), Cacciatore et al. (2005) modified the FSS to define levels of frailty. The modified 
FSS addresses seven domains: disability (ADL), mobility (heavy housework, walk up 
and down stairs, walk half a mile), cognition (MMSE < 24), vision (4 = no problem, 1 = 
blindness), hearing (4 = no problem, 1 = total deafn ss), urinary incontinence (total 
incontinence), and social support (4 = high support, 1 = lowest support). Each domain is 
scored dichotomously and summed. Frailty is categorized into 3 classes based on the sum 
score: Class 1 (0–1 point), Class (2–3 points), Class 3 (4–7 points). Other covariates were 
number of medications, comorbidity, cardiac medications, blood pressure, heart rate, and 
the New York Heart Association (NYHA) functional classification system. Prevalence of 
Class 3 frailty (FSS score 4 to 7, where 7 is most severe level) in those with heart failure 
was 15% compared to 5% without heart failure. Frail heart failure patients were 
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significantly older, prescribed more medications, had poorer cognitive function, more 
medical problems, greater ADL disability, and lower su vival compared to Class 1 (FSS 
score 0–1). In those with heart failure, frailty and the NYHA were not significantly 
correlated. Frailty was a better predictor of mortality than NYHA. None of those with 
Class 3 frailty survived after nine-year follow-up whereas all of those in NYHA Class IV, 
the most functionally limited group, did. The proporti n of frail patients with ADL 
disability was 83% compared to 25% of NYHA Class IV patients.  Mortality rates were 
significantly higher among the frail heart failure group in all classes of frailty in 
regression analyses compared to the non-heart failure group, after adjusting for 
covariates. The modified FSS determined that frailty represented a new independent 
variable for mortality prediction in heart failure. However, the FSS makes distinctions 
between frailty and ADL impairment difficult to determine. 
In the Cooperative Cardiovascular Project, a modifie  FSS was used to define 
frailty in patients who experienced acute myocardial inf rction (AMI; N = 43,370, ≥ 65 
years) to determine the rate of beta blocker prescription (Vitagliano et al., 2004). The 
modified FSS assessed functional impairment in onlythree domains: cognition, mobility, 
and urinary continence. Cognitive impairment was defined by the diagnoses of dementia, 
Alzheimer's disease, chronic confusion, organic brain syndrome, chronic brain syndrome, 
deteriorating mental status, and senility; delirium was classified as no impairment. 
Mobility impairment was defined as ability to walk or unable to walk (or needs a cane, 
prosthesis, brace, assistance device, or crutches, or non-ambulatory). Urinary 
incontinence was defined as continent or incontinen (totally or occasionally). The 
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modified FSS score was the sum of impairments that were rated according to four levels 
of severity. Frailty Stage I classified no impairment. Frailty Stages II, III, and IV 
classified impairments in one, two, or all three domains (Vitagliano et al., 2004). The 
prevalence of frailty with AMI in Stage 1 was 80% (not frail), Stage II, 16%, Stage III, 
3%, and Stage IV, 1%. Those prescribed a beta-blocker were 21% less likely to die 
within one year (relative risk (RR) = 0.79, p = 0.0001). Similar survival was reported in 
those with and without functional impairments thus beta blocker therapy provided a 
survival benefit at all levels of frailty. 
Preclinical disability, functional decline, and ADL disability in community older 
adult populations is relevant to frailty. In the WHAS II (N=436, 70-80 years, community-
living women, least disabled, 18-month follow-up) a preclinical stage of physical 
function decline preceded onset of disability (Fried, Young, Rubin, Bandeen-Roche, & 
WHAS II Collaborative Research Group, 2001). Standardized measures of function and 
disease state were obtained (gait speed, chair stands, handgrip and hip flexor strength, 
balance, spirometry, visual function, treadmill, others). At follow-up, decreased physical 
performance and increased disease frequency was associated with self-reported decline in 
mobility function. Study findings suggest that different levels of disease severity, 
impairment, and physical performance were associated with different levels of self-
reported function. Identifying early stages of functional decline may improve detection of 
older adults at risk of becoming disabled or who are frail. 
Attention to functional decline and ADL disability is particularly important in 
hospitalized adults since these conditions are recognized as adverse outcomes of frailty. 
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At its earliest inception, frailty is hypothesized to precede functional decline and ADL 
disability (Fried, Tangen, et al., 2001; Fried et al., 2004). However, there is considerable 
overlap between frailty and functional decline, disability, and morbidity, where 
boundaries are less distinct as a function of time and the interactions among these. For 
example, the etiology and trajectory of functional decline and ADL disability are 
influenced by stressors associated with hospitalization and care delivery processes (Boltz 
et al., 2012; Boyd et al., 2005; C. J. Brown et al., 2004; C. J. Brown et al., 2009). 
Precursors or risk factors for functional decline ad ADL disability may have linkages to 
frailty through their impact on biologic processes that impact multiple body systems that 
exert cumulative adverse effects over time. Frailty may also develop without evidence of 
functional decline, ADL disability, or illness but the underlying physiologic vulnerability 
is associated with poor response to stressors and recovery, thus functional decline and 
disability may manifest under acute clinical circumstances and rapidly progress. 
In a systematic review 28 of prospective, longitudinal studies, the predictive value 
of frailty indicators on ADL disability was assessed in community-living older adults 
(Vermeulen, Neyens, van Rossum, Spreeuwenberg,  & de Witte, 2011).  Although there 
was variability in the definition and measurement of ADL function and disability 
indicators and data could not be pooled, study findings indicate that weight loss, gait 
speed, grip strength, physical activity, balance, and lower extremity function predicted 
future ADL disability. Slow gait speed and low physical activity were the strongest 
predictors. Study findings suggest that assessing and monitoring physical function may 
help identify older adults who could benefit from mobility-enhancing interventions. 
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Several tools screen for frailty using a functional i ventory then follow-up with 
frailty assessment using CGA. For example, The Vulnerable Elders Survey (VES-13) is a 
13-item assessment a function-based tool developed by the Rand Corporation that 
identifies older people at risk for physical function decline and death (Saliba et al., 2001). 
The VES-13 is a survey tool that includes self-rated h alth and ADL and IADL function.  
In a nationally representative community-based survey (N = 2,205, ≥ 65 years, Medicare 
beneficiaries), a VES-13 score ≥ 3 identified 32% as vulnerable. The vulnerable group 
had 4.2 times the risk of death or functional decline over two-years compared to those 
with scores < 3 (AUC = 0.78). The addition of self-reported diagnoses did not improve 
the predictive ability of this tool. In a longitudinal study of community-living older adults 
in two managed care organizations identified as having moderate to high risk of death 
and functional decline defined by a VES-13 score ≥ 3 at baseline (N = 420, ≥ 65 years, 
mean follow-up, 11 months), VES-13 scores significantly predicted death and functional 
decline (AUC = 0.66; Min, Elliott, Wenger, & Saliba, 2006). The risk of death and 
functional decline increased from 23% among those with VES-13 scores of 3%- 60% 
among those with a score of 10. As demonstrated in the prior study, gender and morbidity 
were not significant predictors. The VES-13 is a usef l screening tool to detect risk of 
health deterioration in a vulnerable older population. Several studies report the use of the 
VES-13 as part of a two-step screening process to identify high risk individuals who 
would benefit from a full CGA and maximize efficiency and case-finding (Molina-
Garrido & Guillen-Ponce, 2010).  
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To facilitate case-finding and screening in primary care the FRAIL Scale was 
developed by an international advisory panel (Abellan van Kan, Rolland, Bergman, et al., 
2008). The FRAIL Scale identifies older adults at risk for health decline, dependency, 
and poor outcomes in a short, practical instrument. FRAIL is an acronym for: (a) Fatigue; 
(b) Resistance (climb stairs); (c) Ambulation (walk  standardized distance); (d) Illnesses 
(number); and (e) Loss of weight (≥ 5%). A maximum score of 48 indicates severe 
frailty. Psychometric or clinical data were not reported. This instrument has gained 
recognition as a practical and clinically relevant tool for frailty screening assessment that 
should be adopted by clinicians across clinical care settings (Heuberger, 2011). 
Comprehensive Geriatric Assessment (CGA) 
Comprehensive geriatric assessment (CGA), a cornerstone in geriatric practice is 
an interdisciplinary diagnostic and treatment process that determines the older adult’s 
multidimensional medical, psychosocial, and functional abilities and needs to develop a 
coordinated care plan, referral to health and social services, and planned follow-up 
(Wieland & Hirth, 2003). CGA provides a multidimensional view of BPSS health status 
based on interprofessional geriatric expertise that identifies deficits in BPSS function and 
risk factors for frailty before objective manifestations occur (Gobbens et al., 2010b, 
2010c, 2011; Whitson et al., 2007).  
The Clinical Global Impression of Change in Physical Fr ilty (CGIC-PF) 
(Studenski et al., 2004) was designed from survey and interview data from experts in 
frailty, geriatric clinicians, and elderly patients and caregivers. The CGIC-PF consists of 
six assessment domains (mobility, balance, strength, endurance, nutrition, neuromotor 
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performance) and seven domains for consequences (medical complexity, healthcare 
utilization, appearance, self-perceived health, ADLs, emotional status, social status). 
Each domain has two to four indicators rated on a seven-point scale which are scored and 
summed (Markedly worse Markedly improved). Frailty level was rated from seven (best) 
to zero (worst). At subsequent visits, a rating scale was used to record changes. The 
CGIC-PF has not been validated, but the investigators recommended that the tool be used 
in clinical practice to monitor frailty status, interventions, and outcomes. 
The CGA is a promising approach for use in hospital settings because it addresses 
frailty as a multidimensional syndrome, is clinically relevant, and can identify specific 
needs and interventions for individuals (Gobbens et al., 2010b, 2011; Jarrett et al., 1995; 
Rønning et al., 2010; Studenski et al., 2004; Wieland & Hirth, 2003). Limitations of CGA 
are that there is (a) no standardized approach to assessment of each domain; (b) reliance 
on subjective clinician judgment or patient self-report; (c) variability in protocols used for 
performance measures; (e) lack of evaluation methods t  etermine reliability and 
validity of CGA assessment tools; and (e) lack or nrmed cut-points for frailty (Chalcroft, 
2010; Studenski et al., 2004). CGA requires geriatric expertise, trained staff, extra time, 
adequatespace, and a high functioning interdisciplinary team.  
Physical Performance Measures 
Tests of physical performance as an indicator of intact integrated body system 
function and risk for physical function decline. Tests of mobility, balance, and muscle 
strength have been used alone or as part of frailty assessment. In a prospective cohort 
study (N = 487, ≥ 65 years), Studenski et al. (2011) found that the S ort Physical 
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Performance Battery (gait speed, chair stands, standing tandem balance) were 
independent predictors of 12-month hospitalization and health and functional decline.  
Performance measures such as gait speed, timed chair stands, balance tests, and 
handgrip strength, may improve precision in detecting frailty since task performance 
reflects integration of many physiologic functions (Purser et al., 2006). Performance tests 
require intact and coordinated function, musculoskeletal strength, balance, and 
endurance, which require intact brain, spinal cord, peripheral nerves, heart and lung 
function (Studenski, 2009).  
In a systematic review, slow gait speed was a consistent risk factor for frailty, 
disability, cognitive impairment, institutionalization, falls, and mortality (Abellan van 
Kan et al., 2009). Gait speed is an important independent predictor of frailty, morbidity, 
physical function impairment, falls, and mortality (Abellan van Kan et al., 2009; Fried, 
Tangen, et al., 2001; Fugate Woods et al., 2005; Hardy, Perera, Roumani, Chandler, & 
Studenski, 2007; Montero-Odasso et al., 2011; Purser et al., 2005, 2006; Studenski et al., 
2011; van Iersel & Rukkert, 2006; Verghese & Xue, 2011). Studenski (2009) noted that 
slowed movement is a universal age-related biological process reflecting decline in 
physiologic vitality and the integrated performance of numerous organ systems. Gait 
speed may serve as a central, core indicator of health and function. Walking requires 
body support, neurocognitive and neuromuscular processes about timing, positioning, 
stance, cadence, and stride length that is influenced by muscle strength, balance, and 
power, and cardiorespiratory fitness. The simultaneous interactive functioning of multiple 
organ systems may provide an estimation of fitness, di ease and symptom burden, and 
169 
 
the energy expenditure required to meet ADL and self-care needs and daily demands 
requiring varying degrees of energy expenditure (Studenski, 2009). In one study, gait 
speed was a significantly associated with self-report d limitations in three home-based 
activities (walking inside the home, climbing up and down stairs; Verghese, Wang, & 
Holtzer, 2011). 
In a study of acutely ill hospitalized older veterans admitted to a geriatric 
evaluation and management (GEM) unit, gait speed was used as an indicator of health 
and functional status (N = 1,388, age 74.2, 98% male, one-year follow-up; Purser et al., 
2005). Study findings reported that slower baseline walking speed (e.g., for each 
reduction of .10 meters/second in walking speed) was associated with poorer health 
status, poorer physical functioning, more disabilities, additional rehabilitation visits, 
increased medical-surgical visits, longer length of stay, and higher costs (M = $1,334, 
range, $869 to $1,798). In contrast, each .10 m/s per year increase in walking speed 
resulted in improved health status and physical functio , fewer ADL and IADL 
disabilities, shorter length of hospital stay, and o e-year cost reductions of $1,188 on 
average. In this study, gait speed was clinically re evant and feasible in assessment of 
acutely ill, hospitalized older adults. Repeated measurement over time would provide 
objective data on health status that may aid in idet fying latent functional decline and 
guide interventions that prevent steady decline and future dependence as well as identify 
those who may be more likely to need supportive healt  and social services in order to 
minimize health care costs and reduce hospitalization.  
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In a study of older adults (N = 333, ≥ 70 years), higher serum IL-6 levels were 
significantly associated with slower gait speed (adjusted for age, gender, education, 
morbidity) where a one-unit increase in baseline log IL-6 level was associated with a 0.98 
cm/s faster gait speed decline per year (p = 0.002; Verghese, Holtzer, et al., 2011). IL-6 
has catabolic effects on muscle which contributes to muscle weakness and slow gait 
speed. In a study of community-living older adults (N = 1,858, ≥ 45 years, Johnston 
County Osteoarthritis Project), faster gait speed (normal walking speed over 8 feet) was 
associated with lower incidence of radiographic andsymptomatic knee osteoarthritis 
(Purser et al., 2012). Slower gait speed may be an early indicator of osteoarthritis, with 
implications for frailty since joint stiffness and pain negatively impacts physical activity. 
Clinically-confirmed osteoarthritis at a younger age increases risk for chronic pain, 
impaired mobility, ADL dysfunction, and frailty (K. Covinsky, 2006).  
Gait speed has been suggested as a vital sign for functional capacity for 
independent living, risk for disability, and as a screening tool to plan care and predict 
adverse health outcomes (Abellan van Kan et al., 2009; Cesari, 2011a; Cesari et al., 2009; 
Ferrucci et al., 2000; Studenski, 2009). Gait speed has implications for independent 
functioning and is predictive of important outcomes. Determining if a person’s walking 
speed is abnormal requires normed values for comparison.  
In a recent meta-analysis of 41 articles to describe normal gait speed for healthy 
adults (N = 23,111, 40–99 years, walk at normal pace for 3 to 0 meters) stratified by age 
and gender (Bohannon & Williams Andrews, 2011), gait speed was homogeneous within 
age groups, ranging from a mean of 143.4 cm/second (14.3m/s) for men aged 40 to 49 
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years to a mean of 94.3 cm/second (9.43m/s) for women aged 80 to 99 years. For older 
adults, studies have reported gait speed cutpoints f 1m/second (Afilalo et al., 2012) and 
0.65 m/s (Purser et al., 2005). In a study of medical and surgical cardiac surgery patients, 
gait speed was a significant independent predictor of frailty and major morbidity and 
mortality (Afilalo et al., 2010; Purser et al., 2006).  In a study of acutely ill, hospitalized, 
older male veterans (n = 1,388, 74.2 years, one-year follow-up; Purser et al., 2005) 
walking speed predicted health status and hospital costs. Each 0.10 m/s reduction in 
baseline walking speed was significantly associated with worse health status, poorer 
physical function, more disabilities, additional rehabilitation and medical-surgical visits, 
longer hospital stay, and higher costs that averaged $1,334. Alternatively, each 0.10 
m/s/year increase in walking speed resulted in improved health status and physical 
function, fewer basic and instrumental disabilities, f wer hospitalization days, and one-
year cost reductions of about $1,188.00. Gait speed is useful in the assessment of acutely 
ill, hospitalized older adults and may help predict those who will need and use more 
health-related services (Purser et al., 2005). Normed data from large samples of middle-
aged and older adults can provide guidance for intepretation of gait speed in clinical 
practice however standardized procedures must be considered, such as distance for 
acceleration and deceleration, measured walking distance, whether a turn involved).  
Other physical performance measures. Physical performance measures 
including tests for balance, pulmonary function, handgrip strength, repeated chair stands, 
are significantly associated with functional decline, falls, and frailty (Fried, Tangen, et 
al., 2001; Fugate Woods et al., 2005; Guralnik & Ferrucci, 2003; Klein, Klein, et al., 
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2003; Speechley & Tinnetti, 1991). Chin A Paw et al. (2003) compared three definitions 
of frailty (N = 450 men ≥ 65 years, three-year follow-up, Zutphen Elderly Study) 
identified as inactivity plus low energy intake; inactivity plus weight loss; and inactivity 
plus low BMI. The combination of inactivity plus weight loss was the strongest predictor 
of mortality and functional decline. The group defin d by inactivity plus weight loss also 
had poor grip strength, slow gait speed, and increased disability compared to those who 
were active with normal BMI. 
Data from the MacArthur Studies of Successful Aging (  = 880, subset of high-
functioning older adults [n = 1189]) and the Established Populations for Epidemiologic 
Studies of the Elderly (EPESE; subset, n = 4030) indicated that poor physical 
performance in handgrip strength, chair stands, and six-minute walk time were associated 
with serum CRP and IL-6 levels (Taaffe et al., 2000). Faster walking speed was 
significantly associated with lower IL-6 and lower CRP in adjusted models (age, gender, 
race, BMI, smoking, nonsteroidal anti-inflammatory d ugs, morbidity). Lower CRP level 
was significantly associated with high grip strength. There were no significant differences 
for chair stands. Performance measures at seven-year follow-up declined significantly for 
grip strength (18%), walking speed (31%), but not chair stands. Baseline IL-6 and CRP 
were not associated with a change in performance. Those unable to undergo testing or 
who died had significantly higher baseline IL-6 and CRP levels and slower walking 
speed. CRP and IL-6 levels did not predict change i physical performance which is 
potentially explained by the high-functioning, physically active older adult sample, since 
physical activity reduces level of inflammatory biomarkers. 
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Runge and Hunter (2006) assert that physical performance tests are essential in 
frailty assessment. Suggested tests include: (a) Gait velocity, which was identified as the 
single best measure of gait stability and predictor of adverse events; (b) Five timed chair 
rises to assess risk for falls and injury; (c) Tandem standing and walking to measure 
balance; (d) Timed Up & Go Test as a global screening procedure; (e) Clinical gait 
analysis; and (f) Mechanography to analyze kinetics during a two-legged jump (Runge & 
Hunter, 2006). In a study investigating the added value of performance tests in predicting 
adverse events in older adults, although gait speed has been validated as the most 
significant predictor, other tests such as repeated chair stands and balance tests are 
equally prognostic and are acceptable substitutes (M. Brown, Sinacore, Binder, & Kohrt, 
2000; Cesari et al., 2009; Purser et al., 2005, 2006; Puts et al., 2005; Theou, Jones, 
Jakobi, Mitnitski, & Vandervoort, 2011).  
Research is needed on performance tests in acutely ill hospitalized adults. 
Guidelines are needed for types of tests appropriate for this population or sub-groups, 
standardized protocols, frequency and timing of administration, methodologies for 
scoring and normed scales for interpretation of results, dedicated time for staff training 
and time for integrating performance testing in clii al care, patient inclusion and 
exclusion criteria, and safety factors based on risk profiles. Performance tests are more 
easily administered in community settings, but the feasibility of administering 
performance tests on busy clinical units in acutely ill hospitalized adults requires further 
research. Given the heterogeneity of the aging population, norms for frailty assessment 
measures are needed since there is little guidance o  utpoints for performance tests 
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performed in acutely ill hospitalized adults that accurately represents health status and 
risk for or level of frailty. Reexamination of referent categories of performance and 
laboratory tests for what constitutes “within normal limits” and “abnormal” in frailty 
assessment is needed (Heuberger, 2011).  
Concordance of Frailty Definitions and Prevalence 
Given substantial diversity in frailty definitions, it is not surprising that there is 
poor concordance in frailty prevalence across reseach studies. In cross-study 
comparisons, only a small% of the sample is classified as frail by different assessment 
tools. For example, van Iersel and Rukkert (2006) compared frailty criteria for two frailty 
assessment frameworks and two performance measures (gait peed, handgrip strength) in 
an acute care geriatrics ward (N = 125) to evaluate concordance and determine the 
validity and ranking of individual predictors. The first framework was based on an index 
of accumulation of deficits and included cognitive decline, ADL disabilities and urinary 
incontinence (Rockwood et al., 1999). The second framework was defined as the cycle of 
physical frailty using the Fried Frailty Index (Fried, Tangen, et al., 2001). The prevalence 
of frailty defined by individual criteria or the two frameworks varied markedly. Gait 
speed classified 88.8% as frail, compared to 62.4% for the CHS cycle of frailty 
framework, 48% for the accumulated deficit framework, and 36% for handgrip strength 
(van Iersel & Rukkert, 2006).  
In the Health and Retirement Study (HRS; N = 11,113, ≥ 65 years), Cigolle et al. 
(2009) compared three definitions of frailty: Functional Domains model (16 variables for 
nutrition, cognitive, physical, sensory function; Strawbridge et al., 1998, Alameda 
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County Study [ACS]), Biologic Syndrome model (five criteria: weight loss, 
exhaustion/fatigue, weakness, gait speed, physical activity; Fried, Tangen, et al., 2001, 
Cardiovascular Health Study [CHS]), and Burden model f accumulated deficits 
(Functional Index, 38 items from a 70-item scale for categories of symptoms, diseases, 
neurological conditions, cognition, mood, mobility, function (Rockwood, Andrew, & 
Mitnitski, 2007; The Canadian Study of Health and Aging [CSHA], 2001). Separate 
analyses were conducted using these tools in different study sub-populations. In the first 
analysis, the prevalence of frailty was compared in the HRS population based on the 
sample characteristics of the populations in which each of the three frailty models were 
originally tested (n = 1,657). For the Functional Domains model, the HRS frailty 
prevalence was 29% compared to 26% for the ACS. For the Biologic Syndrome Model, 
the HRS frailty prevalence was 11% compared to 7% for the CHS. For the Burden 
model, the HRS frailty prevalence was 32%, however, the CSHA does not compute 
prevalence, but estimates proportionate risk levels for frailty by age relative to mortality 
based on deficit accumulation.  
In the next set of analyses where the models were compared to each other in the 
HRS population, 30.2% were frail according to at lest one framework. The Biologic 
Syndrome model classified 10.9% as frail, the Functio al Domains model, 20.3%, and 
the Burden model, 15.4%. Only 3.1% were classified as frail by all three models. In a 
final analysis, sociodemographic and other characteistics of the HRS sample were 
considered. The Functional Domains model showed the least overlap with other models; 
the Biologic model classified 76.1% as frail and the Burden model classified 72.1% as 
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frail. Given the lack of concordance, each model may characterize different but 
overlapping aspects of frailty. 
Kiely, Cupples, and Lipsitz (2009) compared two frailty assessments in 
community older adults (N = 765), the Study of Osteoporotic Fractures (SOF) Index 
(weight loss, inability to rise from a chair five times without using the arms, reduced 
energy level) and the Fried Frailty Index (Fried, Tangen, et al., 2001).The SOF Index 
classified 4.2% as frail whereas the Fried Frailty Index classified 10% as frail. Both 
instruments similarly predicted falls, hospitalizaton, emergency department visits and 
disability according to level of frailty. Despite dissimilar prevalence rates, the shorter 
SOF Index was judged favorably since it similarly predicted poor outcomes and was 
easier to use in practice.  
Two frailty definitions were compared in the Canadian Study of Health and Aging 
(CSHA; N = 2,305, ≥ 70 years) to test convergent validity with each other and other 
health status measures (Rockwood et al., 2007). The frailty phenotype was 
operationalized by modified CHS Frailty criteria (timed-up-and-go test substituted for 
gait speed frailty criteria, low physical activity criteria operationalized as self-report of 
needing assistance to walk or unable to walk versus the CHS physical activity 
questionnaire, exhaustion criteria operationalized by self-report of “tired all the time,” 
weakness criteria was directly assessed on physical exam; other factors pertinent to the 
CHS criteria were obtained from the physical exam to provide convergent validity (e.g., 
test of functional reach, observation of irregular g it pattern). The Frailty Index (FI) was 
operationalized by 70 deficits identified from the clinical exam that included diseases, 
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ADL, signs and symptoms, neurological findings, mobility, and cognition. The frailty 
phenotype and FI demonstrated moderate correlation with each other (R = 0.65) and with 
measures of function but less well with cognition. Each indicator from the frailty 
phenotype was associated with impairment in Functioal Reach. Analysis of the FI does 
not differentiate frail from nonfrail but uses a cut point of 0.25 based on the sum of the 
deficits divided by the number of deficits in the index (70) which corresponds to the 
crossing point of the robust and prefrail group. Because the CHS criteria for the frailty 
phenotype were not exactly reproduced, various calculations were done to determine 
which variables best defined frailty. When comparing the CHS frailty criteria with the FI 
deficits, the frailty phenotype was not as influential as the number of deficits present for 
the FI; there were no significant differences in the distribution of deficits or criteria. Both 
frailty definitions differentiated levels of frailty by severity, and a higher level of frailty 
was associated with more adverse outcomes. The FI does not assume independence of the 
frailty criteria or validate frailty as a clinical syndrome composed of distinct elements. 
The dose-response in the FI deficit accumulation and poor outcomes suggests that the FI 
may characterize different subtypes or aspects of frailty. 
In another study, the physical frailty phenotype (CHS Frailty criteria-named 
Composite A), an index of accumulated deficits (named Composite B), and two 
performance tests (gait speed, grip strength) were compared in their ability to predict 6-
month mortality in hospitalized older adults with minimum two-vessel coronary artery 
disease who were scheduled for cardiac catheterization (N = 309, ≥ 70 years) (Purser et 
al., 2006). Frailty prevalence was 27% by Composite A and 63% by Composite B. Slow 
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gait speed and poor grip strength were stronger predictors of six-month mortality than 
either composite score, as follows:  gait speed (OR = 3.8; 95% CI, 1.1–13.1), grip 
strength (OR = 2.7; 95%, CI, 0.7–10.0), Composite A (OR = 1.9; 95% CI = 0.60–6.1), 
chair-stands (OR = 1.5; 95% CI, 0.5–5.1), Composite B (OR = 1.3; 95% CI, 0.3–5.2). 
In a prospective population-based study, the Frailty Index (FI; 43 items) and the 
Conselice Study of Brain Aging Score (CSBAS; seven it ms) were compared in a rural 
community-living older adults (N = 1,016, ≥ 65 years, four-year follow-up, Italy; 
Lucicesare, Hubbard, Searle, & Rockwood, 2009). The FI (based on the deficit 
accumulation framework) included signs, symptoms, diseases, disabilities, and abnormal 
laboratory measures derived from comprehensive geriatric assessment. The CSBAS 
(modified from the nine-item Easy Prognostic Score developed by Ravaglia et al. (2008) 
includes physical activity, gait, balance, sensory deficits, medications, IADLs, calf 
circumference, self-rated health. In analyses, frailty was assessed along an age trajectory 
and gender was not a significant predictor of mortality based on prior CSBAS research 
and was not included in the frailty indexes. FI scores are computed mathematically as a 
plot of variables with scores that range from 0 to 1, where a value of 0.25 is the cut point 
for a “clinically important level of frailty” (Lucicesare et al., 2009, p. 279). Higher scores 
indicate more severe frailty. The CSBAS score was a sum of variables that range from 0 
to 7. Both measures predicted frailty and correlated w ll with each other (r = .72, p < 
0.001). Frailty was independently predictive of mortality better than age (FI, HR = 5.26; 
95% CI, 1.05–26.42, p < 0.040; CSBAS, HR = 1.52; 95% CI, 1.28–1.81, p < 0.001).  
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Two screening tools, the Barber Questionnaire (BQ) and the Vulnerable Elderly 
Survey (VES-13) were studied in older women diagnosed with early breast cancer (N=41, 
≥ 65 years, outpatient care) and compared to CGA (Molina-Garrido & Guillen-Ponce, 
2010). The BQ is a nine-item tool that was originally developed to identify older persons 
at risk for dependence. The VES-13 is a 13-item tool that assesses age, self-perceived 
health status, ADL and physical fitness, and IADL function. A score > 0 on the BQ or ≥ 3 
on the VES-13 indicated the need for CGA. The CGA included the Barthel Index, 
Lawton-Brody IADL scale, Charlson Comorbidity Index, NSI nutritional screen, 
medications, Pfeiffer Short Portable Mental Status Q estionnaire, and the modified Gijon 
social scale. Deficits in any domain were attributed one point for the domain, and a sum ≥ 
2 points for the CGA indicated increased risk for frailty.  The BQ and VES-13 were 
compared with the CGA. The risk of frailty was 41.76%, 29.3% and 55.7% when 
evaluated with the BQ, VES-13 and CGA, respectively. The correlation between the BQ 
and CGA was fair (ICC = 0.672), but the correlation between the VES-13 and CGA was 
very good (ICC = 0.814). Prediction of frailty risk was intermediate (AUC=0.719) for the 
BQ and high (AUC = 0.876) for the VES-13. The use of the VES-13 followed by CGA 
for VES-13 scores ≥ 3 for screening was recommended as an efficient appro ch to frailty 
assessment since CGA is time- and resource-intensiv. 
Several studies comparing frailty assessment tools have been conducted in the 
hospital setting. In a multicenter study, four frailty assessment tools that were previously 
validated in community populations were tested in older adults admitted to medical 
services in nine hospitals (N = 1,306, ≥ 75 years, subset of SAFES cohort, France) to 
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evaluate their predictive ability for cognitive decline, institutionalization, and mortality at 
one-year follow-up (Dramé et al., 2011). Four multidimensional frailty indexes, 
Winograd (Winograd et al., 1991); Rockwood (Rockwood et al., 1999); Donini (Donini et 
al., 2003); and Schoevaerdts (Schoevaerdts et al., 2004) were used to classify patients 
into three different grades of frailty: G1 indicates not frail; G2 indicates moderately frail; 
and G3 indicates severely frail. The Winograd index included 10 measures that addressed 
economic and social problems, ADL, balance problems or fall risk, cognitive function, 
neuropsychiatric status, pressure ulcer risk, nutritional status, comorbidity, 
polypharmacy, sensory assessment. The Rockwood index included 8 measures for ADL 
and cognitive function.  The Schoevaerdts index included 28 measures that addressed 
age, living situation, perceived health, ADL, IADL, balance or risk of falls, cognitive 
function, nutritional status, comorbidity, polypharmacy. The Donini index included age, 
cognitive function, Mini Nutritional Assessment (MNA) which consists of four parts:  (a) 
Anthropometric measurements (questions, BMI, mid-arm circumference, calf 
circumference, weight loss past three months); (b) Global assessment (living 
arrangements, number of prescribed medications, psychological stress last three months, 
mobility, neuropsychological problems, pressure ulcers); (c) Dietary assessment (6 
questions, number of meals per day, protein, fruit, vegetable intake, decrease in food 
intake in last three months, fluid intake per day, ability to eat alone); and (d) Subjective 
assessment (questions, subjective assessment of patient’s nutritional and health status). 
Laboratory data included serum albumin, lymphocyte ount, hemoglobin, WBC, 
cholesterol, and transferrin. 
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All patients were classified as frail by at least one of the four indexes. The 
Winograd and Rockwood indexes classified patients most often as G2-moderately frail 
(85% and 96%, respectively), and the Donini and Schoevaerdts indexes classified frailty 
in patients most often as G3-severely frail (71% and 67%, respectively). Outcome data 
indicate that 34% experienced rapid cognitive declin , 36% were admitted to an 
institution, and 34% died. With the Rockwood index, all subjects who experienced rapid 
cognitive decline were classified in as G2-moderately frail; whereas, when the Donini 
and Schoevaerdts indexes were used rapid cognitive decline was evidenced in those who 
were classified as G2-moderately frail, and G3-frail. No significant difference was found 
between frailty grade and rapid cognitive decline, but frailty grade was significantly 
associated with an increased risk of institutional admission and death for all four frailty 
indexes. There was poor agreement between the four frailty indexes. This study is the 
first to compare four frailty indexes in hospitalized medical patients and highlights the 
limitations of these frailty assessment tools. It is unclear if any of these assessment tools 
is superior or appropriate for the acutely ill hospitalized adult population. 
Given variation in frailty definitions, it is not unexpected that prevalence rates and 
outcomes differed across studies. Frailty assessment tools may measure different 
components or domains of frailty. The prevalence of frailty may be over-estimated or 
underestimated by different tools. Research is needed to determine the psychometric 
properties of frailty assessment tools to determine frailty constructs and variables, 
measure validity and reliability, and identify the appropriate populations and settings for 
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application. Well-designed cross-comparison studies and original research is needed to 
learn which frailty criteria best characterize or predict frailty in hospitalized adults. 
Frailty and Hospitalized Adults  
Frailty is commonly viewed as a syndrome that affects the aged, very old, or 
terminally ill. Much of what is known about frailty is derived from research on those who 
are at least 65–70 years of age and older based on the premise that frailty is a geriatric 
syndrome inextricably linked to aging and age-related morbidity. There is little research 
about frailty in middle-aged adults but there evidence suggests there may be a subgroup 
at high risk for frailty due to early onset of morbidity, disability, disadvantaged life 
circumstances, lifestyle (poor nutrition, physical inactivity, obesity), environmental 
exposures, and other factors. For these reasons, research on frailty in hospitalized adults 
55 years of age and older is needed. 
The natural history of frailty is indeterminate because there are few longitudinal 
studies designed specifically for frailty. Research indicates there may be subtypes of 
frailty or a frailty typology. Frailty is characterized as a dynamic state, a condition of 
stable instability that is easily disrupted, and that transition between levels of frailty is 
possible. What are the implications of these findings in acutely ill hospitalized adults?  
Research indicates that even when the primary medical problem which resulted in 
hospitalization is resolved, frail person fare worse than nonfrail. The potential positive 
and negative effects of hospitalization on frailty are not known, but are important in order 
to separate those factors from the components of frailty that can be directly assessed.  
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Much of what is known about frailty in community populations may not be 
transferrable to the hospitalized adult. Some of the strongest predictors of frailty are 
performance tests of gait, balance, and muscle strength (Ko, 2011). These tests may not 
be possible to use in acutely ill adults. Research is needed on methodologies to define 
frailty in acutely ill adults, particularly those who are not able to undergo some of the 
frailty assessment methodologies because of medical condition or instability. 
Frailty is difficult to identify since it is not associated with discrete pathological 
processes or medical diagnoses that would be expected to be confined to a single organ 
system with predictable manifestations (Inouye et al., 2007). Distinct causal pathways are 
indeterminate because defining characteristics are interdependent and overlapping (Kane 
et al., 2011). Thus, search for a single etiology can be time consuming, costly, 
burdensome to the patient, and unlikely to yield a definitive diagnosis since multiple 
factors are involved (Buchner & Wagner, 1992; Inouye et al., 2007; Schwab, 2008). In 
the hospital setting, identifying frailty is critical to avoid unnecessary, inappropriate, and 
potentially harmful consequences of diagnostic testing, reatment, and medical, 
pharmacologic, surgical interventions. 
Research indicates that many hospitalized older adults experience functional 
decline prior to admission. There is a substantial body of literature on the iatrogenic 
effects of hospitalization on older adults. A cascade of adverse effects can occur in both 
robust and frail persons. The hazards of immobility, r sk for functional decline and other 
geriatric syndromes related to the stressful hospital environment (disrupted sleep, 
frequent interruptions by strangers, tests schedule throughout the day, missed meals, 
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devices and catheters, treatments), poor care coordination, medication errors, injury, and 
other problems can occur (K. E. Covinsky et al., 2003; Creditor, 1993; Graf, 2006). Some 
problems are system-related (staffing ratio and mix, resources, policies, procedures, 
geriatric care practices, management practices), some are staff-related (relationships, 
patient care quality and safety, person-centered care), nd others pertain to informatics 
(access, acquisition, use of evidence-based knowledge, quality monitoring and care 
improvement initiatives, benchmarking). Do any of these factors impact incident and 
prevalent frailty? Do certain medical and nursing care practices create conditions that 
increase risk for frailty, directly precipitates frailty, or magnifies frailty manifestations in 
those who are frail persons?  Can frailty be propelled along an irreversible course during 
a hospitalization that was expected to be uneventful?  Unplanned 30-day hospital 
readmission is considered a sentinel event and CMS has begun enforcement of 
regulations that impose financial penalties on preventable readmissions (CMS, 2012a, 
2012b). In a case-control study of older adults in a Medicare managed care plan who 
experienced urgent 30-day hospital readmission (N = 144), five factors significantly and 
independently associated with readmission were 80 years of age and older (OR = 1.8; 
95% CI, 1.02–3.2), prior 30-day readmission (OR = 2.3; 95% CI, 1.2–4.6),  ≥ 5 
comorbidities (OR = 2.6; 95% CI, 1.5–4.7), history of depression (OR = 3.2; 95% CI, 
1.4–7.9), and lack of documented patient or family education (OR = 2.3; 95% CI, 1.2–
4.5; Marcantonio et al., 1999 ). Research is needed to identify vulnerable subgroups on 
admission and during hospitalization as health statu  changes to enact appropriate 
assessments, prevention, intervention, and discharge planning. 
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There is a gap in research about the best way to assess frailty in hospitalized 
adults. Older hospitalized adults have higher comorbidity, greater symptom burden, take 
more medications, may need more ADL assistance, and experience more geriatric 
syndromes such as falls, delirium, pain, dehydration, and functional decline (C. C. Chen 
et al., 2011). Disease focused assessments and care eliv ry are often ineffective since 
other problems intertwined with the primary medical problems may not be addressed, or 
are addressed by other specialists with limited communication and collaboration in care 
and discharge planning. Most frailty assessment tools have been tested in community, 
primarily well older adults with stable chronic conditions and many of these tools have 
been applied in selected groups of acutely ill hospitalized older adults, a population for 
which they were not designed and it is unclear how to interpret assessment findings. 
Recent studies have focused on older adults, often 70 years of age and older, admitted for 
elective surgery in various subspecialties, and oncology and cardiology services. A 
variety of approaches have been utilized  to determine if frailty assessment improves risk 
assessment and prediction of complications related to surgery, invasive procedures or 
medical treatment (such as chemotherapy), morbidity, mortality, and length of stay 
compared to traditional risk assessment tools. Few frailty assessment measures (e.g., gait 
speed) have been replicated according to original protocols in which the measure was 
validated as a frailty predictor. Thus the validity and reliability must be considered when 
interpreting findings. Some frailty measures require complex calculations or norming 
data according to the study population and may include computations that include gender 
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and BMI. There are no standardized recommendations for frailty cutpoints for some 
assessment measures that can be utilized in acutely ill hospitalized adults.   
Geriatric medicine has historically utilized comprehensive geriatric assessment 
(CGA) in hospitalized older adults to comprehensively address multidimensional BPSS 
needs associated with the primary admission diagnosis(es), engage the patient and family 
in identifying preferences for care,  prevent geriatric syndromes and functional decline, 
and identify resources for discharge planning. Geriatric medicine is infrequently the 
primary admitting service for older adults thus access to geriatric expertise and CGA 
often requires consultation and referral. CGA is administered by an interdisciplinary team 
to ensure that all relevant BPSS and environmental issues are addressed to ensure optimal 
quality of care and smooth transition from hospital to home. CGA and effective 
interdisciplinary team communication and care coordination can reduce length of stay 
and preventable 30-day readmission. 
 Most frailty research assesses frailty at one timepoint. In longitudinal studies, 
frailty may be assessed at one time point over a period of years. In hospitalized adults, 
frailty assessment at one time point may characterize f ailty at that time point (e.g., on 
admission) that would be extremely useful in risk stratification and care planning. 
However, level of frailty is likely to fluctuate during hospitalization and it would be 
imperative to identify critical data that suggests worsening frailty as well as improvement 
and recovery. Repeated frailty assessment would be instrumental in provision of timely, 
person-centered care since rapid adjustments could be made in the care plan as patient 
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status occurs. These data would be important elements in quality improvement 
monitoring since the efficacy of interventions and frailty trajectories could be examined. 
It is unclear if frailty measures validated in community-living older adults are 
applicable in acutely ill hospitalized adults. The use of lengthy questionnaires, 
performance measures such as gait speed, handgrip strength, and chair raises, collection 
of large amounts of data, and ordering of unconventional biomarkers may not be feasible, 
safe, applicable, or affordable. However, if a systematic approach to frailty assessment, s 
prevention and treatment is initiated and adopted across health care settings where 
findings are available in an integrated electronic medical record, crucial information 
about health status trajectories and responses to acu e illness and other stressors would 
aide in clinical decision-making.  
Frailty assessment upon hospital admission, during hospitalization, at discharge, 
and post-discharge would provide a profile of BPSS function, physiologic stability or 
dysregulation, and outcomes experienced such as untoward events and complications, 
new or worse morbidity, mortality, longer length of stay, and hospital readmission. 
Recommendations on frailty assessment indicate that performance measures, 
specifically gait speed, should be included since it is quick and easy to perform, 
inexpensive, and a strong predictor of frailty (Abellan van Kan et al., 2009; Studenski et 
al., 2011; Studenski, 2009, 2012). Suitable substitutes are repeated chair stands and 
balance tests (Cesari et al., 2009). Adoption of performance measures may be 
challenging, potentially unsafe, even impossible, in some acutely ill hospitalized adults. 
Issues pertaining to staff training, time, space, equipment, data management, and systems 
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that codify administration, interpretation, and care-planning require consideration. 
Timing of administration would influence performance, especially in patients who are 
medically unstable, have experienced acute trauma, are tethered to multiple monitoring 
and intravenous devices, and who are on medications that affect gait, balance, and 
cognition. Gait speed testing has been included in fra lty assessment of hospitalized 
adults admitted to cardiology units or for elective surgery (Afilalo et al., 2012; Purser et 
al., 2006). A major barrier to frailty assessment in hospitalized adults is limited 
knowledge among many health professionals about geriatrics, frailty, and care of the 
elderly with acute and chronic illness from a holistic perspective  (AACN, 2011a, 2011b; 
IOM, 2008).  
Before implementation of a frailty assessment protoc l n hospital clinical units 
and across a health system, research is needed to dtermine frailty components, elements 
of screening and comprehensive assessment, and validation of frailty assessment models 
in different hospitalized subgroups (medical, surgical, critical care, specialty practices, 
etc.). Integration of frail assessment into the EMR using informatics and decision-making 
algorithms for primary and secondary prevention, targeted intervention, and quality 
monitoring tracking systems that signal changes in condition based on nursing and 
interdisciplinary team assessments would optimize tim ly use of clinical data that could 
favorably impact quality of care and accelerate recov ry. Models of care that include 
geriatric nurse specialists would facilitate forward movement in this area.    
Table 3 lists studies of frailty in hospitalized adults. A wide variety of patient and 
hospital characteristics, admitting services, and approaches to frailty assessment are 
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reflected in these studies. Conclusions cannot yet be drawn about best practices for frailty 
assessment in hospitalized adults. Further research is needed on the validity, reliability, 
target populations, and utility of frailty assessment instruments and the implications for 
professional nursing and interdisciplinary team function. 
 
Table 3 
Frailty in Hospitalized Adults 
 
Study 
 
Sample 
Frailty Criteria and 
Definition 
Frailty 
Prevalence 
 
Findings 
Fried Frailty Index 
Afilalo et al., 
2012 
 
Prospective 
cohort study 
 
Canada and 
USA 
N = 152, ≥ 70 
yrs., 34% women. 
Elective cardiac 
surgery patients, 
CABG or valve 
procedure, preop 
assessment. 
 
Fried Frailty criteria and 
an expanded 7 item scale. 
Gait speed, 5m walk; 
handgrip strength, 
exhaustion, physical 
activity, weight loss plus 
cognition (MoCA) and 
mood (HADS). 
Frailty based on 
Fried Frailty 
Index: 26%; 
 
Frail based on: 
-Slow Gait  
Speed: 46%; 
Gait speed best 
independent 
predictor for 
frailty, mortality, 
major morbidity. 
 
3 or more 
impairments on 
Afilalo et al., 
2012 
(cont.) 
Evaluated/compar
ed 4 frailty 
measures: 
1-CHS scale, 5 
item and 7 items 
2- MacArthur 
Study, 4 items 
3- Disability 
scales: Nagi 
Scale, 7 items, 
Katz ADL,6 
items, OARS- 
IADL, 7 items 
4-Gait speed, 5m 
walk 
MacArthur Study of 
Successful Aging-4 items, 
gait speed, handgrip 
strength, inactivity, 
cognitive impairment. 
 
Nagi Disability Scale  
Katz ADL scale 
OARS IADL scale 
-Nagi Disability 
Scale: 76%; 
 
-Katz ADL 
Scale: 32% 
 
Nagi Disability 
Scale (higher 
level disability 
tasks than 
ADL/IADL) 
predictive of 
mortality/ major 
morbidity. 
 
Measurement of 
frailty and 
disability 
complementary. 
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Study 
 
Sample 
Frailty Criteria and 
Definition 
Frailty 
Prevalence 
 
Findings 
Fried Frailty Index (cont.) 
Gharacholou 
et al., 2012 
 
Prospective 
cohort study 
 
USA 
N = 545, ≥ 65 yrs. 
admitted for PCI 
(percutaneous 
coronary 
intervention), pre-
procedure 
assessment. 
Fried criteria plus Short-
Form-36 and the Seattle 
Angina Questionnaire. 
Frail: 19%; 
Intermediate 
frail: 47%; 
Not frail: 21%  
Patients had 
greater 
comorbidity, 
more severe 
angiographic 
disease, poorer 
health status and 
physical 
limitations, more 
angina, lower 
quality of life 
than nonfrail. 
S. Collins, 
2007 
 
Retrospective, 
correlational 
study 
 
USA 
N= 154, 50-94 
yrs, admitted to 
heart failure 
center of a large 
teaching hospital. 
 
Retrospective 
record review. 
Modified Fried Frailty 
criteria, 3 of 5 of 
following: BMI <18.5 
kg/m2 or >30.0 kg/m2; 
Albumin <3.8 g/dl; 
Hemoglobin <13.5 g/dl 
for men or <12.5 g/dl for 
women; NYHA class III 
or 
IV heart failure and/or 
ejection fraction <40%; 
Iowa Fatigue Scale, score 
> 35. 
 
 
Frail: 38% 
 
Anemia:  90% 
of frail females 
compared to 
28% of 
frail males 
(p<.0001) 
Females 
3X more likely 
to be frail 
(p=.002); frail 
females 27X 
more likely to be 
anemic  
(p<.0001) 
compared to 
males. 
Significant (p 
=.05) differences 
in late HF by 
sex; 80%  to 
60% of older 
females. Self-
report of poor 
health 
S. Collins, 
2007 
(cont.) 
   increased the 
likelihood of 
frailty >3X that 
of self- report of 
excellent to fair 
health 
(p=.002). Those 
with ≥ 2 chronic 
illnesses were 
more than 5X 
more likely to be 
frail (p=.042) 
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Study 
 
Sample 
Frailty Criteria and 
Definition 
Frailty 
Prevalence 
 
Findings 
Deficit Accumulation Index 
R. R. Cohen et 
al., 2012 
 
Retrospective 
cohort study 
 
USA 
N = 102, ≥ 65 
yrs., retrospective 
cohort study, 
elective 
abdominal 
surgery patients, 
preop assessment. 
39 variables in the Deficit 
Accumulation Index 
(DAI):  morbidity, vision, 
pain, anemia, albumin, 
BMI, depression, mobility 
impairment, arthritis, 
weight loss, cognitive 
impairment, pressure 
ulcer, etc. 
Frailty 
prevalence not 
specified. 
 Risk of 
complications 
increased with 
greater DAI and 
Braden Scale 
scores 
Braden Scale 
score 
independently 
predicted post-op 
complications.  
The DAI and 
ASA Class ≥ 3 
not predictive of 
complications. 
T. N. 
Robinson, Wu, 
et al., 2011 
 
Prospective 
cohort study 
 
USA 
N = 233, > 65 
yrs., major 
elective surgery 
requiring post-
operative 
intensive care unit 
admission. 
14 frailty characteristics 
for 6 domains: 
Comorbidity burden 
(Charlson Comorbidity 
Index, American Society 
of Anesthesia score, 
medications, hematocrit 
<35%); Function (any 
functional dependence, 
Timed Up & Go test); 
Nutrition (albumin < 3.4 
g/dL, BMI, >10 lb. weight 
loss past 6 months); 
Cognition (Mini-Cog < 3, 
depressed mood); 
Geriatric syndrome (>1 
fall past 6 months); 
Extrinsic frailty (live 
alone).  
Frailty 
characteristics 
related to 
discharge to 
institution: 
Charlson 
Comorbidity 
Index ≥ 3, 
hematocrit < 
35%, any 
functional 
dependence, 
Mini-Cog score 
≤ 3, fall within 
past 6 months 
30% required 
discharge to 
institution. 
 
Multivariate 
logistic 
regression: 
Timed Up & Go 
test ≥ 15 and any 
functional 
dependence most 
closely related to 
discharge 
institutionaliz-
tion. 
Multidimensional Frailty Assessment 
Winograd et 
al., 1991 
 
Prospective 
cohort study 
 
British 
Columbia 
N = 985, study 
sample = 401, 
male, ≥ 65 yrs., all 
patients admitted 
to medical-
surgical units at 
Veteran’s Affairs 
Hospital. 
Independent = 
independent in all ADLs 
during acute illness. 
Frailty = any 1 of 17 
criteria (CV, chronic and 
disabling illness, 
confusion, dependence in 
ADLs, depression, falls, 
impaired mobility, 
incontinence, 
malnutrition, 
polypharmacy, pressure 
ulcers, prolonged bedrest, 
restraints, sensory 
impairment,  
Frail: 27%; 
Independent: 
63%; 
Severely 
impaired: 10% 
Disposition: 
 
Nursing home: 
Independent- 3% 
Frail:  34% 
Severely 
Impaired: 42% 
(p = 0.0001) 
 
Hospital 
readmission: 
Independent: 
49% 
Frail: 58% 
Severely  
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Study 
 
Sample 
Frailty Criteria and 
Definition 
Frailty 
Prevalence 
 
Findings 
Multidimensional Frailty Assessment (cont.) 
Winograd et 
al., 1991 
(cont.) 
 socioeconomic/ family 
problems. 
Severely Impaired = 
severe dementia and ADL 
dependence, terminal 
illness. 
 Impaired: 51% 
(p = 0.34) 
 
D. H. Lee, 
Buth, Martin, 
Yip, & Hirsch, 
2010 
 
Prospective 
study 
 
Canada 
N = 3,826, all 
patients admitted 
for elective 
cardiac surgery, 
preoperative 
assessment. 
Katz Index of ADL (5 
items, any impairment), 
Ambulation, Dementia. 
Frail: 4.1% 
 
Older, female, 
more 
comorbidity 
(diabetes, 
COPD, 
congestive heart 
failure, RR, 
cardiovascular 
disease), higher 
acuity level, 
more complex 
operations. 
J. E. Carlson et 
al., 1998 
 
Prospective 
cohort study 
  
USA 
N = 122, ≥ 60 
yrs., non-elective 
consecutive 
admissions to 14-
bed acute medical 
care unit from ED 
or home. 
Modified version of FIM 
instrument at 4 time 
points: pre-illness, 
admission, discharge, 6-
months post-discharge. 
Seven domains rated on 
1-7 scale: feeding, 
hygiene, bathing, 
toileting, dressing, 
communication, mobility. 
Summed score = 
functional level.  
Frail/Poor 
functional 
homeostasis, 
decline of 1 
point on FIM: 
52%, n = 64 
 
No change or 
increase in 
FIM:  48%,  
n = 58  
Decline in 
functional status 
was a significant 
predictor of 
adverse 
outcomes: 
Readmission, 
Mortality, 
Nursing home 
admission, 
Functional 
decline 
J. E. Carlson et 
al., 1998 
(cont.) 
 Frailty defined as 
substantial amount of 
functional decline during 
illness (magnitude and 
severity); concept of 
Functional Homeostasis. 
  
T. N. 
Robinson, 
Wallace, et al., 
2011 
 
Prospective 
cohort study 
 
USA 
N = 60, ≥ 65 yrs, 
elective admission 
for colorectal 
surgery. 
Abnormalities across 5 
domains summed: 
function (Timed Up and 
Go test ≥ 15 seconds, 10 
foot walk), dependence in 
1 ADL (bathing, dressing, 
toileting, transferring, 
continence, feeding), 
cognition (Mini-Cog  
Nonfrail: 40%; 
Prefrail: 22%; 
Frail: 38% 
 
Higher degree of 
frailty related to 
increased rates of 
discharge 
institutionalizatio
n and 30-day 
readmission. 
 
Frailty status did  
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Study 
 
Sample 
Frailty Criteria and 
Definition 
Frailty 
Prevalence 
 
Findings 
Multidimensional Frailty Assessment (cont.) 
T. N. 
Robinson, 
Wallace, et al., 
2011 (cont.) 
 score ≤ 3, combination of 
a 3-item recall and 
 not differ by 
cancer tumor 
stage or site of 
operation. 
T. N. 
Robinson, 
Wallace, et al., 
2011 
(cont.) 
 clock draw test), albumin 
< 3.4 mg/dL, hematocrit < 
35%, geriatric syndromes 
(≥1 fall past 6 months, 
Charlson Comorbidity 
Index  ≥ 3., chronic 
disease burden.  
Summed score computed 
for positive indicators. 
Frailty defined in ordinal 
scale: nonfrail (0-1 
abnormal finding), 
prefrail (2-3 findings), 
frail (4-7 findings). 
 
 
Frailty predicted 
increased 
surgical and 
hospital costs 
and 6-month 
health care costs.  
 
Frailty 
significantly 
associated with 
older age, 
discharge to 
institution, 30-
day readmission. 
Freiheit et al., 
2010 
 
Prospective 
cohort study 
 
Canada 
N = 374, ≥ 60 
yrs., with 
coronary artery 
disease 
undergoing 
cardiac 
catheterization. 
Frailty measures for 3 
domains:  
Physical Frailty: balance 
(tandem balance ≤ 10 
seconds), gait speed (2.4 
m walk in > 4 seconds)  
Cognitive Frailty: 
cognition (Mini-Mental 
State Exam, lowest decile, 
Letter-naming fluency test 
score ≥ 1.5 SD below the 
mean, Animal naming 
fluency test >  1.5 SD 
below mean, Trail 
Making test, B ≥ 1.5 SD 
below mean), poor self-
rated health, BMI (<21, 
>30 kg/m2),  
Psychosocial Frailty: 
depressive symptoms 
(Geriatric Depression 
Scale >4, Mood-Hope 
Scale > 1, Withdrawal-
Apathy Vigor Scale = 3), 
Lives alone. 
Final Model for 
frailty was 5 
variables: 
 
Poor balance; 
Abnormal BMI; 
Depressive 
   symptoms; 
Cognitive 
    impairment 
   (Trails B); 
Live alone. 
 
For scores ≥ 3, 
10 times as 
likely to have 
ADL disability, 
4 times as likely 
for poor 
HRQoL as 
those with 
scores of 0.  
 
Brief index was 
significant 
predictor of ADL 
dependence 
(OARS 
Multidimensiona
l Functional 
Assessment 
Questionnaire) 
and HRQoL 
(EuroQOL EQ-
5D (mobility, 
self-care, usual 
activities, pain or 
discomfort, 
anxiety or 
depression) 
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Study 
 
Sample 
Frailty Criteria and 
Definition 
Frailty 
Prevalence 
 
Findings 
Multidimensional Frailty Assessment (cont.) 
Freiheit et al., 
2010 
(cont.) 
 Regression analysis 
determined 5 best fitting 
frailty criteria for ADL 
decline: poor balance, 
BMI, impaired Trail-
Making Test Part B 
performance, living alone, 
depressive symptoms. 
Frailty:  >3 criteria 
  
Comprehensive Geriatric Assessment (CGA) 
Rønning et al., 
2010 
 
Prospective 
cohort study 
 
Norway 
N = 187, 137 had 
biomarker data, ≥ 
70 yrs., admitted 
for colorectal 
surgery. 
Modified CHS Frailty 
criteria, CGA and serum 
biomarkers collected 
within 14 days before 
surgery. 
 
Frailty determined by 
mathematical algorithm 
and based on continuum 
with “fit” on one end, 
“frail" 
 
Biomarkers: CRP, IL-6, 
TNF-α, D-dimer. 
 
 
Frailty 
prevalence not 
reported. 
 
CRP and IL-6 
significantly 
higher in 
intermediate 
frail vs fit. 
CRP above 
lower quartile 
significantly 
associated 
with ‘any’ 
(OR= 2.18) or 
‘severe’ (OR= 
2.60) 
complication.  
CGA frailty a 
strong 
independent 
predictor for any 
complications 
Frailty predicted 
any and severe 
post-operative 
complications. 
CGA, higher 
CRP and IL-6 
levels. 
 
IL-6 only 
predictor of 
severe 
complications  
Hilmer, 
Perera, et al., 
2009 
 
Prospective 
cohort study 
 
Australia 
N = 111, ≥ 70 yrs., 
admitted to an 
Australian teaching 
hospital, Medical 
units for aged care, 
general medicine, 
cardiology, other  
 
Validated REFS 
against 
Geriatrician’s 
Clinical Impression 
of Frailty (GCIF) 
(cognition, 
function, 
comorbidity,). 
REFS: Reported 
Edmonton Frailty Scale: 
Age, General health 
status, Function (Katz 
ADL), Cognition 
(MMSE), Mood, 
Nutrition, Number of 
medications, 
Incontinence, Charlson 
Comorbidity Index, 
Social support. 
 
Scoring: range, 0-18: Not 
frail = 0-5; Apparently 
vulnerable  
Frail = 64%; 
Nonfrail =36% 
 
Frail defined 
by sum score 
of 8-18, or 
Moderate to 
Severe Frailty. 
REFS is a 
Modification of 
the Edmonton 
Frail Scale 
(EFS). 
 
Significant 
predictors: age, 
live alone, 
number of meds. 
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Study 
 
Sample 
Frailty Criteria and 
Definition 
Frailty 
Prevalence 
 
Findings 
Comprehensive Geriatric Assessment (CGA; cont.) 
Hilmer, 
Perera, et al., 
2009 (cont.) 
 = 6-7; Mild Frailty=8-9; 
Moderate Frailty=10-11; 
Severe Frail=12-18. 
  
 
 
Dramé et al., 
2008 
 
Prospective 
cohort study 
 
France 
 
N = 870, validation 
cohort n = 436, 
 ≥ 85 yrs., 65% 
female, 2-yr. 
follow-up. 
 
Patients admitted 
to geriatric/ 
medical wards in 9 
teaching hospitals. 
From SAFES 
cohort (Frail 
Elderly Subject: 
Evaluation and 
Follow-up) 
Mortality Risk Index: 
CGA (Katz ADL, 
cognition (MMSE), 
delirium, mood);  
Physical Performance 
(One-leg standing 
balance, Timed Get-Up-
and-Go test);  
Nutrition (Mini-
Nutritional Assessment); 
Comorbidity (Charlson 
Comorbidity Index); 
Pressure Ulcer Risk 
(Norton Scale);  
Sociodemographics (age, 
gender, living location, 
education). 
 
Frailty:  Sum of points for 
each weighted risk factor. 
Did not define frailty but 
risk profile approximates 
other frailty assessments. 
3 Frailty Risk 
Groups: 
High, ≥ 6: 
17%; 
Medium, 3-5: 
56%; 
Low, 0-2: 17% 
 
Mean score = 
4, (SD, 2); 
Median, 4; 
Range, 0-10 
 
Significant 
mortality 
predictors: 
Age, ADL 
dependence, 
malnutrition, 
delirium, high 
comorbidity, 
living in 
institution, 
female gender 
(borderline 
significant). 
 
Kristjansson et 
al., 2010 
 
Prospective 
cohort study 
 
Norway 
N =185, ≥ 70 yrs., 
admitted to 
hospital for 
elective colorectal 
surgery. 
 
CGA conducted 
within 14 days 
prior to colorectal 
surgery. 
CGA domains: Function 
(Nottingham Extended 
Activities of Daily Living, 
Barthel Index), 
Comorbidity (Cumulative 
Illness Rating Index 
(CIRS]), Cognition 
(MMSE), Mood (GDS), 
Nutrition (Mini 
Nutritional Assessment 
[MNA]), Polypharmacy 
(number used daily, ≥ 5). 
Fit: 12%; 
Intermediate:  
46%; 
Frail: 43% 
 
CGA can 
identify frail 
patients with 
significantly 
increased risk of 
severe post-
operative 
complications. 
62% of frail 
patients 
experienced 
complications, 
compared to 
33% of fit, 36% 
of intermediate 
frail. 
196 
 
Table 3. (Cont.) 
 
 
Study 
 
Sample 
Frailty Criteria and 
Definition 
Frailty 
Prevalence 
 
Findings 
Comprehensive Geriatric Assessment (CGA; cont.) 
Kristjansson et 
al., 2010 
(cont.) 
 Frailty: 
 >1 of PADL <19, 
CIRS, any grade 4 
comorbidity, <2 
comorbidities grade 3, 
MMSE < 24, GDS, 
>13, MNA < 17, > 7 
daily meds. 
  
Kristjansson et 
al., 2010 
 
Prospective 
cohort study 
 
Norway 
N = 178, ≥ 70 yrs., 
elective surgery for 
suspected or 
confirmed 
colorectal cancer, 
recruitment from 3 
hospitals, one a 
referral hospital for 
elective surgery. 
CGA domains:  
Function (Nottingham 
Extended Activities of 
Daily Living 
[NEADL, 22 items, 
independence in 
mobility, kitchen, 
domestic, leisure 
activities; 4-point 
scale, range 0-66.] and 
ADL Barthel Index, 6 
items), Comorbidity 
(Cumulative Illness 
Rating Index [CIRS], 
Cognition (MMSE 
<24), Mood (GDS ≥ 
14), Polypharmacy 
(meds used daily, ≥ 5),  
Nutrition (Mini 
Nutritional 
Assessment [MNA], 
18 items), appetite, 
weight loss, diet, self-
perceived health, mid-
arm and calf 
circumference. 
 
MNA Score- summed 
scores for items, range 
0-30:  
Score 17.5-23.5 = Risk 
for malnutrition;  
Score <17 = 
Malnutrition. 
 
 
Fit: 12%; 
Intermediate 
frail: 46%; 
Frail: 43% 
 
 
Severe 
complications 
occurred in 
33% of fit, 36% 
of intermediate 
frail, 62% of 
frail. 
 
83% had severe 
complications, 3 
deaths. 
61% had ≥ 1 severe 
complication. 
 
Age, American 
Society for 
Anesthesia (ASA) 
class, or tumor 
stage not 
associated with 
complications. 
 
Frail vs nonfrail 
increased RR of for 
any complication 
and severe 
complication, 1.59 
and 1.75, 
respectively. 
 
CGA identified 
frail patients who 
have significantly 
greater risk of 
severe 
complications.  
Most common: 
wound infection, 
UTI, pneumonia or 
ventilator 
assistance, cardiac 
(angina, MI, 
arrhythmia, lung 
edema), delirium,  
intra-abdominal  
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(cont.) 
 Frail =  
>1 of ADL <19, CIRS, 
any grade 4  
comorbidity, >2 
comorbidity grade 3, 
>7 daily meds, MNA 
< 17, MMSE < 24, 
GDS, >13 
 
Frail, higher risk for 
severe complications 
in colon cancer 
patients: OR = 3.70; 
95% CI, 1.74-7.88. 
 abscess. 
Makary et al., 
2010 
 
Prospective 
cohort study 
 
USA 
N = 594, ≥ 65 yrs., 
84% Caucasian, 
42% female, 
admitted to 
academic medical 
center for elective 
surgery, 
nonrandom 
selection.  
Exclusion: 
Parkinson’s 
disease, CVA, 
MMSE <18, taking 
carbidopa/ 
levodopa, 
donepezil 
hydrocrohloride, 
anti-depressants. 
CHS frailty criteria; 
frail = 4-5 criteria, 
intermediate frail = 2-
3 criteria, nonfrail, 0-1 
criteria. 
 
Scoring validated in 
study by grouping of 
ORs for outcomes in 
exploratory data 
analysis. 
 
 
Frail: 10.4%; 
Intermediate 
frail: 31%; 
Nonfrail: 58.3% 
 
Comorbidity-
Frail/ Nonfrail: 
Hypertension: 
70.5% /57.8%;  
Arthritis: 29.5% 
/15.9%;  
Diabetes: 
21.3%/ 17.4%;   
Heart failure: 
14.8% / 3.8%;  
COPD:  
14.8%/ 6.4%;  
Cancer:  54.1% 
/74.1%. 
Frailty an 
independent 
predictor of 
surgical 
complications in 
adjusted models.  
 
Intermediate frail 
patients had 2.06 
higher OR, 95% 
CI, 1.18-3.60) of 
complications, 
Frail had 2.54 
times higher OR, 
95% CI, 1.12-5.77. 
 
Mean LOS 
significantly higher 
in frail; 
independently 
predicted LOS in 
all adjusted 
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   analyses.  
 
Mean LOS for 
Minor procedure, 
Frail vs Non-frail: 
1.5 vs 0.7 days;  
For Major 
procedure, Frail 4.2 
vs 6.2 days in 
Nonfrail. 
 
Frailty independent 
predictor of 
discharge to 
assisted living or 
nursing home. 
 
Frailty assessment 
enhanced 
predictive power of 
ASA, Lee, and 
Eagle scores. 
T. N. 
Robinson et 
al., 2009 
 
Prospective 
cohort study 
 
USA 
N = 110, ≥ 65 
yrs., admitted for 
major surgery 
requiring 
postoperative 
intensive care unit 
admission, 95% 
male, surgeries 
mostly 
abdominal/general
, urology, 
thoracic, vascular. 
5 Frailty domains: 
Age, cognition (Mini-
Cog Test), chronic 
under-nutrition (weight 
loss past 6 months, 
BMI, albumin), falls 
past 6 months, 
depression (clinical 
history), anemia 
(hematocrit within 30 
days of surgery). 
 
Disability (Katz ADL) 
and Comorbidity 
(Charlson Comorbidity 
Index) also assessed for 
comparison. 
 
Incident 
mortality at 6 
months: 15% 
 
Post-discharge 
institutional-
ization: 26% 
 
Frailty 
predictors 
significant for 
mortality and 
discharge 
institutionali-
zation: 
cognition, BMI, 
albumin, falls, 
Katz ADL, 
hematocrit; and 
Charlson 
Comorbidity 
Index. 
Frailty assessment 
superior or 
adjuvant to 
preoperative 
assessment that is 
focused on single 
organs or end-
organ functional 
deficits and risk 
stratification based 
on outcomes for 
single organ 
system (e.g., 
cardiac). Outcomes 
relevant to elderly: 
functional status, 
recovery, 
institutionalization 
mortality. 
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Pilotto et al., 
2012 
 
Prospective 
multicenter 
cohort study 
 
Italy 
N = 2,033, ≥ 65 
yrs., admitted to 
20 geriatric units 
in hospitals across 
regions of Italy.  
 
Frailty 
Assessment 
included 4 frailty 
indexes that 
reflect 3 
conceptually 
different frailty 
approaches: 
 
Phenotype: Frailty 
Index-Study of 
Osteoporotic 
Fractures (FI-
SOF);  
 
Deficit 
Accumulation: 
Frailty Index-
Cumulative 
Deficits (FI-CD);  
 
Multi-dimensional 
Multidimensional: 
Prognostic Index 
(MPI), Function 
Index, Compre-  
hensive Geriatric 
Assessment (FI-
CGA). 
FI-CGA: 10 domains, 
cognition, mood and 
motivation, 
communication, 
mobility, balance, 
bowel function, bladder 
function, ADL, IADL, 
nutrition, social 
resources. 
 
FI-SOF: 3 items- low 
energy, unintentional  
weight loss, 5 chair 
stands, level. 
 
FI-CD: 32 items, 
ADLs, IADLs, 
Parkinson’s disease, 
arthritis, stomach 
problems, MI, 
hypertension, stroke, 
hip fracture, broken 
bones, bowel/ bladder 
problems, dementia, 
self-rated health, vision/ 
hearing deficits, 
problems with teeth, 
feet. 
 
MPI- 8 domains: ADL, 
IADL, cognition (Short 
Portable Mental Status 
Questionnaire, 
comorbidity 
(Cumulative Illness 
Rating Scale), nutrition 
(Mini-Nutritional 
Assessment), pressure 
ulcer risk (Exton-Smith 
Scale), number of 
meds, living 
arrangement. 
All frailty 
indexes were 
significantly 
associated with 
1-month and 1-
year all-cause 
mortality in 
crude and age- 
and sex-
adjusted 
models. 
 
The MPI had 
significantly 
greater 
discriminatory 
accuracy than 
other three at 1 
month and 1 
year based on 
area under the 
ROC curve.  
 
Findings suggest 
multidimensional 
MPI was better at 
predicting 
mortality than 
other indexes, e.g., 
FI-CGA (based on 
count of 
impairments) 
compared MPI 
(included  
standardized 
scales, can be 
graded and also 
used as continuous 
scale to assess 
change over time). 
 
MPI predicts 
mortality in 
patients without 
functional 
limitations, with 
malnutrition, 
comorbidity, and 
high number of 
drugs.  
 
The FI-SOF had 
the poorest 
accuracy. 
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Sündermann, 
Dademasch, 
Praetorius, et 
al., 2011 
 
Prospective 
multicenter  
cohort study 
 
Germany 
Switzerland  
Sündermann, 
Dademasch, 
Praetorius, et 
al., 2011 
(cont.) 
N = 400, ≥ 74 
yrs., 52% female, 
admitted for 
cardiac surgery 
(22.5% 
revascularization, 
32% valve, 30.5% 
combined 
procedures). 
 
Comprehensive 
Frailty 
Assessment 
compared to 2 
other risk 
assessments:  
EuroSCORE and 
Society of 
Thoracic Surgery 
(STS) Score. 
Comprehensive Frailty 
Assessment: 
Modified Fried Frailty 
Index-grip strength, 
self-reported  
exhaustion, gait speed, 
physical activity 
assessed via IADL 
scale, omitted weight 
loss; plus  
physical performance 
measures: balance tests, 
chair stands, pick up 
pen from floor. 
Labs: albumin, 
creatinine, BNP. 
Pulmonary function: 
FEV1 (forced 
expiratory volume in 1 
second). 
 
Scoring: 
Nonfrail =  1-10 points 
Intermediate frail =  11-
25 points 
Frail = 26-35 points. 
Frail: 21.7%;  
Intermediate 
Frail: 7.8%; 
Nonfrail: 3.6% 
 
Median frailty 
score = 11 or 
Intermediate 
frail. 
 
 
.
 
Overall 30-day 
mortality, 5.5%. 
Frailty significantly 
related to 30-day 
mortality. 
 
Significantly 
higher frailty score 
associated with 
valve surgery. 
 
Frailty score 
compared to 
EuroSCORE and 
STS Score: 
low/moderate  
correlation. 
ROC curves 
plotted, AUC 
scores: 
EuroSCORE: 0.79 
STS Score: 0.76 
Frailty Score:  0.71 
 
Fukuse,  
Satoda, Hijiya, 
& Fujinaga, 
2005 
 
Prospective 
cohort study 
 
Japan 
N=120, ≥ 60 yrs., 
admitted for 
thoracic surgery. 
 
CGA done within 
2 weeks of 
surgery. 
Frailty characterized 
using CGA domains: 
function (Barthel 
Index), nutrition (BMI, 
arm circumference, 
albumin, transferrin, 
lymphocyte count, 
cholinesterase level), 
cognition (MMSE), 
negative emotions for 
operation. 
ADL 
dependence and 
impaired 
cognition 
significant 
predictors of 
postoperative 
complications, 
especially when 
operation time 
is long.  
 
 
Multiple logistic 
regression found 
MMSE (56% vs 
14%) and Barthel 
Index (44.4% vs 
14%) best model 
for predicting 
complications. 
 
Smoking and 
comorbidity also 
related to 
complications. 
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Afilalo et al., 
2010 
 
Prospective 
cohort study 
 
Canada, USA 
 
N =131, ≥ 70 yrs. 
Elective cardiac 
surgery (CABG, 
valve)  
Four tertiary care 
hospitals. 
Gait speed: 5m walk at 
comfortable pace. 
Slow gait speed an 
indicator of frailty. 
 
Frail/”slow walkers”- 
gait speed  ≥ 6s over 
5meters. 
Frail/Slow 
walkers:  46% 
  
 
 
Gait speed an 
independent 
predictor of 
outcomes –major 
morbidity, 
mortality 
(OR = 3.05; 95% 
CI, 1.23-7.54. 
 
More likely to be 
female, diabetic.  
 
Outcome: 23% -
inhospital mortality 
or major morbidity. 
Jarret et al., 
1995 
 
Prospective 
cohort study 
 
USA 
 
N = 193, ≥ 65 
yrs., admitted to 
large tertiary care 
university 
hospital, general 
medicine service 
to examine 
atypical 
presentation of 
illness and frailty 
in hospitalized 
older adults. 
 
Classified as frail based 
on Barthel Index score: 
Frail score < 95 (n = 
117) 
Well score ≥ 95 (n = 
76) 
 
Feeding, bathing, 
dressing,  
grooming, bladder, 
bowels, toilet use, 
transfers bed to chair, 
mobility on level 
surface-ambulation, 
stairs. 
Score range, 0- 100, 
where higher scores 
indicate worse function. 
 
Outcomes: death, 
nursing home 
admission, long LOS, 
fail to regain premorbid 
functional status. 
 
Frail:  41%;  
Nonfrail:  18% 
 
 
 
Frail elders 
significantly more 
likely to present 
atypically on 
admission, be 
older, female, less 
likely to be from 
community. 
 
Frail significantly 
more likely to have 
delirium (61% vs 
25% in nonfrail), 
had more adverse 
hospital outcomes 
(e.g., functional 
decline, restraints, 
nighttime sedation, 
pressure ulcers, 
long LOS) than 
nonfrail.  
Premorbid 
functional 
dependence (OR = 
2.48), functional 
decline at 
admission (OR= 
5.64), atypical 
presentation (OR = 
2.37), each  
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   independently 
predicted poor 
outcomes, but 
disease severity, 
age, sex did not. 
Oster et al., 
2004 
 
Prospective 
study 
 
USA 
N = 322, ≥ 65 
yrs., admitted to a 
geriatric hospital. 
Gait speed  >1.0 meter/ 
second an indicator of 
independence,  < 0.6 
m/s abnormally slow, 
associated with 
functional decline 
Mean gait speed 
0.53 m/s, 
abnormal, 
associated with 
functional 
decline 
 
 
 
Slower gait speed 
associated with 
longer length of 
stay. 
 
Slower gait speeds, 
< 0.40 m/s had 
significantly 
decreased odds of 
discharge home. 
Comparison of Frailty Assessment Tools used in Hospitalized Adults 
Purser et al., 
2006 
 
Prospective 
cohort study 
 
USA 
 
N = 309 
consecutive 
admissions, ≥ 70 
yrs. 
 
Cardiology 
patients admitted 
for elective 
cardiac 
catheterization. 
Composite A (Fried 
Frailty Index); 
Composite B (Deficit 
Accumulation); 
Gait speed (≤ 0.65 m/s); 
Handgrip strength (≤ 25 
kg); 
Chair stands. 
 
Both Composite A and 
B groups had higher 
prevalence of heart 
failure, cerebrovascular 
disease, prior CABG, 
depression than overall 
cohort. 
Frailty: 
Composite A: 
27%; 
Composite B: 
63%; 
 
Gait speed: 
50%; 
Handgrip 
strength: 50%; 
Chair stands: 
56%. 
Gait speed best 
independent 
predictor of frailty 
and other poor 
outcomes. 
 
ROC analysis done 
for gait speed, 
handgrip strength, 
chair stands to 
determine 
cutpoints. 
 
Frailty by any 
measure 
significantly 
associated with 
mortality. 
 
 
 
Health Care Delivery in Hospitals 
In hospitals, clinical care is distinguished by specialty-focused practice where one 
medical or surgical service assumes responsibility for the patient on admission based on 
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the primary diagnosis. This is appropriate and efficient in focusing expertise on the main 
problem to diagnose, treat, cure or stabilize, and discharge. Patients with multiple 
medical problems, who are medically complex or have  high illness acuity level, or who 
experience adverse events or syndromes are not easily managed by a single medical 
specialty. Medical problems in adults are rarely due to a single entity and initial signs and 
symptoms arise from multiple interacting medical problems, medications, and syndromes 
that do not match textbook presentation or can be resolved based on linear cause and 
effect assumptions (Inouye et al., 2007; Jarrett et al., 1995). Atypical presentation is the 
most common manifestation of illness in the elderly (Berman, Hogan, & Fox, 1987; 
Jarrett et al., 1995). In a study of hospitalized older adults, less than half of presented on 
admission with symptoms of disease consistent with the classic medical model that 
permits appropriate diagnosis and treatment (Fried, Tangen, et al., 2001). Jarrett et al. 
(1995) examined atypical illness presentation in hospitalized older adults classified as 
frail or nonfrail based on the Barthel Index of ADL function (N = 193, ≥ 65 years). More 
frail elders presented atypically (41% versus 18% nonfrail), were significantly more 
likely to present with delirium (61% versus 25%) and had more adverse events (e.g., 
functional decline, restraints, nighttime sedation, pressure ulcers, longer length of stay) 
than nonfrail elders. 
Thus, frailty does not fit into the traditional biomedical model for defining disease 
and treatment. A precept in medicine is “not to multiply causes unnecessarily’’ which 
means that modern medicine is based on the importance of identifying  a single etiologic 
disease mechanism that can be treated (Schwab, 2008, p. 363). Short and long term goals 
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may be at odds with one another (e.g., rapid stabiliz tion and/or cure of medical 
condition and discharge versus chronic disease management and health-promoting self-
care and lifestyle behaviors). The biomedical approach does not adequately address the 
needs of an aging population with multiple medical problems that are intrinsically related 
to one another and to other biopsychosocial factors. 
Interdisciplinary team collaboration is a hallmark in geriatrics. More direct 
involvement of interdisciplinary teams facilitates care coordination and discharge 
planning but there is risk that care may be fragmented and communication limited (N. A. 
Brown & Zenilman, 2010; Molina-Garrido & Guillen-Ponce, 2010; Puts et al., 2010; T. 
N. Robinson et al., 2009). The complexity and ambiguity of frailty requires diversity in 
the health care team in order to address BPSS issues and concerns for inpatient care and 
discharge planning.  Geriatric consultation services and interdisciplinary teams can be 
mobilized by nursing leadership at the bedside in frailty assessment, risk stratification, 
and care coordination with geriatrics, interdisciplinary teams, and discharge planners.   
Hospital Length of Stay and 30-Day Readmission 
Frailty is associated with longer length of stay and high rates of hospital 
readmission. Data from the U.S. National Hospital Discharge Survey for 2007 report that 
although persons 65 years of age and over account fr 13% of the population, they 
account for 37% of hospital discharges, and 43% of hospital days (Hall et al., 2010). The 
average length of stay for those 65 years of age and older was 5.6 days compared to 5.1 
days for those 45 to 64 years of age (Hall et al., 2010). Increased length of stay may be 
due to greater medical complexity and acuity, new morbidity, surgery or treatment-
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related complications, injurious or untoward events (e.g., falls, injury, delirium, pain, 
functional decline), poor response to rehabilitation and other treatment, inadequate social 
support, and complex discharge planning. Unplanned hospital readmission within 30-
days of discharge is considered a sentinel event that may be due to poor inpatient quality 
of care, disease instability at discharge, relapsed m ical condition, development of a 
new problem, medication problems, significant functional decline and dependence with 
inadequate social support or access to health and social ervices, and need for terminal 
care (Marcantonio et al., 1999; Williams & Fitton, 1988). 
 Length of stay and hospital readmission may be an indication of poor health 
status and health disparities. Limited achievement of Healthy People 2010 goals point to 
the need for new approaches to identify and address factors that impede achievement of 
better health outcomes in vulnerable populations (Healthy People 2020, 2013). 
Relationships between social determinants, health disparities, and frailty are relevant in 
acutely ill hospitalized adults and require further study especially with respect to 
transitions in care (Karunananthan et al., 2009; Morley et al., 2006; Szanton, Seplaki, et 
al., 2010; Szanton, Thorpe, et al., 2010; Whitson  et al., 2011).   
There is sufficient evidence that frailty is a formidable public health problem with 
important implications for hospitalized adults and the health care system. Assessment of 
frailty using a BPSS-Stress model provides a comprehensive portrayal of the person and 
the inter-relatedness of health and illness status nd function, medical problems and 
symptoms, sociodemographic characteristics, lifestyl  behaviors, and psychosocial-
spiritual factors in the context of multidimensional, multifactorial frailty. Frailty 
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assessment offers a proactive approach that fosters in disciplinary communication and 
collaboration in the early identification of frailty indicators to guide strategic prevention 
and intervention to improve care and health status outcomes. 
Summary of the Science of Frailty 
Frailty is a physiologically complex, multidimensional syndrome where systemic 
regulatory functions that normally stabilize homeostasis are compromised. Functional 
homeostasis is the ability to accommodate change and stressors associated with aging and 
disease processes without marked physiologic decompensation or functional decline. 
Research suggests that frailty is due to failure of physiologic defenses and loss of system 
redundancies that progressively leads to cellular and organ dysfunction across multiple 
systems (Fried et al., 2009; Krabbe et al., 2004; Nowak & Hubbard, 2009). Normal 
biologic aging is highly variable and produces only modest reduction in the capacity of 
cellular and organ systems to effectively and respond t  the changing internal milieu of 
bodily functions (Bortz, 1982, 1993; Fried et al., 2004; Weiss, 2011). These changes are 
often inconsequential and do not adequately explain how aging independently or 
synergistically influences frailty (Bortz, 1993). Age, disease, and disability are often used 
interchangeably as indicators of frailty but their r lationships are unclear and 
manifestations of each can overlap (Ferrucci et al., 2004; Fried et al., 2004; Grealey, 
1997; Hadley et al., 1993; P. O. Lang et al., 2009). Evidence of frailty without functional 
decline, disease, or disability, or advanced age challenges traditional understanding of 
aging and disease processes since about one-quarter of frail older adults have neither 
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comorbidity nor disability (Fried, Tangen, et al., 2001; Fried et al., 2004; Inouye et al., 
2007; Paixao & Prufer de Queiroz Campos Araujo, 2010; Walston et al., 2006). 
Frailty is due to vulnerability arising from the interplay of aging, 
pathophysiological, genetics, epigenetics, psychological, social, economic, and 
environmental factors, and other determinants, including early life circumstances and 
chronic stressors that have long term physiologic consequences (Ahmed et al., 2007; J. E. 
Carlson et al., 1998; Gouin, Hantsoo, & Kiecolt-Glaser, 2008; Kuh, 2007; Newman et al., 
2001; Rockwood et al., 2005). Frailty is characteriz d by poor physiologic response to 
minor intrinsic or extrinsic stressors that would not typically produce decompensation 
and adverse sequela in nonfrail persons (Levers et al., 2006; Whitson et al., 2007). 
Physiologic dysfunction may be clinically silent until a stressor of sufficient magnitude 
exceeds the threshold for effective, adaptive respon es (Kuh, 2007; Mitnitski, Graham, et 
al., 2002; Xue, 2011). Failure of compensatory mechanisms precipitate a cascade of 
adverse events with potentially catastrophic short and long term outcomes (De Lepeleire 
et al., 2009; Whitson et al., 2007; Xue, 2011).  
Common features of frailty do not fit a classic disea e model (Jarrett et al., 1995). 
There are no validated diagnostic markers, signs or symptoms, or laboratory tests that 
diagnose frailty. The traditional cause-and-effect medical model fails to accurately 
portray frailty since established diagnostic criteria are lacking (Fried, Storer, King, & 
Lodder, 1991; Fried, Tangen, et al., 2001; Inouye et al., 2007; Jarrett et al., 1995) 
Environmental factors and social determinants of healt  require further investigation in 
frailty (Kuh, 2007; Szanton et al., 2005). Extrinsic factors such as inadequate access to 
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health care, poor quality of care, unhealthy living environments, low income, limited 
education, lack of health and social services, transportation, and appropriate types of 
social support increase biopsychosocial risk for illness, disease, disability, and frailty 
(Abellan van Kan et al., 2010; Heath & Phair, 2009; T. Seeman et al., 2007; Szanton, 
Seplaki, et al., 2010; Szanton, Thorpe, et al., 2010). 
Gaps in the Literature 
There are significant gaps in the literature about frailty in middle-aged and older 
hospitalized adults. First, there is a lack of knowledge about frailty in professional 
nursing as evidenced by limited nursing research and substantive publications, inattention 
to frailty assessment, prevention, and treatment in clinical practice, and the absence of 
clinical practice or research conceptual models for frailty to facilitate innovation in 
clinical practice and research (Burnside, 1990; Campbell, 2009; Fugate Woods et al., 
2005; Lekan, 2009; Szanton et al., 2009; Szanton, Seplaki, et al., 2010). Much of the 
nursing literature on frailty has focused on supportive care of the very old and prevention 
of functional decline (Boltz et al., 2008a; Campbell, 2009; Dayhoff, Suhreinrich, 
Wigglesworth, Topp, & Moore, 1998). A significant gap is the absence of a nursing 
diagnosis for frailty in The North American Nursing Diagnosis Association (NANDA) 
International 2012–2014 edition (NANDA International, 2011). This omission 
underscores the need for nursing to examine this syndrome from the nursing perspective 
and bring it into mainstream nursing through codification as NANDA-endorsed nursing 
diagnosis (Hilmer, Perera, et al., 2002).  
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Many health providers including the nursing workforce are under-prepared to 
address the complex needs of frail hospitalized adults and improve clinical outcomes 
(IOM, 2008). Prelicensure and continuing nursing education programs are lacking in 
content that addresses geriatrics, gerontological nursi g, and frailty for classroom 
instruction and clinical application in practice. National initiatives to enhance geriatric 
nursing education and clinical practice have been strongly advocated by professional 
nursing groups and nursing education credentialing organizations such as the American 
Association for Colleges for Nursing and the National League for Nursing . This study 
provides descriptive data about frailty in hospitalized adults 55 years of age and older, a 
much younger age group than is customarily studied in frailty research, and preliminary 
evidence for a practical, clinically relevant approach for assessing level of frailty that 
would guide development of education and clinical pr ctice initiatives.  
Second, the holistic, multidimensional, BPSS-Stress conceptual model is needed 
in frailty research and clinical practice to provide coherence in structuring systems of 
care that integrates nursing, medicine, and the interdisciplinary team in action-oriented 
communication, collaboration, and care coordination (Gilliss, 2011; V. Lee, Fletcher,  
Westley, & Fankhauser, 2004; Lekan, Hendrix, McConnell, & White, 2010; Levers et al., 
2006). Interdisciplinarity is a hallmark of geriatrc care but may not be collaborative in 
clinical nursing practice. Rather, interdisciplinary practice in hospital settings may 
operate in isolation and only when acute complex care issues arise do team members 
together engage in purposeful collaboration with the patient and family. In hospital 
settings, greater reliance on consultation notes and few opportunities for substantive 
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discussion is more common. This often leads to communication, incomplete, conflicting, 
or inaccurate information about patient and family goals, preferences and needs and 
fragmented care and discharge planning. Systematic processes to facilitate 
interdisciplinarity could have considerable impact on quality of care and outcomes, 
morbidity, cascade iatrogenesis, length of stay, and hospital readmission (Gilliss, 2011; 
Potts et al., 1993). The BPSS-Stress model provides a natural platform for team 
collaboration. Research is needed on how informatics and decision algorithms can be 
integrated into the electronic medical record to more readily and easily facilitate adoption 
of frailty assessment in concert with interdisciplinary team communication and care 
coordination to accelerate implementation of best practices in the care of frail 
hospitalized adults. 
Third, the inclusion of four common biomarkers associated with inflammation 
and stress is a novel component of frailty assessment in hospitalized adults. Plasma 
biomarkers provide objective evidence of biologic function that is pertinent to frailty, 
stress, and disease burden. The significance of the biomarkers used in this study in frailty 
assessment in acutely ill hospitalized adults is unclear. Research supports a significant 
inflammatory component in the frailty syndrome, and recent consensus conferences 
endorse the inclusion of biomarkers in frailty asses ment. However, there is a gap in 
understanding of the role of biomarkers in frailty assessment in hospitalized adults, 
including which biomarkers should be used, when should they be procured and how 
often, what reference ranges are appropriate for frailty assessment, and how should the 
values be interpreted (Blaum et al., 2009; Clark et al., 2007; Gruenewald et al., 2006; 
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Gruenewald et al., 2009; Kuchel, 2009; Ranjit, Diez-Roux, Shea, Cushman, Ni, & 
Seeman, 2007; Schmaltz et al., 2005; Szanton et al., 2009; Topinková, 2008). There was 
no other published account identified in the literau e that examined these four 
biomarkers in a hospitalized adult population 55 years of age and older. 
Fourth, the impact of demographic trends have receiv d little attention with 
respect to frailty, including: (a) the rapidly growing older adult population and increased 
longevity; (b) earlier onset and prevalence of chronic disease and disability that is 
intensified by increasing incident obesity at all ages; (c) anticipated increased health care 
utilization; (d) the need for a wider variety of community-based health and social services 
and other supportive resources with the capacity to meet increasingly diverse population 
needs; (e) the growing sociocultural diversity that s implications for health care, health 
literacy, health promotion, prevention and treatment of frailty; and (f) changes in family 
structure and caregiving that place greater emphasis on local informal and formal 
organizations for community-based services (Raphael et al., 1995). The expected increase 
in the incidence and prevalence of frailty as a result of these trends has significant public 
health implications. There is strong evidence that health promotion and disease 
prevention early in life could prevent or reduce incident frailty. Thus innovative, cultural-
and age-relevant, multi-factorial public health initiat ves are imperative to promote health 
and well-being, active life expectancy, and compression of morbidity (Bortz, 1993; Fries, 
1980, 1988; Raphael et al., 1995; Walston et al., 2006).  
Fifth, there is substantial research on functional decline during hospitalization (K. 
E. Covinsky et al., 2011; Creditor, 1993; de Saint-Hubert et al., 2010; Gill et al., 2008, 
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2009, 2010, 2011; Mitty, 2010). Functional decline has been proposed as a proxy for 
frailty because functional decline is an outcome of frailty in the literature (de Saint-
Hubert et al., 2010). Functional decline and frailty are in many ways distinctly different. 
However, with increasing age, there can be substantial overlap even in nonfrail older 
persons. There is insufficient evidence on differentiating risk for functional decline from 
risk for frailty to identify those most likely to benefit from prevention, prehabilitation, 
rehabilitation, and individualized, culturally appro iate intervention.   
Finally, there is an important gap in knowledge what differentiates frailty from 
failure-to-thrive (FTT). These terms are used interchangeably but FTT and frailty are not 
synonymous (Berkman, Foster, & Campion, 1989; Lunney, Lynn, Foley, Lipson, & 
Guralnik, 2003; Verdery, 1997a, 1997b, 1998; Woolley, 2004). FTT is a term derived 
from the pediatric literature that describes infants who are developmentally delayed and 
fail to gain weight (Berkman et al., 1989; Newbern & Krowchuk, 1994; Braun, Wykle, & 
Cowling, 1988; Sarkisian & Lachs, 1996). In geriatrics, FTT, or GFTT, describes older 
adults who mirror the pediatric profile and present with various medical and 
psychological problems, vague symptoms, impaired ADL and IADL function, 
malnutrition, weight loss, cognitive impairment, fatigue, depression, and social 
withdrawal (Newbern & Krowchuk, 1994; Braun, Wykle, & Cowling, 1988; Sarkisian & 
Lachs, 1996; Woolley, 2004). GFTT may also present as non-response to interventions, 
appearance of helplessness and hopelessness, and acceptan e of death by giving up 
(Braun et al., 1988; Newbern & Krowchuk, 1994; Berkman et al., 1989; Roth, 2001). The 
IOM defines FTT in late life as weight loss > 5%, poor nutrition, and inactivity that may 
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be accompanied by depressive symptoms, dehydration, low cholesterol level, and 
impaired immune function (IOM, 1991). Robertson and Montagnini (2004) define GFTT 
as impaired physical and cognitive function, malnutrition, and depression. Clinical 
features of GFTT appear to mirror some features of frailty.  
Despite increased scientific research on frailty, there is no substantive research on 
GFTT nor are there validated assessment tools for either. Despite this, there is an ICD-9 
(International Classification of Disease-version 9) code for FTT in adults, but not frailty. 
Frailty may be inaccurately coded as FTT. GFTT has not garnered as much attention by 
researchers as has frailty but it is important thatdefining characteristics that differentiate 
GFTT from frailty be determined. Since the natural history of frailty is unclear and may 
display multiple typologies (Xue, 2011), it is unclear if GFTT represents the end-of-life 
phase of frailty or is a distinct phenomenon. Current perspectives of GFTT suggest that it 
represents a terminal, irreversible, end-of-life state with no hope for remediation 
(Raudonis & Daniel, 2010). The term FTT or GFTT may reinforce negative ageist 
stereotypes and impede the urgent search for treatabl , reversible causes of clinical 
deterioration (Braun, Wykle, & Cowling, 1988; Sarkisian & Lachs, 1996; Woolley, 
2004). Without an evidence base for GFTT, health provider attitudes of resignation, 
passivity, and therapeutic nihilism may be a powerful driver in clinical decision-making 
that may deny or fail to justify appropriate treatment (Berkman et al., 1989; Robertson & 
Montagninim, 2004; Whooley, 2004). Abandonment of the term FTT and GFTT has been 
recommended (Whooley, 2004). Research is needed to close the gap in understanding the 
relationship between FTT and GFTT and frailty.  
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Chapter Summary 
 
Frailty is a syndrome that predisposes at-risk or vulnerable adults to a myriad of 
adverse outcomes resulting from the accumulation of decrements in physiologic 
processes and dysregulation in regulatory mechanisms across multiple organ systems that 
arise from interactions of age-associated changes, overt and subclinical disease, and 
BPSS and environmental factors (Fried et al., 2004; Newman et al., 2001). The net effect 
is a profound decrease in compensatory reserve and the ability to effectively respond to 
stressors. Acute and chronic, cumulative stress and low-grade chronic inflammation 
contribute to the pathogenesis of frailty and differentially increases risk for accelerated 
aging, morbidity, disability, mortality, and other adverse outcomes. Research is needed to 
better understand frailty indicators, signs, and symptoms and their co-occurrence and 
trajectories so that appropriate assessment and interventions can be implemented when 
they are most likely to be effective (Cesari, 2011; Newman et al., 2001; Whitson et al., 
2007). This is especially important in hospitalized adults where prolonged periods of 
immobility and a cascade of adverse events, or “cascade iatrogenesis” (Potts et al., 1993, 
p. 199) may develop with deleterious consequences despite stabilization or resolution of 
the primary medical or surgical problems (Creditor, 1993; Lafont et al., 2011; Lefevre et 
al., 1992; Mitty, 2010; Olson et al., 1990). Identification of persons at risk for frailty or 
who are frail would facilitate the nursing process and clinical decision-making regarding 
targeted prevention, intervention, and discharge planning.   
Frailty assessment in hospitalized adults is important because clinical instability 
signals a critical time of high risk for a multitude of adverse health events and outcomes 
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(Lafont et al., 2011; Lefevre et al., 1992; Mitty, 2010; Potts et al., 1993). This 
preliminary descriptive study of frailty utilizes existing clinical data and biomarkers 
readily available to nurses and is an important firs step in understanding frailty in this 
under-studied population. 
Frailty is an important public health issue since it is a predictor of morbidity, 
disability, longer length of stay, hospital readmission, need for continued care, 
institutionalization, increased health care utilization and costs, and shortened life span 
(Rantz, Marek, & Zwygart-Stauffacher, 2000; Woo et al., 2006). Demographic data 
projecting continued growth and increased longevity in the aging population highlights 
the importance of frailty since its incidence is exp cted to increase. Frailty exacts a high 
cost in terms of dependency, excess disability, personal suffering, caregiver burden, and 
quality of life (Abellan van Kan et al., 2010; Fillit & Butler, 2009; Grenier, 2002; Mezey 
& Fulmer, 1998). 
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CHAPTER III 
 
METHODS 
 
 
This retrospective, cross-sectional, descriptive study examined frailty in adults 55 
years of age and older who were admitted to the genral medicine, cardiology, or 
orthopedic services at a large academic medical center in central North Carolina during a 
15-month time frame. A descriptive study design wasselected since there is limited 
empirical research on frailty in hospitalized adults. A conceptual model was used to guide 
description of frailty since this construct is ambiguous and poorly understood. This study 
explored the statistical and clinical significance of relationships between biologic, 
psychologic, social, spiritual, and demographic variables and frailty in hospitalized 
adults. Access to existing clinical data from the electronic medical record (EMR) 
facilitated working with a larger sample and wider range of variables than may be 
feasible in a prospective study.   
The purpose of the study was to characterize frailty in hospitalized adults and to 
determine if level of frailty, represented as a Frailty Score, predicted hospital length of 
stay and 30-day hospital readmission.  
Sample 
The study sample was a purposive, convenience sample of hospitalized adults. 
Inclusion criteria were (a) 55 years of age and older on the date of  hospital admission; 
(b) admission to one large academic medical center i  central North Carolina; (c) 
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admission to general medicine, cardiology, or orthopedic service; (d) date of admission 
occurred during a 15-month time frame, June 1, 2010 through August 31, 2011; (e) 
hospital admission included an overnight stay; and (f) hospital encounter had complete 
data for age, gender, race/ethnicity, date of admission, date of discharge, and laboratory 
data for plasma C-reactive protein (CRP) or hs-C-reactive protein (hs-CRP), albumin 
level, hemoglobin concentration, and white blood cell (WBC) count. For patients meeting 
study inclusion criteria with more than one hospital encounter during the study time 
frame, the first encounter with complete data as specified above was selected. Exclusion 
criteria were diagnosis of cancer, excluding dermatologic cancers, and undergoing active 
treatment and hospital length of stay less than 24 hours without an overnight stay.  
Setting 
State Characteristics 
North Carolina (NC) is located in the Southeastern U.S. and is diverse across 
many sectors, especially population characteristics, geography, and employment. In 2010, 
North Carolina ranked 10th in the U.S. in population. The population estimate in 2011 
was 9,656,401, which represents an 18% increase from 2000 to 2010 (U.S. Census 
Bureau, 2012). Much of the population growth has occurred in the cities of Charlotte 
(731,424; 35.2% increase), Raleigh (403,892; 46.3% increase), Durham (228,330; 22.1% 
increase), Greensboro (269,666; 20.4% increase), Wilmington (269,666), and Winston-
Salem (229,617; 23.6% increase); few counties lost residents. The aging population in the 
state is steadily growing, but the proportion of those ≥ 65 years compare to national 
estimates of about 13%. By race and ethnicity, non-Hispanic Whites in 2011 comprised 
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65.3% of the state’s population (13% increase), 21.5% Black (18% increase), 8.4% 
Hispanic or Latino (100% increase), 1.3% Native American, 2.2% Asian; 2.2% reported 
two or more races (U.S. Census Bureau, 2012). About 53% of North Carolinians are 
female, a figure that is comparable to the national average. The state is a popular 
destination for older adult retirees who wish to rel cate to areas with access to medical 
centers, universities, a multi-generational population, a wide range of leisure pursuits, 
and a temperate climate. 
North Carolina (N.C.) is geographically defined by mountain (west), piedmont 
(central), and coastal (east) regions with metropolitan, suburban, and rural communities 
dispersed across the state. The steady growth of urban and suburban communities has 
reduced the number of rural and farming communities and impacted employment in 
communities that lack a diverse economic opportunity base. Despite population growth 
and economic development in some sectors of the stat , loss of jobs in agriculture, 
fishing, industry, and textiles and furniture manufacturing has created economic hardship 
across the state. Growth in agribusiness, manufacturing, and pharmaceuticals has 
increased demand for a workforce with more advanced knowledge and technical skill. 
The per capita income of North Carolinians for 2010 was $24,745 (national 
average, $27,334) and the median household income was $45,570 (national average, 
$51,914; U.S. Census Bureau, 2012). The poverty level in the state exceeds the national 
average. Approximately 15.5% of North Carolinians live below the poverty level 
compared to 13.8% nationally. Transient workers and  large migrant population in the 
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agriculture and service industries often have unstable economic and living circumstances 
that contribute to significant health and social needs. 
In a report on the health status of North Carolinians from the North Carolina 
Institute of Medicine (NC-IOM), there were improvemnts noted in infant mortality, 
cardiovascular disease mortality, and tobacco use among youth (NC-IOM, 2011). 
However, North Carolina ranks 35th in overall health status. Relevant North Carolina 
health indicators that ranked in the bottom one-third of all states were obesity, smoking, 
premature death, infant mortality, and cardiovascular disease (NC-IOM, 2011). Social 
determinants of health such as poverty, unemployment and underemployment, limited 
years or quality of education, inadequate or no healt  insurance, lack of transportation, 
substandard housing, and barriers to high quality healt  care impacts the health of many 
North Carolinians. 
Study Setting 
This study was conducted at a large academic medical center located in central 
North Carolina that is part of a private, not-for-profit health system. The medical center is 
a 943-bed teaching hospital and regional emergency a d Level 1 trauma center. In 
addition to the medical center there are two community hospitals and 25 outpatient 
clinics in the health system. Medical center physicians and nurse practitioners provide 
clinical services to a Veteran’s Affairs Medical Cent r and a continuing care retirement 
community outpatient clinic and inpatient unit. As a designated tertiary/quaternary care 
setting, the medical center admits acutely ill and medically complex patients from across 
the state and nationally. Some patients transfer to the medical center from community 
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hospitals for advanced medical or surgical treatmen. Thus, the inpatient population is 
diverse and the acuity level and complexity of care fo  many patients is high.   
For fiscal year 2010, the medical center had 40,647 inpatient encounters, 
1,101,741 outpatient visits, 68,646 emergency department visits, and 725 patients 
transported by an emergency transport system using medically-staffed helicopters for 
urgent patient transfers. In 2010, the hospital system provided $258.2 million in charity 
health care and other services to low income people. Approximately 20% of medical 
center patients receive Medicaid funding. The medical center and affiliating university is 
distinguished by nationally-renowned geriatric expertis  in nursing, medicine, 
psychology, social work, physical therapy, anthropol gy, and other disciplines. This 
expertise draws older adults to the region for healt  care from affiliates within the 
medical center health system and to retirement communities that provide independent and 
supportive living arrangements and health care. 
The medical center was well-suited for this study because of its size, location, 
draw of patients from across the state and nationally, and diverse demographic and health 
profile of its service population with representation of social determinants of health. This 
setting was equipped with the technological resources to conduct this study and served as 
a real-life laboratory to describe frailty in hospitalized adults.  
Data Access 
Study data was retrieved from the EMR. An exploratory study sample was first 
constructed using a proprietary data query tool developed for the health system for 
clinical research, administrative monitoring, and quality improvement projects. The data 
221 
 
query tool is a software program to access the DataStorage Repository (DSR) of 
archived health system clinical data that are integrat d for retrospective studies (Horvath 
et al., 2011). The DSR included electronic medical record data for inpatient and 
outpatient encounters in the health system since 1996 and contains over 4 million records. 
Using the data query tool, potential cases are randomly assigned a unique identifier (UID) 
that links to health system data including the Patient Identification Key, medical record 
number (MRN), and hospital admission encounter number. These identifiers assured that 
the correct patient encounter was included in the sudy sample. The UID is not linked 
with or documented in the EMR. In a deidentified dataset, only the UID is retained for 
data management.  
Initial query of the DSR required submission of a Review Preparatory to Research 
(RPR) form to the Office of Information and Technology and the medical center 
Institutional Review Board (IRB). The RPR described the study and data to be extracted 
from the DSR using the data query system prior to submission of a study protocol to the 
IRB (Horvath et al., 2011). The RPR for this study was approved on January 14, 2011 by 
the medical center IRB (Record Number 4454). After approval of the RPR, preliminary 
data exploration was conducted. Table 4 illustrates th  query procedure and development 
of the final analytic sample using the data query tool procedures.  
The data query tool searched the DSR with delimitations defined by the inclusion 
criteria. This query yielded 690 patients with one or more independent hospital 
encounters during the study time frame. Almost half(48.7%, n = 336) and the remainder 
had two or more hospital encounters. Table 5 display  frequency data on the number of 
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independent hospital encounters for the 690 patients in the sample. About 2% (n = 24) 
had between nine and eleven hospital encounters. 
 
Table 4 
Data Query to Construct the Study Sample Using Study Inclusion Criteria 
 
Health System: 
DSR 
 Health System Data Storage Repository (DSR) of all P tient Encounters 
 
Health System: One academic medical center, two community hospitals, 
25 outpatient, community, and school-based clinics 
 
Total number of independent encounters in the DSR:  4 million+ 
 
Exploratory 
 Sample 
 
N=690  
Data Query with Delimiters 
 
Setting: one academic medical center 
Study Time Frame:  June 1, 2010 through August 31, 20 1 
Age: 55 years and older 
Admitting Service: General Medicine, Cardiology, Orthopedics 
Admission included an overnight stay 
 
Total number of independent medical center encounters: 690 
(number of patients with one hospital encounter: 336) 
(number of patients with two or more hospital encounters: 354) 
 
Final Analytic 
Sample  
 
N = 278 
Selection of One Independent Hospital Encounter per Patient with  
Complete Data for Inclusion Criteria and Four Biomarkers: 281 
 
Exclusion criteria (cancer diagnosis with active trea ment);  
less than 24 hours without overnight stay 
 
Patients with two or more encounters were examined. One encounter was selected 
based on the study inclusion and exclusion criteria. The final analytic sample included 
278 independent hospital encounters. Following submission and approval of the medical 
center IRB protocol, additional clinical data was retrieved from the EMR using an online 
search tool. All data retrieved for this study were accessed from EMR documentation 
pertaining to health status on admission.  
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Table 5 
 
Frequency Count of Independent Hospital Encounters for the Sample (N = 690) 
 
Count 
 
Frequency 
 
% 
Cumulative 
Frequency 
 
Cumulative % 
1 336 48.70 336 48.70 
2 177 25.65 513 74.35 
3 89 12.90 602 87.25 
4 45 6.52 647 93.77 
5 19 2.75 666 96.52 
6 9 1.30 675 97.83 
7 6 0.87 681 98.70 
8 4 0.58 685 99.28 
9 2 0.29 687 99.57 
10 2 0.29 689 99.86 
11 1 0.14 690 100.00 
  
 
Demographic, Biologic, Psychologic, Social, and Spiritual Domains 
 
Demographic Data 
Demographic variables included preadmission living location (home, other), 
admitting service (general medicine, cardiology, orth pedics), occupation (professional, 
technical/service, self-employed, unemployed, retired, disabled), number of hospital 
encounters during the study time frame (count), discharge disposition (home [self-care, 
home health], extended care [skilled nursing facility, rehabilitation facility, another 
hospital], hospice [home visits, inpatient facility], expired), length of stay (number of 
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days from date of admission to date of discharge), and 30-day readmission to study 
medical center. Data on admissions to other hospital  w s not available. 
Biologic Domain 
Age was recorded as the numeric age on the date of dmission based on year of 
birth. Gender (female, male) and race/ethnicity (White, Black, American Indian, Asian, 
Hispanic/Latino, Other) were recorded as nominal variables. Race/ethnicity was also 
coded as categorical variable, 0 = Minority (Black, American Indian, Asian, 
Hispanic/Latino, or Other), 1 = White. Weight was recorded in kilograms and height was 
recorded in centimeters. Body mass index (BMI) was calculated by dividing weight in 
kilograms by height in meters squared (kg/m2). Other biologic variables were categorical 
and scored as 1 = Yes, 0 = No. these included  unplan ed weight loss of 15 pounds or 
more in the past 6 months, recent unplanned weight loss, poor appetite, acute pain, 
weakness, fatigue, urinary incontinence, pressure ulcer or vascular ulcer, infection, falls 
admission diagnosis, history of falls, fever reported prior to admission or recorded on 
admission, activities of daily living (ADL) assistance needed prior to admission, ADL 
assistive device used prior to admission, unplanned surgery during hospitalization, and 
physician diagnosis or documentation of failure-to-thrive or frail on admission. 
Comorbidity was defined as the count of all medical di gnoses which conform to 
the ICD-9/10 code that were listed on the physician admission or emergency department 
admission forms or other relevant documentation. Each diagnosis category included 
selected ICD-9/10 medical diagnoses pertinent to chr nic inflammation or frailty based 
on empirical evidence in the scientific literature. The 12 medical diagnosis categories 
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were identified based evidence for their high preval nce in the study population age 
group and association with symptoms that require self-management, functional 
impairment, chronic inflammation, and/or frailty.  
The 12 diagnostic categories and corresponding ICD9/10 medical diagnoses  (in 
parentheses) were: (a) hypertension; (b) cardiovascul r  disease (coronary artery disease, 
angina, myocardial infarction, peripheral vascular disease, deep vein thrombosis/ 
pulmonary embolism, heart failure, atrial fibrillation); (c) liver disease (cirrhosis, 
hepatitis); (d) neurological disease (cerebral vascular attack [CVA], transient ischemic 
attack [TIA], Parkinson’s disease); (e) pulmonary disease (chronic obstructive pulmonary 
disease (COPD), bronchitis, emphysema, asthma, pneumonia); (f) endocrine conditions 
(diabetes mellitus, hypothyroidism); (g) cancer, except dermatologic, and not under 
active treatment; (h) cognition (dementia, any type, Alzheimer’s disease, delirium); (i) 
psychological disorders (depression, anxiety, bipolar); (j) musculoskeletal disorders 
(osteoarthritis/degenerative  joint disease, osteoporosis/osteopenia, hip fracture); (k) 
inflammatory or autoimmune disease (Crohn’s disease, systemic lupus erythematous, 
rheumatoid arthritis, HIV/AIDS); and (l) ocular disease (cataracts [corrected or 
uncorrected], glaucoma, macular degeneration, retinopathy, blind). These medical 
diagnoses were coded as categorical variables where 1 = Yes, documented on admission, 
and 0 = No, not documented on admission. Medical diagnoses were identified from 
admission documentation and interdisciplinary notes. The 12 medical diagnosis 
categories were also coded as categorical variables based on EMR documentation of the 
presence of at least one of the medical diagnoses list d for that category. Only one 
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medical diagnosis documented in the EMR for that dignosis category was required to be 
present for that category to be coded as 1 = Yes, or 0 = No.  
Laboratory data was available for four plasma biomarkers: CRP or hs-CRP, 
albumin level, hemoglobin concentration, and WBC count. The variable used in this 
study was the abnormal flag, defined as a laboratory value that is higher or lower than the 
established reference range, accounting for gender diff ences when applicable. The 
abnormal flag was a categorical variable that was coded as 1 = Yes, abnormal flag 
present and 0 = No, abnormal flag not present. Biomarker references ranges coincide 
with reference ranges recommended by the World Health Organization (hemoglobin), 
American Heart Association (CRP, hs-CRP), and the American Society of Clinical 
Pathology (all). CRP and hs-CRP are the same analyte nd were examined as one 
categorical variable. Table 6 provides laboratory reference ranges and testing equipment 
used at the medical center. 
Medications were recorded as the count of all prescription and non-prescription 
medications taken on a routine basis documented on admission, and the count of persons 
whose medication count was  ≥ 5 based on definitions of polypharmacy and its adverse 
effects for frailty, disability, hospitalization, mortality, and falls (Gnjidic et al., 2012). 
The medication count ≥ 5 was coded as 1 = Yes, 0 = No. For sample description, ten 
medication categories related to inflammation, physical function, cognition, and/or frailty 
were identified: (a) statin; (b) non-steroidal anti-i flammatory drug (NSAID), aspirin 
(ASA); (c) corticosteroid, immunosuppressant; (d) angiotensin converting enzyme-
inhibitor (ACE-I), angiotensin receptor blocker (ARB); (e) hormone therapy (estrogen, 
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progesterone, testosterone); (f) opioid; (g) benzodiazepine; (h) diuretic; (i) calcium, 
vitamin D, bisphosphonate; and (j) beta-blocker. The name or number of individual 
medications was not recorded. The medication category was scored as 1 = Yes, if the 
admission medication list included any medications cla sified by that category, or 0 = 
No, if the admission list did not include any such medications. 
 
Table 6 
Laboratory Assay Equipment* and Reference Ranges for Plasma Biomarkers 
 
Biomarker Reference Range Laboratory Value for Abnormal Flag 
CRP, high** 
Low risk:  < .10 mg/dL 
Intermediate risk: .10 - .30 mg/dL 
Abnormal flag,  >0.30 mg/dL 
 High risk:  > .30 mg/dL  
hs-CRP, high < .6 pg/dL  Abnormal flag,  >.6 pg/dL 
Albumin, low 3.5-4.8 g/dL Abnormal flag, <3.6 g/dL 
Hemoglobin, low Women: 12.0 - 15.5 g/dL Abnormal flg, <12.0 g/dL 
 Men: 13.7 - 17.3 g/dL Abnormal flag, < 13.7 g/dL 
WBC, high or low 3.2 - 9.8 X 109 cfu  Abnormal flag ,  >9.8 or <3.2X 109 cfu   
*Laboratory assay equipment: CRP and hs-CRP (Beckman Cyncron Systems Neon Infrared Particle 
immunoassay rate methodology); albumin (Beckman-Colter Unicel DXC 600-800, Broumcresol Purple 
(dcp) Timetest Endpoint); WBC and hemoglobin (Electronic Impedence Differential Lysis Flourescent 
Flow Cytometry and Colorimetric Measurement). 
**Reference range established for risk levels by the Centers for Disease Control and Prevention and the 
American Heart Association: <1 mg/L; low risk, 1-3mg/L; intermediate risk;  > 3mg/L, high risk (Pearson 
et al., 2003).  
 
The Braden Scale is a multidimensional pressure ulcr risk assessment tool that is 
commonly used in practice with established validity and reliability (Anthony, Parboteeah, 
Saleh, & Papanikolaou, 2008; Beeson et al., 2010; Bergstrom & Braden, 2002; 
Bergstrom, Braden, Kemp, Champagne, & Ruby, 1998; Bergstrom, Braden, Laguzza, & 
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Holman, 1987; Bergstrom, Demuth, & Braden, 1987; S. J. Brown, 2004; Pancorbo-
Hidalgo, Garcia-Fernandez, Medina, & Alvarez-Nieto, 2006). The Braden Scale score is 
a composite measure of biologic vulnerability associated with risk for pressure ulcer 
development. The Braden Scale has six subscales: sensory perception, moisture, activity, 
mobility, nutrition, and friction and shearing). Subscales are rated on a three or four point 
Likert-type scale and summed (range, 6 to 23). Lower scores indicate higher risk for 
pressure ulcer development. The Braden Scale score was defined as a continuous variable 
computed as the sum of the six subscales. 
Psychologic Domain 
Psychologic variables included memory problems (self-report or provider 
assessment), abnormal mental status (provider assessment), cognition problems (ICD-
9/10 admission diagnosis of dementia [any type], Alzheimer’s disease, delirium), ICD-
9/10 admission diagnosis of depression, chronic pain (self-report), sleep problems (self-
report, use of continuous positive airway pressure [CPAP] at night), and current tobacco 
use (self-report). These variables were coded as categorical variables. 
Social Domain 
Social domain variables were living arrangement (live alone), marital status 
(married or not married/single [single, separated, divorced, widowed]), caregiver 
concerns (pertained to the nature of the patient’s condition and post-hospital care issues, 
based on self-report or documentation of concerns by care providers), and a high risk 
indicator found on the nursing admission assessment form, “older, disabled, lives alone.”  
These variables were coded as categorical variables. 
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Spiritual Domain 
The spiritual domain included documentation of patient request for a clergy visit 
on the nursing admission assessment or one or more clergy visits documented during 
hospitalization if the visit note indicated patient request. This variable was coded as a 
categorical variable. 
Frailty Components, Indicator Variables, and Measurement 
 
The14 frailty components were defined by 26 indicator variables that included: 
(a) Nutrition (unplanned weight loss of 15 pounds in the six months prior to admission, 
recent unplanned weight loss, poor appetite, BMI <18.5 kg/m2 , BMI >30 kg/m2); (b) 
Fatigue (fatigue, tired, lack of endurance or difficulty sleeping, use of CPAP (continuous 
positive airway pressure) for sleep); (c) Weakness; (d) Chronic pain; (e) Dyspnea; (f) 
Falls (admission diagnosis, history of falls); (g) Vision (cataracts [corrected, 
uncorrected], glaucoma, macular degeneration, diabetic retinopathy, blind); (h) Cognition 
(mental status abnormal, memory problem, dementia [any type, Alzheimer’s disease], 
delirium); (i) Depression (ICD-9/10 code); (j) Social support (live alone, single, caregiver 
concerns, older adult, disabled, and lives alone); (k) CRP or hs-CRP (abnormal flag, 
high); (l) Albumin (abnormal flag, low); (m) Hemoglobin (abnormal flag, low); and (n) 
WBC count (abnormal flag, high or low). Table 7 lists the 14 frailty components and the 
corresponding 26 frailty indicator variables. 
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Table 7 
The 14 Frailty Components and 26 Indicator Variables (N = 278) 
Frailty Component * Indicator Variable 
1. Nutrition  (5) Unplanned weight loss of 15 pounds, past 6 months 
  Recent unplanned weight loss 
  Poor appetite   
  
BMI < 18.5 kg/m2  
BMI > 30 kg/m2 
2. Weakness  Weakness reported or demonstrated 
3.  Fatigue (2) Fatigue, tired, poor endurance 
  Sleep problems, use of CPAP at night 
4.  Chronic pain Chronic pain  
5.  Dyspnea  Dyspnea, shortness of breath 
6.  Falls (2) Falls admission diagnosis 
  History of falls 
7.  Vision  
Ocular diagnosis: cataracts (corrected, uncorrected), 
glaucoma, macular degeneration, retinopathy, blind 
8. Cognition (4)  Memory problem  
  Mental status abnormal  
  Dementia diagnosis 
  Delirium  
9.  Depression  Depression diagnosis 
10. Social support (4) Lives alone 
  Single (single, separated, divorced, widowed)  
  Caregiver concerns  
  Older adult, disabled, and lives alone 
11.. CRP or hs-CRP Plasma CRP or hs-CRP, abnormal flag, high 
12. Albumin Plasma albumin, abnormal flag, low 
13. Hemoglobin Plasma hemoglobin, abnormal flag, low 
14. WBC count Plasma WBC, abnormal flag, abnormal-high or low 
  *Number of indicator variables for the frailty component, if more than one, noted in parentheses. 
 
Characterization and Scoring of Frailty  
Frailty was represented by 14 components that consisted of 26 evidence-based 
indicator variables. All frailty components and indicator variables were defined as 
categorical, binary variables, where “Yes = 1” indicated that an indicator variable or 
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frailty component was present and “No = 0” indicated hat an indicator variable or frailty 
component was not present. Each frailty components was scored as one point. The 
presence of one indicator variable for a frailty component was sufficient to score the 
frailty component as present, or 1 = Yes. A Frailty Score was derived from the sum count 
of the frailty components (not indicator variables) for a ranged of 0 to 14 points. Lower 
scores suggest lower risk for frailty or level of frailty or not frail and higher scores 
suggest increased risk for frailty or higher level of frailty.  
Study Outcome Variables 
The study outcome variables were hospital length of stay and 30-day hospital 
readmission. Length of stay was defined as a count f the number of days from the date 
of admission through the date of discharge. Thirty-da  readmission was defined as 
admission to the study medical center within 30-days of the discharge date. Data for 
length of stay and 30-day readmission was retrieved from the EMR using the data query 
tool for data abstraction from the DSR. The reason for readmission was not recorded. 
Validity 
Validity refers to the extent to which a measure represents what it is designed to 
measure. Face validity assesses the face value and m y be based on expert opinion, 
strength of scientific evidence, and relevance of component elements. Construct validity 
is the extent to which a measure satisfactorily represents all relevant facets of a construct. 
Face and construct validity was met by using prior research, theory, and expert opinion 
from researchers and clinicians in geriatric medicine, nursing, sociology, physical 
therapy, palliative care, and biomedical diagnostics to inform the conceptualization and 
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operational definition of frailty and the 14 frailty components. Construct validity was 
addressed in the data collection process by review of multiple records in the EMR to 
confirm the presence or absence of a frailty component indicator variable. Data collection 
was conducted by study personnel with verification of all records and re-verification of 
selected records by variable or by case by the studen  researcher to ensure data accuracy, 
validity, completeness, and consistency. 
The 14 frailty components and 26 indicator variables w re selected based on 
theory, prior research and empirical evidence from several frailty definitions and 
conceptualizations: the frailty phenotype, deficits accumulation, multidimensional frailty, 
comprehensive geriatric assessment, inflammation, and the study BPSS-Stress conceptual 
model. Three frailty components were based on the frailty phenotype (nutrition, 
weakness, fatigue) and two components were based on modified versions which included 
cognition and depression (Ávila-Funes, et al., 2009, 2011; Bandeen-Roche et al., 2006; 
Bartali et al., 2006; Fried, Tangen, et al., 2001; Fugate Woods et al., 2005; T. E. Seeman 
et al., 2001; Stenholm et al., 2008; Villareal et al., 2006; Xue et al., 2008). Evidence for 
the frailty components and indicator variables is cited in Table 8. 
 
Table 8 
 
Evidence for the Frailty Components and Indicator Va iables 
 
Frailty 
Component 
 
Indicator Variables 
 
References 
1. Nutrition Weight loss of 15 
pounds, past 6 months 
 
Unplanned weight loss 
 
Abellan van Kan et al., 2010; Bales & Ritchie, 2002;  
Bandeen-Roche et al., 2006; Bartali et al., 2006; 
Blaum et al., 2005; Chin A Paw et al., 2003; Cooper 
et al., 2012; Cornali et al., 2005; Fried, Tangen, et al., 
2001; Fugate Woods et al., 2005; Jarosz & Bellar,  
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Table 8. (Cont.) 
 
 
Frailty 
Component 
 
Indicator Variables 
 
References 
1. Nutrition 
(cont.) 
Poor appetite 
BMI < 18.5 kg/m2  
BMI > 30 kg/m2 
 
2009; Jeejeebhoy, 2012; Kinney, 2004; National 
Institute on Aging, 1991; Stenholm et al., 2008; 
Stiffler, Finley, Midha, & Wilber, 2013 
2. Falls  Falls admission 
diagnosis  
 
Self-report, History of 
falls 
Cesari et al., 2004; Ensrud et al., 2008,  2009; Fried, 
Tangen, et al., 2001; Fugate Woods et al., 2005; Gill, 
Allore, et al., 2010; Mahoney, 1998; Nowak & 
Hubbard, 2009; Rubenstein, 2006; Samper-Ternent et 
al., 2012; Speciale et al., 2004; Speechley & Tinetti, 
1999 
 
3. Weakness  Self-report, Health 
provider assessment 
Abellan van Kan et al., 2010; Cesari et al., 2004; K. E. 
Covinsky et al., 2003; Fried, Tangen, et al., 2001; 
Forti et al., 2012; Hardy & Studenski, 2008; Leng et 
al., 2007; Manty et al., 2012; Marzetti & 
Leeuwenburgh, 2006; National Institute on Aging, 
1991; Reuben et al., 2002, 2003;  Stiffler et al., 2013; 
Toye et al., 2006; Walke et al., 2004; Whitson et al., 
2009 
 
4. Vision  ICD-9/10 diagnosis of 
ocular disease: 
cataracts (corrected, 
uncorrected), 
glaucoma, macular 
degeneration, 
retinopathy, blind  
 
Cesari, et al., 2004; C. C. Chen et al., 2011; Hardy & 
Studenski, 2008; Klein, Klein, et al., 2003; Klein t 
al., 2005; Knudtson et al., 2009; Studenski et al., 
2004; Whitson, et al., 2009; Whitson, Ansah, et al., 
2010 
5. Dyspnea  Self-report, Health 
provider assessment 
Brinkley et al., 2009; S. S. Chang et al., 2011; Galizia 
et al., 2011; Guralnik et al., 2000; Hardy & Studenski, 
2008; Schwartz & Weiss, 1993; Walke et al., 2004;  
Whitson et al., 2009 
 
6. Cognition 
 
 
 
Memory problems: 
Self-report, Provider 
assessment  
 
Mental status 
abnormal: 
Self-report, Provider 
assessment 
 
Dementia: 
ICD-9/10 diagnosis of 
dementia, any type, 
Alzheimer’s disease 
Ávila-Funes et al., 2009, 2011; Cesari et al., 2003a; 
2003b; M. G. Cole et al., 2009; M. Cole, McCusker, 
Dendukuri, & Han, 2003;  Ford et al., 2010; 
Fitzpatrick, Stier, et al., 2004; Gill et al., 2006; 
Inouye, Schlesinger, & Lydon, 1999; Juster et al., 
2010; Kiely et al., 2009; Mitniski et al., 2011; Quinlan 
et al., 2011; Ranjit, Diez-Roux, Shea, Cushman, 
Seeman, et al., 2007; Rigney, 2010;  Rockwood et al., 
2004; Rothman et al., 2008; Sands et al., 2003; 
Whitson et al., 2009; Whitson, Ansah, et al., 2010a 
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Table 8. (Cont.) 
 
 
Frailty 
Component 
 
Indicator Variables 
 
References 
6. Cognition 
(cont.) 
Delirium: 
Self-report, Provider 
assessment 
 
7. Depression  ICD-9/10 diagnosis of 
depression, current or 
history 
K. E. Covinsky et al., 1997, 2003, 2010; Lenz et al., 
2005; McEwen, 2003b; Mezuk et al., 2011; Ní 
Mhaoláin et al., 2012; Ostir et al., 2004; Rothman et 
al., 2008; T. E. Seeman et al., 2001; Simonsick et al., 
1998 
8. Fatigue  Fatigue, tired, poor 
endurance: 
Self-report, Provider 
assessment 
Sleep problems: 
Self-report, Provider 
assessment, CPAP at 
night for sleep 
Abellan van Kan et al., 2010; Avlund et al., 2006, 
2007; Fried, Tangen, et al., 2001; Fugate Woods et al., 
2005; Hardy & Studenski, 2008, 2010; Inouye et al., 
2007; Jeejeebhoy, 2012; Manty et al., 2012;  Nationl 
Institute on Aging, 1991; Schultz-Larsen  & Avlund, 
2006; Toye et al., 2006; Vas Fragoso et al., 2009; 
Walke et al., 2004; Whitson et al., 2009 
 
9. Chronic pain Self-report Blyth et al., 2008; K. E. Covinsky et al., 2009; Davis 
et al., 2011; Hardy & Studenski, 2008; Maxwell et al., 
2008; Shega et al., 2012; Walke et al., 2004;  Whitson 
et al., 2009 
10. Social 
support 
Live alone 
 
Single 
 
Caregiver concerns 
 
Older adult, disabled, 
live alone 
Aggar et al., 2011; Andrew et al., 2008; Bilotta et al., 
2010; Chappell, 1991; Fugate Woods et al., 2005; 
Glei et al., 2007; Landi et al., 2004; Loucks et al., 
2006; McEwen, 1993; Newsom & Schultz, 1996; 
Rockwood et al., 2005; Schultz & Williamson, 1993; 
T. E. Seeman et al., 1997; T. E. Seeman & McEwen, 
1996; von Känel et al., 2006; Woo et al., 2005 
 
 Biomarkers Arques et al., 2008; Avlund et al., 2007; Bandeen-
Roche et al., 2009; Barzilay et al., 2007;  Cesari et al., 
2003a, 2003b, 2004; Chaves et al., 2005; Corti et al., 
1994; K. E. Covinsky et al., 2002; De Martinis et al.,
2006; Don & Kaysen, 2004; Ferrucci et al., 1999, 
2002; Ford et al., 2006; Fried, Tangen, et al., 2001; 
Fugate Woods et al., 2005; Glaser & Kiecolt-Glaser, 
2005; Glei et al, 2007; Gruenwald et al., 2006; 
Kanapuru & Ershler,  2009;  Kiecolt-Glaser et al., 
2003; Leng et al., 2002, 2009; Leng, Xue, Huang, 
Ferrucci, et al., 2005; Leng, Xue, Huang, Semba, et 
al., 2005; Loucks, Berkman,  et al., 2006; Loucks, 
Sullivan, et al., 2006; McEwen, 2008; National 
Institute on Aging, 2004; Nielson et al., 2007; Oda & 
Kawai, 2010; Penninx et al., 2004; Puts et al., 2011; 
Reuben et al., 2003; Szanton et al., 2005; Taaffe et al., 
2000; Tak et al., 2009; Taylor, Lehman, Kiefe, & 
Seeman, 2006; Visser et al., 1999; Walston et al., 
2002; Yao et al., 2011 
11. CRP, hs-CRP Abnormal flag, high 
 
12. Albumin  Abnormal flag, low 
 
13 Hemoglobin Abnormal flag, low 
 
14. WBC count Abnormal flag, 
abnormal-high or low 
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Data Acquisition and Data Entry 
Data retrieval from the EMR was conducted by research personnel listed in the 
IRB protocol. Questions about coding were adjudicated by the study investigators and 
recorded in a notebook to ensure ongoing consistent and accurate data retrieval and 
coding. Data was initially entered into a Microsoft Excel© spreadsheet. To ensure data 
entry accuracy, consistency, and completeness, the tud nt researcher verified 100 % of 
data collection forms with data in the EMR. Variables that demonstrated a higher rate of 
coding error were examined and coding errors were co re ted and missing data was 
retrieved from the EMR. After data cleaning, the Microsoft Excel© data file was imported 
into an SPSS (Version 20, IBM, Chicago, IL) file for analysis. SAS (Version 9.3, SAS 
Institute, Cary, NC) was used to convert certain variables yielded from the online data 
query from text format into numeric data. These variables with numeric data were then 
imported into the SPSS data file.  
 Data Analysis 
Sample Description, Data Distribution, and Missing Data 
 Descriptive statistics were computed for quantitative categorical and continuous 
measures. Data were examined for dispersion and variance. For categorical variables, 
measures of dispersion or central tendency included m an (M), median, and mode. For 
continuous variables, measures of variance included range (minimum, maximum), 
standard deviation (SD), 95% confidence interval (95% CI), interquartile range (IQR), 
normality, kurtosis, and skew. Categorical data were r presented by frequency (count), 
number (n), and percent (%). For continuous data, frequencies and interquartile ranges 
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(IQR) were examined. Histograms with superimposed normal curve, normal probability 
P-P plots and Q-Q plots data were examined in comparison to expected values. The P-P 
plots, Q-Q plots, and Stem-and-Leaf plots were visually inspected for normality, 
distribution pattern, and outliers. Kurtosis and skew were examined to assess normality. 
Kurtosis is demonstrated by a distribution of scores at the tails as leptokurtic (pointy) or 
platykurtic (flattened). Skew is a measure of symmetry. Abnormal skew shows an 
asymmetrical clustering of scores at one end of a tail. In a normal distribution, the value 
of skew and kurtosis are 0. For sample sizes > 200, visual inspection of the shape of the 
distribution and kurtosis and skew can be sufficient n assessing normality. The 
Kolmogorov-Smirnov test and Shapiro-Wilk tests were also performed to assess 
normality. Significant tests (p < .05) suggest that the data are significantly different from 
a normal distribution. Missing data was managed by visually inspecting the SPSS data 
file for blank fields and reviewing the EMR to retri ve data. There was no missing data in 
the study sample (Field, 2009; Huck, 2008; Tabachnik & Fidell, 2007).  
Power Analysis 
Power analysis was conducted for linear regression to determine adequacy of the 
sample size, the probability level for statistical significance, and the ability of statistical 
tests to detect an effect. The power of a test is the probability that a given test will find an 
effect assuming that one exists in the population (Field, 2009). A level of power typically 
recommended is .80 and an alpha of .05 (Field, 2009; Huck, 2008). Power analysis was 
performed using NQuery (Version 3.19.2013.20310, Microsoft Corporation, Seattle, 
WA). Power was calculated with alpha set at .05, for 20 predictor variables and sample 
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size of 278. The level of power was .99 indicating the ability to detect a large effect size. 
The study sample size was adequate for multiple linear and logistic regression analyses.  
Analysis  
 Descriptive statistics were computed for demographic, biologic, psychologic, 
social-spiritual variables. Data analysis procedures included bivariate tests of association 
using Pearson and Spearman’s rho correlations and bivariate linear regressions to 
examine relationships between demographic, biologic, psychologic, social, and spiritual 
health status variables and the 14 frailty components a d the Frailty Score. Several 
multiple linear regression procedures were used to examine for significant associations 
between candidate predictor variables and the Frailty Score to determine optimal model 
fit for a parsimonious set of predictor variables. Logistic regression was performed to 
assess if the Frailty Score predicted 30-day hospital readmission. Simple linear regression 
was conducted to assess if the Frailty Score predicted log10 transformed length of stay. 
Conventional procedures for data verification, data ex mination prior to analyses, data 
transformation, and for performing statistical tests were followed (Field, 2009; Huck, 
2008; Tabachnik & Fidell, 2007). 
Statistical analyses were conducted using SAS (Version 9.3, SAS Institute, Cary, 
NC) and SPSS (Version 20, IBM, Inc., Chicago, IL). Two-tailed statistical tests were 
performed with level of significance set at .05 for all analyses unless otherwise specified. 
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Research Questions 
Research Question 1 
What is the proportion of each of the 14 frailty components in hospitalized adults 
55 years of age and older?  
The number (n) and percent (%) of patients in the sample who score 1 on each of 
the 14 frailty components was portrayed using descriptive statistics. Frequency 
distributions, histograms with normal curves, normal probability P-P plots, Q-Q plots, 
Stem-and-Leaf plots, and whisker box plots were analyzed to assess data characteristics. 
Research Question 2 
What is the level of frailty in the sample of hospitalized adults, based on level of 
frailty, or the Frailty Score that ranges from 0 to 14? 
The Frailty Score was examined for frequency, dispersion and variance. Measures 
of central tendency included the mean (M), median, and mode. Measures of dispersion 
and variance included the range (minimum, maximum), standard deviation, 95% 
confidence interval, interquartile range (IQR), normality, kurtosis and skew. Frequency 
distributions, histograms with normal curves and probability P-P plots and Q-Q plots, 
Stem-and-Leaf plots, and IQRs were visually examined. Outliers were checked for data 
entry errors and their impact on central tendency and dispersion.  
Research Question 3 
What are the relationships between demographic, biolog cal, psychological, and 
social-spiritual health status variables and each of the 14 frailty components? 
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Bivariate tests of association were conducted using Pearson and Spearman’s rho 
correlations. Bivariate associations were assessed between each of the 14 frailty 
components and each of the 20 demographic, biological, psychological, social-spiritual 
categorical and quantitative continuous candidate predictor variables. Fourteen 
categorical frailty components and the 14 categorical candidate predictor variables were:  
preadmission location (home, other), gender (female), race/ethnicity (Minority [Black, 
American Indian, Asian, Hispanic-Latino, Other]), current tobacco use, acute pain on 
admission, urinary incontinence on admission, pressure ulcer or vascular ulcer on 
admission, fever prior to or present, infection on admission, ADL assistance prior to 
admission, ADL device used, unplanned surgery during hospitalization, physician 
diagnosis or documentation on admission of failure-to-thrive or frail, and clergy visit 
during hospitalization. The Pearson Chi-square (X2) test statistic and p value was reported 
for the 14 frailty components and the 14 quantitative categorical candidate predictor 
variables. The Fisher’s exact test p value and Pearson Chi-square (X2) test statistic was 
reported when data were unequally distributed among the cells or the expected value in a 
cell was less than five.  
Spearman’s rho correlations were computed for the 14 frailty components and six 
quantitative continuous candidate predictor variables. The six continuous predictor 
variables were age in years on date of admission, BMI raden Scale raw score, 
comorbidity count, total medication count, and number of hospital encounters during the 
study time frame. Spearman’s rho r2 and p value were reported.   
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Research Question 4 
What are the relationships between the demographic, biological, psychological, 
and social-spiritual health status variables and the level of frailty, or Frailty Score, that 
ranges from 0 to 14? 
Multiple linear regression was conducted to assess for linear relationships 
between the 20 categorical and continuous candidate predictor variables and the Frailty 
Score. The standardized β weights, t values, degrees of freedom (df), sample size, F 
statistic, adjusted R2, and p value were reported. Seven statistically significant predictor 
variables were identified. To assess the model and to determine each of the predictor 
variables remained in the model, multiple linear regression was performed with the seven 
significant predictor variables and the Frailty Score. The standardized β weights, t values, 
degrees of freedom (df), sample size, F statistic, adjusted R2, and p value were reported. 
Further statistical analyses were undertaken to explore linear relationships. First, bivariate 
linear regression was conducted for each of the 20 categorical and quantitative 
continuous candidate predictor variables and the Frailty Score. Candidate predictor 
variables with significant correlation coefficients were identified.  Multiple linear 
regression was next performed using the ENTER method where all 20 candidate 
predictor variables were included in the regression m del. The standardized β weights, t 
values, degrees of freedom (df) and sample size, the F statistic, the adjusted R2, and p 
value. Then, multiple regression was performed using the STEPWISE method where 
only candidate predictor variables with p values < .10 in the bivariate linear regression 
were included in the regression model. Selecting predictor variables based on a more 
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liberal alpha of .10 permitted including variables that may demonstrate significant 
associations when analyzed in different combinations with other predictors in accordance 
with the STEPWISE method. The standardized β weights, t values, degrees of freedom 
(df) and sample size, F statistic, adjusted R2, and p value were reported. The results from 
the regression models were compared and summarized.   
Assumptions for linear regression when using continuous variables were checked 
for normal distribution, linearity, independence and multicollinearity, homogeneity of 
variance, homoscedasticity, and normal distribution of residuals. Multicollinearity was 
assessed by examining the variance inflation factor (VIF), tolerance, and eigenvalues. 
Cook’s Distance was examined for overall influence of outliers. Cook’s Distance values 
> 1 would be of concern. The Durbin-Watson test identifi d if residuals were correlated. 
Values range from 0 to 4, where 2 indicate non-correlation, and values < 3 or > 1 are of 
concern. Sample distribution and outliers were inspected using normal probability P-P 
plots, Q-Q plots, Stem-and-Leaf plots, whisker plots, and histograms with a 
superimposed normal curve. The influence of outliers was analyzed to determine the need 
for data transformation. Residuals were examined to assess model fit and influential 
cases. Only 5% of standardized residuals should be greater than +1.96, only 1% should 
be greater than 2.58, and cases close to 3 should be closely inspected. Cases >3 would be 
cause for concern. Histograms of standardized residuals with a superimposed normal 
curve were examined. Data transformation was not performed for any of the candidate 
predictor variables. 
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Research Question 5 
What is the relationship between level of frailty, or Frailty Score, and length of 
hospital stay? 
  Simple linear regression was performed to examine the relationship between the 
Frailty Score (theoretic range, 0-14) as the predictor variable and length of stay as the 
outcome continuous variable. Linear regression assumptions as described above were 
assessed. F statistic was used to examine the model fit. The adjusted R2 was also 
examined. The R2 is the partial correlation between the outcome variable and each of the 
predictor variables, which range from -1 to +1. A positive R2 indicates that as the 
predictor variable increases, the likelihood of the outcome increases. Similarly, as a 
predictor variable decreases, the likelihood of the outcome decreases. A significant 
variable with a low adjusted R2 contributes a small amount in explaining variance i  the 
outcome. The total model and variable adjusted R2, degrees of freedom (df), sample size, 
F statistic, and p value were reported. Length of stay was significantly on-normally 
distributed. A new variable for length of stay was computed using log10 transformation. 
The standardized β weight, t value, degrees of freedom (df) and sample size, the F 
statistic, adjusted R2, and p value were reported. 
Research Question 6 
What is the relationship between level of frailty, or Frailty Score, and 30-day 
hospital readmission? 
The relationship between the Frailty Score (range, 0–14) and 30-day medical 
center readmission was examined using logistic regression. The Frailty Score was the 
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predictor variable and 30-day readmission was the binary outcome variable where 1 = 
readmitted and 0 = not readmitted. Regression assumptions described above were 
assessed. The logistic regression model was assessed by examining the log-likelihood of 
the observed and predicted values of predictor variables to assess the fit of the model. 
The log-likelihood statistic is an indicator of the amount of unexplained variance that 
exists after the model has been fitted. Larger values indicate poor model fit since this 
indicates more unexplained observations. The Hosmer and Lemeshow tests were 
examined to evaluate goodness-of-fit of a logistic regression model and the Chi-square 
test statistic, degrees of freedom, and p value report d. The Wald test statistic, which is 
based on a Chi-square distribution, was used to determine if the standardized β
coefficient for a predictor variable was significantly different from 0. A standardized β 
coefficient that is significantly different from 0 suggests that the predictor is making a 
significant contribution to the outcome. The odds ratio was computed but was not 
applicable since the logistic regression model was not statistically significant (Field, 
2009; Tabachnik & Fidell, 2007). 
Protection of Human Subjects 
  
In accordance with medical center policy, all Protected Health Information (PHI) 
data was removed from the data file. The UID generated for each hospital encounter was 
retained in the data file. The UID is not recorded in the EMR and cannot be linked to 
study data. A list with the Patient Identification Key, MRN, hospitalization encounter 
number, and the UID was secured in the locked office of the Principal Investigator. The 
Patient Identification Key, MRN, and hospitalization encounter number were not 
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available to the dissertation student or study personnel. IRB approval for the study 
protocol was obtained from the medical center and from the university.   
Study Limitations 
This cross-sectional, retrospective, descriptive study to characterize frailty in 
hospitalized adults had several limitations. The study design was based on observational 
data derived from the EMR that was recorded for clini al purposes. Some empirically-
validated frailty criteria such as performance measure  and assessment measures for 
domains of the BPSS-Stress conceptual model were not available in the EMR. Although 
suitable proxies were identified, some of the indicator variables for the frailty 
components were not the most salient based on prior research, theory, and the study 
BPSS-Stress conceptual model. 
Accuracy and completeness of data available in the EMR would be expected to 
vary depending  on health care provider expertise and experience, time constraints, and 
attention to the past medical history that may or may not be pertinent to the immediate 
reason for hospitalization. Secondary data analysis is unavoidably associated with risk for 
incomplete, inaccurate, and/or missing data. To reduc  this risk, clinical data retrieved 
from the EMR was cross-validated with documentation fr m nursing and medicine and 
other various health care providers. All data collection forms and the analytic dataset 
underwent verification by study investigators to ensure completeness, accuracy, and 
consistency in documentation. Coding questions were adjudicated by study investigators 
and decisions logged in a notebook to ensure consiste t documentation. Previously 
completed data collection forms were audited, the EMR reviewed, and corrections made. 
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The study population consisted of admissions to a large academic medical center 
with access to medical and surgical specialists, diagnostic procedures, and treatments not 
typically available at smaller, non-academic hospitals. In this study, one hospital 
encounter was included in the dataset. Only health status on admission documented in the 
EMR was examined. Frailty is a dynamic process that follows a fluctuating course with 
potential for stabilization and recovery or precipitous or progressive decline that may lead 
to poor health outcomes. Thus, frailty was characteized at an arbitrary, static moment in 
time, providing a snapshot of the health status of acutely ill adults on admission. It was 
outside the scope of this study to examine frailty during hospitalization, at discharge, and 
after discharge. There is substantial evidence that hospitalization is independently 
associated with high risk for untoward, potentially preventable events such as falls, 
injury, infection, delirium, pain, medication side effects, pressure ulcers, depression, new 
functional decline and mobility impairment. These untoward events increase risk for the 
inception of frailty or accelerate its progression and severity.  Frailty status on admission 
therefore may provide information about vulnerability to adverse events but exposure 
during hospitalization to risk may significantly alter level of frailty. This may be 
clinically important in patients who have few frailty components or lower level of frailty 
on admission but experience one or more significant adverse events during 
hospitalization that quickly changes their risk status and  increases their vulnerability to 
deleterious consequences to subsequent adverse events. 
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Chapter Summary 
Frailty was characterized in hospitalized adults 55 years of age and older admitted 
to the general medicine, cardiology, and orthopedic services at a large academic medical 
center from June 1, 2010 through August 31, 2011. Fourteen frailty components were 
operationalized to characterize frailty based on prior research and empirical evidence, 
theory, the study conceptual model, and BPSS health sta us variables available in the 
EMR. The sample consisted of 278 independent hospital admissions. Descriptive 
statistics, tests of association and correlation, bivariate and multiple linear regression, and 
logistic regression were performed to examine associati ns between the 14 frailty 
components and 20 BPSS health status variables and if level of frailty, or the Frailty 
Score, predicted hospital length of stay and 30-day hospital readmission. 
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CHAPTER IV 
 
RESULTS 
 
 
Findings from this descriptive, cross-sectional, retrospective study are reported in 
this chapter. This study characterized frailty in hospitalized adults 55 years of age and 
older admitted to the general medicine, cardiology, or orthopedic service in one large 
academic medical center and determined if level of frailty, represented as a Frailty Score, 
predicted hospital length of stay and 30-day hospital readmission.  
Sampling Method and Population 
A preliminary study sample was constructed using data query procedures 
described in Chapter III. Sociodemographic data were r trieved from electronic medical 
records (EMR) archived in the health system Data Storage Repository. The preliminary 
sample yielded 690 independent hospital encounters (admissions) during the 15-month 
study time frame. Individual patients in the preliminary sample had between one and 
eleven hospital encounters. One hospital encounter per patient was selected based on 
study inclusion criteria yielding 281 independent hospital encounters. Three patients were 
excluded based on an admission diagnosis of non-dermatologic cancer with active 
treatment. Thus, the final analytic sample was 278 independent hospital encounters. 
Sample 
 Sample characteristics for the demographic and BPSS domains delineated in the 
study conceptual model are presented in Table 9. The mean age was 70 years (range, 55-
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98 years) with adequate age representation in the sample. Slightly over half were female, 
half were single (single, separated, divorced, widoed), about two-thirds were White. 
There were no encounters where race/ethnicity was identified as Hispanic/Latino. Most 
admissions were from home and one-fifth was from a skilled nursing facility, 
rehabilitation center, or another hospital. Twenty percent of the sample lived alone. Most 
were retired and one out of five was disabled. 
 
Table 9 
 
Sample Characteristics for Demographic, Biologic, Psychologic, and Social-Spiritual 
Domains (N = 278)* 
 
 
Variable 
 
Number (%) or 
Mean (SD), range 
Demographic Domain 
Preadmission location Home 
Other (extended care, rehabilitation 
facility, other hospital) 
224 (80.6) 
54 (15.4) 
Discharge location Home (self-care) or home health 150 (54.0) 
 Skilled nursing facility,  
   rehabilitation facility, another  
   hospital 
105 (37.8) 
 Hospice (home or medical facility) 10 (3.6) 
 Expired  13 (4.7) 
Admitting service General medicine 
Cardiology  
Orthopedics  
194 (69.8) 
55 (19.8) 
29 (10.4) 
Marital status Married 
Widowed  
Single  
Divorced 
Separated  
142 (51.1) 
61 (21.9) 
43 (15.5)  
26 (9.4) 
6 (2.2) 
Occupational status  
 
Employed  
Retired 
Disabled  
Unemployed 
28 (10.2) 
179 (64.4) 
58 (20.9) 
13 (4.7) 
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Table 9. (Cont.) 
 
 
Variable 
 
Number (%) or 
Mean (SD), range 
Demographic Domain (cont.) 
Number of hospitalizations During 15-month study time frame 1.56 (0.93), 1-8 
Length of stay — 9.92 (9.6), 1-72 
30-day hospital readmission — 33 (11.9) 
Biologic Domain 
Gender Female  
Male 
146 (52.5) 
132 (47.5) 
Age In years on admission date 70.2 (10.3), 55-98 
Age tertiles 
 
55-64 years   
65-74 years 
75 years and older 
100 (36.0) 
84 (30.2) 
94 (33.8) 
Race/Ethnicity White (Caucasian) 
Black (African American) 
American Indian 
Asian 
Other 
Hispanic/Latino 
178 (64.0) 
92 (33.1) 
2 (0.7) 
2 (0.7) 
4 (1.4) 
0 
Comorbidity count Sum count of ICD 9/10 medical 
diagnoses on admission 
13 (4.56), 1-26 
Comorbidity categories  
(n = 12) 
    
 
Hypertension 
Cardiovascular disease 
Pulmonary disease 
Liver disease 
Musculoskeletal disorder 
Endocrine disease 
Cognition 
Neurological disease 
Renal disease 
Inflammatory/autoimmune 
Psychiatric disorder 
Cancer 
Vision disorders 
229 (82.4) 
192 (69.1) 
93 (33.5) 
25 (8.6) 
152 (54.7) 
158 (56.8) 
92 (33.1) 
58 (20.9) 
146 (52.5) 
42 (15.1) 
114 (41) 
63 (22.7) 
95 (34.2) 
Infection on admission — 184 (66.2) 
Unplanned surgery — 95 (34.2) 
Failure-to-thrive or frail ICD 9/10 diagnosis on admission 
or MD documentation  
21 (7.6) 
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Table 9. (Cont.) 
 
 
Variable 
 
Number (%) or 
Mean (SD), range 
Biologic Domain (cont.) 
Fever  Prior to or on admission 100 (36) 
Acute pain — 196 (70.5) 
Weakness — 227 (81.7) 
Fatigue — 249 (89.6) 
Urinary incontinence — 66 (23.7) 
Dyspnea, shortness of breath — 104 (37.4) 
Pressure  or vascular ulcer — 81 (29.1) 
Braden Scale score Sum of six subscales, range 6-23 17.89 (3.3), 9-23 
Medication count Sum count of prescription and 
non-prescription medications taken 
on routine basis  
11.87 (5.2), 0-31 
Medication count  ≥ 5 Number of patients with 
medication count  ≥ 5  
264 (95) 
Medication categories  Statin  126 (45.3) 
(n = 10) Nonsteroidal, aspirin  181 (65.1) 
 Corticosterioid,  
     immunosuppressant  
59 (21.2) 
 ACE-Inhibitor, ACE-Receptor 
     Blocker 
135 (48.6) 
 Sex hormone 18 (6.5) 
 Opioid 137 (49.3) 
 Benzodiazepine 57 (20.5) 
 Diuretic 143 (51.4) 
 Calcium, vitamin D,  
     bisphosphonate 
92 (33.1) 
 Beta blocker 142 (51.1) 
BMI — 28.6 (7.64), 13-65 
BMI  >25 kg/m2 — 183 (65.8) 
Plasma Biomarkers*   
CRP or hs-CRP Abnormal flag, high 246 (88.5) 
Albumin Abnormal flag, low 
Plasma value 
258 (92.8) 
2.58 (0.7), 1-4  
Hemoglobin Abnormal flag, low 
Plasma value 
10.44 (1.8), 6-16 
267 (96) 
WBC count Abnormal flag, high or low  206 (74.1) 
 Plasma value 11.70 (4.7), 1-29  
*Refer to Table 6 for abnormal flag laboratory value
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Table 9. (Cont.) 
 
 
Variable Electronic Medical Record 
Number (%) or 
Mean (SD), range 
Psychologic Domain 
Tobacco, current use — 45 (16.2) 
Chronic pain  — 71 (25.5) 
Difficulty sleeping Self-report, use of CPAP at night 152 (54.7) 
Mental status abnormal — 173 (62.2) 
Memory problems — 71 (25.5) 
Depression  ICD 9/10 diagnosis on admission 97 (34.7) 
Delirium  ICD 9/10 diagnosis on admission 70 (25.2) 
Dementia ICD 9/10 diagnosis on admission 25 (9) 
Social-Spiritual Domain 
Live alone — 56 (20.1) 
ADL assistance needed  — 183 (66.8) 
ADL device used  — 175 (62.9) 
Caregiver concern Carer concerns about patient healh 
status, post-hospital care needs, 
resources, finances 
119 (42.8) 
Clergy visit Requested on admission, recorded 
during hospitalization  
65 (23.4) 
 
Multiple morbidity was high. The mean number of medical diagnosis listed on 
admission was 13 (range, 0–26). To ensure accuracy, d ta for chronic medical conditions 
were retrieved from consultation reports or primary care visit notes since all pertinent 
medical conditions may not listed in admission documentation. Acute infection was 
present in two-thirds on admission and over one-third ad a fever prior to or on 
admission. Symptom burden was high. Acute pain was reported in almost three-quarters 
and chronic pain in one-quarter of the sample. Fatigue, weakness, urinary incontinence, 
abnormal mental status, delirium, difficulty sleeping, depression, and vision problems 
were commonly reported on admission, however, fatigue was the most ubiquitous. About 
two-thirds were over-weight or obese, defined as BMI > 25 kg/m2. Pressure ulcer or 
252 
 
vascular ulcers were present on admission in 29% and was one common reason for 
unplanned surgery during hospitalization. The primay reason for admission for about 
10% of the sample was related to falls and almost one-third had a history of falls. The 
mean Braden Scale score was 18 (range, 9–23); lowerBraden Scale scores are predictive 
of higher risk for pressure ulcer development. The mean number of prescription and non-
prescription medications taken on a routine basis documented on admission was 12 
(range, 0–31). About 8% (n = 21) had a physician diagnosis or notation of failure-to-
thrive or frailty. Abnormal flags for the biomarkers associated with inflammation, 
chronic stress, and frailty (CRP or hs-CRP, albumin, hemoglobin, WBC count) were 
highly prevalent. Abnormal flags for three of four biomarkers were present in over 89% 
of the sample.  
Almost three-quarters of the sample were admitted to the general medicine 
service however about one-third had unplanned surgery during hospitalization typically 
as a result of failed medical treatment. The most cmmon surgical procedures were 
incision and drainage of abscesses, treatment of post-surgical incisions, fistulas, 
hematomas, or pressure or vascular ulcers, repair or removal of joint replacement 
hardware, and limb amputation or revision of a prior amputation. No major cardiac, 
orthopedic, gastrointestinal, or neurologic surgical procedures were documented. During 
hospitalization, unit transfers including intensive care occurred but these data were not 
recorded since frailty status on admission was the focus of the study. 
Discharge disposition for more than half of the sample was home (self-care or 
with home health services), extended care (skilled nursing or rehabilitation facility), or 
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another hospital. Less than 5% were discharged to hospice care provided in a medical 
facility. Five percent died during hospitalization. Almost two-thirds (62.9%) had one 
hospital encounter during the 15-month study time frame, however, four patients had five 
hospital encounters and one patient had eight. Extreme outliers accounted for less than 
2% of the sample. Mean length of stay was 9.92 days(SD, 9.96, range, 1–72). Thirty-
three patients (12%) were readmitted within 30-days of hospital discharge.  
Frailty Score 
 The Frailty Score consisted of the sum of 14 frailty components. All frailty 
components and indicator variables were operationalized as categorical, where 1 = Yes, 
present on admission, and 0 = No, not present on admission. Twenty-six indicator 
variables that best represented the study conceptual model domains defined the 14 frailty 
components. Most frailty components were defined by one indicator variable. Five frailty 
components were defined by more than one indicator variable and included Nutrition 
(five), Fatigue (two), Falls (two), Cognition (four), and Social Support (four). Only one 
indicator variable needed to be present to score one p int for the frailty component. 
Frailty components coded as one point were summed to compute the Frailty Score. 
Lower Frailty Scores suggested lower risk for frailty or not frail and higher Frailty Scores 
suggested increased risk for or greater level of frailty. The frequency count and percent 
for the 26 categorical indicator variables for the frailty components for the BPSS domains 
are presented in Table 10. 
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Table 10 
 
Frequency and Percent of the 26 Categorical Indicator Variables (N = 278) 
Indicator Variables n (%) 
Biologic Domain 
1. Unplanned weight loss, 15 pounds, past 6 months 87 (31.3) 
2. Recent unplanned weight loss 103 (37.1) 
3. Poor appetite   158 (56.8) 
4. BMI < 18.5 kg/m2 20 (7.2) 
5. BMI > 30 kg/m2 103 (37.1) 
6. Fatigue 249 (89.6) 
7. Weakness  227 (81.7) 
8. Dyspnea, shortness of breath 104 (37.4) 
9. Falls admission diagnosis 26 (9.4) 
10. Falls history 75 (27) 
11. 
Vision (cataracts, glaucoma, macular degeneration,  
     retinopathy, blind) 
95 (34.2) 
12. Plasma CRP or hs-CRP, abnormal flag, high 246 (88.5) 
13. Plasma albumin, abnormal flag, low 258 (92.8) 
14. Plasma hemoglobin, abnormal flag, low 267 (96) 
15. Plasma WBC, abnormal flag, abnormal-high or low 206 (74.1) 
 Psychologic Domain 
16. Chronic pain  173 (62.2) 
17. Sleep problems, use of CPAP at night 152 (54.7) 
18. Delirium 70 (25.2) 
19. Memory problem 71 (25.5) 
20. Mental status abnormal 71 (25.5) 
21. Dementia 25 (9) 
22. Depression  97 (34.9) 
 Social-Spiritual Domain 
23. Live alone 56 (20.1) 
24. Older adult, disabled, live alone 51 (18.3) 
25. Single (single, separated, divorced, widowed) 136 (48.9) 
26. Caregiver concerns 119 (42.8) 
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Research Question 1 
 What is the proportion of each of the 14 frailty components in hospitalized adults 
55 years of age and older?    
The 14 frailty components were Nutrition, Weakness, Fatigue, Chronic Pain, 
Dyspnea, Falls, Vision, Cognition, Depression, Social Support, and abnormal flags for 
four plasma biomarkers: CRP or hs-CRP (high), Albumin (low), Hemoglobin (low), and 
WBC count (abnormal, high or low). Table 11 reports the frequency count and percent of 
the 14 frailty components identified in the sample. 
 
Table 11 
 
Frequency Count and Percent of the 14 Frailty Components in the Sample (N = 278) 
 
Frailty Component n (%) 
1. Nutrition   227 (81.7) 
2. Weakness   227 (81.7) 
3. Fatigue  249 (89.6) 
4. Chronic Pain  173 (62.2) 
5. Dyspnea   104 (37.4) 
6. Falls   80 (28.8) 
7. Vision   95 (34.2) 
8. Cognition   92 (33.1) 
9. Depression   97 (34.9) 
10. Social Support   190 (68.3) 
11. CRP or hs-CRP, abnormal flag (high)  246 (88.5) 
12. Albumin, abnormal flag (low)  258 (92.8) 
13. Hemoglobin, abnormal flag (low)   267 (96)  
14. WBC count, abnormal flag (abnormal, high or low)  206 (74.1) 
 
Fatigue, Weakness, and Nutrition were documented in over 80% of the sample. 
Chronic Pain and Social Support issues were documented i  about two-thirds of the 
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sample, and Dyspnea, Falls, Cognition, Depression, and Vision problems were 
documented in slightly over one-third of the sample. The prevalence of abnormal flags 
for all four biomarkers was high. Two-thirds of the sample had an abnormal flag for all 
four biomarkers whereas only 1% had one abnormal flag. Low abnormal flag for 
Hemoglobin and Albumin was almost universal. About three-quarters had an abnormal 
flag for WBC count (all but two were high).  
Research Question 2 
What is the level of frailty in the sample, based on a Frailty Score of 0 to 14? 
The mean Frailty Score was 9.03 (SD, 1.98, range, 2-13) and the median and 
mode were 9. The frequency distribution of Frailty Scores indicated that only 4.3% (n = 
6) had a Frailty Score from two to five and 12% (n = 32) had a Frailty Score of 12 or 13. 
The Frailty Score was examined according to procedures described in Chapter 3. The 
Frailty Score was modestly skewed (-.472) indicating hat most scores fell to the right of 
the mean. The data distribution was modestly peaked with little variance indicating slight 
kurtosis (.269). The Kolmogorov-Smirnov and Shapiro-Wilk tests were significant 
indicating a non-normal distribution. Visual inspection of the data indicated that the data 
distribution and degree of non-normality did not warrant transformation. 
Research Question 3 
What are the relationships between demographic, biolog cal, psychological, and 
social-spiritual health status variables and each of the 14 frailty components? 
Tests for association between 20 categorical and quantitative continuous 
candidate predictor variables representing demographic, BPSS domains and the 14 
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categorical frailty components were analyzed using procedures described in Chapter 3. 
Tests of association were performed to examine relationships between the 14 categorical 
candidate predictor variables and each of the 14 categorical frailty components. The 
Pearson Chi-square or Fisher’s Exact test were performed. The Pearson Chi-square test 
statistic and p value and, if indicated, the Fisher’s Exact test p value were examined. The 
Fisher’s Exact test was reported when the expected frequency in each cell was less than 
five. When the Fisher’s Exact test p value was reported, the Pearson Chi-square test 
statistic was documented with the p value. 
Of the 14 candidate predictor variables, eleven were coded as 1 = Yes, present on 
admission, or 0 = No, not present on admission. The 11 variables included ADL 
assistance needed, ADL device used, acute pain, pressure or vascular ulcer, infection, 
fever, current tobacco use, urinary incontinence, unplanned surgery during 
hospitalization, clergy visit during hospitalization, and physician diagnosis or 
documentation of failure-to-thrive or frail on admission. Three demographic variables 
were coded as follows: gender (1 = female; 0 = male), race/ethnicity (1 = Minority 
[Black, American Indian, Asian, Hispanic/Latino, Other]; 0 = Caucasian), and pre-
admission location (1 = home; 0 = other). There wasno Hispanic/Latino representation in 
this study sample. 
For the six quantitative continuous candidate predictor variables, Spearman’s rho 
was computed to examine associations between each candidate predictor variable and 
each of the 14 categorical frailty components. The six continuous candidate predictor 
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variables were age, BMI, comorbidity count, medication count, Braden Scale score, and 
number of hospital admissions during the study time frame.  
Table 12 reports the Chi-square test statistic and Fisher’s exact test p value for 
significant categorical candidate predictor variables and the 14 frailty components. The 
frailty component, Social Support, was significantly associated with the most categorical 
predictor variables (seven): race/ethnicity (Minority), gender (female), preadmission 
location (home), ADL assistance needed, pressure or vascular ulcer, urinary incontinence, 
and clergy visit. The abnormal flag for Fatigue (low) and Hemoglobin (low) were not 
significantly associated with any candidate predictor variables. Depression was 
significantly associated only with race/ethnicity (Minority). Nutrition was significantly 
associated with preadmission location (home) and current tobacco use. Dyspnea was 
significantly associated with infection and unplanned surgery. Weakness was 
significantly associated with ADL assistance needed, ADL device used, pressure or 
vascular ulcer, and urinary incontinence. Chronic Pain was significantly associated with 
ADL assistance needed, ADL device used, acute pain,and physician diagnosis or 
documentation of failure-to-thrive or frailty on admission. Falls were significantly 
associated with ADL assistance needed, ADL device used, current tobacco use, and 
urinary incontinence. Vision was significantly associated with race/ethnicity (Minority), 
female gender, and pressure or vascular ulcer. Cogniti n was significantly associated 
with preadmission location (home), ADL assistance ne ded, and urinary incontinence. 
 
 
Table 12 
 
Tests for Association for 14 Categorical Candidate Pr dictor Variables for the Demographic, Biologic, Psychologic, and 
Social-Spiritual Domains and 14 Categorical Frailty Components (N = 278) 
 
 Variables 
 
Frailty 
Component 
 
 
Race 
 
 
Gender 
 
Pre-admit 
location 
 
ADL 
assist 
 
ADL 
device 
 
Acute 
pain 
 
Pressure 
Ulcer 
 
 
Infection 
 
Tobacco 
use 
 
 
Incont. 
 
 
Fever 
 
 
Surgery 
 
Clergy 
visit 
Failure-
to-thrive 
or frail 
Nutrition — — 
5.352 
.019* 
— — — — — 
4.889 
.033* 
— — — — — 
Weakness — — — 
19.663 
.000* 
— — 
7.185 
.006* 
— — 
6.701 
.010* 
— — — — 
Fatigue — — — — — — — — — — — — — — 
Chronic Pain — — — 
6.966 
.009* 
17.003 
.000**  
57.815 
.000**  
— — — — — — — 
8.070 
.008* 
Dyspnea — — — — — — — 
9.614 
.003* 
— — — 
9.094 
.003* 
— — 
Falls — — — 
8.339 
.005* 
12.023 
.001**  
— — — 
4.736 
.047* 
6.215 
.019* 
— — — — 
Vision  
 
. 
5.319 
.023* 
— — — — 
5.361 
.026* 
— — — — — — — 
Cognition — — 
17.893 
.000**  
9.450 
.002* 
— — — — — 
36.464 
.000 
— — — — 
Depression 
5.436 
.026* 
— — — — — — — — — — — — — 
Social Support 
11.561 
.003* 
4.501 
.039* 
10.823 
.001**  
10.516 
.002* 
— — 
14.983 
.000**  
— — 
5.720 
.022* 
— — 
4.013 
.049* 
— 
CRP, hs-CRP — — — — — — — 
8.135 
.009* 
— — 
6.500 
.011* 
5.530 
.018* 
— — 
Albumin  — — — 
12.297 
.001**  
4.867 
.032* 
— — 
4.323 
.049 
— — — — — — 
Hemoglobin  — — — — — — — — — — — — — — 
WBC count  — — 
4.291 
.039* 
9.005 
.004* 
— — 
4.421 
.036* 
7.807 
.006* 
— 
5.209 
.024* 
— 
11.220 
.001**  
— — 
§Only statistically significant variables reported.   
Pearson Chi-square test statistic and Fisher’s Exact  test  p value reported for all variables  
*Statistical significance, p < .05 (2-tailed) 
** Statistical significance, p < .001 level (2-tailed)
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Albumin abnormal flag (low) was significantly associated with Weakness, Vision, Social 
Support, WBC count abnormal flag (abnormal, high or low). Unplanned surgery was 
significantly associated with Dyspnea, CRP or hs-CRP abnormal flag (high), and WBC 
count abnormal flag (abnormal, high or low).  
Categorical candidate predictor variables significantly associated with the 14 
frailty components were examined. ADL assistance needed was significantly associated 
with the most frailty components (seven): Weakness, Chronic Pain, Falls, Cognition, 
Social Support, Albumin abnormal flag (low), and WBC count abnormal flag (abnormal, 
high or low). Urinary incontinence was significantly associated with five frailty 
components: Weakness, Falls, Cognition, Social Support, and WBC count abnormal flag 
(abnormal, high or low). Race/ethnicity (Minority) was significantly associated with three 
frailty components: Vision, Depression, and Social Support. Candidate predictor 
variables significantly associated with one or two frailty components were acute pain 
(Chronic Pain), fever (CRP or hs-CRP abnormal flag, hi h), physician (MD) 
documentation of failure-to-thrive or frail on admission (Chronic Pain), clergy visit 
(Social Support), current tobacco use (Nutrition, Falls), and female gender (Vision, 
Social Support). Use of an ADL device was significantly associated with Chronic Pain, 
Falls, and Albumin abnormal flag (low). There were no significant patterns of association 
between frailty components and any individual or cluster of candidate predictor variables.  
Table 13 reports significant Spearman’s rho correlation rs and p values for the 
quantitative continuous predictor variables and 14 categorical frailty components. Vision 
was significantly associated with the most continuous predictor variables (four): age, 
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comorbidity count, lower Braden Scale score, and number of hospital admissions during 
the 15 month study time frame. Nutrition and Dyspnea w re significantly associated with 
BMI. Weakness was significantly associated with three: age, BMI, and Braden Scale 
score. Depression was significantly associated withhig er comorbidity count and higher 
medication count. Dyspnea was associated with BMI and comorbidity count. Falls was 
significantly associated with BMI and comorbidity count, and number of hospital 
encounters. Cognition was significantly associated with age and lower Braden Scale 
score. Chronic Pain was significantly associated with BMI and Social Support was 
significantly associated with lower Braden Scale score. Fatigue was not significantly 
associated with any predictor variables. Three biomarkers, CRP or hs-CRP (abnormal 
flag, high), low albumin (abnormal flag, low), and WBC count (abnormal flag, high or 
low), were significantly associated with lower Braden Scale scores. Hemoglobin 
abnormal flag (low) was significantly associated with medication count. 
 
Table 13 
    
Tests for Association between 14 Quantitative Continuous Candidate Predictor Variables 
and each of the 14 Categorical Frailty Components: Significant Spearman’s rho Point 
Biserial Correlation rs and p Value
§
 (N = 278) 
 
  
Age 
 
BMI 
Comorbidity 
count 
Medication 
count 
Braden 
Scale score 
Number of 
hospitalizations 
Nutrition — 
.188**  
.000 
— — — — 
Weakness 
.128* 
.034 
.119* 
.048 
— — 
-.269**  
.000 
— 
Fatigue — — — — — — 
Chronic pain — 
.147* 
.014 
— — — — 
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Table 13. (Cont.) 
 
  
Age 
 
BMI 
Comorbidity 
count 
Medication 
count 
Braden 
Scale score 
Number of 
hospitalizations 
Dyspnea — 
.146* 
.015 
.162**  
.007 
— — — 
Falls 
.252**  
.000 
— 
.181**  
.002 
— 
-.145* 
.015 
— 
Vision  
.233**  
.000 
— 
.250**  
.000 
— 
-.143* 
.017 
.140* 
.020 
Cognition 
.223**  
.000 
— — — 
-.374**  
.000 
— 
Depression — — 
.172**  
.004 
.202**  
.000 
— — 
CRP, hs-CRP — — —- — 
-136* 
.023 
— 
Albumin — — — — 
-.184**  
.002 
— 
Hemoglobin — — — 
.129* 
.031 
— — 
WBC count 
.160**  
.008 
— — — 
-.331**  
.000 
— 
Social support — — — — 
-.201**  
.001 
-- 
§Only statistically significant values reported 
  *Spearman’s rho rs and p < .05 level (2-tailed) 
**  Spearman’s rho rs and p < .01 level (2-tailed) 
 
Candidate predictor variables significantly associated with the most frailty 
components were lower Braden Scale score and age. Lower Braden Scale scores were 
significantly associated with nine frailty components: Weakness, Falls, Vision, 
Cognition, CRP or hs-CRP (abnormal flag, high), Albumin (abnormal flag, low), and 
WBC count (abnormal flag, high or low), and Social Support. Age was significantly 
associated with seven frailty components: Weakness, Falls, Vision, Cognition, and WBC 
(abnormal flag, high or low). BMI was significantly associated with Nutrition, Weakness, 
Chronic Pain, and Dyspnea. Comorbidity count was significantly associated with 
Dyspnea, Falls, Vision, and Depression.  
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The four biomarkers were not significantly associated with many categorical or 
continuous variables. Three of the four biomarkers were significantly associated with 
infection on admission. WBC count abnormal flag (abnormal) was significantly 
associated with the most variables (five): pressure ulc r or vascular ulcer, infection on 
admission, urinary incontinence, ADL assistance needed, and unplanned surgery during 
hospitalization. CRP or hs-CRP abnormal flag, high) was significantly associated with 
infection and fever prior to or on admission. Albumin abnormal flag (low) was 
significantly associated with ADL assistance needed, ADL device used, and infection. 
Hemoglobin abnormal flag (low) was not significantly associated with any variables.  
Research Question 4 
 
What are the relationships between the demographic, biological, psychological, 
and social-spiritual health status variables and level of frailty, represented as the Frailty 
Score that ranges from 0 to 14? 
The Frailty Score and candidate predictor variables w re examined for regression 
model assumptions as described in Chapter III. Tests for multicollinearity between 
candidate predictor variables were acceptable indicating there were no strong linear 
relationships that could bias the regression models (Field, 2009; T. A. Lang & Secic, 
2006). First, tests for association were performed b tween the 20 quantitative categorical 
and continuous candidate predictor variables and the Frailty Score. The Pearson Chi-
square test statistic and p value or the Fisher’s Exact test and p value were computed for 
the categorical predictor variables and Spearman’s rho rs and p value were computed for 
the continuous candidate predictor variables and the continuous dependent variable, the 
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Frailty Score. This analysis yielded 12 statistically significant predictor variables. 
Significant predictor variables were age, female gender, Braden Scale score, current 
tobacco use, pressure ulcer or vascular ulcer, urinary i continence, ADL assistance 
needed, ADL device used, medication count, comorbidity count, preadmission location 
(home), and number of hospitalizations during the 15-month study time frame. Predictor 
variables that were not statistically significant were race/ethnicity (Minority), BMI, acute 
pain, fever, infection, unplanned surgery, clergy visit, and physician (MD) diagnosis or 
documentation of failure-to-thrive or frail on admission.  
Multiple Linear Regression for Candidate Predictor Variables and Frailty Score 
Multiple linear regression was conducted for the 20 candidate predictor variables 
and Frailty Score (N = 278). The multiple linear regression, or model 1, was statistically 
significant. Seven statistically significant predictor variables were identified in the 
regression model: older age, lower Braden Scale score, urrent tobacco use, acute pain, 
ADL assistance needed, urinary incontinence, and higher comorbidity count. Regression 
coefficients are reported in Table 14. Model 1 explained 26% of the variance in the 
Frailty Score. Predictor variables with the highest standardized β coefficients were 
current tobacco use, ADL assistance needed, and lower Braden Scale score. Collinearity 
test statistics were acceptable.  
 Next, multiple linear regression was performed using the seven statistically 
significant predictor variables identified above and the Frailty Score to test model fit for a 
more parsimonious model. The findings from this multiple linear regression indicate that 
all predictor variables remained statistically significant. Predictor variables with the 
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highest standardized β coefficients were Braden Scale score, ADL assistance needed, 
current tobacco use, and higher comorbidity count. Collinearity statistics were 
acceptable. The regression standardized β coefficients, 95% CI, and p values are reported 
in Table 15.   
 
Table 14 
Multiple Regression β Coefficients for the Frailty Score and 20 Categorical and 
Quantitative Continuous Candidate Predictor Variables (N = 278) 
 
Standardized 
Coefficients 
95% Confidence 
Interval for β 
 
Modela 
 
β 
 
t 
 
Sig. 
Lower 
Bound 
Upper 
Bound 
Constant  3.830 .000 2.636 8.215 
Age  in years on admission .141 2.223 .027* .003 .051 
Gender (female) .097 1.725 .086 -.055 .828 
Race/ethnicity (Minority) -.017 -.304 .762 -.520 .381 
BMI .083 1.436 .152 -.008 .051 
Braden Scale Score -.154 -2.341 .020* -.171 -.015 
Total number of encounters .050 .910 .364 -.125 .339 
Tobacco use, current .199 3.662 .000** .496 1.650 
Pressure ulcer or vascular ulcer .094 1.610 .109 -.092 .912 
Acute pain  .109 2.014 .045* .011 .933 
ADL assistance needed .155 2.381 .018* .112 1.181 
ADL device used  .013 .214 .831 -.448 .557 
Clergy visit during hospitalization  .049 .895 .371 -.272 .726 
Pre-admission location (home) .001 .011 .991 -.598 .596 
Urinary incontinence  .136 2.291 .023* .089 1.178 
Medication count, higher .055 .878 .381 -.026 .088 
Comorbidity count, higher .140 2.288 .023* .009 .144 
Unplanned surgery  -.013 -.247 .805 -.503 .391 
Failure-to-thrive or frail per MD diagnosis or 
documentation  
.004 .065 .984 -.813 .869 
Fever prior to or recorded on admission .053 .971 .333 -.226 .664 
Infection  .005 .080 .936 -.449 .487 
Adjusted R2 = .260, df (20, 257), F = 5.865, df (20, 257), p = .000, Durbin-Watson = 1.851 
a Dependent variable: Frailty Score     
*Statistical significance, p < .05 level (2-tailed)  
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Table 15 
Multiple Regression Coefficients for Frailty Score and Seven Significant Predictor 
Variables (N = 278)a  
 
                                                              Standardized                                                              
Coefficients 
 95% Confidence 
Interval for β 
 
Modela. 
 
β 
 
t 
 
Sig. 
Lower 
Bound 
Upper 
Bound 
Constant  9.376 .000 6.744 10.329 
Age  in years on admission .116 2.134 .034* .021 .528 
Braden Scale score -.201 -3.274 .001**  -.194 -.048 
Tobacco use, current .177 3.339 .001**  .391 1.516 
Acute pain  .115 2.171 .003**  .046 .951 
ADL assistance needed .194 3.397 .001**  .341 1.281 
Urinary incontinence  .134 2.293 .023* .088 1.157 
Comorbidity count, higher .166 3.109 .002**  .026 .118 
Adjusted R2 = .254, df (7, 270), F = 14.483, df (7, 270), p = .000, Durbin-Watson = 1.809 
a Dependent variable: Frailty Score     
*Statistical significance, p < .05 level (2-tailed)  
** Statistical significance, p < .01 level (2-tailed) 
 
Multiple Linear Regression Using ENTER and STEPWISE Method 
To further explore conceptual and operational constructs of frailty, a second set of 
multiple linear regression models, or model 2, were performed using the ENTER and 
STEPWISE method. First, bivariate linear regression was performed for each of the 20 
candidate predictor variables and the Frailty Score. Level of significance for candidate 
predictor variables was set at p < .10 to provide slightly more liberal inclusion criteria 
(Field, 2009; Tabachnik & Fidell, 2007). Bivariate regression identified 14 statistically 
significant predictor variables: age in years on date of admission, female gender, 
comorbidity count, medication count, pressure ulcer or vascular ulcer, Braden Scale 
score, infection, urinary incontinence, acute pain, current tobacco use, ADL assistance 
needed, ADL assistive device used, preadmission location (home), and number of 
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hospital encounters during the study time frame. The ot er six candidate predictor 
variables were not statistically significant and not i cluded in subsequent analyses. Table 
16 displays bivariate linear regression standardized β coefficients and p values for the 
Frailty Score and the 20 candidate predictor variables. 
 
Table 16 
Bivariate Linear Regression Coefficients for the Frailty Score and 20 Candidate Predictor 
Variables (N = 278) 
                              
 
Variable 
 
Β 
Regression 
Coefficient 
(Sig., p < .10) 
Biologic Variables 
 Constant .000  
1. Age in years on admission  .212 p = .000 
2. Gender (female) .154 p = .010 
3. Comorbidity count .242 p = .000 
4. Medication count .182 p = .002 
5. Pressure ulcer or vascular ulcer  .253 p = .000 
6. Braden Scale score -.375 p = .000 
7. Infection  .104 p = .084 
8. Urinary incontinence  .247 p = .000 
9. Acute pain .106 p = .077 
Psychological Variables 
10. Tobacco use, current  .141 p = .019 
Social Variables 
11. ADL assistance needed  .337 p = .000 
12. ADL device used .234 p = .000 
268 
 
 
Table 16. (Cont.) 
 
 
Variable 
 
Β 
Regression 
Coefficient 
(Sig., p < .10) 
Demographic Variables 
13. Preadmission location (home) .212 p = .000 
14. Total number of encounters .117 p = .051 
       
      
 Regression 
Coefficient 
Not Sig. 
15. BMI .044 p = .460 
16 Race/ethnicity (Minority) .075 p = .214 
17. Unplanned surgery  .000 p = .996 
18. Fever prior to or on admission .022 p = .717 
19. Failure-to-thrive or frail per MD diagnosis or 
documentation 
.064 p = .287 
20.  Clergy visit during hospitalization  .081 p = .178 
a Dependent variable: Frailty Score     
 
Next, multiple linear regression was performed using the ENTER method for the 
14 statistically significant candidate predictor vaiables identified from bivariate linear 
regression and the Frailty Score. Seven statistically significant variables were identified: 
female gender, higher comorbidity count, current tobacco use, acute pain, urinary 
incontinence, ADL assistance needed, and lower Braden Scale score. Predictor variables 
with the highest standardized β coefficients were current tobacco use, ADL assistance 
needed, and higher comorbidity count. The regression m del was statistically significant. 
Collinearity statistics were acceptable. Table 17 repo ts the standardized β coefficients, 
95% CI, and p values for the multiple regression.  
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Table 17 
 
Multiple Regression Coefficients for Frailty Score and 14 Significant Predictor Variables 
using ENTER Method (N = 278)  
 
 Standardized 
Coefficients 
  
95% CI for β 
Modela β t Sig. Lower Bound Upper Bound 
Constant  4.863 .000 3.719 8.781 
Age  in years .107 1.812 .071 -.002 .043 
Gender (female) .112 2.054 .041* .019 .872 
Medication count, higher .056 .925 . 356 -.024 .066 
Comorbidity count, higher .149 2.506 .013* .014 .116 
Pressure or vascular ulcer .096 1.680 .094 -.072 .906 
Tobacco use, current .185 3.472 .001** .431 1.561 
Acute pain .112 2.110 .036* .003 .940 
Urinary incontinence .138 2.356 .019* .105 1.177 
Total number of encounters .045 .837 .403 -.131 .324 
Infection  .007 .129 .989 -.416 .474 
ADL assistance needed .160 2.488 .013* .139 1.194 
Pre-admission location (home) .019 .331 .741 -.481 .675 
Braden Scale score -.142 -2.177 .030* -.163 -.008 
ADL device used .014 .235 .814 -.437 .556 
Adjusted R2 = .266, df (14, 263), F = 8.163, df (14, 263), p = .000, Durbin-Watson = 1.817 
a. Dependent Variable: Frailty Score     
Significant predictor variables highlighted in Bold  
*Statistical significance at the .05 level (2-tailed) 
**Statistical significance at the .001 level (2-tailed)   
 
Multiple linear regression using the STEPWISE method was then performed with 
the 14 predictor variables and Frailty Score to determine if a more parsimonious set of 
predictor variables could be identified. The multiple linear regression model was 
statistically significant. The STEPWISE multiple linear regression model yielded seven 
statistically significant predictor variables for the Frailty Score: lower Braden Scale score 
ADL assistance needed, higher comorbidity count, current tobacco use, female gender, 
urinary incontinence, and acute pain. The negative coefficient for the Braden Scale score 
suggests an inverse relationship where a lower Braden Scale score is associated with a 
higher risk for pressure ulcer development. Collinearity test statistics were acceptable. To 
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validate the regression model findings and parsimony, multiple linear regressions were 
repeated for the Frailty Score and the seven predictor variables using the ENTER and 
STEPWISE method (T. A. Lang & Secic, 2006). The results for the multiple linear 
regression models were similar and all predictor variables remained statistically 
significant. Table 18 reports the standardized β coefficients, 95% CI, and p values for the 
multiple regression using STEPWISE method.    
 
Table 18 
 
Multiple Regression Coefficients using STEPWISE Method for 14 Significant Predictor 
Variables and the Frailty Score (N = 278)  
 
                                                              Standardized 
Coefficients 
  
95% CI for β 
Modela β t Sig. Lower Bound Upper Bound 
Constant  9.775 .000 6.885 10.359 
Braden Scale score (lower) -.201 -3.281 .001**  -.194 -.048 
ADL assistance needed .190 3.345 .001**  .327 1.264 
Comorbidity count, higher .197 3.710 .000**  .040 .132 
Tobacco use, current .166 3.169 .002* .338 1.449 
Gender (female) .141 2.689 .008* .150 .971 
Urinary incontinence .146 2.524 .012* .150 1.211 
Acute pain .109 2.073 .039* .024 .920 
R2 = .261, df (1, 270), F = 15.000, df (14, 263), p = .000, Durbin-Watson test = 1.793 
a. Dependent Variable: Frailty Score     
*Statistical significance at the .05 level (2-tailed) 
**Statistical significance at the .001 level (2-tailed)                                                                                
 
 
Comparison of the Multiple Regression Models 
  
 Each of the multiple regression models identified sven statistically significant 
predictors of the Frailty Score. Six predictor variables were common to each of the 
multiple regression models: lower Braden Scale score, current tobacco use, higher 
comorbidity, acute pain, ADL assistance needed, and uri ary incontinence. Age was the 
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seventh significant predictor variable in model 1 where multiple linear regression was 
performed using all 20 candidate predictor variables. In model 2, multiple linear 
regression using the ENTER and STEPWISE method for 14 predictor variables yielded 
female gender as the seventh significant predictor variable. In sum, all multiple linear 
regression models yielded the same six significant predictor variables for the Frailty 
Score. Age or female gender was significant in some but not all regression models. 
Research Question 5 
What is the relationship between level of frailty, or Frailty Score (range, 0 to 14), 
and hospital length of stay? 
The mean length of stay was 9.92 days (SD, 9.58, range, 1-72), the median was 7 
days and the mode was 5 days. Simple linear regression was performed to examine if 
level of frailty or the Frailty Score., the continuous independent variable predicted the 
continuous dependent variable, hospital length of stay.  
Length of stay displayed a non-normal distribution and significant skew and 
kurtosis. Deletion of outliers and truncation of outliers with substitution of scores at the 
50th percentile for those cases was performed with little change in distribution 
parameters. Therefore, log10 transformation was performed (Field, 2009; Tabachnik & 
Fidell, 2007). Using the Frailty Score as the predictor variable and the log10 transformed 
length of stay variable as the outcome variable, th linear regression model was 
statistically significant. The standardized β coefficient for the Frailty Score was .053, t =
5.319, p = .000, 95% CI, .033 to .072. The adjusted R2 = .090, df (1, 276), F = 29.293, df 
(1, 276), p = .000. The Durbin-Watson test for correlation among residuals in linear 
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regression was acceptable (1.983; Field, 2009). Although the regression model was 
statistically significant, the model explained only 9% of variance in the log10 transformed 
length of stay with implications for clinical significance (Field, 2009; T. A. Lang & 
Secic, 2006).  
Research Question 6 
What is the relationship between level of frailty, reflected as the Frailty Score, 
and 30-day hospital readmission? 
Thirty-day hospital readmission and level of frailty represented as the Frailty 
Score was examined using logistic regression. Hospital readmission was the outcome 
binary variable, where “1” indicated 30-day readmission and “0” indicated not 
readmitted. Thirty-three patients (11.9%) were readmitted within 30 days of discharge. 
Pearson’s and Spearman’s rho correlation coefficients for the Frailty Score and 30-day 
readmission were not significant. Logistic regression was conducted with the Frailty 
Score as the continuous predictor variable and 30-day readmission as the binary outcome 
variable. Analysis of the logistic regression determined that that the Frailty Score was not 
a significant predictor of 30-day hospital readmission in this study population. The 
logistic regression standardized β coefficient for the Frailty Score was .100, df (1), 95% 
CI, .913 to 1.337, p = .307. Observed and predicted values computed as the log-
likelihood was used to assess the fit of the model. The -2 log-likelihood for 30-day 
readmission was 201.497. This finding suggests poorfit and more unexplained 
observations in the model. The Hosmer and Lemeshow test to evaluate goodness-of-fit of 
the logistic regression model was not significant, Chi-square = 4.121, df (5), p = .532. 
273 
 
 
The Wald test statistic was not significant, 1.043, df (1), p = .307 (Field, 2009; T. A. 
Lang & Secic, 2006). The odds ratio OR of 1.105 indicated that the odds of 30-day 
readmission did not change as the Frailty Score increased. Therefore, the (OR) was not 
applicable (Tabachnik & Fidell, 2007). 
Chapter Summary 
 This descriptive, cross-sectional, retrospective study characterized frailty in 
acutely ill hospitalized adults 55 years of age andolder (N = 278). Frailty was 
characterized by a Frailty Score that was computed by the sum of 14 frailty components 
defined by 26 indicator variables retrieved from the EMR. Findings from descriptive 
statistics, tests of association and correlation, and multiple linear regression and logistic 
regression models were examined to identify significant predictors of level of frailty, or 
the Frailty Score,  and if the Frailty Score predicted longer length of hospital stay, and 
30-day hospital readmission.  
 Higher Frailty Scores were common in the study sample. The mean, mode, and 
median for the Frailty Score were 9 (SD, 1.98, range, 2-13). Fewer than 5% had a Frailty 
Score of less than five. A slight majority of the sample was female, about one-third were 
African American, and most were admitted from home. Comorbid illness was prevalent. 
The mean number of medical diagnoses was 13 and the medication count of prescription 
and non-prescription medications was 12. Symptom burden was high. A majority of the 
sample reported fatigue, weakness, ADL dependence, urinary incontinence, vision 
problems, acute and chronic pain, poor appetite, sle p problems, fever, infection, and 
abnormal mental status. Over one-third of the sample had unplanned surgery. The mean 
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Braden Scale score was 18 (SD, 3.3, range 9-23), where scores < 18 indicate physiologic 
vulnerability and high risk for pressure ulcers. About a third of the sample had pressure 
or vascular ulcers on admission. Nine percent of hospital admissions were related to falls 
and 27% had a history of falls. Over 89% had abnormal flags for one or more plasma 
biomarkers that included CRP or hs-CRP, hemoglobin, albumin, and WBC count and 
two-thirds had abnormal flags for all four. The mean length of stay was about 10 days 
(SD, 9.6, range, 1-72) and 12% were readmitted within 30 days of hospital discharge. 
Multiple linear regression models were utilized to identify a parsimonious, 
statistically significant set of predictor variables. Seven statistically significant predictor 
variables for the Frailty Score were identified in all models: lower (worse) Braden Scale 
score, ADL assistance needed, higher comorbidity count, current tobacco use, urinary 
incontinence, and acute pain. However, only six predictor variables were significant in all 
models. The seventh significant predictor variable in model 1 was age and in model 2, 
female gender. Predictor variables significantly associated with frailty in the literature but 
were not significant predictors in this study were race/ethnicity (Minority) and low body 
weight or BMI < 18.5 kg/m2. In simple linear regression and logistic regression models, 
the Frailty Score was a significantly predictor of longer length of hospital stay but not 30-
day hospital readmission. 
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CHAPTER V 
 
DISCUSSION 
 
 
The purpose of this cross-sectional, retrospective, descriptive study was to 
examine frailty in hospitalized adults 55 years of age and older admitted to general 
medicine, cardiology, or orthopedic services at a large academic medical center. Limited 
research suggests that hospitalized older adults are at high risk for frailty and that frail 
patients experience worse outcomes compared to those who are not frail. However, 
research about frailty in hospitalized middle-aged an older adults admitted to medicine 
services was not identified in targeted literature searches. Most research examined frailty 
in medically-stable community-living older adults and few studies included adults less 
than 65 years of age. The present study addressed thi  gap in knowledge by 
characterizing frailty in hospitalized adults 55 years of age and older. This chapter 
presents study findings and their implications, limitations, conclusions, and 
recommendations. 
This study was guided by the biological-psychological-social-spiritual (BPSS) 
model and stress theory. Frailty was defined as a multidimensional, multifactorial 
syndrome that arises from cumulative dysfunction in BPPS domains that dynamically 
interact in response to intrinsic and extrinsic stre sors over the life course leading to 
incremental or precipitous decline in physiologic reserve and compensatory function 
across organ systems and failure to effectively respond to and recover from destabilizing 
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health events (Abellan van Kan, Rolland, Bergman, et al., 2008; Abellan van Kan et al., 
2010; Anpalahan & Gibson, 2007; Bergman et al., 2007; Clegg, 2011; H. J. Cohen, 2000; 
Engel, 1977, 1981; Ferrucci et al., 2004; Fried et al., 2004, 2005, 2009; Gobbens et al., 
2010b; Markle-Reid & Brown, 2003; McEwen, 1993; McEwen & Stellar, 1993; Nowak 
& Hubbard, 2009; Rockwood et al., 2005; Rockwood, Hogan, & MacKnight, 2000; 
Santos-Eggimann et al., 2009; T. E. Seeman et al., 1997;  Selye, 1955; Walston et al., 
2006; Whitson et al., 2007). Fourteen (14) evidence-based frailty components defined by 
26 indicator variables characterized frailty. Frailty ndicator variables were selected based 
on close approximation with frailty criteria validated in prior research, alignment with the 
study conceptual model, and were available in the electronic medical record (EMR). 
Inclusion of biomarkers associated with inflammation, nutrition, and frailty as frailty 
components provided physiologic data for laboratory indices with prior significant 
associations with frailty. The use of readily available data from the EMR was a practical 
and clinically-relevant first step in characterizing frailty in hospitalized adults. A Frailty 
Score was computed by summing the 14 frailty components; higher Frailty Scores 
suggested greater level of frailty.  
 The study sample consisted of 278 independent hospital encounters for adults 55 
years of age and older admitted to the general medicine, cardiology, or orthopedic service 
of one large academic medical center during a 15-month time period. The mean age was 
70 years with good sociodemographic representation. Descriptive data portrayed an 
acutely ill hospitalized population with high comorbidity and symptom burden, more 
functional impairment, psychosocial problems, and social support issues, and evidence of 
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physiologic stress based on high prevalence of abnormal biomarkers. These data supports 
conceptions of frailty as a multidimensional, multifactorial syndrome and extends 
understanding of frailty a biologic process associated with aging, disease, disability 
(Clegg, Young, Iliffe, Rikkert, & Rockwood, 2013; Gobbens et al., 2010a, 2010b; 
Rønning et al., 2010; Sternberg et al., 2011). 
Frailty Components and the Frailty Score 
A substantial proportion of the sample had higher Frailty Scores. The Frailty 
Score mean and range was similar across three age groups with a modest increase with 
age. These findings suggest that a higher Frailty Score was not unique to the elderly or 
very old. Study findings identified a high prevalenc  of frailty components and ADL 
impairment which was comparable to other studies in hospitalized older adults (Afilalo et 
al., 2012; R. R. Cohen et al., 2012; Dasgupta et al., 2009; Freiheit et al., 2010; 
Gharacholou et al., 2012; D. H. Lee et al., 2010; Makary et al., 2010; Sonnenblick, 
Raveh, Gratch, & Yinnon, 2007).  The high prevalence of frailty components and higher 
Frailty Scores may be associated with unique sample characteristics such as the admitting 
diagnosis, higher comorbidity, symptom burden, and ADL and mobility impairments, and 
more complex psychosocial issues requiring increased health and social service needs 
after discharge. The BPSS factors underlying the frailty components may have been long-
standing or temporal to hospitalization. 
The most prevalent non-biomarker frailty components were Fatigue, Weakness, 
Nutrition, Chronic Pain, and Social Support followed by Vision, Cognition, and 
Depression, each of which have been  significantly associated with frailty, inflammation, 
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stress, and functional impairment in prior research (Bao et al., 2008; Bruce, 2001; K. E. 
Covinsky et al., 1997, 2010; Kamaruzzaman, Ploubidis, Fletcher, & Ebrahim, 2010; Ní 
Mhaoláin et al., 2012; Rockwood & Mitnitski, 2007; van Gool et al., 2003). A high 
proportion had abnormal flags for all four biomarkers. Prior research reports significant 
associations between low hemoglobin, low albumin, high CRP or hs-CRP, and abnormal 
WBC counts and frailty, especially in hospital populations (Fukuse et al., 2005; 
Herrmann et al., 1992; Purser et al., 2006; T. N. Robinson et al., 2009; T. N. Robinson, 
Wu, et al., 2011; Rønning et al., 2010; Sündermann, Dademasch, Praetorious, et al., 
2011; Sündermann, Dademasch, Rastan, et al., 2011). 
Study findings were clinically relevant since evidenc d-based frailty components 
defined by sociodemographic, health status, functioal, clinical, and laboratory data 
characterized a high level of frailty in hospitalized adults 55 years of age and older.  The 
literature is replete with evidence for frailty as  geriatric syndrome. The cumulative 
effects of normal aging processes, morbidity and symptoms, lifestyle behaviors, life 
stressores and coping strategies, and social support intersect and produce differential risk 
for frailty and its covert and overt frailty manifestations. In the present study, the greater  
frequency of higher Frailty Scores across age ranges suggested that the interactive and 
multiplicative effects of BPSS factors as previously described  may have negative 
repercussions on homeostasis and allostasis of sufficient magnitude to alter physiologic 
functions and  initiate a pathway to frailty. The high prevalence of the frailty components 
Fatigue, Weakness, Chronic Pain, Depression, and Nutrition, and the four inflammatory 
biomarkers suggested aberration in physiologic functio . These findings might not be 
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expected in younger hospitalized adults, 55-64 years of age or in older adults who were 
otherwise healthy and fit prior to acute illness and hospitalization. Study findings 
provided preliminary descriptive data that challengd the notion of frailty is a syndrome 
of the aged, the very old, the disabled, persons with multiple morbidity and symptoms, or 
the terminally ill. Study findings underscore the importance of examining frailty in 
hospitalized adults 55 years of age and older since higher Frailty Scores were identified 
across the sample. 
Frailty Components and Health Status Variables 
There were 20 categorical and quantitative BPSS health st tus variables in the 
study. Few frailty components were significantly associated with the demographic 
variables of age (older), gender (female), and race/ethnicity (Minority) in tests of 
association. Although causality cannot be assumed, significant associations between 
health status variables and frailty components showed no consistent patterns with the 
exception of a few variables that were significantly associated with more frailty 
components. Not surprisingly, study findings  are not i  complete agreement with frailty 
research conducted in community-living adults (Ahmed et al., 2007; Bandeen-Roche et 
al., 2006; Fernandez-Bolañoset al., 2008; Fried, Tangen, et al., 2001; Fugate Woods et 
al., 2005; Hirsch et al., 2006; Santos-Eggimann et al., 2009) and hospitalized adults 
(Afilalo et al., 2009; Dramé et al., 2008; Hilmer, Perera, et al., 2009; D. H. Lee et al., 
2010; Makary et al., 2010). In many studies, demographic variables such as 
race/ethnicity, gender, and age were significantly associated with frailty components such 
as comorbidity and symptoms. Unexpectedly, Fatigue was not significantly associated 
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with any health status variables even though it was the most prevalent non-biomarker 
frailty component in the study sample and is a significant predictor of frailty in the 
literature (Bandeen-Roche et al., 2006; Fried, Tangen, et al., 2001; Fugate Woods et al., 
2005; Hardy & Studenski, 2010; Xue et al., 2008). The personal experience of the 
debilitating effects of fatigue among frail elderly has been described (Toye et al., 2006). 
Given the high prevalence of fatigue in this study sample further analysis is needed. 
Since the frailty component, Fatigue, was based on self-report and health care provider 
appraisal, future research in hospitalized adults should include standardized assessment. 
Fatigue may represent physiologic dysregulation linked to subclinical disease, systemic 
inflammation, acute illness, comorbidity, psychosocial stress, and increased physiologic 
effort to maintain homeostasis (Avlund et al., 2006, 2007; Bautmans et al., 2005; Hardy 
& Studenski, 2008, 2010; Walston et al., 2006).  
The frailty component, Dyspnea, was less common; however, dyspnea and fatigue 
co-occur in many chronic conditions and their combined negative impact on health status 
and function increases risk for frailty (Ekman et al., 2005; Leidy & Haase, 1996; Walke 
et al., 2004; K. Woo, 2000). Dyspnea may have been under-reported if it occurred only 
on exertion. High comorbidity and symptom burden in the sample may have influenced 
symptom management. For example, dyspnea (and fatigue) may be avoided or minimized 
by behavioral changes, such as self-imposed reduction in physical activity and mobility 
and reduced social interaction. The high level of self-reported ADL assistance needed in 
the study sample may be related to dyspnea and fatigue hat was provoked by physical 
activity needed for self-care and daily function.  
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Weakness is an undisputedly a significant frailty indicator (Fried, Tangen, et al., 
2001; Topinková, 2008; Vanitallie, 2003). However, in this study, Weakness was 
significantly associated with few variables related o demographics, function, health 
status, and urinary incontinence. Weakness was among few frailty components 
significantly associated with age. Weakness was not significantly associated with female 
gender, where previous research demonstrated significant gender-based differences in 
strength and muscle mass that may be influential in the higher prevalence of frailty in 
women compared to men (Fugate Woods et al., 2005; Hubbard & Rockwood, 2011; 
Santos-Eggiman et al., 2009). Weakness’s significant association with age, ADL 
assistance, and BMI suggests a trilogy of factors that adversely impacts behaviors such as 
physical activity, which is a critical component in the cycle of frailty.  
Notably, the lack of significant associations between Fatigue and any candidate 
predictor variables leaves a puzzling gap in understanding frailty since weakness and 
fatigue interact in reciprocal ways that lead to prgressive reduction in the frequency, 
duration, and intensity of physical activity with deleterious consequences including 
frailty (Landi, Abbatecola, et al., 2010; Peterson et al., 2009; Weiss, Hoenig, Varadhan, 
Simonsick, & Fried, 2010; Xue et al., 2008; Yang & Lee, 2010). 
Nutrition was significantly associated with two variables, demographic 
(admission from home) and behavior (tobacco use). In this study, unplanned weight loss 
and poor appetite was documented in a considerable proportion of the sample. In prior 
research, nutritional deficits, malnutrition, unplanned weight loss, poor appetite, and low 
BMI were significantly associated with frailty (Bart li et al., 2006; Fried, Tangen, et al., 
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2001; Hogan et al., 2003; Lally & Crome, 2007; Levers t al., 2006; Markle-Reid & 
Browne, 2003; Rodríguez-Mañas et al., 2012; J. Woo, Leung, & Morley, 2012). Poor 
appetite and nutrient intake and unintentional weight loss in persons who are overweight 
is associated with frailty criteria such as weakness, fatigue, lower physical activity, 
sarcopenia, and with frailty (Bales & Ritchie, 2002; Villareal et al., 2006; Jarosz & 
Bellar, 2009; Kinney, 2004). In this study, over half of the sample was overweight or 
obese. Obesity may be an important predictor of frailty since adipose tissue is a 
biologically active source of proinflammatory cytokines such as CRP that contributes to 
chronic systemic inflammation and a catabolic state that leads to muscle wasting and 
sarcopenia, key frailty indicators (Blaum et al., 2005; Cooper et al., 2012; Hubbard & 
Woodhouse, 2010; Jarosz & Bellar, 2009 Visser, 2011). Catabolic processes can be 
exacerbated since obesity has been linked to high calori  but poor nutrient intake (Kaiser, 
Bandinelli, & Lunenfeld, 2009; Kaiser et al., 2010). In the present study, weight loss and 
poor appetite may be related to acute illness or chronic disease exacerbation, and may not 
an indicator of a progressive and irreversible pathw y of decline that leads to 
malnutrition and frailty (Kaiser et al., 2010).   
Almost half of the sample had Braden Scale scores < 18, which suggests global 
physiologic vulnerability, nutritional and mobility problems, and higher risk for pressure 
ulcers. The sample was also characterized by ADL dependence and abnormal biomarkers 
associated with malnutrition, but none of the biomarkers were significantly associated 
with Nutrition. However, the high prevalence of abnormal flags for Albumin (low) and 
Hemoglobin (low) suggests malnutrition may have been a persistent problem. 
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In this study, Chronic Pain was not significantly correlated with comorbidity or 
polypharmacy despite evidence that adults often experience multiple sources of pain that 
arises from multiple conditions and require multiple types of analgesics. There is limited 
research on chronic pain and frailty. In one study, frail men with high comorbidity were 
significantly more likely to report pain compared to healthy men (Blythe et al., 2008). 
Chronic pain adversely impacts biologic processes, ymptoms, function, and behaviors 
that set the stage for frailty across the life span (Whitson et al., 2009). Considering that 
hospitalized adults may experience different sources and types of pain, it is essential that 
pain assessment and intervention is comprehensive a this is more likely to promote rapid 
recovery, improve function, and prevent frailty (Rastogi & Meek, 2013). Chronic Pain 
was the only frailty component significantly associated with physician documentation of 
failure-to-thrive or frail on admission. This finding underscores the importance of 
interdisciplinary communication and collaboration t optimize pain management. 
As shown in previous studies, Cognition in this study was significantly associated 
with age, function, symptoms, and health status. Cogniti n indicator variables, cognitive 
impairment and delirium, are each significantly and independently associated with frailty 
and worse outcomes (Ávila-Funes et al., 2009; Boyle, Buchman, Wilson, Bienias, & 
Bennett, 2007; Buchman, Boyle, Wilson, Tang, & Benntt, 2007; Inouye et al., 2007; 
Mitnitski et al., 2011; Panza et al., 2011; Rothman et al., 2008; Song, Mitniski, & 
Rockwood, 2010, 2011). Cognitive impairment of any type is important in hospitalized 
adults since it is associated with iatrogenic events, poor prognosis, longer length of stay, 
readmission, and mortality (Eeles et al., 2012; Inouye & Charpentier, 1996; Khan et al., 
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2012; Quinlan et al., 2011). Delirium warrants attention since it may be a cognitive 
manifestation of frailty due to compromised multisystem function and compensatory 
reserve that precipitates or accelerates progression of frailty (Inouye et al., 1999, 2007; 
Quinlan et al., 2011).  
In accordance with prior research, Depression was significantly associated with 
demographics (race/ethnicity [Minority]) and health s atus (Fried, Tangen, et al., 2001; 
Fugate Woods et al., 2005; (Bookwala & Lawson, 2011; Lenze et al., 2005; Mezuk et al., 
2011; Ní Mhaoláinet al., 2012; van Gool et al., 2003; Whitson et al., 2007). Depression 
occurs at higher rates in African-Americans who are frail (Hirsch et al., 2006; Szanton et 
al., 2005). Significantly higher rates of depression and CRP levels have been documented 
in African American compared to White community-living younger and older adults, 
independent of demographic and health status risk factors, and behaviors (Deverts et al., 
2010). In the present study, high CRP or hs-CRP was not ignificantly associated with 
race/ethnicity (Minority). 
Similar to previous research, Falls were significantly associated with age, physical 
function, symptoms (urinary incontinence), and behaviors (current tobacco use), which 
are each significantly associated with frailty (Ensrud et al., 2007, 2008, 2009; Inouye et 
al., 2007). Prior research substantiates significant associations between falls and frailty, 
injury, functional decline, dependence, and mortality (Anpalahan, & Gibson, 2007; 
Ensrud et al., 2007, 2008, 2009; Fried, Tangen, et al., 2001; Fugate Woods et al., 2005; 
Hilmer, Perera, et al., 2009; Runge & Hunter, 2006; Pol et al., 2011; Nelson, Dufraux, 
Cook, 2007; T. N. Robinson, Wallace, et al., 2011; Speciale et al., 2004). In this study, 
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current tobacco use was documented in a small percentag  of the sample, however, 
tobacco use warrants attention since it is associated with poor physical function, chronic 
inflammation, and frailty (Hubbard et al., 2009; Rapuri et al., 2007). In one study, heavy 
smokers were the most frail, light smokers were intrmediate frail, and those who never 
smoked were the fittest (Hubbard et al., 2009). In this study, only data on current tobacco 
use was available. Data on lifelong smoking patterns may yield different findings. 
 Vision problems were significantly associated with demographic, clinical, and 
health status variables. The findings of this study are in agreement with other studies 
where vision impairment is associated with frailty (Brody et al., 2001; B. K. Keller, 
Morton, Thomas, & Potter, 1999; Klein, Klein, et al., 2003; Whitson, Ansah, et al., 
2010). In the present study, Vision was significantly associated with comorbidity but not 
ADL impairment. Vision impairment affects risk for frailty through adverse effects on 
physical and cognitive function, mobility, fall risk, social interaction, and mood 
(Bookwala & Lawson, 2011; Klein, Klein, et al., 2003). Prior research has found 
significant relationships between poor vision and cognitive impairment, mobility 
impairment, and disability where the estimated odds ratio associated with combined poor 
vision and cognitive impairment was greater than the estimated odds ratio associated with 
poor vision or cognitive impairment alone (Whitson et al., 2007). Frailty is considered as 
a pre-disability condition in most cases, thus attention to vision and cognition is 
warranted (Abellan van Kan, Rolland, Bergman, et al., 2008). 
In this study, Social Support concerns were significantly associated with 
demographics, function, symptoms, health status, behaviors, and spirituality. Social 
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Support significantly correlated with the most health status variables, suggesting that 
factors other than biologic processes may be contributory to health status and frailty 
(Andrew et al., 2008; T. E. Seeman, 1997; T. E. Seeman et al., 2003). Previous reports 
cite similar findings where psychosocial factors, social determinants, inadequate social 
networks, and lack of needed social support resources adversely impact health status, 
function, and risk for frailty (Bilotta et al., 201; Loucks, Berkman, et al., 2006; Loucks, 
Sullivan, et al., 2006; Newsom & Schulz, 1996; Rockwood & Bergman, 2012). Social 
vulnerability and frailty has been studied by examining relationships between biologic 
markers and measures of cumulative BPSS stress and the impact on individual and across 
physiologic systems. Higher numbers of abnormal biomarkers (allostatic load) has been 
associated with physiologic dysregulation and frailty (Gruenewald et al., 2009; 
Rockwood & Bergman, 2012; T. E. Seeman et al., 1997; Szanton et al., 2009).  In the 
present study, four biologic markers provided physiologic evidence of potential 
dysregulated systemic processes. Despite the high prevalence of abnormal biomarkers, 
there were no patterns of association between biomarkers and demographic and BPSS 
health status variables. 
Abnormal flag for WBC count (abnormal) was significantly associated with the 
most variables including demographic, health status, and function. Research indicates 
that abnormal WBC count is a significant predictor of frailty in community-living women 
(Leng et al., 2005; Leng, Hung, et al., 2009; Leng, Xue, et al., 2009). In the present study,  
the abnormal flag for WBC count may be a temporal finding related to admission 
diagnoses of  infection, pressure orvascular ulcer, and urinary incontinence. WBC count 
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was the only biomarker significantly associated with age. In a study of  younger and older 
adults (n = 196, 20–35 years; n = 314, 70–85 years, Denmark) the number of leukocytes, 
lymphocytes and neutrophils was associated with fatigue in both age groups (Avlund et 
al., 2012). Among older adults, the relationship betwe n fatigue and leukocytes, 
lymphocytes and neutrophils was not significant when adjusting for physical activity and 
disability and in the younger group, the relationship between neutrophils and fatigue was 
not significant when adjusting for depression. There may be a potential  role of 
leukocytes, neutrophils and lymphocytes in development of fatigue. In the present study, 
tests of association between Fatigue and WBC count were not statistically significant.  
Abnormal flag for CRP or hs-CRP was significantly associated with health status, 
chronic disease, and symptoms. In community-living older men hs-CRP levels were 
significantly higher in frail than non-frail men (Almeida, Norman, van Bockxmeer, 
Hankey, & Flicker, 2012). In hospitalized adults, CRP is used to assess acute infection, 
treatment response, and surgical recovery. However, relationships between CRP or hs-
CRP and frailty have not been studied in hospitalized adults.  
Abnormal flag for Albumin level was also highly prevalent in this study and was 
significantly associated with function and health status. Research in hospitalized adults 
identifies low albumin level is a significant predictor of morbidity and has been 
suggested as a composite marker for chronic disease, poor nutritional status, functional 
impairment, and frailty. In this study, findings are in agreement where abnormal flag for 
Albumin (low) was significantly associated with poor ADL function and low Braden 
Scale score, a composite indicator of multisystem dysfunction (Arques et al., 2008; Corti 
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et al., 1994; K. E. Covinsky et al., 1999; Herrmann et al., 1992). A particularly relevant 
finding of this study is the high prevalence of low albumin and high CRP or hs-CRP 
levels. Research indicates that the combination of low albumin levels and high levels of 
CRP are significant predictors of frailty, evidence that is germane to the present study 
and warrants further analysis (Nelson et al., 2000; Visser et al., 2005; Wu, Shiesh, Kuo, 
& Lin, 2009). Hemoglobin abnormal flag (low) was sign ficantly associated only with 
medication count. Low hemoglobin level and anemia are associated with decreased 
muscle strength and physical performance in older aults but in this study, there were no 
significant associations with any of the variables for demographics, symptoms, health 
status, and function (Izaks et al., 1999; Penninx et al., 2004). This finding is unexpected 
since tissue and organ oxygenation and perfusion are dependent on the iron-binding 
capacity of hemoglobin. Significant associations with demographic, function, and health 
status variables would be biologically relevant. 
In future analyses, using the actual plasma value rathe  than abnormal flag may 
yield different findings. There may be thresholds for each biomarker that significantly 
differentiate level of risk and increased vulnerability for frailty. Research indicates that 
even modest deviations from the reference range for multiple biomarkers (which suggests 
failure of homeostasis and allostasis resulting in increased allostatic load) is more 
predictive of multisystem dysregulation that is associated with frailty than any one highly 
abnormal biomarker (Gruenwald et al., 2009; McCaffery, Marsland, Strohacker, 
Muldoon, & Manuck, 2012). There is no known research on which biomarkers are most 
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appropriate, clinically relevant, feasible, cost-effective, and the laboratory value cutpoints 
for frailty risk stratification and outcome prediction in hospitalized adults. 
Demographic, Biological, Psychological, Social-Spiritual Variables and Frailty Score 
Relationships between demographic, biological, psychological, social-spiritual 
variables and the Frailty Score were analyzed in multiple linear regression models. Seven 
predictor variables were yielded in three regression m dels: one regression model for the 
20 candidate predictor variables and two models for the 14 candidate predictor variables. 
In each regression model, six predictor variables wre identical: lower Braden Scale 
Score, higher comorbidity, acute pain, urinary incontinence, current tobacco use, and 
ADL assistance needed. The seventh predictor variable n the first multiple regression 
model with 20 predictor variables was age and in the second model where multiple 
regression was performed using the ENTER and STEPWISE method with 14 candidate 
predictor variables, female gender. None of the demographic variables (age, 
race/ethnicity [Minority], female gender) were significant predictors in all regression 
models. Race/ethnicity (Minority, mostly Black) was not a significant predictor in any of 
the regression models in contrast to prior research where higher level of frailty is 
significantly associated with African American race (Hirsch et al., 2006; Xue, 2011). In 
the Women’s Health and Aging Study, African American r ce was significantly 
associated with frailty but not when adjusted for income and education; older White 
women had the same odds for frailty as African American women based on lower 
socioeconomic status (Szanton, Seplaki, et al., 2010). 
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Age is an important frailty predictor since advancing age is associated with multi-
organ system changes related to normal aging and disease processes, increased 
prevalence of disease and symptoms, functional limitations, and detrimental lifestyle 
changes (Izaks & Westendorp, 2003; Fried et al., 2001; Mitnitski, Graham, Mogilner, & 
Rockwood, 2002; Rockwood, Song, & Mitnitski, 2011). In this study, age and Frailty 
Score means and ranges were similar across age tertil s. Thus, some hospitalized adults 
in the 55 to 64 year old age group had more frailty components than might be expected 
for their age, while some in the 75 years of age and older had fewer frailty components 
than might be expected for their age. Although Frailty Scores increased modestly with 
age, study findings affirm that older age is not synonymous with frailty in part due to 
heterogeneity in the aging population. Since aging changes advance at different rates in 
organ systems and experience and cope with age-relat d changes and disease conditions 
in different ways explains the loose correlation between biologic and chronologic age 
(Bortz, 1993, 2002; 2010; Mitnitski et al., 2002). While age and multiple morbidity are 
often used to estimate risk for adverse outcomes related to medical or surgical 
interventions, findings from the present study suggest that frailty assessment may provide 
additional information about overt or covert biopsychosocial vulnerabilities and risk for 
poor outcomes in hospitalized adults (D. H. Lee et al., 2010). 
Race/ethnicity (Minority) was not a significant predictor of the Frailty Score 
which contrasts with research that identifies higher pr valence and severity of frailty in 
African Americans, especially African American women compared to white men and 
women (Fugate Woods et al., 2005; Hirsch et al., 2006; Szanton et al., 2009). Other 
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factors not measured in this study may be influential such as education attainment, 
socioeconomic status and financial security, social position, living environment, 
occupation, access to health care, health care quality, biopsychosocial factors, life 
stressors, level of cumulative stress, sociocultural factors (racism, sexism, ageism, 
classism), and social determinants.  
Comorbidity and medication count was high in this study sample. Several frailty 
definitions use a count of medical conditions (Farhat et al., 2011; Kulminski, 
Ukraintseva, Culminskaya, Arbeev, Land, Akushevich, & Yashin, 2008; Rockwood et 
al., 2005). Medical condition counts provide an estima ion of disease burden but clinical 
and symptom manifestations can vary thus underestimating the clinical significance and 
relevance with respect to BPSS function and stress. 
The Braden Scale score was a significant predictor of the Frailty Score in the 
three regression models. Almost half of the study sample had low Braden Scale scores 
indicating multisystem vulnerability. The Braden Scale score significantly correlated with 
eight of 14 frailty components, including three biomarkers, health status, age, and 
hospital length of stay. In a study of hospitalized ol er adults who underwent abdominal 
surgery, where frailty was defined by the deficit acumulation framework and 39 
predictor variables, the Braden Scale score was the only significant predictor of post-
operative complications (Cohen et al., 2012).  Because the Braden Scale is a composite 
score for six subscales that when summed, estimate aggregated risk associated with 
multisystem impairments, it captures a more global depiction of biologic vulnerability 
that is more than a composite of loosely related or unrelated deficits. 
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Research indicates that frailty is significantly associated with longer length of stay 
In the present study, the Frailty Score was significantly associated with longer length of 
stay (Afilalo et al., 2010; D. H. Lee et al., 2010; Ostir, Berges, Kuo, Goodwin, 
Ottenbacher, & Guralnik, 2012; Sunderman et al., 2011; Winograd et al., 1991). 
According to the U.S. Census Bureau, mean length of stay for hospitalized patients 65 
years and older was 5.7 days compared to four days in patients younger than 65 years 
(U.S. Census Bureau, 2003). In a study of older adults admitted for elective surgery, 
preoperative frailty defined by the Fried Frailty Index was significantly associated with 
longer length of stay (intermediate frailty: incidenc  rate ratio (IRR) = 1.49, 95% CI, 
1.24-1.80; frail: IRR = 1.69, 95% CI, 1.28-2.23) (Makary et al., 2010). Frailty assessment 
improved the predictive power (p < 0.01) of other risk assessment indices. In cardiology 
inpatients, two frailty indices and individual performance measures were significant 
predictors of longer length of stay (Purser et al., 2005). In a study of hospitalized older 
adults, significant predictors of longer length of stay were walking difficulties, fall risk, 
malnutrition risk, and cognitive impairment (P. O. Lang et al., 2006).  
The Frailty Score was not significantly associated with 30-day readmission in this 
study. Substantive research demonstrates significant associations between frailty and 
hospital readmission (Andrew et al., 2008; Fugate Woods et al., 2005; J. E. Carlson et al., 
1998; Goldstein, Dominguez, & Vallone, 1991; Landi et al., 2004; Marcantonio et al., 
1988; Marcantonio et al., 1999; Williams et al., 1988; Winograd et al., 1991; Woo et al., 
2005). In the present study, the high prevalence of symptoms in the Frailty Score was 
notable (e.g., fatigue, weakness, poor appetite, dyspnea, acute pain, chronic pain, urinary 
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incontinence, fever, depressive symptoms, poor vision). Co-occurring symptoms and 
their deleterious effects are associated with higher hospitalization rates (Gill et all, 1999; 
Fried et al., 2009; Jarrett et al., 1995; Whitson et al., 2009). Although the Frailty Score 
did not predict 30-day readmission in this study, this finding should not overshadow the 
evidence that 37 percent had two or more hospitalizations and four percent had four or 
more hospitalizations during the study time period. In addition, since data collection did 
not track admissions to other hospitals, it is possible that the 30-day readmission is under-
estimated. Characteristics of patients who were and were not readmitted within 30 days 
of discharge were not analyzed in this study. 
Implications 
Frailty was characterized by a multidimensional Frailty Score that included 14 
evidence-based frailty components defined by 26 indicator including four biomarkers 
associated with inflammation, malnutrition, and frailty. The sample is atypical since all 
four biomarkers are not commonly ordered in hospitalized adults. The Frailty Score 
significantly predicted longer hospital length of stay but not 30-day readmission in 
hospitalized adults 55 years of age and older admitted to the general medicine, 
cardiology, or orthopedic service in one academic medical center.  
The Frailty Score mean and range was similar across three age groups. Although 
the majority of frailty research characterizes frailty as a syndrome of the aged and 
concentrates research in community-living, medically stable older adults, a few studies 
have examined frailty in community-living middle-aged adults (Chen, Wu, Chen, & Lue, 
2010; Santos-Eggimann et al., 2009) and hospitalized adults age 60 years of age and 
294 
 
 
older (Fukuse et al., 2005). Identifying frailty in hospitalized adults 55 years and older is 
important because there is potential for greater benefit from prevention and intervention 
strategies in this group compared to the very aged, where frailty may be more advanced 
and compounded by physiologic aging changes, comorbidity, and disability. 
Interventions targeted to midlife adults and older adults who have lower Frailty Scores 
may be more likely to benefit from interventions to prevent, delay, or halt progression of 
frailty. In the very aged, when frailty is more advnced and compounded by aging 
changes and chronic disease, the magnitude of benefit from interventions may be limited. 
However, a nihilistic approach to frailty prevention and intervention in the elderly or very 
old is both unwarranted and unethical since research has found that interventions focused 
on physical activity, mobility, and nutrition for example can yield significant benefit. 
Sensitive attention to patient and family preferences is important as the RN is often in a 
position to encourage and facilitate active engagement in living life fully and functioning 
at a level that is in accordance with patient and family wishes. Symptom management 
would be essential to make active engagement feasibl .  It is also appropriate, however, 
to consider compassionate care interventions for frailty at advanced stages when there are 
physiologic and BPSS indicators of transition to the end-of-life or active dying phase. 
In this study, high comorbidity was common and was a significant predictor of the 
Frailty Score. Most frailty research finds significant associations between higher 
comorbidity and frailty (Bandeen-Roche et al., 2006; Fried et al., 2001; Fugate Woods et 
al., 2005; Weiss, 2011). However, studies that do not fi d significant associations 
between comorbidity and frailty lend support to the concept that frailty is a distinct 
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clinical syndrome (Bandeen-Roche et al., 2006; Fried et al., 2004). Alternatively, a high 
medication count was almost universal but was not a significant predictor of the Frailty 
Score. The Braden Scale score was a significant predictor of the Frailty Score. Few frailty 
studies have examined pressure ulcer risk assessment instruments such as the Braden 
Scale as a predictor or correlate of frailty in hospitalized adults. In a study of hospitalized 
older adults following abdominal surgery the Braden Scale score was the only significant 
predictor of post-operative complications, longer length of stay, and discharge to an 
institution rather than home (R. R. Cohen et al., 2012). In a study comparing four 
uniquely different frailty instruments in in hospital zed older adults admitted to geriatric 
units (N = 2,033, ≥ 65 years, Italy) and mortality prediction (Pilotto et al., 2012). The 
four instruments were the FI-SOF (modified version of the Fried Frailty Scale used in the 
Study of Osteoporotic Fractures), the FI-CD (Frailty Index based on the cumulative 
deficit framework), the FI-CGA (Frailty Index based on comprehensive geriatric 
assessment), and the MPI (Multidimensional Prognostic Index). The MPI includes eight 
domains (function, cognition, nutrition, comorbidity, medications, co-habitation status, 
and the Exton Smith Scale, a pressure ulcer risk asessment instrument). All-cause 
mortality rates were 8.6% after one-month and 24.9% after one-year follow-up. All four 
frailty instruments were significantly associated with one-month and one-year all-cause 
mortality however the MPI demonstrated significantly higher discriminatory power for 
prediction of one-year mortality compared to the three other instruments for patients 
without ADL or IADL functional limitations (or both) or cognitive impairment and 
greater prognostic accuracy in patients with malnutrition, comorbidity (>3 medications), 
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and polypharmacy (>7 medications). Inclusion of pressure ulcer risk assessment in frailty 
assessment requires further investigation.   
In the present study, there was a high prevalence of frailty components that 
represented symptoms. Symptom burden can adversely aff ct BPSS function, increase 
stress, and worsen inflammatory processes that increase risk for frailty or hastens its 
progression and severity. Symptom burden and sympto expression may be important in 
frailty since symptom manifestations represent a more global indication of physiologic 
capacity for homeostasis. In a study examining chronic disease, symptoms, and function 
in older adults, symptoms were more relevant indicators of function and disability than 
medical diagnoses, findings that are pertinent to frailty (Whitson et al., 2009). In the care 
of frail adults, symptoms are crucial targets for intervention (Morley, 2010; Newman et 
al., 2010; O’Connell, Hawkins, Baker, & Ostaszkiewicz, 2011; Schultz-Larsen & 
Avlund, 2006; Shega et al., 2011). The high prevalence of distressing symptoms in 
hospitalized adults requires a multifaceted approach to symptom assessment, using 
standardized tools to evaluate symptom quality and severity, and a range of interventios 
that may alleviate individual symptoms as well as symptom clusters (Chen et al., 2011). 
Fatigue definitions and measurement vary across studies and may include 
questions about tiredness, energy level, difficulty getting going, trouble sleeping, poor 
concentration, weakness, and ADL function (Avlund et al., 2006; Bandeen-Roche et al., 
2006; Fried et al., 2001; Fugate-Woods et al., 2005; Hardy & Studenski, 2010; Xue et al., 
2008). Fatigue impacts risk for or progression of frailty due to greater physiologic effort 
to maintain homeostasis in the context of subclinical disease, comorbidity, symptoms, 
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and biopsychosocial stressors (Avlund, Damsgaard, Sakari-Rantala, Laukkanen, & 
Schroll, 2002; Bautmans et al., 2005; Hardy & Studenski, 2008, 2010; Schultz-Larsen & 
Avlund, 2006; Walston et al., 2006; Woo, 2000).  
Chronic pain is important in frailty since it reduces the capacity to respond to 
biopsychosocial stressors. In the present study, chronic pain was reported by over a 
quarter of the sample. There can be multiple sources of chronic pain, which was not 
addressed in this study.  In the hospitalized setting, acute pain may command greater 
attention than chronic pain due to common conditions such as osteoarthritis. In acutely 
ill, instable patients, chronic pain may be under-tr a ed. Attention to alleviation of 
chronic and acute pain may facilitate mobility and recovery and reduce risk for 
depression, delirium, poor nutritional intake, incotinence, incident frailty, and lessen 
severity or progression of frailty (Davis, Robinson, Le, & Xie, 2011; Jarrett et al., 1995; 
Pine et al., 2000).  
Depression is significantly associated with frailty. Depression is common in 
adults and often overlooked. In a study of community-living adults 60 years of age and 
older, those who were classified as pre-frail or frail had significantly higher depression 
scores compared to nonfrail adults (Ní Mhaoláin et al., 2012). In a systematic review of 
depression and frailty, a number of studies supported a bidirectional relationship between 
frailty and depression (Mezuk et al., 2011). Assessment of depression would facilitate 
early diagnosis and treatment and reduce risk for or worsening of frailty (Inouye et al., 
2007; Ní Mhaoláin et al., 2012). 
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In hospital settings, risk assessments are commonly performed for falls, pain, and 
pressure ulcers as standard nursing practice. As a syndrome, frailty represents a more 
unstable, vulnerable state that may be a final commn pathway for syndromes such as 
falls, delirium, pain, malnutrition, urinary inconti ence, functional decline, and pressure 
ulcers (Anpalahan & Gibson, 2007; Inouye et al., 2007). Comprehensive frailty 
assessment that incorporates risk factors for geriatric syndromes could improve precision 
in identifying high risk hospitalized adults. Nursing leadership would be critical in 
coordinating communication, and collaboration among interdisciplinary team members to 
facilitate optimal care for hospitalized adults who are at risk for frailty or who are frail.  
Strengths  
 The present study addressed a gap in knowledge by examining frailty defined by 
14 frailty components in a younger acutely ill hospitalized adult population 55 years of 
age and older. Study findings challenge the notion that frailty is unique to the aged or 
very old since higher Frailty Scores were documented across age tertiles. Rather than 
frailty being defined as a geriatric syndrome, it is better understood as a condition 
associated with complex, nonlinear physiologic interactions across multiple body systems 
that are influenced by intrinsic and extrinsic stresors that incite inflammation and other 
systemic responses (Fried et al., 2009). The intersection of multifactorial BPSS stressors, 
vulnerabilities, and pathologies exert cumulative adverse effects on health status and sets 
the stage for frailty.  
Frailty research in hospitalized adults has focused more on pre-operative surgical 
risk in the elderly, usually among those 70 years of age and older. Demographic data 
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portray an aging population that is living longer with increasing numbers who elect to 
undergo surgical and other invasive procedures to not ly potentially extend the lifespan 
but most importantly, to improve quality of life. There is evidence that pre-operative risk 
assessment tools often fail to identify those at high r sk for poor post-operative outcomes. 
Frailty measures and instruments have been utilized as an adjunct in preoperative risk 
assessment to improve detection of patients more likely to experience post-operative 
complications, mortality, and other adverse outcomes (Afilalo et al., 2010, 2012; R. R. 
Cohen et al., 2012; Makary et al., 2010). The present tudy examined frailty in a 
naturalistic sample of medical admissions with few exclusion criteria. This is an 
understudied population. The use of a systematic appro ch to construct a study sample 
using a data query tool facilitated selection of variables associated with frailty and 
construction of a dataset with sufficient power for statistical analyses. The study sample 
was medically complex, had higher mean Frailty Scores, more comorbidity and 
symptoms and longer length of stay. Frailty characterization provided a different lens to 
view population acuity, risk factors, BPSS needs, domains of assessment and priorities in 
clinical care and discharge planning. 
Limitations 
The study had several limitations. The study design was cross-sectional, 
descriptive, and retrospective. EMR data extraction focused on health status on admission 
thus frailty was characterized at a static moment in time. The natural history of frailty and 
transitions in level of frailty before, during, and after hospitalization could not be 
examined. The study population included medical admissions at a large academic 
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medical center. Some admissions were referred for specialist treatment and diagnostic 
procedures not available at other hospitals. The study sample may represent a more 
acutely ill, medically complex group compared to community or regional hospitals. Some 
patients had unplanned surgery or invasive procedures. Data on surgery, procedures, and 
intensive care unit transfers was not collected.  
Secondary analysis of medical records is associated with the risk for incomplete, 
inaccurate, or missing data. Variables selected to represent the demographic, biologic, 
psychologic, social-spiritual domains and the 14 frailty components were limited to 
observational data available in the EMR. Frailty criteria cited in the literature with 
demonstrated validity such as standardized assessment instruments for ADL and IADL 
function, mobility, strength, cognitive function, depression, symptoms, and social 
networks and support, for example, were not available. Data recorded on the nursing and 
physician admission assessment relies heavily on patient self-report or information 
provided by a proxy. Pol and colleagues (2011) compared  the validity of self- and proxy-
report of ADL and IADL function and found  moderate to good agreement between 
patients and proxies (70%–90%,  p < .001). Cognitive impairment and delirium were 
significantly associated with greater disagreement. Comparison of patient and proxy 
ratings with clinician-observed performance was not conducted. In the present study, 
degree of mobility and functional impairments were not quantified and standardized 
instruments were not used. EMR documentation was conducted according to hospital 
policy and professional standards. Provider expertis , me constraints, and the patient or 
patient proxy’s ability to provide accurate information were potential threats to reliability 
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and validity of information recorded in the EMR. Toensure data integrity, multiple 
sources in the EMR were reviewed to cross-validate information. Data verification of 
data collection forms and analytic database was performed for the full sample.  
Inclusion criteria included laboratory data for four plasma biomarkers not 
routinely ordered for all hospital admissions. Medical factors that warranted ordering all 
four biomarkers during one hospital encounter may significantly differentiate this group 
from other hospitalized adults. The study sample may be unique since descriptive data 
portrayed high comorbidity, polypharmacy, ADL impairment, and symptom burden, and 
social support concerns in this group. Thus, the Frailty Score may over-estimate level of 
frailty in this hospitalized adult population. External validity is of concern and 
generalizability of study findings is limited. 
The relative contribution of each biomarker individually and in combinations was 
not examined in this study and requires further analysis. The addition of other 
hematologic, urine, and salivary biomarkers (e.g., fasting blood glucose, glycosylated 
hemoglobin, creatinine, high density lipoprotein, blood urea nitrogen, creatinine 
clearance, cortisol, others) should also be considered as these are associated with 
inflammation and multi-organ system function. Other biomarkers that are readily 
available or may be prospectively obtained such as systolic and diastolic blood pressure, 
BMI, waist circumference, heart rate variability, ejection fraction, and others, may 
improve frailty characterization. 
Length of stay may have been influenced by patient and family preferences for 
care that changed during the hospital course. About a third of admissions involved 
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unplanned surgery. Failed medical treatment of complex roblems that resulted in 
surgical intervention may have contributed to longer length of stay. Subgroup analysis of 
unplanned surgery was not conducted in this study. Length of stay may have been 
influenced by cascade iatrogenesis, or the serial development of multiple potentially 
preventable medical problems that arise from a minor event often unrelated to the reason 
for admission and snowball as other problems develop resulting in continued need for 
acute care (Creditor, 1993; Mitty, 2010; Thornlow et al., 2009). 
Conclusion 
In this hospitalized sample of 278 adults age 55 years and older, high comorbidity 
and symptom burden, polypharmacy, ADL impairment, high prevalence of infection and 
pressure or vascular ulcers, lower Braden Scale score , and frequent unplanned surgery 
suggested a high level of medical acuity, complexity, dependence, and greater 
psychosocial needs. The mean Frailty Score was high and younger age was not protective 
lending support to the notion that frailty was not unique to the aged, very old, or 
terminally ill. The most prevalent non-biomarker frailty components were Fatigue, 
Weakness, and Nutrition. A majority of the sample had three or four abnormal 
biomarkers suggesting compromised physiologic functio , homeostasis, and 
compensatory reserve. Almost half of the sample had lower Braden Scale scores 
suggesting biologic vulnerability. The Braden Scale was significantly associated with the 
most frailty components and demographic and BPSS variables. In different multiple 
regression models, eight predictor variables were statistically significant predictors of the 
Frailty Score. Six predictor variables were common to all three models: Braden Scale 
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score, ADL assistance, comorbidity, tobacco use, urinary incontinence, and acute pain. In 
two regression models, female gender was significant, whereas age was significant in one 
regression model. In linear regression and logistic regression models, the Frailty Score 
significantly predicted longer hospital length of stay but not 30-day hospital readmission. 
In sum, external validity and generalizability of study findings are limited by the 
unique features of the sample and setting, thus study findings should be interpreted in 
consideration of these limitations.   
Recommendations for Education, Practice, and Research  
 The following recommendations are proposed for nursi g education, practice, 
research, and public policy. 
Education 
Research over 30 years has substantiated the importance of frailty with significant 
implications for nursing practice across clinical settings and in the community. Nursing 
education must keep pace with the growing body of literature on frailty. A nursing 
diagnosis for frailty has not been defined or published (NANDA International, 2011). In 
order for nursing education to advance in addressing frailty in the curriculum to prepare 
learners for future clinical practice, a conceptual and operational definition for a nursing 
diagnosis for frailty needs to be developed, validate , and published. This would increase 
awareness of this syndrome and provide guidance to nursing faculty and students, as well 
as clinicians, and researchers. Differentiating failure-to-thrive from frailty is important, as 
previously discussed, since clinical decision-making would be potentially biased since 
these terms are often used synonymously. Assuming that frailty is an end-stage condition 
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with no hope for amelioration can lead to passivity and therapeutic nihilism despite 
evidence that frailty may be improved or reversed. Conversely, differentiating these two 
conditions would guide decision-making about when to initiate palliative care and 
symptom management (instead of continuing exhaustive diagnostic testing or treatments 
associated with adverse side effects) and discussion  about end-of-life care are most 
appropriate (Raudonis & Daniel, 2010). Patient prefer nces for care must also be 
considered since research suggests that hospitalized frail elderly value good 
communication and information about health status and if able, participation in decision 
making about care (Ekdahl et al., 2010). This approach is critical in nursing education 
where the concept of caring is central to person-center d care. Nursing care and caring of 
frail adults requires caring skills that balance protection and independence, help find 
meaning in life, preserves quality of life, and advocates for the preferences and needs of 
this vulnerable population (Erlen, 2007; Heath & Phair, 2009). 
Innovative teaching strategies about frailty are neded for classroom and clinical 
instruction across the nursing curriculum. Classroom instruction that incorporates 
selected readings, resources, and active learning strategies (case studies, high and low 
fidelity simulations, role play, interviews with older adults, individual and group 
assignments focused on different frailty trajectories in relation to different nursing 
practices and models of care). Preventing hazards of hospitalization and functional 
decline is a high priority nursing concern (Anpalahan & Gibson, 2007; Boltz et al., 2012; 
Brown,  Williams, Woodby, Davis, & Allman, 2007; K. E. Covinsky et al., 2003; 
Creditor, 1993). Content on the impact of public policy and health care financing on 
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health disparities and vulnerable populations (local, regional, national, global issues) 
would elucidate factors that unfairly predisposes some persons to frailty (Albert, Im, & 
Raveis, 2002; Geronimus, 2001; Geronimus et al., 2006, 2007; James et al., 1992; Kuh, 
2007; Kuchel, 2009; Laditka & Laditka, 2002; Mullings, 2005; Szanton et al., 2005; 
Whitson et al., 2011). Frailty is an ideal paradigm for the unfolding case study that could 
examine a single hospitalization experience or takea more a life-course approach. These 
and other learning experiences would facilitate analysis and application of complex 
concepts of multidimensional frailty, physiologic loss of complexity, and importantly, 
nursing implications for clinical leadership in direct care and in system change.  
Clinical learning experiences applying the nursing process would enhance critical 
thinking and clinical reasoning skills in the comprehensive multidimensional assessment 
of frailty. Active collaboration with the interdisciplinary team to communicate diverse 
clinical information to develop, in collaboration with the patient, family and significant 
others, an individualized plan of care capitalizes on disciplinary expertise and facilitates 
person-centered care and optimal health status outcomes. Curricular content on how to 
work with interdisciplinary teams and to assert clini al leadership at the bedside is 
needed since much of nursing education focuses on direct care of patients (Benner, 
Sutphen, Leonard, & Day, 2010; Byrum, 2001; Grossman & Valiga, 2013; A. Robinson 
& Street, 2004; Dyer et al.,  2003). Nurses in direct care positions must be prepared to 
initate and facilitate effective interdisciplinary communication, collaboration, and care 
coordination (Byrum, 2010; Walker, Hogstel, & Curry, 2007). 
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In hospital and home health care settings where fedral guidelines have enacted 
pay-for-performance models with financial penalties for 30-day hospital readmission and 
long length of stay, frailty screening and comprehensive interdisciplinary assessment and 
care coordination will aide in optimizing quality of care and outcomes. Assessment and 
prevention/intervention protocols are integrated in nursing practice in many hospital 
settings for geriatric syndromes such as falls, mobility, pressure ulcers, pain, urinary 
incontinence, and delirium. Education is needed about h w nurses can use data generated 
from comprehensive frailty assessment is assimilated into algorithms that identify frailty 
risk level and guide primary and secondary prevention and targeted intervention. 
Increased attention in nursing education to geriatrics, geriatric syndromes and frailty is 
crucial. Attention to preventable untoward events is of paramount importance as federal 
guidelines and other regulatory bodies emphasize pati nt safety and quality of care. 
Nurses need access to easily understood information b ut frailty and nursing care 
implications to accelerate adoption of best practices. 
Interdisciplinary learning opportunities in nursing education builds on a strong 
tradition in geriatric nursing and medicine on the vital role of interdisciplinary team 
collaborations in addressing the complex needs of older adults, especially those who are 
frail. The IOM and the Carnegie Report emphasize  int rdisciplinary collaboration as an 
essential element in contemporary health care that contributes to improved inpatient care 
and transitions in care that reduce hospital length of stay and readmission (IOM, 2001; 
Benner et al., 2010; Gilliss, 2011). Nurse educators must increase education in 
prelicensure and continuing education programs to prepare registered nurses in clinical 
307 
 
 
leadership skills to facilitate interdisciplinary collaboration and care coordination in the 
care of frail adults (Byram, 2001; Gilliss, 2011; Lekan, 2009; Lekan et al., 2010; 
McConnell, Lekan, Bunn, Egerton, Corazzini, Hendrix, & Bailey, 2009; Pfaff, 2002). 
The high level of comorbidity and symptoms in the study sample warrants 
increased attention in nursing education on symptom management. Symptoms co-occur 
across multiple diseases and interact in ways that intensify the symptom experience. 
Treating symptoms one at a time is unlikely to yield the best outcomes since symptoms 
are not neatly traced to one diagnosis, and treatment of one symptom may have an 
adverse effect on another (T. E. Seeman, Guralnik, Kaplan, Knudson, & Cohen, 1989; 
Whitson et al., 2009, 2011). Therefore, symptom management must include 
comprehensive symptom assessment that considers how ymptoms interact in order to 
determine approaches most likely to be effective. Attention in nursing education on 
pharmacologic interventions for pain management needs to be balanced by a focus on 
evidence-based non-pharmacologic pain relieving strategies. Nursing education would 
contribute to improved care of frail adults by shifting the focus and mental model of 
frailty as a state of irreversible decline leading to death to a complex physiologic state 
that is multifactorial, and thus amenable to interventions such as symptom management 
that would improve comfort, function, and quality of life. 
Proactive nursing care could improve prevalent and inci ent frailty and reduce 
adverse outcomes. Concerns about the preparedness of the health care workforce in care 
of the elderly compels greater rigor in prelicensure and continuing nursing eduction in 
geriatric nursing (IOM, 2008). Educational programs to enhance geriatric nursing 
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expertise would improve the clinical reasoning and decision-making in the care of frail 
adults and appropriately educate patients and families about frailty risk factor reduction, 
chronic disease and symptom management, and strategies o reduce preventable or 
inappropriate hospitalization (Ingold et al., 2000; IOM, 2011). There are exemplars for 
delivery of geriatric nursing content in novel, relevant, and feasible ways in prelicensure 
and continuing nursing education programs (Barba & Fay, 2009; Barba & Gendle, 2006; 
Hancock et al., 2006; Kowlowitz, Davenport, & Palmer, 2009; Lekan, 2009; Lekan et al., 
2010; McConnell et al., 2009). 
Clinical Practice 
Nursing’s adoption in clinical practice of frailty assessment, risk stratification, 
primary and secondary prevention, and intervention will be imperative in order to provide 
high quality, person-centered care that minimizes risk for frailty and its adverse 
consequences. In this study, many hospitalized adults 55 years of age and older had 
higher Frailty Scores. In many cases, unrecognized vulnerability based on subjective 
assessment and younger age exposes high risk hospitalized adults to unnecessary risk 
since appropriate assessments and interventions would n t be implemented. Standard risk 
assessments for falls, pain, nutrition, delirium, and pressure ulcers, for example, provide a 
narrow, condition-specific risk profile that may not reflect the intersection and interaction 
of multiple risk factors in association with comorbidity that magnify risk for frailty (C. C. 
Chen et al., 2011; Inouye et al., 2007; Quinlan et al., 2011; Potts et al., 1993; Rozzini, et 
al., 2000; Sager & Rundberg, 1998; Sorace et al., 2011; Thornlow et al., 2009). The 
Frailty Score in this study included frailty components found in risk assessment tools for 
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common conditions that occur in hospitalized adults (falls, delirium, pressure ulcers, 
incontinence, pain). Frailty reflects an advanced stage of vulnerability not captured in 
individual focused risk assessments performed for these syndromes in hospital settings. 
Elements of comprehensive geriatric assessment (CGA) that focus on BPSS domains can 
also be integrated into nursing assessment, such as selected standardized tests for 
physical and cognitive function. Registered nurses document volumes of clinical data 
about health and BPSS status. Data generated from multiple sources of information can 
be aggregated and strategically used in care planning. Development of informatics 
systems and algorithms to facilitate these processes u ing data from the EMR would 
make use of the volume of clinical data that is present in the EMR but not integrated for 
purposes such as estimating frailty risk and identifyi g appropriate targeted interventions. 
Awareness of the hazards of hospitalization needs to emphasize how conventional 
care processes contribute to iatrogenesis, geriatric syndromes, functional decline, and 
frailty (Anpalahan & Gibson, 2007; Creditor, 1993; Lin et al., 2010; Mahoney, 1998; 
Mahoney, Sager, & Jalalddin, 1988; Mitty, 2010; Olson, Johnson, & Thompson, 1990; 
Potts et al., 1993; Quinlan et al., 2011). Restricted mobility and limited physical activity 
is common in acutely ill adults, especially older adults with mobility and cognitive 
impairment. Immobility has profound adverse effects on physiologic, biopsychosocial, 
and physical function that increases risk for frailty. Integration of in-bed range of motion 
and isometric exercise and early mobilization plus hysical and occupational therapy as 
indicated may prevent patients being discharged in worse physical condition despite 
resolution of medical problems (Arora, Plein, Chen, Siddique, Sachs, & Meltzer, 2009; 
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2009; Ávila-Funes et al., 2011; Boltz et al., 2012; C. J. Brown et al., 2004, 2009; Gill, 
Allore, et al., 2010).  
Chronic pain is an important frailty risk factor. In the hospital setting, acute pain 
may command greater attention than chronic pain and may be under-treated (Maxwell et 
al., 2008). Decline in functional status especially related to pain during hospitalization 
can be long-lasting and impact frailty (Boyd et al., 2005; C. J. Brown et al., 2004, 2007, 
2009; Graf, 2006). Alleviation of chronic pain may f cilitate mobility and recovery and 
reduce risk for or severity of frailty (Pine et al., 2000; Winograd, Gerety, Brown, & 
Kolodny,1988). 
Research indicates that frailty is a dynamic state wi h fluctuations in level of 
frailty (Campbell & Buckner, 2007; Fried et al., 2009; Lipsitz, 2004; Puts et al., 2005). 
Frailty assessment on admission, during hospitalization, and at discharge would provide 
useful information about baseline status, the impact of acute illness and hospitalization on 
homeostasis, compensatory reserve, and recovery, and changes that warrants attention. 
This information would be critical in discharge planning, care coordination, referral, and 
strategic planning with family and other caregivers (Duke, 2005; K. E. Covinsky et al., 
2003; Horwitz, 2012; Naylor, Kurtzman, Grabowski, Harrington, McClellan, & 
Reinhard, 2012; Winograd et al.,1988). Education and evidence-based policies and 
procedures for symptom management, palliative care, and end-of-life care is needed to 
facilitate appropriate goal setting in later stages of frailty (Gill, Gabhauer, et al., 2010; 
Nicholson, Meyer, Flatley, Holman, & Lowton, 2012; Raudonis & Daniel, 2010). 
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Interdisciplinary communication and collaboration is essential in the care of 
hospitalized frail adults. The complex, multidimensional nature of frailty compels 
dynamic interaction among care providers. Interdisciplinary team members perform 
discipline-focused standardized assessments that yield crucial information about health 
status, and actual and potential problems. However, th se focused assessments may not 
fully capture the BPSS vulnerability associated with frailty. Frailty assessment initiated 
by the RN that integrates interdisciplinary assessment data would provide a 
comprehensive database for risk stratification and t rgeted prevention and intervention.  
A critical element of RN leadership would be to facilitate interdisciplinary 
communication, care coordination, and discharge planning to facilitate optimal inpatient 
care and appropriate transitions in care and referral. Nursing models to  enhance quality 
of care require nursing leadersip to ensure collaborative interdisciplinary teamwork in the 
care of frail elderly (E. Chang, Hancock, Hickman, Glasson, & Davidson, 2007; Duke, 
2005; Fitzpatrick, Salinas, et al., 2004; Winograd et al.,1988 ). Models of care to improve 
geriatric care in hospital settings such as NICHE (Nurses Improving Care of 
HealthSystem Elders), ACE (Acute Care for Elders) units, and the use of standardized 
geriatric syndrome assessment tools in clinical care h ve slowly been adopted by health 
systems (Boltz et al., 2008a, 2008b; Counsell et al., 2000; Jayadevappa, Bloom, Raziano, 
& Lavizzo-Mourey, 2003; Mezey et al., 2004; Mezey & Mitty, 2011; Palmer, Counsell, 
& Landefeld, 1998; Panno, Kolcaba, & Holder, 2000). These program initiatives have 
demonstrated improvements in quality of care and outcomes for older adults but 
widespread adoption has been slow and sustaining programs difficult. RN leadership at 
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all levels of the organization is critical in initia ng and sustaining these models. Proactive 
engagement with interdisclinary team members could improve the quality and 
sustainability of these programs. By taking an active role in monitoring systematic and 
consistent implementation and evaluation of frailty assessment and care delivery, nursing 
provides a valuable linkage for interdisciplinary teamwork that could hasten recovery and 
reduce hospital-acquired adverse events, poor outcomes, length of stay and readmission 
(Barba & Gendle, 2006;  Lekan et al., 2010; McConnell et al., 2009; Pfaff, 2002; 
Winograd et al.,1988). 
Research 
Further research is needed using advanced analytic procedures such as factor 
analysis, correspondence analysis, and other models to valuate the frailty components 
and indicator variables for the Frailty Score. Additional demographic and BPSS variables 
should be examined as frailty components. Development and testing of frailty screening 
tools and multidimensional frailty assessments for th se who screen positive is needed 
(Rockwood & Bergman, 2012). Before widespread use, validation of these instruments 
should be conducted in hospital settings that vary by size, ownership, location, service 
population, nursing practice models and staffing, and medical, surgical, and specialty 
services (Perera et al., 2010). The value of geriatric nursing expertise  and role the 
clinical nurse specialist should be evaluated (Boltz et al., 2008a; 2008b; Fitzpatrick, 
Salinas, et al., 2004; Fulmer et al., 2002; Mezey et al., 2004). 
The relative contribution of each biomarker as a comp nent of the Frailty Score 
requires further analysis. Research is needed to determine the added value of CRP or hs-
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CRP in frailty assessment since it is not commonly rdered in hospitalized adults. 
Consensus conferences and research have yet to idenify which biomarkers, number of 
biomarkers, or combination of biomarkers best characte ize frailty in hospitalized adults 
who are acutely ill. Inclusion of other biomarkers such as creatinine, fasting glucose, 
glycosylated hemoglobin, lipids (cholesterol, LDL, HDL, lipid ratios), cortisol, 
epinephrine, norepinephrine, and others that are associated with chronic inflammation, 
malnutrition, and frailty should be considered in light of their relevance, feasibility, and 
cost in the hospital setting and any potential burden to patients.  
In this study, the abnormal flag for biomarkers was used as a categorical variable 
in analyses. Prior research in community medically-stable older adults examining 
multiple biomarkers found that even marginally abnormal values above or below the 
reference was predictive of frailty as the numbers of marginally abnormal biomarkers 
increased (Gruenewald et al., 2006; Puts et al., 2005). A larger aggregate of marginally 
abnormal biomarkers signaled an increased level of global physiologic instability and 
vulnerability. In hospitalized acutely ill adults, the use of abnormal flags for biomarkers 
may not be sufficient. Thus, future research should analyze plasma values to determine if 
there are thresholds that more precisely differentiate risk. 
Longitudinal research is needed to describe the etiologies, precursors, risk factors, 
natural history, and trajectories of frailty in hospitalized adults 55 years of age and older. 
A better understanding is needed about subtypes or dimension of frailty and differences 
in frailty trajectories in hospitalized adults experiencing acute illness, surgery, and BPSS 
stressors (Puts et al., 2005; Sarkisian et al., 2008; Sourial et al., 2010). This would help 
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determine the most appropriate assessments and interve ions and when they are most 
likely to be effective (Cesari, 2011b; Newman et al., 2001; Whitson et al., 2007). Future 
studies should assess pre-hospital BPSS status and frailty on admission, during 
hospitalization, and post hospitalization. Investigation of health system processes that 
contribute to prevalent and incident frailty is need d. 
Research on educational and clinical practice improvement models to disseminate 
knowledge about frailty in hospitalized adults is needed. The proportion of hospitalized 
adults who are 65 years of age and older has increased over the past few decades and is 
estimated at over 50% with higher rates on medical units (Sonnenblick et al., 2007). 
Advancing age is accompanied by diversity in comorbidity and BPSS function thus goals 
and treatment should be considered in light of risk for frailty and geriatric syndromes. 
Preventing frailty, functional decline, and geriatric syndromes requires a workforce with 
geriatric expertise which is insufficient in many hospital settings (Mezey et al., 2004; 
Mezey & Fulmer, 1998). Research on methods and models for interdisciplinary 
collaboration to address frailty and geriatric syndromes is needed since the inter-
relationships of these conditions require interdisciplinary expertise (Conroy, Stevens,  
Parker, & Gladman, 2010). 
Qualitative and mixed methods studies are needed to xplore perception of frailty 
and its natural history in hospitalized adults from the perspective of frail individuals and 
health care providers (Nicholson, Meyer, Flatley, & Holman, 2012; Lindhardt, Hallberg, 
& Poulsen, 2008). Much of the qualitative research on frailty is from disciplines related 
to, gerontology, medicine, women’s studies, anthropol gy, social sciences, and 
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psychology (Becker, 1994; Chater, 2002; Gealey, 1997; Gray, 1998; Grenier, 2002; 
Greneir & Hanley, 2007; Jett, 1994; Kaufman, 1994; van Kempen et al., 2012). Nursing 
research on frailty is desperately needed since nurses are frontline care providers in 
frequent contact with frail adults across care settings. Little is known about effective 
nurse caring behaviors for frail adults (Erlen, 2007; Gealey, 1997; Lekan, 2009; 
Lindhardt et al., 2008). Care preferences at different stages of frailty need to be explored 
with frail adults and caregivers as indicated. Nursing research is needed since little is 
known about how nursing can anticipate needs and negotiate discussions about cae 
preferences. There is evidence that frail older adults need support in maintaining the 
balance of accumulated losses and sustaining and creating new ways to maintain 
connections between personal experience and routines, social relationships, and the 
environment (Becker, 1994; Nicholson, Meyer, Flatley, & Holman, 2012; Nicholson, 
Meyer, Flatley, Holman, & Lowton, 2012). Home care focused on psychosocial issues 
and person-centered care instead of medical treatment and cure promotes better provider-
client relationships and quality of life as frailty progresses (Horowitz, 1985; Nicholson, 
Meyer, Flatley, Holman, & Lowton, 2012; van Kempen et al., 2012).  
There is evidence of stigma associated with the diagnostic label of frailty (Becker, 
1994; Chater, 2002; Fillit & Butler, 2009; Gray, 1998; Grenier, 2002; Grenier & Hanley, 
2007; Jett, 1994; Kaufman, 1994; Palmore, 2004). Qualitative research describes aversion 
to the term frailty or frail when that label is used to by health professionals to describe 
that person’s health status. Studies report  discordance between health professional 
perspectives of frailty and perspectives held by persons who have consciously made 
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lifestyle adaptations to diminishing resilience and function. The over-medicalization of 
frailty has been cited as a barrier to productive discssions about living well in the context 
of  frailty and associated morbidity, disability, and symptoms.  Nursing research is 
needed to determine how socially constructed meanings about frailty that conflicts with 
personal experience have an impact on health status, lifestyle behaviors, and emotional 
well-being that influence risk for frailty (Becker, 1994; Chater, 2002; Gray, 1998; 
Grenier, 2002; Kaufman, 1994). Such research would address a void in the literature 
about best practices at different stages of frailty nd reframe perspectives to facilitate 
person-centered care and interventions that focus on personal goals, caregiving and 
treatment preferences, symptom management, and discuss ons about what constitutes a 
good death (Gallagher, 2013; Kehl, 2006; Raudonis, & Daniel, 2010). 
Research is needed to articulate the leadership role of the RN in frailty assessment 
and in facilitating interdisciplinary communication, collaboration, and care coordination 
(Fulmer et al., 2002; Lekan et al., 2010; Pfaff, 200 ). Incorporation of frailty assessment 
in the nursing process and using the EMR data in collab ration with the interdisciplinary 
team more strategically would improve patient and organizational outcomes.  
Public Policy  
 Frailty has entered the national health care agenda. As part of the Affordable Care 
Act, the CMS issued guidelines focused on reducing unplanned, preventable hospital 
readmissions that are linked to benchmarking of hospital performance and penalties that 
reduce payment to hospitals with excess readmission (CMS, 2012a, 2012b; Kautter et 
al., 2008–2009). Hospital’s readmission performance is compared to the national average 
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for patients with certain conditions adjusted for patient demographics, comorbidities, and 
patient frailty (CMS, 2012b). Based on prior work with risk models used for Managed 
Care Organizations such as PACE, CMS determined that diagnosis-based risk 
adjustments do not provide the most accurate prediction of expenditures associated with 
care of frail elderly. CMS defines frailty in terms of functional impairments with a focus 
on ADL function (Kautter et al., 2008–2009). CMS acknowledges frailty research that 
describes the biologic, phenotype of frailty and its clinical features of weight loss, 
weakness, fatigue, inactivity, low nutrient, sarcopenia, abnormal gait and balance, and 
decreased bone mass. Although CMS recognized the complexity of the frailty syndrome, 
ADL function was determined as the primary element in risk adjustment formulas based 
on prior research on its validity in risk models. CMS regulations levy fiscal penalties for 
preventable events that occur during hospitalization and for 30-day readmission. Since 
level of frailty is part of the risk adjustment formula, mobilization of resources to define 
frailty that adheres to CMS guidelines and incorporates additional evidence-based BPSS 
predictors to address multidimensional aspects of frailty, especially those amenable to 
intervention, would enhance quality of care. Frailty definition should not be limited to 
chronologic age as defined by CMS (65 years of age and older), given findings from the 
present study and other literature on frailty in adults under 65 years of age. 
Stipulations in the Affordable Care Act related to the Hospital Readmissions 
Reduction Program  for three chronic conditions (heart failure, pneumonia, acute 
myocardial infarction) may have unintended consequences for older adults who need 
long term health and social services and other supports. Although designed to reduce 
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fragmented care and poor communication and improve transitions in care for chronic 
disease management, Naylor et al. (2012) found that the provisions in the Affordable 
Care Act inadequately addressed the unique needs of subgroups of vulnerable elders. 
Frail older adults experience fluctuations in health status, have multiple providers, and  
undergo frequent transitions in care (hospital, home health, rehabilitation, nursing home). 
There is lack of integration and inadequate numbers and types of community resources to 
meet the needs of chronically ill older adults. In contrast, an unintended consequence is 
that since only three diagnoses are subject to the 30-day readmission penalty, readmission 
for other diagnoses is likely to continue since reimbursement from these admissions more 
than offset the fiscal penalty. Naylor and colleagues (2012) recommend that policy 
makers anticipate unintended consequences and advance p yment policies that integrate 
care and support providers in implementing evidence-based transitional care practices 
and integrate measurement and reporting requirements into performance systems. The 
primary goal is for older adults to achieve better h alth outcomes through a more rational, 
organized, and integrated health system that promotes stability in chronic disease 
management and reduces costs due to preventable health care resource utilization. 
An important policy issue is for frailty to be designated an ICD-10 code with 
diagnostic criteria. Failure-to-thrive (FTT) has an ICD-9/10 code, although this condition 
lacks substantive research and is poorly defined. The code for FTT may be used by 
default for frailty. An ICD-10 code for frailty is needed so health care providers can 
provide an accurate diagnostic label in order to asses  the health status of populations and 
track clinical data at the individual and aggregate lev l. Administrative databases could 
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also track financial data related to frailty within health care settings and across the health 
system to monitor resource utilization, care processes and quality, costs, and other  
outcomes.  
National and local initiatives are needed to develop information technology 
systems to integrate frailty assessment, risk stratification, and primary and secondary 
prevention and treatment into the EMR with decision-prompts to facilitate adoption of 
best practices for optimal patient and system-level outcomes. Using informatics 
technology, decision trees, and algorithms to synthesize information from frailty 
assessment would facilitate the use of relevant information from interdisciplinary 
assessments and contribute to development of evidence-based care plans for frail adults. 
Methods for data tracking and analysis would permit ti ely appraisal of clinical 
information that could guide care management and early detection of untoward events.  
Chapter Summary 
 Frailty was examined in this cross-sectional, descriptive, retrospective study in 
278 hospitalized adults 55 years of age and older amitted to an internal medicine, 
cardiology, or orthopedic unit at a large academic edical center. Frailty was 
characterized by a Frailty Score consisting of 14 evidence-based frailty components 
defined by 26 indicator variables from data available in the EMR. The majority of frailty 
research has been conducted in medically-stable community-living older adults. There is 
scarce research on frailty in acutely ill hospitalized adults.  
In the present study, the Frailty Score mean and rage was similar across age 
tertiles with a modest increase in the Frailty Score with age. Frailty indicators were 
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identified in midlife adults not expected to be at risk for frailty or to be frail. Thus, a need 
exists to examine frailty in hospitalized adults 55 years of age and older to enhance early 
detection, primary and secondary prevention, and palliative and end-of-life care, and 
facilitate appropriate transitions in care.  
Most definitions of frailty describe it as a geriatc syndrome that evolves as part 
of the aging process, manifests in the aged who have medical problems and/or disability, 
and frequently occurs in the very old and terminally ill. Clinicians report that frailty is 
often readily observable based on intuitive, subjectiv  assessment (Rockwood et al., 
2005; Studenski et al., 2004). In this study, few physicians documented a diagnosis or 
clinical impression of frailty, or the related construct, failure-to-thrive. These terms often 
described the fragile appearance and tenuous health st tus of an older patient. That a high 
number of frailty components were identified in adults 55 to 64 years of age contrast with 
prevailing conceptions of frailty as a geriatric syndrome that affects the very old. 
In the present study, frailty was defined using multidimensional, BPSS 
components. The integration of multiple domains of human functioning in the 
conceptualization of frailty underscores the inter-relatedness of these domains in health 
and illness and the complexity introduced by aging changes, multiple morbidity, 
symptoms, and functional limitations (Abellan van Kan et al., 2010; I. Brown et al., 1995; 
Ferrucci et al., 2004; Gobbens et al., 2010c; Rockwod & Bergman, 2012). This view is 
gaining greater acceptance in comparison to the two dominant frailty definitions, the 
biologic model (Fried, Tangen, et al., 2001) and the deficit accumulation model 
(Rockwood & Mitnitski, 2011), which are more challenging to implement and provide 
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limited guidance for frailty prevention and intervention. Consensus conference 
recommendations and expert opinion encourage clinicians to “look at patients as whole 
people and not just as a single illness” (Rockwood & Bergman, 2012, p. 35). This 
perspective is relevant to care delivery in hospital settings since patients are admitted for 
a primary problem and assigned a primary service yet it is unlikely that only one medical 
problem will require monitoring and intervention. Istability in one physiologic area 
begets instability across body systems. Given the study sample characteristics that point 
to high acuity and complexity of care, the role of nursing in assuming leadership in frailty 
assessment and interdisciplinary team communication, c llaboration, and care 
coordination is compelling in order to effectively and favorably impact health status 
outcomes, hospital length of stay, and readmission.  
In this study, the Frailty Score was significantly associated with longer length of 
stay but not 30-day hospital readmission. Although research indicates that frailty status is 
significantly associated with longer length of stay, data about admissions from dependent 
care settings such as skilled nursing facilities and ssisted living were not analyzed. 
Research indicates that this population has higher hospitalization and readmission rates 
compared to independent living older adults (Fried & Mor, 1997; Ouslander & Berenson, 
2011). The study sample was constructed to include admissions that had laboratory data 
for four biomarkers related to inflammation, malnutrition, and frailty. These criteria may 
differentiate this sample as more acutely ill and vulnerable to longer length of stay.  
Research indicates that many unplanned hospital readmissions are preventable 
(Dasgupta et al., 2009; Hilmer, Perera, et al., 2009; Ingold et al., 2000; Jencks, Williams, 
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& Coleman, 2009). Reasons for hospital readmission were outside the scope of this study. 
Many factors influence hospital readmission: new acute illness, chronic disease 
exacerbation, lack of effective discharge planning a d follow-up, discharge before 
medically stable, no access to a primary care provider, and lack of preparedness of 
caregivers in the home or dependent care setting to recognize significant change in the 
patient’s condition so the provider can be notified, treatment initiated, and hospitalization 
prevented (Fried & Mor, 1997; Ouslander & Berenson, 2011).  
The present study was a preliminary descriptive invstigation of frailty in 
hospitalized adults 55 years of age and older admitted to medicine services to address a 
lack of scientific knowledge and substantive research to guide practice in this setting at a 
time when the demographics of the U.S. aging population predict increased health care 
needs and utilization. Translation of existing knowledge and frailty assessment tools from 
research conducted in medically stable, community-living older adults to acutely ill 
adults in the hospital setting has limited utility and questionable validity and presents 
barriers to implementation in practice. The present tudy incorporated validated frailty 
components and biomarkers to characterize a sample of hospitalized adults where higher 
Frailty Scores were documented across age tertiles. There is ample evidence from this 
study for continued investigations to identify components of a clinically-relevant, 
practical, and feasible frailty assessment instrument for use in clinical practice that 
considers the unique characteristics of acutely ill hospitalized adults. 
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